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 I
The evolution of venom, nature’s most complex concoction, has underpinned the predatory 
success and diversification of numerous animal lineages. Slithering serpents to buoyant jellyfishes 
employ venom, a cocktail of pharmacologically active peptides, salts, organic molecules such as 
combination thereof. These astonishing predators have fascinated humans since millennia. Injection 
of even miniscule amounts of some of these toxin proteins can breakdown and paralyse prey-animals 
within minutes. Despite the fact that most of these animals use sophisticated warning behaviours to 
avoid close encounters, millions of people die every year worldwide from accidental envenoming by 
various species. It is estimated that nearly four million people suffer envenoming by various species 
every year and over 125,000 succumb to its fatal effects. Bites from certain organisms (e.g. many 
species of viperid snakes, spiders, etc.) can induce haemolysis, myolysis and/or necrosis and can 
inflict permanent damage. Frequent bites from these animals, in both developed and developing 
countries, accentuate the importance of venom research. Inter and intraspecific variations in venom 
composition, driven by factors like geography, diet, phylogenetic history, predator pressure, etc., 
complicate the production of effective antivenom. Therefore, understanding the genetic basis of 
the diversification of venom-encoding genes across various vertebrate and invertebrate venomous 
animal lineages can provide fundamental biological insights about species evolution, ecological 
specialization, and genetic novelties which may be of major importance for antivenom and drug-
discovery research.
This thesis not only focuses on unravelling the true biological diversity of venom-components 
in the animal kingdom, but also aims to examine their complex molecular evolutionary histories 
and the forces (geography, diet, arm’s race, influence of natural selection, etc.) that sculpt them. As 
part of my doctoral research, I not only studied a vast majority of venomous animal lineages, such as 
scorpions, spiders, centipedes, cone snails, coleoids (octopus, sepia and cuttlefish), lizards, snakes and 
mammals (vampire bats), but also their non-toxic homologues in non-venomous lineages, such as 
turtles, crocodiles, birds and mammals. I further reconstructed the molecular evolutionary histories 
of a plethora of venom-components: cysteine-rich secretory protein (CRiSP), three-finger toxin 
(3FTx), phospholipase A2, nerve growth factors (NGF), snake venom metalloproteinase, serine 
protease, Kunitz protease inhibitor, natriuretic peptide, helokinestatin, crotamine/b-defensins, 
lectin, Kallikrein, pacifastin, L-amino acid oxidase, veficolin, epididymal secretory protein, 
cystatin, pituitary adenylate cyclase-activating polypeptide, desmallipins, plasminogen activator, 
hyaluronidase, etc.]. I have also evaluated the regime of evolution followed by their  non-venomous 
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homologues, like CRiSP, NGF, brain-derived neurotrophic factor (BDNF), neurotrophin-3 
(NT-3), scorpion venom single von Willebrand factor C-domain peptides (SV-SVCs), etc. These 
studies evaluated the molecular evolutionary histories of venom-components using state-of-the-art 
methodologies, and enabled the identification of common evolutionary mechanisms permitting 
the adoption (and subsequent diversification) of the venom protein arsenal from non-toxic 
physiological proteins. Research carried out as part of this thesis further revealed several interesting 
evolutionary mechanisms. Main highlights include: i) most predatory venom components evolve 
rapidly under the influence of positive selection; ii) venom-components that employ a non-specific 
mode of toxic action do not experience co-evolutionary arms race and hence do not evolve rapidly; 
iii) most predatory venom components evolve through RAVER (Rapid Accumulation of Variations 
in Exposed Residues); iv) venom varies depending on ecological factors such as the diet of the 
species; v) venom can vary intraspecifically, along the species distribution range; vi) venom in 
distantly related animal lineages have been influenced by similar evolutionary mechanisms and lead 
to the origination of convergently evolved molecular scaffolds with similar targets; vii) only state-
of-the-art selection assessment methodologies can unravel the episodic nature of natural selection 
on invertebrate venom-encoding genes that have evolved over long periods of evolutionary time, 
relative to their vertebrate counterparts, and have relatively shorter generation times.
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 A evolução do veneno, uma das mais complexas misturas da natureza, tem sustentado o 
sucesso da diversificação de inúmeras linhagens de animais predadores. Serpentes deslizantes a 
medusas flutuantes utilizam veneno, um cocktail de peptídeos farmacologicamente activos, sais, 
e moléculas orgânicas. Esses predadores surpreendentes têm fascinado os seres humanos desde há 
milénios. A injecção de algumas dessas proteínas tóxicas, mesmo em quantidades minúsculas, pode 
paralisar e aniquilar presas em poucos minutos. Apesar do fato da maioria desses animais usaram 
comportamentos de alerta sofisticados para evitar encontros inoportunos, milhões de pessoas 
morrem por ano em todo o mundo do envenenamento acidental causado por várias espécies de 
animais venenos. Estima-se que cerca de quatro milhões de pessoas sofram envenenamento por várias 
espécies de animais venenosos por ano e mais de 125 mil sucumbem aos seus efeitos fatais. Picadas 
de certos organismos (por exemplo, muitas espécies de cobras viperinas, aranhas, etc) podem induzir 
hemólise, miólise e/ou necrose, podendo causar danos permanentes. Mordidas frequentes destes 
animais, simultaneamente em países desenvolvidos e em desenvolvimento, acentuam a importância 
da pesquisa de venenos. Variações inter- e intra-específicas na composição do veneno, impulsionados 
por factores como geografia, dieta, história filogenética, pressão predatória, etc, dificultam a produção 
de um antiveneno eficaz. Portanto, a compreensão da base genética da diversificação de genes 
que codificam veneno em várias linhagens de animais vertebrados e invertebrados pode fornecer 
informações fundamentais sobre a evolução dessas espécies, especialização ecológica, e novidades 
genéticas que podem ser de grande importância para a investigação de anti-venenos e a descoberta 
de novas drogas.
 Esta tese não só se concentra em desvendar a diversidade biológica dos componentes do 
veneno no reino animal, mas também tem como objectivo analisar as suas histórias evolutivas 
complexas e as forças que o influenciam (geografia, dieta, influência da selecção natural, etc). Nesta 
dissertação foram estudadas a grande maioria das linhagens de animais venenosos, como escorpiões, 
aranhas, centopéias, Conus gastrópodes, coleoides (polvo, sépia e choco), lagartos, cobras, mamíferos 
(morcegos), etc, mas também os seus homólogos não-tóxicos em linhagens não-venenosas, como 
insectos, tartarugas, crocodilos, aves, mamíferos, etc. Foram ainda reconstruídas as histórias evolutivas 
moleculares de uma grande quantidade de componentes do veneno: proteína secretora rica em 
cisteína (CRiSP), toxina de “três dedos” (3FTx), fosfolipase A2, factores de crescimento dos nervos 
(NGF), metaloproteinases do veneno de cobra, serina protease, inibidor da protease Kunitz, péptido 
natriurético, helokinestatin, crotamina/b-defensinas, lectina, calicreína, pacifastina, L-amino ácido 
Resumo

Molecular evolution of venoM
oxidase, veficolina, proteína de secreção do epidídimo, cistatina, polipéptido activador do adenilato - 
ciclase da pituitária, desmalipinas, activador do plasminogénio, hialuronidase, etc. Foi ainda avaliado 
o regime de evolução dos vários homólogos não- venenosas, como CRiSP, NGF, o factor neurotrófico 
derivado do cérebro (BDNF), neurotrofina -3 (NT-3), veneno de escorpião único - factor de von 
Willebrand peptídeos do domínio-C (SV- SVC), etc. Estes estudos avaliaram as histórias evolutivas 
moleculares de componentes do veneno utilizando metodologias estado-da-arte, que identificaram 
mecanismos evolutivos comuns que permitiram a adopção (e subsequente diversificação) do arsenal 
de proteínas do veneno a partir de proteínas fisiológicas não-tóxicas. Os resultados obtidos nesta 
tese revelaram ainda vários mecanismos evolutivos interessantes. Os principais destaques incluem: 
i) a maioria dos componentes do veneno predatório evoluíram rapidamente sob a influência da 
selecção positiva; ii) componentes do veneno que utilizam um modo não-específico de acção tóxica 
não tiveram uma corrida armamentista co-evolutiva e, portanto, não evoluíram rapidamente; iii) a 
maioria dos componentes do veneno predatório evoluem segundo o RAVER (Rápida Acumulação de 
Variações em Resíduos expostos); iv) o veneno varia de acordo com factores ecológicos, como a dieta 
das espécies, v) o veneno pode variar intra-especificamente, ao longo da zona de distribuição das 
espécies; vi) os venenos em linhagens de animais relacionados foram influenciados por mecanismos 
evolutivos similares e levaram à origem de estratégias evolutivas molecular convergentes para fins 
semelhantes; vii) apenas metodologias estado-da-arte para avaliação de selecção podem desvendar 
a natureza episódica da selecção natural em genes codificadores de venenos em invertebrados que 
surgiram há longos períodos de tempo, relativamente aos seus homólogos de vertebrados, com 
tempos relativamente curtos de geração.
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Chapter I
1.1 Introduction to venom and venom research
Venom is defined as ‘a secretion, produced in a specialised gland in one animal and 
delivered to a target animal through the infliction of a wound (regardless of how tiny it may 
be), which contains molecules that disrupt normal physiological or biochemical processes in the 
victim so as to facilitate feeding or defence by the producing animal’ (Fry et al. 2009a; Fry et al. 
2013a). This definition encompasses creatures normally considered venomous (e.g., scorpions, 
snakes, spiders, centipedes) as well as animals that have not been traditionally recognised 
as such (e.g., leeches, ticks, vampire bats, coleoids). Acknowledgement of the evolutionary 
analogy of the recruitment and use of toxins in all these animals increases the number of 
known independent occasions in which venom has evolved independently. In addition, this 
acknowledgement improves our understanding of the factors underlying the evolution of venoms 
and their associated proteins while also drawing attention to the vast pool of unstudied toxins.
Venom has been a key innovation in the evolutionary history of an incredibly diverse 
range of animals. Even using the traditional definition of venom, venom systems are believed to 
have evolved independently on at least twenty occasions in extant lineages (Fig. 1.1). If lineages 
such as ticks, leeches, vampire bats, etc., are rightfully recognised as venomous, the number of 
independent evolutionary events in which venom has originated increases to over thirty. Intriguing 
fossil evidence has also led to speculation about the possibility of extinct venomous lineages 
represented by the theropod dinosaur Sinornithosaurus (Gong et al. 2010), a genus of feathered 
dromaeosaurid dinosaur, and the extinct pantolestid mammal Bisonalveus browni (Gong et al. 
2010). Euchambersia, a genus from the family Therocephalia (ancestral mammalian lineage), are 
known to have had venom glands attached to their canine teeth. Hence, they have been theorized 
to have used venom for predation in the Late Permian epoch 250 million years ago. The extant 
venomous organisms belong to a vast variety of lineages, such as arthropods (scorpions, spiders, 
centipedes, bees, wasps, caterpillars of certain moths - Lonomia), cnidarians (jellyfish, anemone), 
molluscs (cone snails, squid, cuttlefish, octopus), fishes (sharks, stingrays, pufferfish, chimaeras, 
teleost fishes like catfish, stonefish, scorpionfish, lionfish, surgeonfish, rabbitfish, onejaws, etc.), 
amphibians (certain species of salamanders with sharp ribs for injecting venom), mammals 
(vampire bats, certain species of shrews, male platypus, slender loris), snakes (cobras, kraits, 
vipers, the so called ‘non-venomous’ snakes), lizards (monitor lizards, helodermatid lizards), etc.
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Figure 1.1 Venomous lineages in the Animal kingdom
Adapted from (Casewell et al. 2013) with permission.
Legend: Schematic tree of venomous life in the animal kingdom. The tree demonstrates the 
evolutionary relation between animal lineages and highlights the frequency with which venom systems 
are found in the animal kingdom. Colored branches highlight major animal lineages that include 
members with venom systems. Red branches indicate a predatory role for venom, blue a defensive role, 
and green a role in intraspecific competition. The phylogeny is based on the tree of life presented in 
Pennisi (Pennisi 2003). Note that several animal lineages have been pruned from the tree to facilitate 
presentation. Animal lineages studied during the course of my PhD are highlighted in red font.
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A diversity of envenoming machineries have been independently invented by a plethora 
of venomous lineages in the animal kingdom (Fig. 1.2). While both wasps and bees are 
known to use their stingers for delivering painful toxins for defence, certain species of wasps 
can additionally use potent venom for predation or for depositing eggs in their paralysed host 
animals. Larvae of certain species of moths from the genus Lonomia are covered with urticating 
bristles that deliver powerful toxins capable of causing haemolysis, renal failure, haemorrhage and 
ultimately death. The potency of venom varies from species to species in these moths. Scorpions 
on the other hand use their telson or the stinger, located at the base of their tail (metastoma) 
for delivering venom. All scorpions are predatory and rely on their venom for prey-subjugation 
and defence. Spiders use their fangs, the ends of chelicerae or mouth parts, for injecting 
venom into prey-animals. In contrast, centipedes have modified the first pair of walking legs 
into venomous appendages called forcipules/poison claws/maxillipids, for injecting venom.
Within the toxicofera reptilian clade, venom was a single ancient innovation: iguanian and 
anguimorph lizards share a common venomous ancestor with snakes (Fig 1.1; Fry et al. 2006). 
However, in Iguania, venom glands develop only to an incipient stage and are known to have 
very little ecological relevance. In contrast, in anguimorph lizards, such as monitor lizards and 
Gila monsters, the mandibular venom glands are encapsulated and compartmentalized, while the 
maxillary glands are developmentally suppressed (Fig. 1.2; Fry et al. 2006). Snakes, however, possess 
highly developed but non-compartmentalised maxillary venom glands, while their mandibular 
glands are developmentally suppressed. There is a tremendous diversity of fang and venom gland 
morphologies in the advanced snakes (Caenophidia) that arose from the dental uncoupling in the 
ancestral lineage (Fry et al. 2008; Vonk et al. 2008). Even within the advanced snakes, at least four 
distinct lineages have derived at least four different types of fang architecture (Lamprophiidae family: 
Atractaspis and Homoroselaps genera; Elapidae and Viperidae families). Elapidae and Viperidae 
possess intricate hollow-front, fanged, and high-pressure delivery systems (Fig. 1.2; Fry et al. 2008).
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Figure 1.2 Venom delivery systems
Adapted from (Lewis and Garcia 2003) with permission.
Legend: Venom delivery apparatus (harpoon, nematocyst, teeth and sting) in the animal kingdom.
Molecular evolution of venom
The major goal of the modern molecular evolutionary biology is the identification and 
understanding of the forces of natural selection that shape genetic diversity of life. Although 
mutation is considered as the ultimate source of all genetic variation, it is by far the weakest 
of the evolutionary forces and by itself cannot rapidly change the frequency of the mutants in 
a population. This is because mutation rates are not high in all genes and in all organisms and 
without the influence of natural selection, reverse mutations could nullify the effect of primary 
mutations. Thus, the observed differences in genes are unlikely to result from mutations alone. 
Mutation generates multiple genetic variants in a population, and the existence of such genetic 
variability is termed polymorphism. However, genetic polymorphisms do not persist indefinitely 
and new mutations eventually succumb to one of two evolutionary fates: (i) increase in frequency 
and eventually get ﬁxed in the population or (ii) elimination from the population. The probability 
that a recently generated mutation is ﬁxed or eliminated depends on two factors: (i) the degree 
to which the mutation increases or decreases the fitness of the individual and (ii) the size of the 
population concerned, typically denoted the letter ‘N’. Beneﬁcial or advantageous mutations are 
those that increase an individual’s ﬁtness relative to the wild-type (invidviduals with the plesiotypic 
sequence), whilst deleterious mutations decrease relative ﬁtness, and neutral mutations have no 
appreciable ﬁtness effect. In population genetics this property of a mutation is quantiﬁed as ‘S’ 
selection coefﬁcient, which is positive for beneﬁcial mutations, zero for neutral mutations, and 
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negative for deleterious mutations. The vast majority of mutations are deleterious to some extent, 
and through careful experimentation it has been possible to estimate selection coefficients for some 
organisms (Crill et al. 2000). The recent advancement in sequencing technology has generated 
tremendous genomic sequence data which in turn has facilitated improvements in the estimation 
of mutational effects on the fitness of the organism (Nielsen et al. 2005). Natural selection could 
either increase the frequency of a beneficial mutation until it becomes ﬁxed in the population 
(positive selection), or could decrease the frequency of a deleterious mutation until it is eliminated 
from the population (negative selection). Selection pressure that does not affect the frequency of 
neutral mutations is known as neutral selection. The greater the selection coefﬁcient of a mutation 
– either positive or negative – the more rapidly the mutation frequency will change. In contrast, 
the effect of genetic drift (neutral selection) is to cause the frequencies of all types of mutations 
to ﬂuctuate randomly through time, with no net tendency towards increase or decrease, until 
the mutations become either ﬁxed or eliminated. The size of the random ﬂuctuations is greater 
if ‘N’ is small and lesser if ‘N’ is large. Genetic drift originates in the absence of other forces of 
selection (positive or negative). Under this scenario, each member of a generation is equally likely 
to be the parent of any member of the subsequent generation and the random sampling effect this 
creates is greater if the number of potential parents involved is smaller. Although these ﬂuctuations 
are very small in large populations, they are still of critical importance, because new mutations 
begin at very low frequencies (i.e., in single individuals) and are therefore highly susceptible to 
elimination by the tiniest of random effects. Hence most mutations, whether beneﬁcial or neutral 
or deleterious, are swiftly lost in populations large or small. Another important consequence of drift 
is that it takes much longer for a newly generated mutation to reach ﬁxation by genetic drift than 
by selection; in the simplest of cases, it takes on average 4N generations for a neutral mutation to 
be ﬁxed via drift in a diploid population (or 2N generations in a population of haploid individuals).
Understanding the nature of selection shaping the molecular diversity of venom is not 
only intriguing from an evolutionary point of view, but is vital from a therapeutic purpose as 
well. Millions of people die worldwide, in both developed and developing countries, as a result 
of envenoming by various animals. Insights into the molecular evolution of venom-components 
is essential for developing antivenom of greater efficacies. Moreover, venoms are enriched with a 
plethora of bioactive components that have evolved over millions of years of evolutionary time to 
target specific molecular receptors in prey animals. As a result, venoms are also viewed as a great 
resource for the discovery of novel drugs. The scientific consensus is that the evolutionary selection 
pressure upon defensive venoms (e.g., fish and bee venom) are largely directed at the development 
of streamlined venom, with the primary action of immediate, intense localised pain (Church and 
Hodgson 2001; Peiren et al. 2005; de Graaf et al. 2009). In contrast, predatory venoms are shaped 
by a classic co-evolutionary arms race, where evolving venom resistance in prey and the evolution 
of novel venom composition exerts reciprocal selective pressures on one another in a situation 
that conforms to the Red Queen hypothesis of Van Valen (Valen and Van Valen 1973). Powerful 
purifying selection pressures acting on predatory venoms for millions of years have resulted in highly 
complex modern venom arsenals that consist of a diversity of potent compounds with exquisite target 
specificity. Variation in venom composition is not only observed between different lineages, but also 
between the closely related species within a clade (Mackessy 2010). Intraspecific variation in venom 
composition often originates as a result of the evolution of prey-specific toxins in species with 
specialised diets (Jorge da Silva et al. 2001; Barlow et al. 2009). Significant variation in venom profile 
has even been demonstrated within individual species with widespread geographical distributions 
(Calvete et al. 2010). Venom can also vary intraspecifically as the result of numerous other factors, 
including sibling differences (Menezes et al. 2006), ontogenic changes in prey-preference (Andrade 
and Abe 1999) or behaviour. In Sydney funnelweb spiders (Atrax robustus), juvenile male spiders 
and female spiders of all ages have similar insecticidal predatory venoms, whilst sexually mature 
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males (who stop feeding and leave the burrows in search of females) have a vertebrate-specific 
defensive venom (Sutherland and Tibballs 2001). It is this adaptive complexity and innovation 
that makes predatory venoms ideal candidates for the discovery of therapeutic lead compounds.
Molecular diversity of venom
Venoms are enriched with a diverse array of different peptides, many of which are bioactive (Fig. 
1.3). Cone snail venoms for example have an enormous diversity of small peptides (conotoxins and 
conopeptides), which have evolved in around 500 species of fish-,mollusc- and worm-hunting cone 
snails for rapid prey paralysis and defence. They are extremely important pharmacological probes, 
due to their small size, relative ease of synthesis, structural stability and extreme target specificity. It 
is estimated that >50,000 conopeptides exist, but <0.1% have been characterized pharmacologically. 
Of those characterized to date, a surprising number have been found to be highly selective for a diverse 
range of mammalian ion channels and receptors associated with pain signalling pathways, including 
the nicotinic acetylcholine receptors (α-conotoxins), the noradrenaline transporter (χ-conopeptides), 
sodium channels (µ- and  µ O-conotoxins), calcium channels (ω-conotoxins), the N-methyl-D 
-aspartate (NMDA) receptor (conantokins) and the neurotensin receptor (contulakins) (Lewis and 
Garcia 2003). Although cone snails are not the only species that produce toxin peptides, those found 
in spiders, snakes, sea anemones and scorpions are usually of larger size. Venom peptides need to be 
sufficiently stable to survive chemical degradation in solution at ambient temperature and enzymatic 
degradation by processing proteases present in the venom itself, as well as those in the tissues of prey 
species. This stability is often achieved naturally through the use of post-translational modifications 
(PTMs) and/or disulphide bonds which fold the peptide into a stabilized structure. Typical PTMs 
include amidation (C-terminal), sulphation (Tyr), bromination (Trp), glycosylation (Thr), γ 
-carboxylation (Glu), hydroxylation (Pro), pyroglutamation, N-C-cyclization and isomerization to 
D -amino acids. Specific enzymes are used during the production of venom peptides to introduce 
these modifications at specific locations, which can enhance peptide bioavailability and potency in 
addition to stability. Despite these modifications, venom peptides are not always optimal for all 
requirements associated with potential therapeutic applications. Issues surrounding the therapeutic 
use of peptides include formulation, cost of production, stability, selectivity and mechanism of 
action. Chemical synthesis of analogues allows structure–activity relationships to be developed that 
can guide the coordinated optimization of these features. As part of this process, optimised oxidation 
conditions need to be established to favour the correct formation of disulphide bonds after synthesis.
 33
Chapter I
Figure 1.3 Diversity of venom-components in the animal kingdom
Legend: Three-dimensional models of various venom-components in the animal kingdom are 
presented. Secondary structures are highlighted and disulphide bonds are presented as yellow sticks.
Convergent evolution of venom
The majority of venom components have evolved to target physiological systems reachable by 
the bloodstream. In particular, the neurological and haemostatic systems have been convergently 
targeted via a myriad of innovative pathways (Fig. 1.4) (Fry et al. 2009a). A consistent feature of 
venom proteins is a stable molecular scaffold of cross-linked cysteines (Fry 2005); this characteristic 
appears to facilitate modification of non-structural residues, which in turn facilitates protein 
neo-/sub-functionalisation. A remarkable degree of convergence exists not only in terms of the 
choice of the molecular toxin scaffold, but also in target specificity and bioactivity (Fry et al. 
2009a). Superimposition of sequences from functionally-convergent toxins reveals tremendously 
useful information regarding structure-function relationships. An example of this is the platelet-
aggregation inhibiting RGD tripeptide motif. This motif has been independently derived on 
numerous occasions within a myriad of distinct protein scaffolds, ranging from snakes (two different 
occasions: disintegrins and three finger toxins) to a wide variety of invertebrate species, including 
ticks (e.g., Ixodes sp., Argas sp., Rhipicephalus sp., Amblyomma sp.), tabanid flies (e.g., Tabanus sp.), 
true bugs (e.g., Triatoma sp., Rhodnius prolixus), mosquitoes (e.g., Anopheles sp., Aedes sp., Culex sp.), 
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sand flies (e.g., Lutzomyia sp., Phlebotomus sp.), leeches (e.g., Macrobdella sp., Placobdella sp.), worms 
(e.g., Ancylostoma sp.) etc. (Fry et al. 2009a; Assumpcao et al. 2012). This reinforces the fact that 
biological targets within prey animals are the primary drivers of the evolution of toxin structures.
Figure 1.4 Convergent evolution of venom
Adapted from (Fry et al. 2009a) with permission.
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Legends: (a) Sites of convergent haemotoxic toxin activity are displayed and are represented 
by numbers (1–9). Each number represents a different physiological target that is targeted 
convergently by different toxins present in different venomous lineages or in the same venomous 
lineage. Toxin names and animal lineages acting on each target are listed below each numbered 
legend, with pictures of the venomous lineages relating to the key at the bottom of the figure. (b) 
Sites of convergent neurotoxic toxin activity are displayed and are represented by numbers (1–7).
1.2 Importance of venom research
Natural compounds have been utilised for medicinal purposes since ancient time. The majority 
of commercial drugs being used today in both developed and developing countries are based on 
natural products. Most of these products are based upon plants, but research into animal venoms 
holds great potential for the discovery of novel medicinally-useful natural products. In addition 
to aiding in defence against predators, the toxic secretions of venomous organisms, which have 
evolved over millions of years of evolutionary time, induce paralysis and systematic breakdown 
of homeostasis in prey animals. As a result, a remarkable arsenal of biochemical weaponry has 
originated, including toxins with astonishing specificity and affinity for various types of cells and 
receptors, particularly those that participate in vital physiological pathways. Hence, animal venom 
has been perceived as rich source of novel biochemical compounds for use in drug design and 
development. Modern toxinological research, although biased towards a narrow range of taxa, 
has focussed on utilising this exquisite biochemical arsenal, not only in elucidating the intricate 
biological pathways but also to aid in the development of lifesaving pharmaceutical drugs (Table 
1.2). A major limitation of the use of venom proteins thus far has been the very narrow taxonomical 
range studied. Entire groups of venomous animals remain virtually ignored. Those that have been 
examined have apparently been selected due to their medical significance or ease of collection, 
rather than as a result of their ecological or evolutionary uniqueness. Understanding the complex 
evolutionary mechanisms shaping different venom components is essential for the development of 
extremely effective drugs. A multidisciplinary approach, spanning methods such as transcriptomics, 
proteomics, bioactivity testing and molecular evolution analyses has the potential to unravel the 
true biodiversity of toxins and provide invaluable information for drug design and development.
The last two decades have seen a surge in research exploiting the extraordinary biological 
potency of venom, in order to develop novel drugs and diagnostics for human diseases, or as probes 
to study cells and their receptors. Encouraged by the substantial medicinal and fiscal success of 
the Bristol-Myers Squibb ACE inhibitor, captopril, many pharmaceutical companies have invested 
in venom-based drug discovery programs. The majority of the currently approved products were 
developed from snake venom proteins with distinct cardiovascular specificities, particularly those 
that target thrombin, fibrinogen and integrin receptors. Rapid advances in proteomics, genomics and 
transcriptomics have since resulted in affordable technology platforms that enable mining of venom 
proteins/peptides for drug discovery from species which, unlike snakes, produce venom in very small 
quantities. For example, the toxin repertoires of spiders and cone snails are estimated to contain 
more than 10 million compounds available for bioprospecting. These reports illustrate that venom 
peptides, particularly those enriched with the molecular stability imparted by extensive disulphide 
bonding, are driving the development of, amongst other things, new analgesics, anti-tumour agents 
and even insecticides. Drug bioprospecting activity will likely continue to rise as largely unstudied 
venomous animal lineages are exploited for discovery of novel lead compounds. Venoms are now 
beginning to receive a great deal of attention as natural sources of novel diagnostic and therapeutic 
compounds. The venom pool studied to date, often with particular focus on certain toxin types through 
selective assaying, represents an infinitesimally small representation of the true diversity available. An 
understanding of the evolutionary and ecological biology of different venomous animal lineages is 
therefore fundamental to the optimal selection of biological targets for future drug discovery programs.
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Bites from venomous animals are primarily diseases of the poor that kill over million people every 
year in India alone. In contrast, it is estimated that about 7500 people die in sub-Saharan Africa as a 
result of bites from venomous animals. It is widely accepted that tropical countries, with the lowest per 
capita government expenditure on health and the lowest per capita GDP, suffer the highest snakebite 
mortality (Harrison et al. 2011). The public health tragedy of snakebite is that the communities and 
countries most afflicted by snakebite are the least able to access or afford effective treatment. The World 
Health Organisation has recently recognised the scale of the problem by designating snakebite as a 
Neglected Tropical Disease. Yet, the problem continues to haunt the lives of the rural poor in these 
undeveloped and developing countries and a lot remains to be done in regards to the production of 
effective antivenom and management and treatment of bites from venomous animals. The treatment 
of envenomated patients is complicated by the enormous diversity of venom-components that have 
evolved to systematically breakdown the homeostasis of the prey animals. Antiquated means of 
antivenom production, such as immunization of horse and rabbits, results in extremely nonspecific 
antivenom that itself could pose a threat to the health of the bite victim. As a result, it is important 
to understand the molecular evolutionary histories of venom-components and to identify regions 
in them that undergo episodic adaptations. Distinguishing such regions from those that remain 
extremely conserved can be useful in the production of designer antivenom which is artificially 
synthesized using novel immunological strategies. Designer antivenom can be extremely efficient in 
neutralising the effects of venom, as it targets the regions that remain highly conserved in venom-
components. Hence, the understanding of venom evolution and the forces driving it is warranted.
1.3 Methodology employed
The following section describes the general methodology employed during my 
PhD research for studying the evolution of venom and has been depicted in Figure 1.5.
Venom gland transcriptomics:
 Venom gland transcriptomics, analysed in the following studies, were constructed in our 
collaborator’s (Dr. Bryan Fry) Venom Evolution Laboratory at the University of Queensland, 
Australia. They extracted total RNA from the dissected venom gland using the standard TRIzol 
Plus method (Invitrogen). Extracts were enriched for mRNA using standard RNeasy mRNA mini 
kit (Qiagen) protocol. mRNA was reverse transcribed, fragmented and ligated to a unique 10-base 
multiplex identifier (MID) tag prepared using standard protocols and applied to one PicoTitrePlate 
(PTP) for simultaneous amplification and sequencing on a Roche 454 GS FLX+ Titanium platform 
(Australian Genome Research Facility). Automated grouping and analysis of sample-specific MID 
reads informatically separated sequences from the other transcriptomes on the plates, which were 
then post-processed to remove low quality sequences before de novo assembly into contiguous 
sequences (contigs) using v 3.4.0.1 of the MIRA software program. Assembled contigs were 
processed using CLC Main Work Bench (CLC-Bio) and Blast2GO bioinformatic suite (Gotz et 
al. 2008; Gotz et al. 2011) to provide Gene Ontology, BLAST and domain/Interpro annotation.
Sequence retrieval and alignment
I utilised the sequences assembled by the methods outlined above, after refining and annotating 
them, for conducting phylogenetic and selection assessments. I also retrieved nucleotide sequences 
from National Center for Biotechnology Information (NCBI: http://www.ncbi.nlm.nih.gov/). New 
toxin sequences recovered from various venom gland transcriptomes were identified by comparing 
their translated DNA sequences with those of previously characterised toxins using a BLAST search 
(Altschul et al. 1997) implemented in the UniProtKB protein database. Translated nucleotide sequences 
were aligned using MUSCLE 3.8 (Edgar 2004) and the alignments were manually inspected to rectify 
errors. Amino acid alignments generated this way were used for guiding nucleotide alignments. 
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Phylogenetics
Phylogenetic analyses were performed to allow the reconstruction of molecular evolutionary 
histories of various toxin types. Since many toxin forms are only known from their amino acid 
sequences, amino acid datasets were often used for the Bayesian inference. When enough nucleotide 
sequences of all toxin representatives were available, I employed the Bayesian method of tree 
reconstruction on the nucleotide alignments. MrBayes 3.2.1 (Ronquist et al. 2012) was employed 
for the Bayesian inference, using lset rates=invgamma with prset aamodelpr=mixed command, 
which enables the program to optimise between nine different amino acid substitution matrices 
implemented in MrBayes. The analysis was performed by running a minimum of 1x107 generations 
in four chains, and saving every 100th tree. The log-likelihood score of each saved tree was plotted 
against the number of generations to establish the point at which the log likelihood scores reached 
their asymptote, and the posterior probabilities for clades established by constructing a majority-rule 
consensus tree for all trees generated after completion of the burn-in phase. Trees were also generated 
using maximum-likelihood inferences. Maximum-likelihood method implemented in PhyML 
(Guindon et al. 2010) was utilised and node support was evaluated with 1,000 bootstrapping replicates.
Test for Recombination 
To overcome the effects of recombination on the phylogenetic and evolutionary interpretations 
(Posada and Crandall 2002), I employed Single Breakpoint algorithms implemented in the HyPhy package 
and assessed recombination on all the toxin forms examined in this study (Kosakovsky Pond et al. 2006; 
Delport et al. 2010). When potential breakpoints were detected using the small sample Akaike information 
Criterion (AICc), the sequences were compartmentalized before conducting selection analyses.
Selection Analyses 
The simplest way of identifying the nature of selection using genetic sequence data is by 
calculating the ‘summary statistics’ from the multiple sequence alignment of the gene of interest. 
Ideally, the sequences should represent different individuals from a single population or multiple 
individuals from different population or species. However, the sequences should belong to 
the same gene or homologous genes. In order to detect the presence of selection, statistics that 
summarize the relative frequency of polymorphic sites are calculated from the observed alignment. 
These statistics are then compared against the values expected to occur under a “null model” 
of neutral evolution. If the observed statistics are signiﬁcantly different from their expected 
values, then the neutral null model can be rejected. In addition to assuming that all mutations 
are either lethal (and therefore unobserved) or neutral, the null “standard neutral model” also 
assumes a constant effective population size, a constant mutation rate, no recombination, 
no migration, random mating and lastly, that each mutation occurs at a different nucleotide 
site (also known as the “inﬁnite sites” assumption). The advantage of summary statistics lies in 
their simplicity; however, the rejection of the model does not necessarily indicate the action of 
selection, as rejection can result by the violation of any of the aforementioned model assumptions.
One of the ﬁrst and most commonly used summary statistics is 
Tajima’s D (Tajima, 1989), which for n observed sequences is deﬁned as:
D = π - (S/k) / √V
Where, π equals the average number of sites that differ between each pair of sequences, S equals 
the number of polymorphic or segregating sites in the alignment and V represents variance. Under 
the null “neutral model” both population diversity (S) and pairwise divergence (π) are generated 
by genetic drift. Hence, D is expected to equal zero, if all the aforementioned assumptions of the 
neutral model are met. S, which represents the number of polymorphic sites, ignores the frequency of 
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polymorphic sites in the population. As a result, S is sensitive to the existence of rare, low-frequency 
variants in the population. In contrast, π is more affected by the presence of intermediate-frequency 
variants, as they can generate differences between pairs of sequences in the sample. Tajima’s D 
therefore summarizes the distribution of site frequencies of polymorphic sites, with signiﬁcantly 
negative D values resulting from an excess of rare variants, and significantly positive values reﬂecting 
an excess of intermediate frequency sites. As a rule-of-thumb, negative D values might signify a 
recent bout of positive selection or a rapidly growing population, whereas positive D values might 
signify the presence of population structure, balancing selection, or a population declining in size.
Other statistical tests that closely resemble Tajima’s D test have been proposed that concentrate 
on slightly different properties of polymorphic sites. For example, Fu and Li’s D and F (1993) 
statistics compare π and S against the number of “singletons” (polymorphisms found only in one 
sequence) in an alignment. In contrast, the related H statistic introduced by Fay and Wu (2000) 
considers the abundance of very high-frequency variants relative to that of intermediate-frequency 
variants, and is thought to be more powerful in detecting the signature of genetic hitchhiking 
associated with a selective sweep. The H statistic uses an “outgroup” sequence from a closely related 
population or species to identify sites that have become ﬁxed in the main study population. When 
using Tajima’s D or related statistics to detect the presence of selection, it is important to remember 
that they all test whether the distribution of polymorphism is different from that expected under the 
null “neutral model”. Deviation from this model could be due to natural selection, but this is by no 
means the only assumption of the neutral model. For example, population structure or changes in 
population size will also affect the distribution of polymorphisms in a population, and considerable 
further work must be done to rule out these alternative explanations before selection becomes 
the most likely or sole remaining explanation. Furthermore, summary statistic methods assume 
that the sampled sequences have been taken randomly from the population under investigation.
Mutations in protein encoding genes can be categorised as either synonymous (silent or dS) or 
non-synonymous (replacement or dN). Due to the inherent redundancy of the genetic code, silent 
mutations do not alter the amino acid sequence, whereas replacement/non-synonymous changes 
do. If we ‘assume’ that selection is likely to act less strongly on silent mutations, then the observed 
differences between the patterns of silent (dS) and replacement (dN) changes should reﬂect the 
nature of selection governing the evolution of the gene of interest. Computation of dN/dS is 
affected by sampling strategy employed. Ideally, each sequence should be from a different species/
population or from different individuals of single population/closely related populations. When 
these prerequisites are met, the relative rate of accumulation of replacement ﬁxations to the rate of 
silent ﬁxations (denoted dN/dS or ω) could be calculated. If all replacement ﬁxations are neutral 
then, by deﬁnition, the ratio of the two rates must equal to one and hence a statistically signiﬁcant 
deviation from dN/dS=1 identifies selection. It should be noted that dN and dS are calculated per 
replacement or silent site, respectively, thereby taking into account the fact that random mutations 
generate more replacement changes than silent changes due to the structure of the genetic code. 
Slower rate of replacement ﬁxation, i.e. dN/dS<1, signifies negative selection, which acts more 
strongly against replacement changes. Exceptional selection constraints can be observed when dN/
dS≈0, i.e. when dS=0. Crucially, if dN/dS is signiﬁcantly greater than one, then positive selection must 
have occurred, because no other obvious process can result in a faster ﬁxation rate for replacement 
changes. The modern interpretation of dN/dS is that it reﬂects on the differences in selective forces 
acting on silent versus replacement changes. Thus, it does not strictly assume that all silent changes 
are selectively neutral. Silent changes in coding sequences may be selected because the sequence 
contains overlapping reading frames or contains functional secondary DNA or RNA structure, or 
because there is a ﬁtness advantage in using some codons in preference to others. Although these 
factors should always be borne in mind, it is often reasonable to make the simplifying assumption 
that all silent mutations are effectively neutral. When employing dN/dS methods, one should 
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avoid making the common mistake of equating the absolute value of dN/dS with the “strength” 
of selection or the average selection coefﬁcient of replacement ﬁxations. As an example, consider a 
codon within which an advantageous replacement mutation arose and rapidly got ﬁxed some time 
in the past – a codon that could not be bettered by any subsequent mutation. After a sufﬁcient 
period of evolution, several silent/neutral changes will have accumulated within the selected codon, 
leading to an observed dN/dS close to zero! Hence high dN/dS values most commonly occur when 
genes undergo recurrent rounds of selection, rather than single selective sweeps. As a result dN/dS 
methods are most successful in detecting adaptation when they are applied to genes that are under 
antagonistic co-evolution, such as that generated by sexual conﬂict, predator–prey interactions, 
or host–parasite interactions. Unlike summary statistics, dN/dS methods do not require strong 
assumptions regarding the sampled population and are therefore considered to be more robust.
I evaluated the influence of natural selection on various toxin-encoding genes using state-of-the-
art maximum-likelihood models (Goldman and Yang 1994; Yang 1998) implemented in CodeML of 
the PAML (Yang 2007). I utilized the two-ratio model as well as the optimised branch-site test (Yang 
and Nielsen 2002; Zhang et al. 2005) to detect evolutionary selection pressures acting upon various 
toxin lineages. The two-ratio model evaluates selection across the lineages alone, while the branch-
site model allows ω to vary across the sites of the protein and along the branches in the tree. The latter 
is known for its reasonable power and accuracy to detect short bursts of episodic adaptations (Zhang 
et al. 2005). However, both the two-ratio and branch-site models require the foreground (lineages 
under positive selection) and background lineages (lineages lacking positive selection) to be defined 
a priori. Such predefined biological hypotheses are often unavailable and it becomes difficult to 
define the foreground lineages. Therefore, I treated each toxin type being compared as a foreground 
branch alternatively and tested multiple hypotheses. A likelihood-ratio test was then conducted by 
comparing the model that allows ω to be greater than 1 in the foreground branch, with a null model 
that does not (ω constrained 1). It has been suggested that while implementing multiple hypotheses 
using branch and branch-site models, it is necessary to control the family-wise error rate (FWER 
or Type I error) (Zhang et al. 2005). I used Bonferroni correction to account for such errors. It 
uses α/n as the significance level to test each hypothesis, where ‘α’ is the significance level and ‘n’ 
is the number of independent true null hypotheses. I further utilized branch-site Random Effects 
Likelihood (REL) (Kosakovsky Pond et al. 2011) to identify lineages evolving under the influence 
of episodic diversifying selection pressures. Unlike the aforementioned lineage-specific models, 
branch-site REL does not require a priori identification of foreground and background branches.
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Figure 1.5 Methodology employed in venom research
Legend: A rough schematic workflow of venom research is presented. A) Venom/venom gland is 
collected from the animal under study. B) m-RNAs are isolated and randomly sequenced using 
next-generation sequencing. C) Collected venom is used for proteomic analyses to understand the 
expression profiles. D) Sequenced nucleotides are aligned. E) Phylogenetic trees are constructed 
using both maximum-likelihood and Bayesian interferences. F) The structure of venom protein is 
elucidated or a homology model is built using an already elucidated structure of a similar protein 
which shares the same structural scaffold and is utilized for bioinformatics analyses. G) Various 
evolutionary mechanisms are studied using the multiple sequence alignment and phylogenetic 
tree files generated using methods outlined above. Forces of natural selection influence the 
molecular evolution of venom-encoding genes are evaluated using state-of-art selection assessment 
methods. Positively and negatively selected sites are then mapped onto the crystal structure/
homology model of the protein. H) The results of all the aforementioned tests are then utilized 
for designing antivenoms of greater efficacies. They are also extremely important for biodiscovery.
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Since lineage-specific models assess the effects of selection only along the branches, they often 
fail to identify regions in proteins that might be affected by episodic selection pressures and ultimately 
underestimate the strength of selection. Hence, I employed site-specific models that estimate 
positive selection statistically as a non-synonymous-to-synonymous nucleotide-substitution rate 
ratio (ω) significantly greater than 1. FUBAR (Murrell et al. 2013) implemented in HyPhy (Pond 
et al. 2005), which supersedes Single likelihood ancestor counting (SLAC), Fixed Effects Likelihood 
(FEL) and Random Effects Likelihood (REL) assessments, was employed to provide additional 
support to the aforementioned analyses and to detect sites evolving under the influence of pervasive 
diversifying and purifying selection pressures. Mixed Effects Model Evolution (MEME) (Murrell et 
al. 2012) was also employed to efficiently detect episodically diversifying sites. Further support for 
the results of the nucleotide-level selection analyses was obtained using a complementary protein-
level approach implemented in TreeSAAP (Woolley et al. 2003). To clearly depict the proportion of 
sites under different regimes of selection, an evolutionary fingerprint analysis was carried out using 
the evolutionary selection distance (ESD) algorithm implemented in datamonkey (Pond et al. 2010).
Structural analyses 
To depict the natural selection pressures influencing the evolution of various venom-components, 
I mapped the sites under positive selection on the homology models created using Phyre 2 webserver 
(Kelley and Sternberg 2009). Pymol 1.3 (DeLano 2002) was used to visualize and generate the images 
of homology models. Consurf webserver (Armon et al. 2001) was used for mapping the evolutionary 
selection pressures on the three-dimensional homology models. GETAREA (Fraczkiewicz and Braun 
1998) was used to calculate the Accessible Surface Area (ASA) or the solvent exposure of amino-acid 
side chains. It uses the atom co-ordinates of the PDB file and indicates if a residue is buried or exposed 
to the surrounding medium by comparing the ratio between side chain Accessible Surface Area (ASA) 
and the “random coil” values per residue. An amino-acid is considered to be buried if it has an ASA 
less than 20% and exposed if ASA is more than or equal to 50%. When ASA ratio lies between 40%-
50%, it is highly likely that the residues have their side chains exposed to the surrounding medium.
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1.4 Structure of thesis
This thesis has been structured into the following chapters.
Chapter I introduces readers about the basics of ‘venom’ in animal lineages. It 
not only accentuates the importance of understanding the molecular evolution of genes 
that encode them, but also explains how to study them using state-of-art methodologies.
Evolution of venom in vertebrates: The evolution of venom in various 
vertebrate animal lineages is described in the following chapters. Chapters 
II-V essentially describe the evolution of venom in vertebrate lineages.
Chapter II deals with the invention and evolution of venom in basal Toxicofera lineages. Toxicofera 
(Greek for “those who bear toxins”) encompasses the order serpents and the infraorder Anguimorpha 
(Helodermatidae, Varanidae and Iguania). This hypothetical clade represents nearly 60% of all extant 
reptiles (~4600 species) and includes all snake (basal and advanced snakes) and venomous lizard 
lineages. Chapter II deals with the evolution of venom in basal snakes (e.g., Pythons and Boas) and 
Anguimorpha lizards (Iguania, Helodermatidae and Varanidae). While chapter 2.1 describes our work 
that unravelled the molecular evolution of venom-components in basal snake (boas and pythons) and 
lizard (Iguania) lineages for the first time, chapter 2.2 describes our work that highlighted the evolution 
of venom, also for the first time, in extremely endangered alligator lizard species, Abronia graminea.
Chapter III explains the evolution of venom in advanced snake lineages (Elapidae, Viperidae, 
‘non-front-fanged’ advanced snakes). These chapters, derived from my selected publications, describe 
the molecular evolution and diversification of venom in both the medically significant and insignificant 
species of advanced snakes. Chapter 3.1 not only explains the evolutionary mechanisms that have 
shaped cysteine-rich secretory proteins (CRiSPs) in the venom glands of advanced snakes (Elapidae, 
Viperidae and ‘non-front-fanged lineages) and lizards, but also the evolution of non-venomous 
CRiSP homologues in mammals. CRiSPs are one of the fascinating proteins for research, as they 
are essential for venomous snakes and lizards for prey-paralyses. In contrast, their non-venomous 
homologues in mammals participate in extremely important pathways, such as, immune system, 
reproduction, etc. This sub-chapter correlates the evolution of venom CRiSPs with the invention 
and diversification of venom delivery system (VDS) in advanced snakes and Anguimorpha lizards. 
Chapter 3.2 deals the evolution of multidomain venom-components in advanced snakes. This sub-
chapter describes our work on snake venom metalloproteinases (SVMPs) in extremely venomous 
vipers of the genus Echis and a species of lamprophiid snakes called Psammophis mossambicus, where 
we show that differential selection pressures have governed the evolution of various domains in 
these completely different families of snakes. Finally, chapter 3.3 deals with the evolution and 
diversification of three-finger toxins (3FTxs), one of the most potent venom components found in 
snakes. Despite the fact that they are one of the most widely studied components, I unravel several 
intriguing facets of their molecular evolutionary history for the first time. This sub-chapter correlated 
the evolutionary history of 3FTxs with the invention and diversification of VDS in advanced snakes.
Chapter IV deals with the evolution of venom proteins in vampire bats (Desmodus rotundus), 
which are one of the venomous mammals. This is the first study that describes the molecular evolution 
of venom proteins in vampire bats. We show that vampire bats have invented a very unique way 
of preventing the development of immunological resistance in the prey-animals they feed upon.
Chapter V explains the evolution of neurotrophins in various mammalian and reptilian lineages. 
This chapter shows how nerve growth factors in the venom glands of advanced snakes have adopted 
unique evolutionary mechanisms to participate in the prey-envenoming process, while their non-
venomous homologues evolve under the heavy constraints of negative selection. We studied the evolution 
of nerve growth factors (NGF), brain-derived neurotrophic factors (BDNF) and neurotrophin-3 
(NT-3) in various mammalian and reptilian (turtles, crocodiles, lizards and Toxicofera) lineages.
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Evolution of venom in invertebrates: The evolution of venom in various 
invertebrate animal lineages is described in the following chapters. Chapters 
VI and VII essentially describe the evolution of venom in invertebrate lineages.
Chapter VI deals with the evolution of venom in various Arthropod lineages. While chapter 
6.1 explains the origin and diversification of toxin scaffolds in various scorpion lineages, chapter 
6.2 deals with the evolution and diversification of venom in spiders. Chapter 6.1 provides 
several intriguing insights into the origin and diversification of three out of four known toxin 
scaffolds in scorpions, such as the cysteine-stabilised CSα/b motif, inhibitor cysteine knots 
(ICK) and disulphide-directed b-hairpin (DDH). This chapter explains the evolution of major 
scorpion toxins (various sodium channel toxins, potassium channel toxins, lipolytic toxins, 
etc.) in both medically significant and insignificant species. Chapter 6.2 describes our work on 
Barychelidae spider venoms, which unlike Theraphosidae (commonly known as tarantulas) 
spider family, are very poorly studied.  We identified several novel scaffolds for the first time 
in spider venoms. We also highlight the differential rate of evolution of these toxin clades. 
Chapter VII explains our work describing the molecular evolution of venom in coleoids 
(octopus, squid and cuttlefish) for the first time. We highlight how phylogenetic unrelated toxins 
in the animal kingdom evolve through common evolutionary mechanisms. We show that coleoid 
venoms have significant potential not only for understanding the fundamental aspects of venom 
evolution but also as an untapped source of novel toxins for use in drug design and discovery.
Chapter VIII represents the final chapter of this thesis and describes the major findings, 
and conclusions. I not only enlist all the major findings of my fellowship in this chapter, but also 
derive conclusions regarding the evolution of venom in various lineages of the animal kingdom.
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2.1
Squeezers and Leaf-cutters:
Differential diversification and 
degeneration of the venom 
system in Toxicoferan reptiles
Peer-reviewed, scientific publications resulting from this chapter.
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4.1.1 Abstract
Although it has been established that all toxicoferan squamates share a common venomous 
ancestor, it has remained unclear whether the maxillary and mandibular venom glands are evolving 
on separate gene expression trajectories or if they remain under shared genetic control. We show 
that identical transcripts are simultaneously expressed not only in the mandibular and maxillary 
glands, but also in the enigmatic snake rictal gland. Toxin molecular frameworks recovered in this 
study were three-finger toxin (3FTx), CRiSP, crotamine (b-defensin), cobra venom factor, cystatin, 
epididymal secretory protein, kunitz, L-amino acid oxidase, lectin, renin aspartate protease, 
veficolin, and vespryn. We also discovered a novel low-molecular weight disulfide bridged peptide 
class in pythonid snake glands. In the iguanian lizards, the most highly expressed are potentially 
antimicrobial in nature [crotamine (b-defensin) and cystatin], with crotamine (b-defensin) also 
the most diverse. However, a number of proteins characterized from anguimorph lizards and 
caenophidian snakes with hemotoxic or neurotoxic activities were recruited in the common 
toxicoferan ancestor and remain expressed, albeit in low levels, even in the iguanian lizards. In 
contrast, the henophidian snakes express 3FTx and lectin toxins as the dominant transcripts. 
Even in the constricting pythonid and boid snakes, where the glands are predominantly mucous-
secreting, low-levels of toxin transcripts can be detected. Venom thus appears to play little role in 
feeding behaviour of most iguanian lizards or the powerful constricting snakes, and the low levels 
of expression argue against a defensive role. However, clearly the incipient or secondarily atrophied 
venom systems of these taxa may be a source of novel compounds useful in drug design and discovery.
4.1.2 Introduction
Venom secretory proteins evolve by a process in which the duplicate of a gene encoding for 
a key regulatory or bioactive protein is recruited for selective, tissue-specific expression in a venom 
gland (Kordis and Gubensek 2000; Fry 2005). Subsequently, the venom gland specific gene isoform 
is further duplicated, often explosively. Evidence of accelerated evolution and positive selection is 
characteristic of this ‘birth and death’ model of venom protein evolution (Nei et al. 1997; Duda 
et al. 1999; Kordis and Gubensek 2000; Fry et al. 2003b; Binford et al. 2009; Weinberger et al. 
2010; Casewell et al. 2011a; Chang and Duda 2012). For example, the A-superfamily of conotoxin 
genes isolated from venomous cone snails is amongst the most rapidly evolving protein-coding 
gene family identified in metazoans to date (Chang and Duda 2012). In particular, the bioactive 
residues on the surface of the toxic protein molecules undergo the highest level of accelerated 
evolution (Juárez et al. 2008; Casewell et al. 2011a; Sunagar et al. 2012; Brust et al. 2013). This 
diversification produces neo-functionalised forms with a myriad of new activities and potencies 
(Kordis and Gubensek 2000; Fry et al. 2003b; Casewell et al. 2011a; Chang and Duda 2012).
We have previously demonstrated that a core set of toxin-encoding genes was expressed in the 
oral glands of the common ancestor of all venomous reptiles (Toxicofera clade of squamates). This 
ancestral set was subsequently augmented by the recruitment of additional toxins and formed the 
substrate for the evolution of the complex venoms observed in modern venomous lizards and snakes 
(Fig. 2.1.1: A) (Fry et al. 2003a; Fry et al. 2003b; Fry 2005; Fry et al. 2006; Fry et al. 2008; Fry et 
al. 2009a; Fry et al. 2010a; Fry et al. 2012b). Although Toxicofera, which consists of three lineages 
(Anguimorpha lizards, Iguania lizards, and Serpentes) is well established as a monophyletic clade 
within the squamate reptiles (Vidal and Hedges 2005; Fry et al. 2006); phylogenetic studies based 
on nuclear genes have thus far failed to resolve the relative relationships of the snake/iguanian/
anguimorph trichotomy [cf. (Townsend et al. 2004; Fry 2005; Vidal and Hedges 2005)]. However, 
other sources of evidence such as SINEs and morphology favour the clustering of snakes with 
anguimorph lizards (Piskurek et al. 2006; Lee 2009). We therefore follow this arrangement here 
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(Fig. 2.1.1: A). The ancestral toxicoferan condition was the possession of thin, simple sero-mucous 
glands in both the mandibular and maxillary regions (Fry et al. 2006). These glands produced active 
substances that were the substrate for the evolution of toxins. Iguanian lizards apparently split off 
while this system was only in an incipient stage and little derivation has subsequently occurred 
within this clade. The apparent lack of specialisation of the venom system within the Iguania is likely 
due to the fact that most species are insectivorous or vegetarian; however, we have shown that toxin 
genes continue to be expressed by the oral glands of these lizards (Fry et al. 2006). In the snakes 
and Anguimorpha lizards, by contrast, the venom system has been extensively diversified (Fry et al. 
2006; Fry et al. 2008; Fry et al. 2009a; Fry et al. 2010b; Fry et al. 2012b). In the anguimorph lizards, 
specialisation of the mandibular gland was favoured, whilst in snakes it was the maxillary gland that 
became most specialised; in both lineages highly derived forms exists, including encapsulated glands.
Snakes are known for their extensive development of oral glands, which may include a great 
variety of secretory structures mainly in the upper but also in the lower jaw, some of which develop in 
association with the dental lamina. Intriguing questions arise in relation to the number, volume and 
diversification of these glands: why are there so many glands differing in general architecture, gross 
anatomy, and histochemistry, and how are these differences reflected in their function? In particular, 
within the complex of the circumlabial oral glands, the glands at the corner of the mouth (rictal glands) 
have received little attention except for a few detailed studies and some general investigations (Gabe 
and Saint 1969; Gans and Gans 1978). McDowell (McDowell 1986) carried out a detailed study of 
the corner of the mouth of a large number of caenophidian snakes and described the rictal glands 
and muscles of the area together with a reinterpretation of the homology of the involved structures. 
Underwood (Underwood 2002) investigated the circumlabial oral glands of a series of ‘‘basal’ snakes’ 
including Cylindrophis ruffus and the powerful constricting snake Aspidites melanocephalus and paid 
special attention to the glands of the rictal region. In C. ruffus, he found well-developed maxillary 
and mandibular glands as well as superior and inferior rictal glands. He described the lobules of the 
maxillary and mandibular glands as mixed: serous glands leading to mucous tubules that open into 
the oral cavity via short ducts along the margin of the lips. The C. ruffus superior and inferior rictal 
glands consisted of branched serous tubules opening into mucous tubules that led into wide mucous 
ducts opening directly into the corner of the mouth. Phisalix and Caius (Phisalix 1918; Phisalix 
1922) reported that the secretions of the rictal glands of Eryx conicus and six species of uropeltids 
were toxic to birds. These interesting observations do not appear to have been taken any further 
in the more than 80 years since they were reported. More recently, a test of oral secretions from a 
wide range of Australian snakes produced a curious cross-reactivity between oral secretions of the 
pythonid A. melanocephalus and tiger snake venom in the Australian SVDK (Snake Venom Detection 
Kit) (Jelinek et al. 2004). This result may be indicative of the fact that toxins are still being secreted 
from the oral glands of A. melanocephalus in detectable quantities. Thus, the over-arching aim of this 
study was to examine the diversification of these glands and their secretory proteins in ‘basal’ snakes 
and iguanian lizards in order to elucidate several intriguing aspects of reptile venom evolution. 
We also examined the genome of Anolis carolinensis for genes encoding putative toxin sequences. 
The relative expression of genes in mandibular versus maxillary glands has remained 
uninvestigated. In addition, the molecular evolution of any associated secreted proteins in ‘basal’ 
snakes has remained entirely neglected and that of the iguanian lizards has been hampered by only a 
single species having been investigated to-date and with only limited sequencing (Fry et al. 2006). In 
this study, iguanian lizards and ‘basal’ snakes were both shown to express (at detectable levels) toxin 
types typically associated with the venoms of caenophidian snakes or anguimorph lizards. Our results 
revealed that the mandibular and maxillary glands are under a single system of genetic control, with 
identical transcripts being simultaneously expressed in both glands. Additionally, we showed that the 
rictal glands of snakes not only also secrete toxins and thus represent an unappreciated source of venoms 
but that this gland is under the same gene-expression control as the mandibular and maxillary glands.
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4.1.3 Methods
Specimens Examined
Boidae
Boa constrictor imperator THM captive born; unknown geographical founder origin
Eunectes notaeus HM captive born; unknown geographical founder origin
Corallus hortulanus HM captive born; unknown geographical founder origin
Cylindrophiidae
Cylindrophis ruffus THM Malaysia
Pythonidae
Antaresia childreni HM Kununurra, Western Australia
Aspidites melanocephalus THM Port Headland, Western Australia
Morelia spilota mcdowelli THM captive born stock; Brisbane, Queensland founder stock
Python regius HM captive born; unknown geographical founder origin
Iguania
Agamidae
Amphibolurus longirostris H Newman, Western Australia
Chlamydosaurus kingii TH Kununurra, Western Australia
Ctenophorus nuchalis H Newman, Western Australia
Physignathus lesueurii TH Sydney, New South Wales
Uromastyx aegyptica TH captive born; unknown geographical founder origin
Chameleonidae
Chamaeleo calyptratus TH captive born; unknown geographical founder origin
Anolis equestris TH Miami, Florida
Iguana iguana TH captive born; unknown geographical founder origin
Anguimorpha
Varanus glauerti T Kununurra, Western Australia
Varanus tristis T Perth, Western Australia
Other
Cordylidae
Cordylus tropidosternum H captive born; unknown geographical founder origin
Gekkonidae
Gekko gecko H captive born; unknown geographical founder origin
Sincidae
Eumeces obsoletus H captive born; unknown geographical founder origin
Teiidae
Ameiva ameiva H captive born; unknown geographical founder origin
Xantusidae
Lepidophyma flavimaculatum H captive born; unknown geographical founder origin
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Histology
Histological sections were prepared from the intact head and the excised venom gland and 
delivery system. Whole heads were removed and a cut made to the underside to allow fast penetration 
of the fixative (10% neutral buffered formalin). After a minimum of 2 days excess tissue was removed 
and specimens were immersed in Kristensen’s decalcification solution and placed on a rotor for up to 
3 weeks (depending on the size of the head). Before processing the heads were bisected longitudinally 
for cutting transversely, at 3 microns, in 2 separate blocks. The processing schedule was: 10% 
neutral buffered formalin 2 hours; absolute ethanol 4 x 1 hour; histolene 3 x 1 hour; followed by 
paraffin wax 2 x 90 minutes. The sections were taken every 100 microns and matching sections 
were stained with Periodic Acid Schiff’s stain and Masson’s Trichrome stain. In other specimens, the 
venom gland, venom duct, and the adjacent bony and muscular tissue were excised and placed in 
decalcifying solution (Cal-Ex, Fisher) for 72–168 hours. Each sample was dehydrated and cleared 
through a progressive ethanol series and Cyto-Sol (Fisher) prior to embedding in Paraplast (Fisher). 
Serial sections were cut at 10-12 microns. All species were sectioned in the frontal plane; when 
available, the contralateral venom gland and delivery system were sectioned either parasagitally or 
transversely. Sections were stained using a variant of Van Gieson’s stain — which provides clear 
distinction between connective tissue, muscle, and epithelium — or with hematoxylin and eosin.
Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) was used to examine the three dimensional shape and 
internal anatomy of the venom glands. Formalin-ethanol fixed heads were first submersed in 
Fomblin (Solvay Solexis) and placed under vacuum to prevent air artefacts. Depending on head 
size, imaging was performed on either 9.4 T (small/medium) or 17.6 T (large) vertical 89-mm-
bore systems (Bruker BioSpin, Rheinstetten, Germany) with a Bruker Micro2.5 gradient system 
of 1 T/m and transmit/receive birdcage radio-frequency coil with diameter of 10–30 mm. Bruker 
ParaVision 4.0 software was used for image acquisition. Anatomical images were acquired using 
a 3D gradient echo sequence. The field-of-view and matrix were varied to fit the individual 
samples, resulting in voxel sizes between (40)3 mm3 and (70)3 mm3. Imaging parameters 
were: TE = 8 ms, TR = 40 ms, flip angle 200, 4–8 averages, total scan time 3–9 h per sample, 
depending on size and resolution. Image segmentation of glands was performed manually in 
Amira 4.1 (Mercury Computer Systems Inc.) and three-dimensional surface renderings generated.
Transcriptomes
Mandibular venom glands of three specimens were pooled and total RNA extracted using 
the standard Invitrogen TRIzol Plus method (). Extracts were enriched for mRNA using standard 
RNeasy mRNA mini kit (Qiagen) protocol. mRNA was reverse transcribed, fragmented and ligated 
to a unique 10-base multiplex identifier (MID) tag prepared using standard protocols and applied 
to one PicoTitrePlate (PTP) for simultaneous amplification and sequencing on a Roche 454 GS 
FLX+ Titanium platform (Australian Genome Research Facility). Automated grouping and analysis 
of sample-specific MID reads informatically separated sequences from the other transcriptomes on 
the plates, which were then post-processed to remove low quality sequences before de novo assembly 
into contiguous sequences (contigs) using the MIRA software program. Assembled contigs were 
processed using CLC Main Work Bench (CLC-Bio) and Blast2GO bioinformatic suite (Conesa 
et al. 2005; Conesa and Götz 2008; Gotz et al. 2008) to provide Gene Ontology, BLAST and 
domain/Interpro annotation. The above analyses assisted in the rationalisation of the large numbers 
of assembled contigs into phylogenetic ‘groups’ for detailed phylogenetic analyses outlined below.
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Phylogenetics
Phylogenetic analyses were performed to allow reconstruction of the molecular evolutionary 
history of each toxin type for which transcripts were bioinformatically recovered. Toxin sequences were 
identified by comparison of the translated DNA sequences with previously characterised toxins using 
a BLAST search (Altschul et al. 1997) of the UniProtKB protein database. Molecular phylogenetic 
analyses of toxin transcripts were conducted using the translated amino acid sequences. Comparative 
sequences from other venomous reptiles and physiological gene homologs identified from non-venom 
gland transcriptomes were included in each dataset as outgroup sequences. To minimize confusion, 
all sequences obtained in this study are referred to by their Genbank accession numbers (http://www.
ncbi.nlm.nih.gov/sites/entrez?db=Nucleotide) and sequences from previous studies are referred to 
by their UniProtKB accession numbers (http://www.expasy.org/cgi-bin/sprot-search-ful). Resultant 
sequence sets were aligned using CLC Mainbench. When presented as sequence alignments, the leader 
sequence is shown in lowercase and cysteines are highlighted in black. > and < indicate incomplete 
N/5’ or C/3’ ends, respectively. Datasets were analysed using Bayesian inference implemented on 
MrBayes, version 3.2 (Ronquist et al. 2012). Two different run conditions were used in order to test 
for congruence: lset rates=invgamma with prset aamodelpr=fixed (WAG) and lset rates=gamma with 
prset aamodelpr=mixed. The analysis was performed by running a minimum of 1x107 generations 
in four chains, and saving every 100th tree. The log-likelihood score of each saved tree was plotted 
against the number of generations to establish the point at which the log likelihood scores reached 
their asymptote, and the posterior probabilities for clades established by constructing a majority-rule 
consensus tree for all trees generated after completion of the burn-in phase.Test for Recombination
Recombination can mislead phylogenetic and evolutionary selection interpretations (Posada 
and Crandall 2002). Hence, we evaluated the effect of recombination on all the toxins examined 
in this study (‘basal’ snake: lectin, three-finger toxin, epididymal secretory protein; iguanian lizard: 
cystatin, crotamine (b-defensin), veficolin; crotaline snake: crotamine (b-defensin); homalopsid 
snake: veficolin; caenophidian snake and anguimorph lizard: CRiSP) by employing Single Breakpoint 
Recombination implemented in the HyPhy package (Frost et al. 2005; Kosakovsky Pond et al. 2006; 
Delport et al. 2010). Potential breakpoints were detected using the small sample Akaike information 
Criterion (AICc) and the sequences were compartmentalized before conducting the selection analyses.
Selection Analysis
Sophisticated likelihood models of coding-sequence evolution (Goldman and Yang 1994; 
Yang 1998) implemented in CODEML of the PAML (Yang 2007) package were employed to 
evaluate the selection pressures on the major toxin transcripts recovered from ‘basal’ snake and 
iguanian serous and mucus glands. We first employed the lineage-specific one-ratio model which 
assumes a single w for the entire phylogenetic tree. This model tends to be very conservative and can 
only detect positive selection if the w ratio averaged over all the sites along the lineage is significantly 
greater than one. Because such lineage-specific models assume a single w for the entire tree, they 
often fail to identify regions in proteins that might be affected by episodic selection pressures 
and ultimately, underestimate the strength of selection. Hence, we employed site-specific models 
which estimate positive selection statistically as a non-synonymous-to-synonymous nucleotide-
substitution rate ratio (w) significantly greater than 1. We compared likelihood values for three 
pairs of models with different assumed w distributions as no a priori expectation exists for the same: 
M0 (constant w rates across all sites) versus M3 (allows w to vary across sites within ‘n’ discrete 
categories, n≥3); M1a (a model of neutral evolution) where all sites are assumed to be either under 
negative (w<1) or neutral selection (w=1) versus M2a (a model of positive selection) which in 
addition to the site classes mentioned for M1a, assumes a third category of sites; sites with w>1 
(positive selection) and M7 (b) versus M8 (b and w), and models that mirror the evolutionary 
constraints of M1 and M2 but assume that w values are drawn from a b distribution (Nielsen 
Molecular evolution of venoM  
and Yang 1998). Only if the alternative models (M3, M2a and M8: allow sites with w>1) show a 
better fit in Likelihood Ratio Test (LRT) relative to their null models (M0, M1a and M7: do not 
allow sites w>1), are their results considered significant. LRT is estimated as twice the difference 
in maximum likelihood values between nested models and compared with the c2 distribution with 
the appropriate degree of freedom - the difference in the number of parameters between the two 
models. The Bayes empirical Bayes (BEB) approach (Yang et al. 2005) was used to identify amino 
acids under positive selection by calculating the posterior probabilities that a particular amino acid 
belongs to a given selection class (neutral, conserved or highly variable). Sites with greater posterior 
probability (PP ≥ 95%) of belonging to the ‘w>1 class’ were inferred to be positively selected.
Further, Single Likelihood Ancestor Counting (SLAC), Fixed-Effects Likelihood (FEL) 
and Random Effects Likelihood models (Kosakovsky Pond et al. 2005) implemented in HyPhy 
(Pond et al. 2005) were employed to further provide significant support to the aforementioned 
analyses and to detect sites evolving under the influence of positive and negative selection. The 
more advanced Mixed Effects Model Evolution (MEME) (Murrell et al. 2012) was also used to 
detect episodic diversifying selection. MEME employs Fixed-effects likelihood (FEL) along the sites 
and Random-effects likelihood (REL) across the branches to detect episodic diversifying selection.
For the effective comparison of iguanian and crotaline snake crotamines (b-defensin); 
iguanian and homalopsid veficolins and anguimorph lizard and caenophidian snake cysteine-
rich secretory proteins (CRISPs), we employed Codeml Clade Model C analysis (Bielawski and 
Yang 2004). The significance of the analysis was tested by comparison with site model M1a.
Structural analyses
In order to depict the selection pressures shaping the evolution of basal toxins, we mapped 
the sites under positive selection on the homology models created using Phyre 2 webserver (Kelley 
and Sternberg 2009). Pymol 1.3 (DeLano 2002) was used to visualize and generate the images 
of homology models. Consurf webserver (Ashkenazy et al. 2010) was used for mapping the 
evolutionary selection pressures on the three-dimensional homology models while Selecton webserver 
(Doron-Faigenboim et al. 2005) was used to identify hypervariable regions on the basal toxins.
Proteomics
Aspidites melanocephalus were obtained from Port Headland (Western Australia), the same 
population utilized as a ‘negative control’ by Jelinek et al. (Jelinek et al. 2004). Specimens were 
anaesthetized using zoletil (3 mg/kg) and then injected subcutaneously with pilocarpine (20 mg/
kg) periglandular to the labial glands. Polyethylene equipment was used to collect and process 
samples in all cases. Samples were subsequently filtered using 20 Å syringe filters to remove large 
mucoidal strands and then lyophilised. Reduction and alkylation was undertaken by redissolving 3 
µg of sample from each of the localities in 50 µl of 100 mM ammonium carbonate. After sonication 
and vortexing, 50 µl of 2% iodoethanol/0.5% triethylphosphine in acetonitrile was added to the 
re-dissolved sample. The reaction mixture was incubated for 2 h at 37˚C, before being dried and re-
suspended in 15 µl of 2.5% acetonitrile (ACN) and 0.5% formic acid. Additionally, 3 µl of reduced 
and alkylated sample was re-suspended in 30 µl of 40 mM ammonium bicarbonate, before being 
incubated overnight with 750 ng trypsin. Digestion was stopped by addition of 1 µl of concentrated 
formic acid. 5 µl (1 µg) of each sample was processed by LC/MS using a Vydac Everest C18 column 
(150 mm X 7.5 mm, 5 mm particle size, 300 Å pore size) at a flow of 500 ml/min and a gradient of 
1–40% solvent B (90% ACN, 0.1% formic acid) over 25 min coupled with an AB SCIEX 5600 
Triple TOF mass spectrometer. MS2 spectra were acquired at a rate of 20 scans/sec. MS2 spectra 
were searched against translated A. melanocephalus mandibular and maxillary gland transcriptomes 
using Proteinpilot v4.0 (ABSciex) and further analysed using CLC Main Workbench v6.6.
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Surface charge molecular modelling
Homology models were built using the NMR-structure of Bungarotoxin from Bungarus 
candidus venom as a template (PDB-code: 2JQP). Alternative templates (1ABT, 1CDT, 1KBA 
and 2H7Z) were investigated, since not all of the sequences yielded a suitable similarity score 
to a single template structure. The bungarotoxin structure used in this study was selected for 
its best fit to the cysteine sequence pattern. Regions of insertions and deletions were moved 
to loop structures rather than modelled in the core of the protein. Target template alignments 
were generated using SPDBV (Bordoli et al. 2009). Model structures were obtained from 
SwissModel server using the “project mode” option (Bordoli et al. 2009). Electrostatic surfaces 
were calculated using APBS (Baker et al. 2001) and visualized in VMD (Humphrey et al. 1996).
4.1.4 Results
Gland arrangements
 The rictal glands of the ‘basal’ snake C. ruffus were large enough that they indented the 
mandibular and maxillary glands (Fig. 2.1.1: B). In this anatomically simple and presumably basal 
condition, entirely serous tubules merge (Fig. 2.1.1: C) to join a single duct descending vertically 
slightly anterior to the corner of the mouth. C. ruffus maxillary and mandibular glands were mixed 
glands, with the mandibular gland containing a greater proportion of serous cells than did the maxillary. 
The mandibular and maxillary glands of the constricting boid and pythonid snakes (Aspidites, Boa, 
Corallus, Eunectes, and Morelia) were also mixed but were predominantly composed of mucoid cells 
with only scattered serous cells (Fig. 2.1.1: D). The iguanian lizards had mixed sero-mucous maxillary 
and mandibular glands, with small insectivorous or vegetarian species of any size having primarily 
mucous cells while species that feed on vertebrates, such as Anolis equestris, contained a greater 
proportion of serous cells at the base of the gland arrangements (Fig. 2.1.1: E). In contrast, all non-
toxicoferan lizards examined in this study (Amieva amieva, Cordylus tropidosternum, Eumeces obsoletus, 
Gecko gecko and Lepidophyma flavimaculatum) had mandibular mucous glands (eg Lepidophyma 
flavimaculatum in Fig. 2.1.1: F) and had only extremely small maxillary glands or lacked them entirely.
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Figure 2.1.1 Toxin recruitment in Toxicofera
Legend: Cladogram of evolutionary relationships of toxicoferan reptiles (Fry et al., 2006; 
Lee, 2009; Piskurek et al., 2006; Vidal and Hedges 2002, 2004, 2005, 2009) showing relative 
timing of toxin recruitment events and derivations of the venom system. * indicates toxin 
type with relative gene recruitment event timing changed due to results from this study. B) 
Magnetic resonance imaging of C. ruffus showing the rictal (green) and maxillary/mandibular 
glands (orange). Histochemically stained in B) Masson’s Trichrome C. ruffus rictal gland and C) 
Periodic Acid Schiff’s Aspidites melanocephalus mandibular gland; both with 5mm histology scale 
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bars. Mandibular glands stained with D) Masson’s Trichrome Anolis equestris showing the mixed 
sero-mucous gland or E) Periodic Acid Schiff’s Lepidophyma flavimaculatum showing the purely 
mucous secreting gland. N = nucleus; SE = secretory epithelial cells (SE); V = enlarged vesicles..
Transcriptome sequencing
Sequencing of transcriptomes of iguanian lizard and ‘basal’ snake glands, recovered transcripts 
encoding for proteins homologous to toxins previously characterised from anguimorph lizards or 
caenophidian snakes: 3FTx, CRiSP, crotamine (b-defensin), CVF (cobra venom factor), cystatin, 
ESP (epididymal secretory protein), kunitz peptide, L-amino oxidase, lectin, RAP (renin aspartate 
protease), veficolin, and vespryn (Table 2.1.1). Phylogenetic analyses showed all toxicoferan 
sequences to be monophyletic relative to endogenous body sequences, strongly suggestive of a 
single early recruitment, and in most cases the lizard and snake sequences were not reciprocally 
monophyletic, thus conclusively demonstrating a single early origin for that protein type. 
Intriguingly, whenever a particular toxin type was recovered, identical toxin transcripts were present 
in mandibular and maxillary glands within a species and in the case of C. ruffus, the identical 
transcripts were also recovered from the rictal gland in addition to the aforementioned glands.
Table 2.1.1
3FTx recovered from the ‘basal’ snakes form a clade with the reptile and bird specific toxins 
(Fry et al. 2003b; Fry et al. 2008; Pawlak and Kini 2008) from non-front fanged snakes along 
with the sequences from the viperid snake Sistrurus catenatus Fig. 2.1.2. The C. ruffus and A. 
melanocephalus isoforms shared a unique, newly evolved cysteine immediately prior to doublet 
formed by the eighth and ninth ancestral cysteine. This results not only in a novel cysteine 
pattern but also in an odd number of cysteines (eleven). These changes would have structural 
implications not only for disulphide-bridging but also in the potential facilitation of dimerisation. 
One C. ruffus variant has an exon deletion removing a significant N-terminal stretch of residues 
including five cysteines, resulting in a novel short peptide containing six cysteines (Fig. 2.1.3).
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Figure 2.1.2
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Some iguanian lizard crotamine (b-defensin) sequences shared with the anguimorph lizard 
sequences unique proline-rich, highly charged N-terminal extensions not seen in the snake venom 
forms (Fig. 2.1.4). Sequence alignment and lack of phylogenetic affinity indicates that these novel 
proline rich regions are convergently evolved. The iguanian crotamine (b-defensin) sequences 
were also the most phylogenetically divergent of all the iguanian transcript types (Fig. 2.1.5). 
Figure 2.1.3 Sequence alignment of three-finger toxins
Legend:  1. JX467124.1, 2. JX467170.1, 3. JX467122.1, 4. JX467123.1, 5. O93422 Naja atra, 
6. Q9PRI1 Micrurus corallinus, 7. Q9W717 Naja atra, 8. Q9W727 Bungarus multicinctus, 9. 
P25676 Hemachatus haemachatus, 10. O12961 Bungarus multicinctus, 11. Q9PW19 Bungarus 
multicinctus, 12. Q9YGH9 Bungarus multicinctus, 13. P43445 Bungarus multicinctus, 14. P01409 
Dendroaspis angusticeps, 15. P22947 Dendroaspis polylepis, 16. P25677 Naja annulifera, 17. 
P24778 Hemachatus haemachatus, 18. P80495 Dendroaspis polylepis, 19. P14534 Bungarus fasiatus, 
20. P82662 Ophiophagus hannah, 21. A7X3L3 Enhydris polylepis, 22. A7X3M3 Psammophis 
mossambicus, 23. A0S864 Boiga irregularis, 24. Q9W7J9 Pseudonaja textilis, 25. P15818 Bungarus 
multicinctus, 26. Q9YGI0 Bungarus multicinctus, 27. P0C1Y9 Dendroaspis angusticeps, 28. P25681 
Dendroaspis polylepis, 29. P81946 Dendroaspis angusticeps, 30. P10459 Laticauda laticaudata, 31. 
P60237 Dendroaspis angusticeps. ‘+’ indicates N-terminal known only from peptide sequencing.
Figure 2.1.4 Sequence alignment of Toxicofera crotamine (b-defensins)
Legend:  1. Q2XXN6 Pogona barbata, 2. Q2XXP0 Pogona barbata  3. Pogona barbata, 4. 
Pogona barbata  5. Uromastyx aegyptica, 6. Uromastyx aegyptica, 7. JX467135 Varanus tristis, 8. 
JX467132 Varanus glauerti, 9. JX467133 Varanus glauerti, 10. JX467134, Varanus glauerti, 
11. JX467131 Varanus glauerti, 12. O57540 Crotalus durissus terrificus, 13. G9DCI6 Crotalus 
oreganus helleri, 14. G9DCI4 Crotalus oreganus helleri, 15. H2FLD8 Thamnodynastes strigatus.
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All lizard kunitz sequences had the same two-domain structure as the sequence from the 
venom of the caenophidian snake Austrelaps labialis (Fig. 2.1.6). Phylogenetic analyses showed 
that the two domain forms were basal to the derived mono-domain form (Fig. 2.1.7). The 
‘basal’ snake lectin toxins had the galactose-binding EPN tripeptide functional motif while the 
C. calyptratus form is of the lactose-binding QPD motif. Phylogenetic analysis showed that the 
sequences containing the functional motifs EPN and QPD were not reciprocally monophyletic (Fig. 
2.1.8). Two variants of novel cysteine-rich peptide class were recovered from the A. melanocephalus 
and C. ruffus (Genbank accession numbers JX467493 and JX467494), which did not displayed 
homology to any previously characterised peptide class from any source, toxin or non-toxin. 
Figure 2.1.6 Sequence alignment of Kunitz peptides
Legend:  1. JX459935 Abronia graminea, 2. JX467158 Heloderma suspectum cinctum, 3. 
JX467155 Chameleo calyptratus, 4. JX467157 Iguana iguana, 5. H9G8B3 Anolis carolinensis, 
6. H9GQ81 Anolis carolinensis, 7. H9GRC6 Anolis carolinensis, 8. B2BS84 Austrelaps labialis, 
9. B5L5M7 Austrelaps superbus, 10. Q6T6S5 Bitis gabonica, 10 A7X3V4 Telescopus dhara. Grey 
blocks indicate kunitz peptide domains that are posttranslationally cleaved from the precursor.
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Figure 2.1.8
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Molecular evolution analyses
Examination using the highly conservative ORM (one ratio model) revealed considerable 
variability in molecular evolutionary rates in the proteins encoded by the transcripts we recovered. w 
values ranged from indicating strong influence of positive selection through to tremendous negative 
selection: crotaline snake crotamine (b-defensin) = 1.42; ‘basal’ snake lectin = 1.30; caenophidian 
snake CRiSP = 1.15; varanid crotamine (b-defensin) 1.10; homalopsid snake veficolin = 0.86; 
anguimorph lizard CRiSP = 0.56; iguanian lizard veficolin = 0.52; iguanian lizard crotamine 
(b-defensin) = 0.43; iguanian lizard cystatins = 0.42; ‘basal’ snake 3FTx = 0.48; toxicoferan ESP = 0.34.
Since lineage-specific models of selection such as ORM often fail to detect episodic diversifying 
selection that affects only a few sites in the protein, we also employed site-specific models (Tables 
2.1.2-2.1.3; Fig. 2.1.9). Like ORM, site model M8 w values also ranged widely (Tables 2.1.2-
2.1.3 and Fig. 2.1.9): crotaline snake crotamine (b-defensin) = 3.23; ‘basal’ snake lectin = 1.51; 
varanid lizard crotamine (b-defensin) = 1.10; caenophidian snake CRiSP = 1.21; ‘basal’ snake 
3FTx = 0.77; anguimorph lizard CRiSP = 0.70; iguanian lizard crotamine (b-defensin) = 0.70; 
iguanian lizard cystatin = 0.55; iguanian lizard veficolin = 0.49; toxicoferan reptile ESP = 0.47. The 
Bayes Empirical Bayes (BEB) method identified sites under positive selection for some toxin types 
(Tables 2.1.2-2.1.3 and Fig. 2.1.9): 25% (40 sites) in the ‘basal’ snake lectins; 24% (14 sites) in 
the crotaline snake crotamine; 10% (24 sites) in the homalopsid caenophidian snake veficolin; 8% 
(17 sites) in the caenophidian snake CRiSP; 2% (4 sites) in the anguimorph lizard CRiSP; while 
identifying only a single positively selected site each in iguanian crotamine (b-defensin) and veficolin.
Table 2.1.2
Comparing the w values estimated by the above models can be misleading, since the genes being 
compared may have a different proportion of sites under selection. Hence, we employed the Clade 
Model C approach for effectively comparing the evolution of anguimorph lizard, iguanian lizard 
and crotaline snake crotamines; iguanian lizard and homalopsid snake veficolins and anguimorph 
lizard and caenophidian snake CRISPs (Table 2.1.3). Clade model analyses indicated that the 
crotaline snake crotamines (w=4.43) and homalopsid snake veficolins (w=3.06) have accumulated 
greater variations than their iguanian lizard crotamine (b-defensin) (w=3.61) and veficolin (w=0.33) 
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counterparts. The varanid crotamine (b-defensin) peptides were less diverse (w=1.97) than either the 
snake or iguanian lizard counterparts, which may be a reflection of the fact that the varanid sequences 
were recovered from two closely related species while the other lizard and snake sequences were 
representative of much greater taxonomical diversity. The analysis also revealed that the caenophidian 
snake CRISPs (w=3.94) have evolved more rapidly than the anguimorph lizard CRISPs (w=2.04). 
All these aforementioned analyses were significant (P<<0.001) in comparison with site model 
M1a. Single Likelihood Ancestral Counting (SLAC), Fixed Effects Likelihood (FEL), Random 
Effects Likelihood (REL), Mixed Effects Model of Evolution (MEME) and the identification 
of hypervariable regions, conclusively support these results (Tables 2.1.2-2.1.3 and Fig. 2.1.9).
Table 2.1.3
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Figure 2.1.9A
Legend:  Molecular evolution of basal lectin, 3FTx, epididymal secretory protein (A, B and C, 
respectively) and iguanian Cystatin (D). The number of positively-selected sites (Codeml: Model 8, PP 
≥ 0.95, Bayes-Empirical Bayes approach) and hypervariable regions are highlighted in red and orange, 
respectively. Various omega statistics (M8 omega value, total number of positively selected sites detected 
by M8 (PP ≥ 0.95, BEB)) and the number of positively and negatively selected sites detected by HyPhy 
integrative approach (SLAC and FEL: 0.05 significance; REL 50 Bayes factor) are also indicated.
 69
ChaptEr ii
Figure 2.1.9B
Legend:  Molecular evolution of iguanian lizard and crotaline snake crotamines (b-defensins) (A 
and B, respectively), iguanian lizard and Homalopsidae snake veficolins (C and D, respectively). 
The number of positively-selected sites (Codeml: Model 8, PP ≥ 0.95, Bayes-Empirical Bayes 
approach) and hypervariable regions are highlighted in red and orange, respectively. Various 
omega statistics (M8 omega value, total number of positively selected sites detected by M8 (PP 
≥ 0.95, BEB)) and the number of positively and negatively selected sites detected by HyPhy 
integrative approach (SLAC and FEL: 0.05 significance; REL 50 Bayes factor) are also indicated.
Proteomics
Proteomic analysis of the A. melanocephalus secretion was able to confirm the presence of the 
two dominant transcript types: 3FTx and lectin. Tandem MS spectra of tryptic fragments provided 
high confidence matches for each of the two toxin sequences (Appendix 1.1). The low number of 
identified proteins, despite the large amount of analysed sample (1 µg), supports the histological 
findings that the maxillary and mandibular glands of A. melanocephalus are primarily mucoidal but 
that low levels of protein secretion continue. The 3FTx present in the secretion was present in the 
identical <10kDa region in 1D gel analysis under reducing and non-reducing conditions (Fig. 2.1.10), 
demonstrating that the free cysteine (Fig. 2.1.3) is buried and thus does not promote dimerisation.
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Figure 2.1.10
Figure 2.1.11
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4.1.5 Discussion
Toxin gene recruitment events appear to have occurred in batches on three occasions: up to 
ten recruitments at the base of the toxicoferan tree; six in the common ancestor of anguimorph 
lizards and snakes; and eight more in the common ancestor of the caenophidian snakes (Fig. 
2.1.1). Thus this venom system appears to have a punctuated molecular evolutionary history. 
Our results significantly changed our perception of the relative timing of gene recruitment 
events for several toxin types (Fig. 2.1.1). 3FTx recruitment, previously thought to have occurred 
within the caenophidian snakes before the Viperidae split-off 54 million years ago (MYA), now 
appears to have occurred within the ancient Afrophidian snake clade at 104 MYA, a backwards shift 
of 50 million years (Vidal et al. 2009). RAP was previously only known from Echis venoms within 
the Viperidae snakes and thus was considered to be the result of a recruitment event some 20 MYA. 
As we recovered it from B. constrictor, the recruitment may also have occurred within the ancestral 
Afrophidian snakes, a backwards shift of 84 million years. Intriguingly, a homologous renin aspartate 
protease sequence from the A. carolinensis genome was nested within the snake sequences, strongly 
suggestive of recruitment at the base of the toxicoferan reptile radiation some 166 MYA, which 
would be a shift of 146 million years from Echis. However, sequencing of homologous iguanian 
lizard mandibular or maxillary gland mRNA transcripts or proteins must first be accomplished before 
this timing can be absolutely confirmed. Other toxin types, however, were conclusively shown to 
be ancestral to the toxicoferan reptiles: CRiSP, CVF, kunitz, L-amino oxidase, lectin, and veficolin. 
CRiSP, CVF, lectin and veficolin were previously sequenced from both snakes and anguimorph 
lizards but not from iguanian lizards, and thus this represents a backwards shift of 22 million years 
for the recruitment of this toxin type. Kunitz peptides and L-amino oxidase were considered exclusive 
to caenophidian snakes and thus our perception of the age of these toxin types shifts over 112 MYA. 
This ancestral molecular diversity is particularly intriguing considering that the iguanian lizards 
have only poorly developed ‘incipient’ venom glands. Despite these glands being of no obvious use 
in the feeding ecology of insectivorous or vegetarian species, and being predominantly mucoid in 
these lineages, they still secrete active peptides. Intriguingly, the highest expression level and greatest 
evidence of duplication and diversification within the iguanian transcripts was observed for the 
crotamine (b-defensin) and cystatin peptides. All other transcript types were recovered in lower 
levels and typically with only one or two isoforms. It is noteworthy that the ancestral activity of 
these two peptide types is antimicrobial (Shah and Bano 2008; Semple and Dorin 2012) - an activity 
which is retained by at least some isoforms expressed in the venoms of highly toxic front-fanged 
snakes. Another ancestral protein type, L-amino oxidase, also has well-documented anti-microbial 
activity (Gjersoe and Hundstad 2010). Thus, the trigger for the development of the toxicoferan 
venom system may have been the rapid co-option of a newly developed antimicrobial peptide 
secreting system. However, it must be highlighted that the other toxin classes ancestrally recruited 
and still expressed even in the iguanian venom system (at very low levels) include those which have 
been developed into neurotoxins [CRiSP (Brown et al. 1999; Yamazaki et al. 2002a; Yamazaki 
et al. 2002b; Wang et al. 2005; Wang et al. 2006a), vespryn (Pung et al. 2006) or hemotoxins: 
kunitz, lectin and likely veficolin (Yamazaki and Morita 2007)]. Thus, in the Iguania the evidence 
favours an antimicrobial function for the secretions of their ‘incipient venom system’. There is 
no known predatory function for the system within vegetarian or insectivorous species, although 
the significantly enlarged protein secreting region of species which predate upon vertebrates 
(Fig. 2.1.1: E) does point to a possible role in prey-capture. Conversely, the rapid accumulation 
of novel secretory frameworks appears to have underpinned the rapid radiation of the other 
toxicoferan reptile lineages (anguimorph lizards and the snakes). In particular, the venom system 
likely led to the explosive diversification of the caenophidian snakes (Pyron and Burbrink 2012).
The well-developed rictal glands in the ‘basal’ snake C. ruffus (Fig. 2.1.1: B), which are 
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entirely serous in composition (Fig. 2.1.1: C), suggest an active role for these structures in the 
life of these serpents. Similarly, the mandibular and maxillary glands of Cylindrophis are sero-
mucous while those of the powerful constricting highly derived boid and pythonid snakes, stain 
histologically as predominantly (but not exclusively) mucoidal. Of particular note is the encoding 
of the same toxin transcripts in maxillary, mandibular and rictal glands. This supports not only 
the hypothesised shared evolutionary history of the mandibular and maxillary glands (Fry et al. 
2006) but also provides the first evidence that the rictal glands are derived from the same system. 
The difference in gland structures and types between C. ruffus and the boid/pythonid snakes 
parallels the differences in their predatory ecology: with C. ruffus being representative of the 
presumably ‘basal’ snake condition in being only weak constrictors and feeding upon prey that 
is typically not wider than their head; while boid/pythonid snakes represent a derived clade that 
has developed powerful constriction as a new adaptation in order to predate upon massive prey 
items often much wider than their head. Thus, alternate selection pressures operate upon the oral 
glands of these snakes: C. ruffus would benefit from chemical assistance in prey capture; while 
the boid/pythonid snakes easily dispatch their prey using powerful constriction but have a need 
for appreciable amounts of mucous to lubricate the fur of mammalian or feathers of avian prey 
items. However, consistent with positive reaction generated by A. melanocephalus oral secretion 
in snake venom detection kit trials (Jelinek et al. 2004), our data demonstrates that the toxin 
genes are not only still transcribed but are also continue to be translated and secreted as relics 
of the venom system that the boids/pythonids have down-regulated. Although it is noteworthy 
that while A. melanocephalus is unusual amongst pythonids in that it feeds primarily on reptiles 
(slender prey items not dissimilar to those which C. ruffus preys upon), it is probable that their 
oral secretions are of little to no use in prey capture as the snakes rely upon constriction to kill 
the prey items. Despite this, however, they may be problematic for human bite victims as a result 
of their capacity to produce false-positives in the medical diagnosis of snake envenomation.
Our sequencing of transcripts that are homologous with well-characterised toxin types also 
provides new evidence for the continued diversification of the secreted proteins even within the 
glands of ‘basal’ snakes and iguanian lizards. One example is the cysteine changes in the 3FTx of 
‘basal’ snakes that could have profound structural implications not only on the conformation of the 
peptide but also the facilitation of dimerisation. However, our demonstration that the 3FTx in the 
A. melanocephalus secretion occupy the same <10kDa location under reducing and non-reducing 
conditions, demonstrates that the free cysteine (located as part of the cysteine-triplet near the 
C-terminus) is buried into the molecular core and thus does not promote dimerization. Our results 
also provide evidence for ancient derivations such as the early loss of cysteine four in the lectins with 
the replacement by glycine in one of the early duplicates. It had previously been unclear whether the 
EPN motif (which blocks platelets through mannose-binding sites), or the QPD motif (which blocks 
platelets through galactose-binding sites) was ancestral as the caenophidian snakes and anguimorph 
lizards each have both forms (Fry et al. 2004; Fry et al. 2010b). In this study, QPD was present in the 
sole sequence recovered from an iguanian lizard (Chamaeleo calyptratus). Thus the QPD motif appears 
to be ancestral whilst the EPN is an ancient derivation. However, as neither motif is monophyletic, a 
degree of convergence in one or the other or both cannot be ruled out. Some ‘basal’ snake isoforms 
have a glycine substituted for the fourth cysteine, a derivation shared with some caenophidian snake 
homologs but not lizards This indicates a secondary loss of this cysteine early in snake evolutionary 
history. In the kunitz peptides, the ancestral dual domain form previously sequenced from the 
caenophidian snake Austrelaps labialis was also recovered from the iguanian lizard C. calyptratus as 
well as the anguimorph lizards Abronia graminea and Heloderma suspectum cinctum (Koludarov 
et al. 2012). However, the derived mono-domain form favoured in caenophidian snake venoms was 
also recovered from iguanian lizards (C. calyptratus and C. kingii). Thus the loss of the first domain 
was a derivation that occurred prior to the organismal diversification of the toxicoferan ancestor.
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Evidence provided by various analyses of different ‘basal’ snake and iguanian peptides/proteins 
and mapping of mutations on the homology models indicates that several of these have accumulated 
variation under the strong influence of positive selection (Tables 2.1.2-2.1.3 and Fig. 2.1.9). The 
‘basal’ snake lectins in particular seem to have evolved rapidly (w=1.51; 40 positively selected (25%) 
sites). This estimated variation combined with the putative haemotoxic activity revealed by the 
conservation of functional motifs, may indicate a continuing role of lectins by these snakes, which 
are not known for using venom in prey capture. These analyses also revealed hypervariable regions in 
iguanian lizard crotamine (b-defensin) and veficolin basal toxins. The observed variation in several 
regions could be a result of the putative antimicrobial function of crotamine (b-defensin) peptides.
The recovery of novel protein scaffolds from the glands studied here reinforces how little 
is known about the protein composition of reptile venoms or the evolutionary history of the 
glands. This is underscored by the number and diversity of novel scaffolds recovered despite the 
relatively limited sampling employed, including an entirely new peptide class discovered in the 
pythonid libraries. The toxin types recovered in this study should not be considered as the full 
suite because the relatively limited sampling only recovered the dominant forms. More extensive 
sampling will no doubt recover novel isoforms of types identified to date as well as entirely new toxin 
classes. Of interest for follow-up investigations should be the relative secretion by the segregated 
mucous lobules in the independently derived mandibular systems of varanid and helodermatid 
lizards as well as the derived maxillary system of snakes. Both of these systems also have mucous 
and protein secreting cells divided into discrete glands, with the protein glands encapsulated. In 
the case of the anguimorph lizards, the varanids and helodermatids have independently derived 
the mandibular glands into complex compartmentalised glands. Further work is also needed 
to examine the relationship between transcription and translation, and thus the presence and 
representation of the proteins themselves in the secretory mixtures. These results highlight the 
relatively untapped potential of such complex mixtures as sources of novel investigational ligands 
or lead compounds for use in drug design and development. Of particular focus of follow-up work 
by us will be to investigate the bioactivity of iguanian and anguimorpha crotamine (b-defensin) 
peptides to determine relative degree of antimicrobial activity versus more derived activities such 
as neurotoxicity. It is hoped that these results will stimulate further investigation of these neglected 
glands and their secretory proteins in an increasingly diverse range of toxicoferan reptile species.

2.2
Structural and molecular 
diversiﬁcation of the 
Anguimorpha lizard 
mandibular venom gland 
system in the arboreal species 
Abronia graminea
Peer-reviewed, scientific publications resulting from this chapter.
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2.2.1 Abstract
In the past, toxinological research on reptiles has focused principally on clinically important 
species. As a result, our understanding of the evolution of the reptile venom system is limited. 
Here, for the first time, we describe the structural and molecular evolutionary features of the 
mandibular toxin-secreting gland of Abronia graminea, a representative of one of the poorly 
known and entirely arboreal lineages of anguimorph lizards. We show that the mandibular gland 
is robust and serous, characters consistent with those expected of a toxin-secreting gland in 
active use. A wide array of transcripts were recovered that were homologous to those encoded by 
the indisputably venomous helodermatid lizards. We show that some of these toxin transcripts 
are evolving under active selection and show evidence of rapid diversification. Helokinestatin 
peptides in particular are revealed to have accumulated residues that have undergone episodic 
diversifying selections. Conversely, the natriuretic peptides have evolved under tremendous 
evolutionary constraints despite being encoded in tandem with helokinestatins by the same 
gene precursor. Of particular note is the sequencing for the ﬁrst time of kunitz peptides from 
a lizard toxin-secreting gland. Not only is kunitz peptide shown to be an ancestral toxicoferan 
toxin, the ancestral state of this peptide is revealed to be a dual domain encoding precursor. 
This research provides insight into the evolutionary history of the ancient toxicoferan reptile 
venom system. In addition, it shows that even ‘clinically irrelevant’ species can be a rich source 
of novel venom components, worthy of investigation for drug design and biomedical research.
2.2.2 Introduction
The evolution of reptilian venoms has previously been inferred to have occurred at the 
base of a strongly supported clade termed the Toxicofera (Anguimorpha, Iguania and Serpentes) 
(Vidal and Hedges 2005; Fry et al. 2006; Wiens et al. 2012). Whilst nuclear gene sampling has 
been unable to resolved the relative relationships within this clade, the use of SINES has been 
useful (Piskurek et al. 2006). Critical to this conclusion of a single early evolution of reptile 
venom was evidence that toxin genes sampled from a variety of toxicoferan taxa demonstrated 
monophyly of lizard and snake toxins to the exclusion of non-venom homologues and that in 
some cases snake and lizard genes were not reciprocally monophyletic (Fry et al. 2006; Fry et al. 
2010a). One limitation to this approach is the potential inﬂuence incomplete sampling of gene 
homologues (i.e. both venom and non-venom duplicate genes) could have upon phylogenetic 
analyses-potentially resulting in gene trees that falsely depict toxin genes as monophyletic [cf. 
(Casewell et al. 2012a)]. However, the incorporation of recently sampled non-venom gene 
homologues into toxin family gene trees provided further support for the single early origin 
hypothesis, with character reconstruction analyses supporting the premise that reptile venom 
evolved at the base of the Toxicofera (Casewell et al. 2012a). Historically, the two members of 
the genus Heloderma were considered the only venomous lizards. However, recent discoveries 
on the origins of venom and associated structures in snakes and lizards have however, led to a 
paradigm shift in our understanding of the evolution of squamate venom systems (Vidal and 
Hedges 2005; Fry et al. 2006; Fry et al. 2009c; Fry et al. 2009d; Fry et al. 2012a). The current 
data suggest that venom in reptiles appeared approximately 170 million years ago and that 
all modern venomous reptiles share a common venomous ancestor. As a result, these animals 
have been collectively placed in the clade Toxicofera. The ancestral toxicoferan reptile possessed 
both maxillary and mandibular serous dental glands of relatively simple structure. These glands 
produced pharmacologically active compounds that acted as a substrate for the subsequent 
evolution of all the reptilian toxins. Iguanian lizards diverged whilst this system was still in a 
primitive state, and thus their dental glands apparently conferred no ecological advantage and 
have either been secondarily lost completely or retained in a seemingly incipient condition.
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The remainder of the clade subsequently split into two major radiations: the snakes, 
which evolved complex maxillary glands and in many cases lost the mandibular glands entirely 
and the anguimorph lizards in which the mandibular glands were retained and diversified whilst 
the maxillary glands were lost completely in all but one species examined to-date. As the toxin-
secreting systems of anguimorph lizards have received less attention than those of the more 
medically important venomous snakes, it remains unknown to what extent different toxin 
types have undergone structural and functional innovation within this major clade. Detailed 
knowledge of the Anguimorpha toxins is crucial for understanding of the structure, function 
and composition of the ancestral Toxicofera venom system, as well as for investigation of the 
parallel diversiﬁcation of the venom system in the two primary clades of venomous reptiles.
 Helodermatid lizards produce clinically complex envenomations with symptoms including 
extreme pain, acute local swelling, nausea, fever, faintness, myocardial infarction, tachycardia, 
hypotension and inhibition of blood coagulation (Bogert and del Campo 1956; Bouabboud and 
Kardassakis 1988; Hooker and Caravati 1994; Strimple et al. 1997; Cantrell 2003; Beck 2005). 
Venom studies have revealed a great diversity of components present in the venom of helodermatid 
lizards (Table 2.2.1). Previous work by us has shown that all anguimorph lizards share a core toxin 
arsenal produced by the mandibular toxin-secreting gland [Table 2.2.1; (Fry et al. 2006; Fry et al. 
2009a; Fry et al. 2010b)]. In our studies to-date, we have shown that Anguimorpha mandibular 
gland transcripts indeed encode bioactive peptides and proteins, with targets ranging from anti-
platelet (type III phospholipase A2) to novel peptides acting upon the cardiovascular system 
(celestoxin, cholecystokinin, goannatyrotoxin, helokinestatin and natriuretic) (Fry et al. 2006; Fry 
et al. 2009c; Fry et al. 2009d; Fry et al. 2010a; Fry et al. 2010b). Despite even non-helodermatid 
anguimorph species being a rich source of novel compounds, within the family Anguidae only 
three species have previously had their venom systems studied: Gerrhonotus infernalis (terrestrial), 
Celestus warreni (semi-fossorial) and Pseudopus apodus (fossorial) (Fry et al. 2010b). In particular, 
arboreal lineages have not been studied to-date. We address this imbalance by conducting in-depth 
analyses of the transcripts from the mandibular toxin-secreting gland of Abronia graminea, an 
arboreal generalist predator of both invertebrates and small vertebrates such as skinks. The results 
provided insights into toxin evolutionary history and the selection pressures that might have shaped 
them. Of particular focus were the natriuretic and helokinestatin peptides, which uniquely share 
a precursor, with the helokinestatins being a de novo evolution within the natriuretic precursor.
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Table 2.2.1 A. graminea sequences recovered
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2.2.3 Methods
Species Examined
Four A. graminea specimens were collected in the wild by BGF and ACS from 
Esperance, Mexico under the University of Melbourne Animal Ethics approval number 
03126. Animals were placed under surgical level anaesthesia using Zoletil and euthanised 
by decapitation whilst under anaesthesia. Glands were then dissected or heads preserved 
in formalin. Histology Histological sections were prepared from one specimen.
Whole heads were removed and a cut was made to the underside to allow fast penetration of the 
ﬁxative (10 % neutral buffered formalin). After a minimum of 2 days excess tissue was removed and 
the head immersed in Kristensen’s decalciﬁcation solution and placed on a rotor for 3 weeks. Before 
processing the head was bisected longitudinally for cutting transversely, at three microns, in two separate 
blocks. The processing schedule was: 10 % Formalin 2 h; Absolute ethanol 4 9 1 h; Histolene 3 9 1 h; 
Parafﬁn wax 2 9 90 min. The sections were taken every 100 microns stained Masson’s Trichrome stain.
cDNA Library Construction and Analysis Mandibular toxin-secreting glands of three specimens 
were pooled and total RNA extracted using the standard TRIzol Plus method (Invitrogen). Extracts 
were enriched for mRNA using standard RNeasy mRNA mini kit (Qiagen) protocol. mRNA was 
reverse transcribed, fragmented and ligated to a unique 10-base multiplex identiﬁer (MID) tag 
prepared using standard protocols and applied to one PicoTiterPlate for simultaneous ampliﬁcation 
and sequencing on a Roche 454 GS FLX? Titanium platform (Australian Genome Research Facility). 
Automated grouping and analysis of sample-speciﬁc MID reads informatically separated A. graminea 
sequences from the other transcriptomes on the plates, which were then post-processed to remove low 
quality sequences before de novo assembly using the MIRA software programme. Assembled contigs 
were processed using CLC Main Work Bench (CLC-Bio) and a variety of other bioinformatic tools to 
provide Gene Ontology, BLAST and domain/Interpro annotation (Conesa et al. 2005; Conesa and 
Götz 2008; Gotz et al. 2008). The above analyses assisted in the rationalisation of the large numbers 
of assembled contigs into phylogenetic ‘groups’ for detailed phylogenetic analyses outlined below.
Phylogenetic Analyses
Phylogenetic analyses were performed to allow reconstruction of the molecular evolutionary 
history of each toxin type for which transcripts were bioinformatically recovered. Toxin sequences 
were identified by comparison of the translated DNA sequences with previously characterised toxins 
using BLAST search (Altschul et al. 1997) of the Swiss-Prot/Uni-Prot protein database (http://
www.expasy.org/tools/blast/). Molecular phylogenetic analyses of toxin transcripts were conducted 
using the translated amino-acid sequences. Comparative sequences from other venomous reptiles 
and physiological gene homologues identified from non-venom gland transcriptomes were 
included in each dataset as outgroup sequences. To minimize confusion, all sequences obtained 
in this study are referred to by their Genbank accession numbers (http://www.ncbi.nlm.nih.gov/
genbank/) and sequences from previous studies are referred to by their UniProt/Swiss-Prot accession 
numbers (http://www.expasy.org). Resultant sequence sets were aligned using the programme CLC 
Mainbench. When presented as sequence alignments, the leader sequence is shown in lowercase 
and cysteines are highlighted in black. > and < indicate incomplete N/50 or C/3’ ends, respectively. 
Datasets were analysed using Bayesian inference implemented on MrBayes, version 3.1.2 (Ronquist 
et al. 2012). The analysis was performed by running a minimum of 1x107 generations in four 
chains, and saving every 100th tree. The log-likelihood score of each saved tree was plotted against 
the number of generations to establish the point at which the log-likelihood scores of the analysis 
reached their asymptote, and the posterior probabilities for clades established by constructing 
a majority rule consensus tree for all trees generated after the completion of the burn-in phase.
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Selection Analyses
In order to test whether natriuretic peptides and helokinestatins were inﬂuenced by positive- 
or negative-selection pressures, we employed the maximum likelihood models of coding-sequence 
evolution implemented in CODEML in PAML (Yang 2007) programme package version 
4, which compares the maximum likelihood estimates of dN and dS across an alignment to a 
predeﬁned distribution and uses empirical Bayes methods to identify individual positively selected 
site (Nielsen and Yang 1998). Site-speciﬁc models (Nielsen and Yang 1998) were employed for 
detecting diversifying selection across the sites in the helokinestatin and the natriuretic propeptide 
alignments. They statistically detect diversifying selection as a non-synonymous-to-synonymous 
nucleotide substitution rate ratio (ω) significantly greater than 1. Since no priori expectation exists 
for the distribution of ω values, we compared likelihood values for three pairs of models with 
different assumed b distributions: M0 (constant ω rates across all sites) versus M3 (allows the ω to 
vary across sites within ‘n’ discrete categories, n≥3); M1a (a model of neutral evolution) where all 
sites are assumed to be either under negative (ω=1) or neutral selection (ω=1) versus M2a (a model 
of positive selection) which in addition to the site classes mentioned for M1a, assumes a third 
category of sites; sites with ω>1 (positive selection) and M7 (b) versus M8 (b and ω), and models 
that mirror the evolutionary constraints of M1 and M2 but assume that ω values are drawn from 
a b distribution (Nielsen and Yang 1998). The estimations are considered signiﬁcant, only if the 
alternative models (M3, M2a and M8: allow sites with ω>1) show a better ﬁt in Likelihood-Ratio 
Test (LRT) relative to their null models (M0, M1a and M7: do not allow sites ω>1). LRT is estimated 
as twice the difference in maximum likelihood values between nested models and compared with the 
c2 distribution with the appropriate degree of freedom (the difference in the number of parameters 
between the two models). The Bayes empirical Bayes (BEB) approach (Yang et al. 2005) was used 
to identify amino acids under positive selection by calculating the posterior probabilities that a 
particular amino acid belongs to a given selection class (neutral, conserved or highly variable). Sites 
with greater posterior probability (PP≥95 %) of belonging to the ‘ω>1’ were inferred to be positively 
selected. We further employed a lineage-speciﬁc two-ratio model as well as the optimised branch-site 
test (Yang and Nielsen 2002; Zhang et al. 2005) to assess selection pressures acting upon individual 
lineages. A LRT was conducted by comparing the two-ratio model that allows omega to be greater 
than 1 in the foreground branch, with the null model that does not. The branch-site model by 
comparison, allows omega to vary both across sites of the protein and across branches in the tree and 
has reasonable power and accuracy to detect short bursts of episodic adaptations (Zhang et al. 2005).
Detection of positive selection using the aforementioned lineage-speciﬁc methods requires 
the foreground (lineage to be tested for positive selection) and background branches (rest of the 
lineages) to be deﬁned a priori. We used GA-Branch test (Pond and Frost 2005b) implemented 
in the HyPhy (Pond et al. 2005) package that does not require this information and works on the 
principle that there could be many models that better ﬁt the data than a single priori hypothesis 
and uses a robust multi-model inference to collate results from all models examined and provides 
conﬁdence intervals on dN/dS for each branch. We also used the branch-site Random-effects 
likelihood (REL) (Kosakovsky Pond et al. 2011) that performs a series of LRTs to identify lineages 
in the phylogeny that have a proportion of sites evolving under episodic diversifying selection 
pressures. The more advanced Mixed Effects Model Evolution (MEME) (Murrell et al. 2012) was 
also used to detect episodic diversifying selection. MEME employs Fixed-effects likelihood (FEL) 
along the sites and REL across the branches to detect episodic diversifying selection. We employed 
REL, FEL and Single Likelihood Ancestor Counting (SLAC) models (Kosakovsky Pond et al. 2005) 
to further provide signiﬁcant support to the above analyses and to detect sites under positive and 
negative selection. For clear depiction of the proportion of sites under selection, an evolutionary 
ﬁngerprint analysis was carried out using the ESD algorithm (Pond et al. 2010) implemented in 
Datamonkey. It has been suggested that the maximum-likelihood method of evaluating positive-
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selection produces false-positive results when no positively selected sites exist (Suzuki and Nei 
2004) or when positively and negatively selected sites are mixed (Anisimova et al. 2002).For this 
reason, further support for the PAML results was sought using a complementary protein level 
approach implemented in TreeSAAP (Woolley et al. 2003) which measures the selective inﬂuences 
on 31 structural and biochemical amino-acid properties during cladogenesis, and performs 
goodness-of-ﬁt and categorical statistical tests based on ancestral sequence reconstruction. Amino-
acid variability was estimated using the Selecton (Doron-Faigenboim et al. 2005) web server.
Test for Recombination
Recombination can confound phylogenetic and evolutionary selection analyses (Posada and 
Crandall 2002). Hence, we evaluated the effect of recombination on natriuretic and helokinestatin 
domains by employing Single Breakpoint Recombination and Genetic Algorithms for Recombination 
Detection (GARD) implemented in the Datamonkey server (Pond et al. 2005; Delport et al. 
2010). Potential breakpoints were detected using the small sample Akaike Information Criterion 
(AIC) and the sequences were compartmentalized before conducting the aforementioned analyses.
2.2.4 Results
Histology
The mandibular toxin-secreting gland of A. graminea consists of numerous discrete 
compartments. Similar to those of other Anguimorpha lizards examined to-date (Fry et 
al. 2010b), there is an arrangement of one compartment per tooth (Fig. 2.2.1: A). These 
glandular structures are enclosed by basally nucleated secretory epithelial cells that form a 
large vesicular region along the medial surface of the gland (Fig. 2.2.1: B). The toxin vesicles 
appear to be released via exocytosis into the lumen of the toxin-secreting gland (Fig. 2.2.1: B).
Figure 2.2.1
Toxin Molecular Evolution
BLAST analyses of transcripts recovered from A. graminea toxin-secreting gland cDNA 
libraries identiﬁed seven previously characterized toxicoferan toxins: CRiSP, cystatin, kallikrein, 
lectin, B-type natriuretic peptide, nerve growth factor, type III phospholipase A 2 and vascular 
endothelial growth factor. Phylogenetic analysis showed that they clustered together with 
homologous sequences from the mandibular toxin-secreting gland of other anguimorph lizards and 
also homologous sequences produced by the maxillary venom glands of snakes. The VEGF sequences 
were an exception, forming a clade with snake similar snake venom gland forms not secreted into 
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the venom rather than with the derived form secreted in snake venoms (Fig. 2.2.2). Key functional 
residues were conserved for CRiSP and cystatin sequences and CRiSP sequences also conserved the 
cysteine pattern. The A. graminea lectin sequences contain the EPN tripeptide motif that facilitates 
haemotoxic activity via the mannose-binding site (Drickamer 1992; Fry et al. 2008, 2010b). 
Figure 2.2.2
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Phylogenetically the A. graminea lectin sequences grouped with the sequence from Varanus indicus 
(which also contains the EPN motif ), rather than with the sequence from the more closely related 
Pseudopus [Ophisaurus] apodus (which contains instead the galactose-binding QPD motif ) (Fig. 2.2.3). 
Figure 2.2.3
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We recovered the ﬁrst full-length anguimorph lizard PLA 2 sequence obtained to date and this was 
revealed to have an extraordinarily long pro-peptide domain within the precursor region (Fig. 2.2.4).
Figure 2.2.4
Molecular evolution of venoM  
The A. graminea PLA 2 also had a long C-terminal tail containing multiple di-basic post-translational 
cleavage sites previously noted as a characteristic of Anguimorpha lizard PLA 2 (Fry et al. 2006; Fry et 
al. 2009d; Fry et al. 2010b). We also recovered kunitz peptides for the ﬁrst time from any lizard oral 
secretion—this toxin had previously only been recorded from snake venoms. The fragment recovered 
was of the two-domain type only sequenced once from a snake (Austrelaps labialis) (Doley et al. 2008). 
For comparison’s sake, we also sequenced a fragment from the mandibular venom gland of Heloderma 
suspectum cinctum and both anguimorph lizards contained the c-terminal extension (Fig. 2.2.5). 
Figure 2.2.5
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Phylogenetic analysis recovered the lizard and A. labialis two-domain 
forms as basally divergent from all the mono-domain forms sequenced from 
snake venoms, and the snake venom forms were non-monophyletic (Fig. 2.2.6).
Figure 2.2.6
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The highest degree of molecular evolution was displayed in the natriuretic transcripts. All A. 
graminea natriuretic sequences share a pattern along with those from G. infernalis of ﬁve helokinestatin 
variants contained with the precursor region (Fig. 2.2.7). The A. graminea sequences also contain a 
new variant PPPFIPFIP inserted after the third shared domain. This repeat preserves the conserved 
helokinestatin pattern of PPPxxPxxP, where the x residues are almost invariably hydrophobic (F, I, V, 
L). The domain encoding the natriuretic peptide shows the same high level of conservation shared with 
other anguimorph venom forms of this peptide. However, the A. graminea natriuretic peptide sequences 
share with those of Gerrhonotus the change to glutamic acid (E) from the ancestral key functional 
residue aspartic acid (D) at ring position 7. This is one of two mutations previously shown by us to 
greatly reduce the aortic smooth muscle relaxing potency of the Gerrhonotus form (Fry et al. 2010b).
Figure 2.2.7
The A. graminea sequences also uniquely contained the helokinestatin variant PPPFLPLVPR 
inserted after the ﬁfth helokinestatin repeat. The assumption of a single phylogenetic history for 
all sites in a sequence, which is a prerequisite for most phylogenetic analyses, can be violated by 
recombination which may cause elements with different genetic backgrounds to blend together. 
Thus, recombinant genes cannot be accurately described by a single/unique tree topology and 
recombination can inﬂuence selection analyses signiﬁcantly by elevating false positives. Recombination 
can have more impact on the site-to-site and branch-to-branch omega estimations relative to the 
global estimates. We screened natriuretic peptide and helokinestatin domains for recombination 
using GARD and SBP algorithms. GARD failed to identify any regions that underwent signiﬁcant 
recombination. SPB however, identiﬁed a single potential breakpoint at the 100th position with 
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a model-averaged support of 100 % and an IC (model with two trees) improvement of 79.73 
over the base (single tree) model when using the AIC. Subsequent analyses were conducted by 
compartmentalizing the multiple sequence alignment into two non-recombinant units. Initial 
selection analyses of full-length helokinestatin/natriuretic precursor (site-models, branch-models, 
branch-site models, SLAC, FEL, REL and evolutionary ﬁngerprinting) unanimously conﬁrmed the 
high degree of conservation, a trend observed in the natriuretic domain of this proprotein in other 
anguimorph venoms investigated to date (Tables 2.2.2-2.2.3; Fig. 2.2.8) (Fry et al. 2006; Fry et al. 
2009d; Fry et al. 2010a; Fry et al. 2010b). This was conﬁrmed by selection analyses at the level of the 
proteome conducted using TreeSAAP which apparently conﬁrmed that none of the 31 biochemical 
or structural properties of this proprotein were under signiﬁcant inﬂuence of selection. Although 
the branch and branch-site models failed to detect any signiﬁcant positive selection, the free-ratio 
model, GA-branch and Branch-site REL tests identiﬁed a small proportion of sites within the A. 
graminea and Heloderma lineages that had undergone signiﬁcant diversifying selection. In contrast, 
most of the varanid lizard natriuretic sequences appear to have evolved under negative selection. 
The observed diversifying selection in the Abronia and Heloderma sequences is a result of the 
presence of helokinestatin regions within them, which is unique to this clade and absent entirely in 
the varanid lizard venom form (Fry et al. 2006; Fry et al. 2009d; Fry et al. 2010a; Fry et al. 2010b). 
The two-speed rate of evolution was subsequently conﬁrmed by compartmentalizing the sequences 
into helokinestatin and natriuretic domains and performing selection analyses in CODEML which 
revealed that the former exhibits weaker evolutionary constraints than the latter (ω=0.60 and 0.30, 
respectively). Furthermore, investigations identiﬁed sites under the inﬂuence of positive Darwinian 
selection in the helokinestatin domain, in comparison with the natriuretic domain that largely 
remains under negative selection (Table 2.2.3). All the positively selected sites in the helokinestatin/
natriuretic precursor detected by SLAC, FEL and REL came only from those that specifically encode 
the helokinestatin domain. On the other hand, 27 % of the sites in natriuretic peptides were under 
negative selection in comparison with the 5 % of the total residues of the helokinestatin domain. Out 
of the four codons detected by MEME test as under the inﬂuence of episodic diversifying selection 
(signiﬁcance 0.05), three belonged to the helokinestatin domain whilst only one belonged to the 
natriuretic domain, further providing evidence for the differential selection pressures acting on the two 
domains of the pro-protein (Table 2.2.3). Assignment of sites into variable and invariable categories 
using the selecton web server revealed a greater number of variable codons in the helokinestatin 
domain than the natriuretic domain (21.36 and 12.19 % of total codons, respectively). In addition, 
the helokinestatin domain contained fewer sites evolving under constrained selection pressures than 
the natriuretic domain (27.27 and 41.46 % of total codons, respectively-Table 3). It should be 
noted that some varanid lizard lineages, namely Varanus komodoensis and one of the hypothetical 
ancestral clades (node 15: Fig. 2.2.8: B and node 14: Fig. 2.2.8: C), also exhibit a small proportion 
of sites with signiﬁcant diversifying selection. This indicates that the positive evolutionary selection 
pressures act on the natriuretic peptide domain, a phenomenon previously observed in other 
toxicoferan venom components (Fry et al. 2006; Fry et al. 2009d; Fry et al. 2010a; Fry et al. 2010b; 
Sunagar et al. 2012) and presumed to be the result of predator–prey co-evolutionary arms races. This 
could also be indicative of an active role for these components in the venom arsenal of these species.
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Figure 2.2.8
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Table 2.2.2 Maximum-likelihood parameter estimates for helokinestatin and natriuretic 
peptides
Table 2.2.3 Molecular evolution of helokinestatin domains
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2.2.5 Discussion
A ‘use it or lose it’ evolutionary trajectory has been documented previously in toxicoferan 
reptiles. Secondary loss or reduction of the venom system has been documented in several lineages 
of snakes including within highly toxic elapid clades (Li et al. 2005a; Li et al. 2005b; Fry et al. 2008; 
Fry et al. 2009a; Fry et al. 2009d; Fry et al. 2010a; Fry et al. 2012a). Thus, the presence of robust 
glands and evidence of active molecular evolution of some of the encoded proteins suggests that 
the toxin-secreting system is biologically and ecologically relevant for A. graminea. The A. graminea 
toxin-secreting glands examined in this study exhibited signs of active secretion, with cells full of 
secretory granules. In addition, the molecular evolution of A. graminea toxins displayed varying rates 
of evolution between different protein types, which provides further evidence that these components 
are biologically relevant and are ‘seen’ by active selection pressures. Some molecular derivations 
appear lineage-speciﬁc. For example addition to the ancestral kallikrein cysteine arrangement, a 
form was found in the A. graminea library that has only ever been recovered from the mandibular 
toxin-secreting glands other Anguimorpha lizards [(C. warreni and G. infernalis (Fry et al. 2010b)]. 
This Anguimorpha lizard-speciﬁc isoform includes a deletion resulting in the loss of 12th ancestral 
cysteine and the insertion of a new cysteine in between ancestral cysteines 9 and 10. We also 
showed for the ﬁrst time that the kunitz peptide toxin type is plesiotypic to all toxicoferan reptiles, 
as evidenced by the snake sequences being non-monophyletic relative to the lizard sequences.
The helokinestatin encoding domain which has evolved de novo within the natriuretic 
precursor pro-pep region displayed the most active molecular evolution of any toxin transcript 
recovered in this study. Several sequences of this toxin type possessed sites undergoing signiﬁcant 
episodic diversifying selection, which may be indicative of the active role of this component in 
the toxic arsenal of A. graminea. Thus, it would be quite interesting for future studies to assess 
the effect of the presence/absence of helokinestatins on the pharmacological activity of the oral 
secretions. In contrast, the natriuretic peptide encoding domain located just downstream of this 
element exhibits tremendous conservation. This shows that even very closely related toxins can 
undergo differential selection pressures. The natriuretic peptide region highlights the usefulness 
of toxins in understanding the structure–function relationships of the ancestral body form. We 
previously showed that the change from D (glutamic acid) to E (aspartic acid) at ring position 7 and 
I (isoleucine) to V (valine) at ring position 9 both resulted in signiﬁcant reduction in the potency of 
action upon vascular smooth muscle (Fry et al. 2010b). Both changes would normally be considered 
as conserved substitutions as they are negative/negative and hydrophobic/hydrophobic, respectively. 
In both cases however, whilst the substitutions have essentially the same chemical properties, they 
result in steric differences. This mirrors and reinforces the exquisite subtlety of venom peptide 
targeting. The extraordinarily long pro-pep region of the A. graminea PLA 2 may ultimately be 
shown to contain also posttranslationally liberated peptides, as has been demonstrated for some of
the other precursors with lengthy pro-pep regions such as the helokinestatin/natriuretic 
precursors. The NGF and VEGF sequences were interesting in their relationships to non-toxin 
sequences. The NGF sequences also seem to be under profound evolutionary constraints. Intriguingly, 
the A. graminea and snake venom gland transcripts of this protein are virtually identical to the G. 
infernalis (E2E4J3) and Heloderma suspectum (C6EVG7) nuclear gene sequences obtained for use 
in taxonomical studies (Wiens et al. 2010). This indicates that the NGF expressed in venom may be 
the same gene as is used in the body and therefore may be a rare case of a venom protein resulting 
from a non-duplicated gene. The VEGF sequences reinforce the value of phylogenetic analyses to 
establish homology, as there are two clades of VEGF that have been sequenced from snake venom 
glands: one type that is a part of the vasculature of the venom gland and the other type which is 
the form actually secreted in the venom. The form recovered in this study was of the former type 
and thus the VEGF toxins are not known to-date as a basal toxicoferan venom component and 
appear to be restricted to the advanced snakes. Consistent with the distinction between the body 
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form of a protein and its toxin homologue, the vascular VEGF display much less sequence variation 
than the venom sequences, indicating that they are evolving under negative selection whilst the 
actively secreted forms are evolving under positive selection. Our results show that even small 
arboreal anguimorpha lizard lineages retain the ancestral venom system and that the continued 
diversiﬁcation is indicative of continued evolution operating under selection pressure. Thus, these 
lizards are technically venomous. It should be stressed, however, that in no way do we suggest that 
these animals are ‘venomous’ from the perspective of a threat to human health and thus should 
not be considered as ‘venomous’ from the stand-point of dangerous animal legislation. We instead 
consider the analogy with spiders to be relevant: like spiders, anguimorpha lizards are venomous 
from a biological/evolutionary perspective but are harmless from the perspective of human health. 
Due to the relative sampling employed, the toxin types recovered in this study from the mandibular 
venom gland of A. graminea are no doubt but a subset of the total diversity encoded. More intensive 
sampling would almost certainly recover novel isoforms of known toxin types, perhaps even 
changing our knowledge of the timing of recruitment events, as well as even recovering entirely new 
suites of bioactive compounds. Regardless, this study has advanced our knowledge of lizard venom 
evolution by showing that even obscure arboreal species can be a rich source of novel sequences. 
Such new information is not only just of use for evolutionary investigations but also provides a 
pragmatic platform for the investigation of novel components as lead compounds in drug design 
and development. The strong evidence of positive selection on certain secretory toxins as well as 
the evolutionary conservation of others is highly suggestive of the active use of these secretory 
toxins in the ecology (either predatory or defensive) of this anguimorph lizard. Confirmation in 
future studies of the presence of these toxins in the secretory-proteome of A. graminea will add 
further strength to the hypothesis that the toxin-secreting oral glands of many toxicoferan lizards are 
not merely examples of ‘exaptation’ (for future development into ‘true venom glands’) but play an 
important role in the ecology of these species and are thus are true ‘venom glands’ by any deﬁnition.
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3.1.1 Abstract
Cysteine-rich Secretory proteins (CRiSPs) are glycoproteins found exclusively in 
vertebrates and have broad diversified functions. They are hypothesized to play important 
roles in mammalian reproduction and in reptilian venom, where they disrupt homeostasis of 
the prey through several mechanisms, including among others, blockage of cyclic nucleotide-
gated and voltage-gated ion channels and inhibition of smooth muscle contraction.
We evaluated the molecular evolution of CRiSPs in toxicoferan reptiles at both nucleotide 
and protein levels relative to their non-venomous mammalian homologues. We show that the 
evolution of CRiSP gene in these reptiles is significantly influenced by positive selection, and in 
snakes (ω=3.84) more than in lizards (ω=2.33), while mammalian CRiSPs were under strong 
negative selection (CRiSP1=0.55, CRiSP2=0.40 and CRiSP3=0.68). The use of ancestral sequence 
reconstruction, mapping of mutations on the three-dimensional structure and detailed evaluation 
of selection pressures, suggests that the toxicoferan CRiSPs underwent accelerated evolution aided 
by strong positive selection and directional mutagenesis; while their mammalian homologues are 
constrained by negative selection. Gene and protein-level selection analyses identified 41 positively 
selected sites in snakes and 14 sites in lizards. Most of these sites are located on the molecular 
surface (nearly 76% in snakes and 79% in lizards) while the backbone of the protein retains 
a highly conserved structural scaffold. Nearly 46% of the positively selected sites occur in the 
cysteine-rich domain of the protein. This directional mutagenesis, where the hotspot of mutations 
are found on the molecular surface and functional domains of the protein, acts as a diversifying 
mechanism for the exquisite biological targeting of CRiSPs in toxicoferan reptiles. Finally, our 
analyses suggest that the evolution of toxicoferan-CRiSP venoms might have been influenced by 
the specific predatory mechanism employed by the organism. CRiSPs in Elapidae, which mostly 
employ neurotoxins have experienced less positive selection pressure (ω=2.86) compared with 
the so called ‘non-venomous’, ‘non-front-fanged’ advanced snakes (ω=4.10) that rely on grip and 
constriction to capture the prey, and the Viperidae, a lineage that mostly employs haemotoxins 
(ω=4.19). Relatively lower omega estimates in Anguimorpha lizards (ω=2.33) than snakes (ω=3.84) 
suggests that lizards probably depend more on pace and powerful jaws for predation than venom.
3.1.2 Introduction
Each year, thousands of people die worldwide from envenomation by various species; despite 
the fact that many of these animals have sophisticated warning behaviour to avoid close encounters 
and that the resultant bites are mostly accidental or defensive in nature. Frequent bites from 
these animals in both developed and developing countries accentuates the importance of venom 
research. Intraspecific variation in venom composition, is likely influenced by multiple factors, 
including their phylogenetic history, diet, predator pressure, etc. (Sasa 1999; Barlow et al. 2009), 
can be large (Daltry, Wuster, Thorpe 1996; Tsai et al. 2007), which complicates the production 
of antivenom. Therefore, the assessment of diversifying mechanisms and selection pressures 
influencing the evolution of venom-encoding genes can potentially provide valuable information 
for structure-based drug design and the production of life-saving antidotes of greater specificity.
Venomous predators often employ a concoction of polypeptides and other molecules 
with diverse biological activities in their venom to attack multiple homeostatic systems within 
the prey in very specific and targeted manners. Venom components can target numerous 
physiological pathways, tissues and cell types that are accessible via blood and lymphatic systems 
or by direct injection into the musculature. Evolution of the venom arsenal in snakes has been 
studied considerably, with research recently focusing largely on venom-coding genes including 
phospholipase A2, snake venom disintegrins, snake venom metaloproteinases (SVMP) and 
lectins. (Kini, Chan 1999; Calvete et al. 2003; Fry 2005; Morita 2005; Lynch 2007; Soto et al. 
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2007; Peichoto et al. 2010). However, there is a lack of understanding of the evolution of cysteine-
rich secretory proteins (CRiSPs) in toxicoferan reptiles, a hypothetical venomous clade comprising 
all the venomous and related non-venomous reptile species of the suborder Serpentes and Iguania 
(Snakes and Lizards: Anguidae, Varanidae and Helodermatidae). CRiSPs belong to a large family 
of proteins found extensively in vertebrates and they participate in diverse biological processes 
(Kitajima, Sato 1999; Udby et al. 2002; Gibbs et al. 2007; Gibbs, O’Bryan 2007). CRiSPs are 
particularly enriched in the pancreatic tissues, salivary glands, reproductive tracts (Kierszenbaum et 
al. 1981; Haendler et al. 1993; Schambony et al. 1998) and reptilian venom ducts (Hill, Mackessy 
2000; Yamazaki, Hyodo, Morita 2003; Fry et al. 2006). They have diverse biological activities 
including inhibition of various ion-channels and the inducement of proteolysis and paralysis of 
prey. There are several venom CRiSPs with no known acute toxic effects or functions (Chang, Mao, 
Guo 1997).  Scope and details of mammalian and reptilian CRiSPs in reproduction, immune system 
and venom are poorly understood and will require increased evolutionary and functional analyses. 
CRiSPs are single polypeptide proteins with molecular weights of ~20-30 kDa (Yamazaki, 
Morita 2004; Yamazaki, Morita 2007) and are known to have a high degree of amino acid sequence 
similarity, and a highly conserved specific pattern of 16 cysteine residues. Ten of these cysteine residues 
form an integral part of the highly conserved cysteine-rich domain (CRD) at the C-terminus. The 
CRD is composed of two domains, a hinge region and an ion-channel regulator domain (ICR).  A 
few reptilian venom CRiSPs have been shown to interact with ryanodine receptors (RyRs), perhaps 
through the ICR, to inhibit the release of Ca2+ ions, thus inhibiting smooth muscle fiber functions 
(Nobile et al. 1994; Morrissette et al. 1995). ‘Pseudechetoxin’ isolated from the venom of Australian 
king brown snake (Pseudechis australis) has been shown to inhibit cyclic nucleotide-gated (CNG) 
ion channels.  Many other targets such as Potassium and Calcium channels have also been suggested 
(Wang et al. 2005; Wang et al. 2006) and there could be many more targets yet to be discovered.
There are three types of CRiSPs in most mammals [CRiSP1:  AEG or Acidic Epidydymal 
Glycoprotein (AEG), CRiSP2: Testis-specific protein 1 and CRiSP3: specific granule 
protein)]. A fourth type has been described only in mice (CRiSP 4). It is hypothesized that 
the ancestral salivary gland CRiSP was modified as a venom-component in the toxicoferan 
reptiles rather than the usual gene-recruitment events that have led to the multiple copies of 
other venom proteins like PLA2, disintegrins, metaloproteinases, defensins, etc. (Fry 2005).
In this study, we assessed for the first time the evolutionary history and selection pressures influencing 
the toxicoferan CRiSPs using both gene- and protein-level approaches. We tested the hypothesis of 
whether reptilian CRiSP variation has accumulated under the regime of positive selection and if their 
mammalian homologs were constrained because of their importance in other functions. Finally, we 
investigate the implications of observed mutations in the three-dimensional structure of the snake 
and lizard CRiSP proteins to obtain further insight into the evolution of reptilian toxicoferan venom.
3.1.3 Methods
Sequence Retrieval and Alignment
To assess the molecular evolution of cysteine-rich secretory proteins, we compiled a 
dataset of 119 nucleotide sequences (46 Snakes + 21 Lizards + 52 Mammals).  Nucleotide and 
protein sequences were downloaded from National Center for Biotechnology Information 
(NCBI: http://www.ncbi.nlm.nih.gov/) and UniProt databases (http://www.uniprot.org/) 
respectively. The sequences (identified by their GenBankTM accession numbers) were retrieved 
by using BLAST. Complete cDNA sequences from each lineage of toxicoferan-reptiles 
(Elapidae: AY299475.1; Viperidae: AY181983.1; ‘Non-front-fanged’ (NFF) advanced snakes: 
DQ139891.1; Anguimorpha lizards: EU790958.1) were used to retrieve the reptilian CRiSPs 
while one sequence from each type of mammalian CRiSPs (CRiSP1: GU985267.1; CRiSP2: 
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BT030687.1; CRiSP3: BC102058.1) was used for the retrieval of the mammalian sequences.
The translated nucleotide sequences were aligned using MUSCLE 3.8 (Edgar 2004). The 
alignments were manually inspected and edited by eye. We used the 16 universally conserved 
cysteine residues as anchors to refine the alignment. Gblocks (Talavera, Castresana 2007) was 
used to remove regions that had gaps in more than 50% of the sequences in the alignment.
Phylogenetic Analyses
The best-fit model of nucleotide substitution for our dataset was determined as TIM3+G+I by 
jModeltest (Posada 2008), according to Akaike’s information criterion (AIC). Model averaged parameter 
estimates of gamma shape parameter (alpha) and the proportion of invariant sites (pinvar) were used 
for phylogenetic reconstruction.  The phylogenetic relationships among the toxicoferan-reptilian 
CRiSPs were determined using Bayesian and maximum-likelihood approaches. MrBayes version 3.1 
(Huelsenbeck, Ronquist 2001; Ronquist, Huelsenbeck 2003) was used for Bayesian inference. Tree 
searches were run using four Markov chains for a minimum of 10 million generations, sampling every 
100th tree. The log likelihood score of each saved tree was plotted against the number of generations 
to establish the point at which the log-likelihood scores of the analyses reached their asymptote. 
25% of the total trees sampled were discarded as burnin. The posterior probabilities for clades were 
established by constructing a majority rule consensus tree for all trees generated after the completion 
of the burnin. The analyses were repeated three times to make sure that the trees generated were not 
clustered around local optima. An optimal maximum likelihood phylogenetic tree was obtained using 
PhyML 3.0 (Guindon et al. 2010) and node support was evaluated with 1,000 bootstrapping replicates. 
Phylogenetic trees were rooted using the mouse (NM_009639.2) and the human (X94323.1) 
CRiSP3 sequences. Dendroscope (Huson et al. 2007) was used to prepare the phylogenetic tree.
Sequence divergence (F84 genetic distance) was plotted against the transition (s) and 
transversion (v) rates and a test of nucleotide substitution was carried out using DAMBE (Xia, 
Xie 2001; Xia et al. 2003) to evaluate the influence of saturation of nucleotide substitutions 
on the evolutionary inferences. Recombination analyses were done using Single Breakpoint 
Recombination and Genetic Algorithms for Recombination Detection (GARD) implemented in the 
Datamonkey server  (Pond, Frost, Muse 2005; Kosakovsky Pond et al. 2006; Delport et al. 2010).
Selection Analyses
Maximum likelihood models of coding-sequence evolution implemented in CODEML 
in the PAML  (Yang 2007) package of programs version 4 were used to test the hypothesis 
that functional diversification of snake and lizard venom CRiSP genes is driven by positive 
Darwinian selection. PAML compares the maximum likelihood estimates of dN and dS 
across an alignment to a predefined distribution and uses empirical Bayes methods to 
identify individual positively selected site (Nielsen, Yang 1998; Yang, Bielawski 2000). 
We evaluated the evidence for positive selection on CRiSP genes in the toxicoferan reptiles and 
their homologous mammalian counterparts by employing branch models. The most simple one-ratio 
model assumes the same dN/dS for all the branches in the phylogenetic tree (Goldman, Yang 1994). 
The assumption of constant evolutionary selection pressure on all the lineages in the phylogenetic 
tree over millions of years of evolutionary time sounds quite unrealistic. Hence, the free-ratio model 
assumes separate dN/dS ratios for all branches in the tree. However, this model is parameter rich and 
is prone to inaccurate estimations (Yang et al. 2000). Both the one-ratio and the free-ratio models 
detect positive selection when the average of omega values over the entire length of protein is greater 
than one – i.e. when the majority of the amino acids are under the influence of selection. To assess 
selection pressures acting upon individual lineages, we employed the two-ratio model as well as the 
optimised branch-site test (Yang, Nielsen 2002; Zhang, Nielsen, Yang 2005). A likelihood-ratio 
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test was conducted by comparing the two-ratio model that allows omega to be greater than 1 in the 
foreground branch, with the null model that does not. The branch-site model by comparison, allows 
omega to vary both across sites of the protein and across branches in the tree and has reasonable 
power and accuracy to detect short bursts of episodic adaptations (Zhang, Nielsen, Yang 2005). 
Unlike the lineage specific branch and branch-site models, the GA-Branch Test implemented 
in the HyPhy (Pond, Frost 2005) package does not require the foreground and background branches 
to be defined a priori. The algorithm works on the principle that there could be many models that 
better fit the data than a single a priori hypothesis and uses a robust multi-model inference to collate 
results from all models examined and provides confidence intervals on dN/dS for each branch.
Another draw-back of most lineage specific models is that they assume a single omega value 
for the entire length of the sequence. They lack the ability to identify sites in proteins that might be 
under the influence of positive selection more than others, such as the surface of venom molecules. 
Thus lineage specific models can underestimate the degree of positive selection acting on biological 
sequences. To account for rate variation among sites we used the site-specific models (Nielsen, Yang 
1998; Yang 2000), which are powerful tools for detecting diversifying selection. Positive selection 
is detected statistically as a non-synonymous-to-synonymous nucleotide-substitution rate ratio (ω) 
significantly greater than 1. Because no a priori expectation exists for the distribution of ω values, 
we compared likelihood values for three pairs of models with different assumed ω distributions: 
M0 (constant ω rates across all sites) versus M3 (allows the ω to vary across sites within ‘n’ discrete 
categories, n≥3); M1a (a model of neutral evolution) where all sites are assumed to be either under 
negative (ω <1) or neutral selection (ω = 1) versus M2a (a model of positive selection) which in 
addition to the site classes mentioned for M1a, assumes a third category of sites; sites with ω >1 
(positive selection) and M7 (Beta) versus M8 (Beta and ω), and models that mirror the evolutionary 
constraints of M1 and M2 but assume that ω values are drawn from a beta distribution (Nielsen, 
Yang 1998). Only if the alternative models (M3, M2a and M8: allow sites with ω >1) show a better 
fit in Likelihood Ratio Test (LRT) relative to their null models (M0, M1a and M8: do not show 
allow sites ω >1), are their results considered significant. LRT is estimated as twice the difference in 
maximum likelihood values between nested models and compared with the c2 distribution with the 
appropriate degree of freedom - the difference in the number of parameters between the two models. 
The Bayes empirical Bayes (BEB) approach (Yang, Wong, Nielsen 2005) was used to identify amino 
acids under positive selection by calculating the posterior probabilities that a particular amino acid 
belongs to a given selection class (neutral, conserved or highly variable). Sites with greater posterior 
probability (PP ≥ 95%) of belonging to the ‘ω > 1 class’ were inferred to be positively selected.
Some studies have suggested that the maximum-likelihood method of evaluating 
positive selection produces false positive results even when no positively selected sites exist 
(Suzuki, Nei 2004) or when positively selected sites and negatively selected sites are mixed 
(Anisimova, Bielawski, Yang 2002). Further support for the PAML results was obtained 
using a complementary protein level approach implemented in TreeSAAP (Woolley et al. 
2003). Models of reptilian and mammalian cysteine-rich proteins depicting the overall 
conservation of Amino acids were built using the Consurf webserver (Ashkenazy et al. 2010).
Detection of positive Darwinian selection across lineages using branch and branch-site 
models requires the foreground branches (lineages tested to be under positive selection) and 
background branches (rest of the lineages) to be defined a priori. When a predefined biological 
hypothesis is unavailable or the functions of genes are not well understood, then it becomes difficult 
to define foreground branches. A possible approach then would be to treat each branch in the 
phylogeny alternately as the foreground lineage and test multiple hypotheses. A likelihood-ratio 
test can then conducted by comparing a model that allows omega to be greater than 1 in the 
foreground branch, with the same model where foreground branches are constrained to have an 
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omega equivalent to 1. It is suggested that when using the branch-site model to test multiple 
branches in the phylogenetic tree for positive selection, it is necessary to control the family-wise 
error rate (FWER or Type I error) (Zhang, Nielsen, Yang 2005). Bonferroni’s correction is the 
easiest method to achieve this, which uses α/n as the significance level to test each hypothesis; 
where ‘α’ is the significance level and ‘n’ being the number of independent true null hypotheses. 
If the lineages have different proportion of sites under selection, then comparing their 
omega estimates to assess the strength of selection could be misleading. This can be overcome 
by estimating the omega simultaneously for the datasets being compared. We employed the clade 
model analyses (Bielawski, Yang 2004) to facilitate an effective comparison between different 
lineages of reptiles. These models are based on the branch-site models allowing variations in the 
omega value among the sites with a proportion of sites evolving under divergent selection between 
the clades. To clearly depict the proportion of sites under selection, an evolutionary fingerprint 
analysis was carried out using the ESD algorithm implemented in datamonkey (Pond et al. 2010).
Ancestral Sequence Analyses
To understand the evolutionary pathway that shaped the extant cysteine-rich secretory 
proteins over millions of years, we reconstructed ancestral sequences using the ancestral 
sequence reconstruction (ASR) algorithm implemented on the Datamonkey server (Delport 
et al. 2010) and used a maximum-likelihood based joint reconstruction approach (Pupko et al. 
2000). We evaluated selection pressures acting on the ancestral toxicoferan-reptilian CRiSPs 
and mapped the sites under positive selection on their three-dimensional crystal structure.
Functional Divergence
We used the maximum-likelihood method implemented in Diverge 2.0 (Gu 1999) to 
test if there was any significant change in evolutionary rates at Amino acid sites of the cysteine-
rich secretory proteins after the reptilian lineages diverged. The method estimates the expected 
substitutions at each Amino acid site and then calculates the coefficient of functional divergence 
(q) which is the probability that evolutionary rate at a site is statistically independent between the 
two gene-clusters. Such sites are referred to as Type I sites if they are conserved in one subfamily but 
vary greatly in another, implying that they have been subjected to different functional constraints 
and hence might have different functions. The coefficient of functional divergence (q) and the 
posterior probability for functional divergence were calculated for each position in the alignment. 
Structural analyses
To depict the underlying effects of the selection pressures on reptilian and mammalian 
CRiSPs, we mapped the sites under positive selection on their crystal structures. We used the Swiss-
model server (Arnold et al. 2006)  to search for the homologous sequence with the highest identity, 
whose three-dimensional structure was already deduced empirically by X-ray crystallography or 
NMR.  The crystal structures of 2gizA (Natrin: Naja atra) and 2ddbB (Pseudecin: Pseudechis 
porphyriacus) were obtained from the Swiss-model server as the best-fit template for the target 
CRiSP sequences from Ophopphagus hannah: AY299475.1 (~86% identity) and Varanus tristis: 
GU441468.1 (~50% identity) respectively while 1wvrA (Triflin: Trimeresurus flavoviridis) was 
determined as the best fit template for the mammalian CRiSPs (~86% identity). Sequences of 
all these structures were used in the analyses. Pymol (DeLano 2002) was used to produce the 
images of the three-dimensional models of CRiSPs. The program GETAREA (Fraczkiewicz, Braun 
1998) was used to calculate the Accessible Surface Area (ASA) / solvent exposure of Amino acid 
side chains. It uses the atom co-ordinates of the PDB file and indicates if a residue is buried or 
exposed to the surrounding medium by comparing the ratio between side-chain Accessible 
Surface Area (ASA) and the “random coil” values per residue. An Amino acid is considered to 
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be buried if it has an ASA less than 20% and exposed if ASA is more than or equal to 50%.
3.1.4 Results and Discussion
Lizards are generally not associated with venom, not because they lack venom but because 
most lizards lack a specialized venom-delivery apparatus to inject venom into the prey for maximum 
effect. Until recently, only two species of lizards (genus Heloderma) with venom potent enough to 
kill humans were considered venomous. Despite possessing an arsenal of deadly venom components, 
most NFF advanced snakes cannot efficiently deliver venom in sufficient quantities, and thus 
do not pose a serious medical threat to humans. However, it is now recognized that even the 
Anguimorpha lizards and all NFF advanced snakes possess venom-encoding genes (Fry et al. 2006).
Many venom-components are hypothesized to evolve via the birth and death model of 
evolution, where new genes are created by repeated duplication events, and are subsequently 
either maintained in the genome or deleted or become non-functional by pseudogenisation (Fry 
et al. 2003a; Lynch 2007). Directional selection reinforces the functionally important toxin types 
through adaptive evolution, creating a venom-gland-specific multigene family (Fry et al. 2008). 
The likelihood of neofunctionalisation is increased through random mutation, gene conversion 
and unequal crossing-over (Fry et al. 2003a). The inevitable arms race between the predator and 
prey leads to precise biological targeting as a single amino acid change could alter the specificity 
or potency of the toxin. Toxicoferan-reptilian CRiSPs are unique in that they are derived through 
the evolutionary modification of an ancestral CRiSP present in the salivary gland rather than 
gene-recruitment events (Fry 2005). Mammals, in contrast, have three types of CRiSPs (and a 
fourth type in mice) that derive from mammalian lineage specific gene duplication events.
To assess how these venom proteins evolved in the reptilian lineage in comparison with their non-
venomous mammalian homologues, we employed both nucleotide and Amino acid-level selection 
analyses. We conducted the site, branch, branch-site and clade model tests to identify sites under positive 
selection and to assess its influence on the three-dimensional structure and function of the CRiSP protein.
CRiSP Phylogeny
Bayesian and maximum-likelihood analyses of toxicoferan-reptilian CRiSPs retrieved 
phylogenetic trees with similar topologies (Figure 1). The overall topology of these phylogenetic 
trees is not in concordance with the generally accepted reptilian phylogeny (Kelly, Barker, 
Villet 2003). Viperidae is the most basal clade of Colubroids or the advanced snakes followed, 
by Elapidae and the NFF advanced snakes. However, the phylogenetic trees incorrectly depict 
Elapidae as the most basal clade, which reflects often-observed differences between the gene and 
species trees (Rosenberg 2002). We note that three elapid sequences form a clade within the NFF 
advanced snake CRiSPs, while other sequences from the same species group with other elapids as 
expected. The topology of the phylogenetic trees could be the result of ancestral polymorphisms 
given that CRiSPs were recruited in reptiles before the divergence of the toxicoferan lineages.
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Figure 3.1.1 Molecular phylogeny of toxicoferan-reptilian CRiSPs
Legend: Branches with the Bayesian posterior probability (B.P.P) greater than 0.85 and 850 
or more (out of 1000) bootstrap replicate support (BS) are presented as thick lines. Branches 
that have lower BS (<850) but a stronger B.P.P support (> 0.85) are presented as “B.P.P | B.S”. 
Branches under positive selection are represented as gray lines (red lines in the online version of 
the publication). The three-dimensional models of CRiSPs depicting the Amino acid variability 
are also shown along with the omega estimate (Clade Model C) of the respective lineages.
When studying sequences that are separated by millions of years of evolutionary time, 
saturation of nucleotide substitution can bias evolutionary inferences. Substitution saturation 
can result in an underestimation of dS and an inflation of dN/dS. We plotted the sequence 
divergence (F84 genetic distance) against the transitions (s) and transversions (v) rates and 
found no evidence for nucleotide saturation at the 3rd position or any other position.  The 
Index Score (ISS) remained significantly lower than the critical score (ISS.C). We also 
evaluated the effects of recombination and found no evidence for recombination in the dataset.
Selection Analyses
To assess the consequence of positive Darwinian selection on CRiSP proteins, we 
used likelihood models of coding-sequence evolution (Goldman, Yang 1994; Yang 1998) 
implemented in CODEML of the PAML (Yang 2007) package (Table 1 and Table 2).
The one-ratio model is the simplest of the branch-specific models and estimates a 
single ω value for all branches in the phylogeny. The estimate of global ω for the snake 
CRiSP gene under this model is 1.14. This is an average over all codons and lineages and 
thus highlights the dominant role of positive selection in shaping snake venom CRiSPs. 
Global ω estimates for lizard CRiSPs was 0.78 (Table 2). In contrast, mammalian CRiSPs 
exhibit significant negative selection (CRiSP1: 0.42, CRiSP2: 0.32 and CRiSP3: 0.50). 
Because the branch-model estimates omega for each lineage by averaging over all the branches 
and the site-models by averaging over all the sites, they often fail to identify episodic adaptations that 
affect only few Amino acids and/or lineages. Hence, we employed the branch-site model (Table 1) 
that allows omega to vary both across the lineages in the phylogenetic tree and across the sites in the 
genes and hence have a reasonable power and accuracy to detect short bursts of episodic adaptation 
targeting fewer Amino acid residues (Zhang, Nielsen, Yang 2005).  The branch-site model-A 
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identified ~25% of sites (ω=3.76) in snakes and only ~18% of the sites (ω=3.21) in lizards as under 
positive selection. The omega-estimates for individual snake lineages, revealed greater evidence of 
positive selection in Viperidae (~15% of sites; ω=5.66) than Elapidae (~16% of sites; ω=5.52) and 
NFF advanced snake (~8% of sites; ω=6.73) considering both the number of positively selected 
sites and the strength of positive selection (Table 1). We employed multiple-test corrections using 
Bonferroni’s test to keep the family-wise error rate (FWER) less than alpha (at 0.1% significance).
The estimated ω in snakes under the clade models is 3.84 in comparison with 2.33 in 
lizards (LRT=295.3, degree of freedom=3, P << 0.001), again highlighting the dominant role of 
positive Darwinian selection on the snakes. The analyses of individual snake lineages revealed that 
the influence of positive selection on Viperidae (ω=4.19) is more than that of Elapidae (2.86) 
and the NFF advanced snake lineages (ω=4.10) [LRT=231.39; degree of freedom=3; p<<0.001]. 
Table 3.1.1 Lineage-specific maximum-likelihood parameter estimates for toxicoferan-rep-
tilian CRiSPs
Model ωa Likelihood Prop. of sites withω>1b
Sites with 
ω>1c Signi
d
Caenophidia
Two-ratioModel 1.21 -10370.88844 - - *P << 0.001
Branch-site Model A 3.76 -9915.548688 25.3% 23 (PP ≥ 0.99) 13 (PP ≥ 0.95) *P << 0.001
Clade Model C 3.84 -9876.069435 20.0% - P << 0.001
Anguimorpha
Two-ratio Model 0.64 -10465.99893 - - *P << 0.001
Branch-site Model A 3.21 -10093.64418 18.1% 3 (PP ≥ 0.99)12 (PP ≥ 0.95) *P << 0.001
Clade Model C 2.33 -9876.069435 20.0% - P << 0.001
‘Non-front-fanged’ advanced snakes
M8 1.42 -3508.159988 28.0% (ω2= 3.89)
22 (PP ≥ 0.99)
16 (PP ≥ 0.95) P << 0.001
Two-ratio Model 1.16 -10382.84638 - - N.S
Branch-site Model A 6.73 -9997.185149 8.1% 3 (PP ≥ 0.99)3 (PP ≥ 0.95) *P << 0.001
Clade Model C 4.10 -6578.072786 23.7% - P << 0.001
Viperidae
M8 1.42 -2077.819161 22.7%(ω2= 5.24)
18 (PP ≥ 0.99)
7 (PP ≥ 0.95) P << 0.001
Two-ratio Model 1.05 -10383.8539 - - N.S
Branch-site Model A 5.66 -9998.09742 15.0% 3 (PP ≥ 0.99)6 (PP ≥ 0.95) *P << 0.001
Clade Model C 4.19 -6578.072786 23.7% - P << 0.001
Elapidae
M8 1.50 -2874.216899 25.3%(ω2= 4.45)
15 (PP ≥ 0.99)
14 (PP ≥ 0.95) P << 0.001
Two-ratio Model 1.28 -10381.65348 - - N.S
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Model ωa Likelihood Prop. of sites withω>1b
Sites with 
ω>1c Signi
d
Branch-site Model A 5.52 -9981.464478 16.1% 4 (PP ≥ 0.99)6 (PP ≥ 0.95) *P << 0.001
Clade Model C 2.86 -6578.072786 23.7% - P << 0.001
Legend:
a: dN/dS (weighted average)
b: Proportion of sites with ω>1
c: Number of sites with ω>1 under Bayes empirical Bayes approach with a posterior probability (PP) 
of more than or equal to 0.99 and 0.95
d: Significance of the model in comparison with the null model
*: Significant at 0.001after Bonferroni correction
NS: Not significant
We further employed the site specific models that account for rate variation across the 
sites (Table 2). Estimates using the Bayes Empirical Bayes (B.E.B) approach implemented in 
M8 suggested that up to ~26% of the residues in snakes and 16% of the residues in the lizard 
CRiSPs are under positive selection. In snake CRiSPs, site model M2a and M8 detected 37 and 
38 positively selected Amino acid residues respectively under the B.E.B approach. Model M2a 
detected 24 sites with PP ≥ 0.99 and 13 sites with PP ≥ 0.95 while site model M8 detected 26 
sites with PP ≥ 0.99 and 12 sites with PP ≥ 0.95. In lizards however, model 2 identified only 
10 Amino acid sites (2 sites with PP ≥ 0.99 and 8 sites with PP ≥ 0.95) under selection while 
model 8 identified 14 such sites (6 sites with PP ≥ 0.99 + 8 sites with PP ≥ 0.95). Clearly, 
Darwinian selection seems to be much more influential in snake than lizard CRiSPs both in terms 
of number of Amino acids under selection and the strength of selection (Table 1 and Table 2).
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Table 3.1.2 Site-specific maximum-likelihood parameter estimates for toxicoferan-reptilian 
CRiSPs
Model Likelihood (l) ωa Parameters Significanceb No. of Sites with  ω>1c
Caenophidia
M0 (One ratio) -6964.393838 1.14 = ω0
M0 (constrained) -6965.771794 1.0 ω0constrained to 1
M1 (Neutral) -6711.896261 0.55
P0: 0.48460
ω0: 0.07
P1: 0.48460
ω1: 1.0
M2 (Selection)* -6595.953989 1.24
P0: 0.39687
ω0: 0.05
P1: 0.36260
ω1: 1.0
P2: 0.24054
ω2: 3.58
P << 0.001
M3 (Discrete)* -6593.227401 1.37
P0: 0.43544
ω0: 0.08
P1: 0.38890
ω1: 1.0
P2: 0.17566
ω2: 1.0
P << 0.001 24(PP ≥ 0.99)13 (PP ≥ 0.95)
M7 (beta) -6713.705160 0.52 p: 0.16753q: 0.15459
M8 (beta and  ω)* -6598.579842 1.22
p0: 0.745
p: 0.162
q: 0.183
p1: 0.255
ω: 3.43
P << 0.001 26 (PP ≥ 0.99)11 ( PP ≥ 0.95)
Anguimorpha
M0 (One ratio) -3647.864377 0.78 =ω0
M0
(constrained) -3650.682815 1.0 ω0constrained to 1
M1
(Neutral) -3588.206161 0.59
P0: 0.45529
ω0: 0.10
P1: 0.54471
ω1: 1.0
M2
(Selection)* -3566.671365 1.04
P0: 0.38959
ω0: 0.10
P1: 0.47093
ω1: 1.0
P2: 0.47093
ω2: 3.73
P << 0.001 2 (PP ≥ 0.99)8 (PP ≥ 0.95)
M3
(Discrete)* -3566.221975 1.01
P0: 0.23786
ω0: 0.00
P1: 0.56320
ω1: 0.68
P2: 0.19894
ω2: 3.15
P << 0.001
M7 (beta) -3590.931288 0.59 p: 0.18663q: 0.12454
M8
(beta and  ω)* -3566.284106 1.02
p0: 0.836
p: 0.304
q: 0.183
p1: 0.253
ω: 3.44
P << 0.001 6 (PP ≥ 0.99)8 ( PP ≥ 0.95)
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Legend:
a: dn/ds (weighted average)
b: Significance of the model in comparison with the null model 
c: Number of sites with ω > 1 under the Bayes empirical Bayes approach with a posterior probability 
(PP) more than or equal to 0.99 and 0.95
*: Models which allow ω > 1
The omega estimation under M8 for the mammalian CRiSPs was 0.55, 0.40 and 0.68 for CRiSP1, 
CRiSP2 and CRiSP3 respectively. The likelihood ratio of model 8 was not significant in comparison 
with model 7 (Table 3) and none of the models of positive selection were significant in comparison 
to their null models (Supplementary material). To evaluate if mammalian CRiSPs evolve under the 
influence of negative selection we employed the Fixed-effects likelihood and Random-effects likelihood 
models that identify Amino acids evolving under positive and negative selection. The results suggest 
that there is a strong influence of negative selection on the mammalian CRiSPs (Table 3), which may 
be attributed to functional constraints on these proteins, perhaps because of their hypothesized role in 
reproductive pathways and any genetic variation might easily affect homeostasis. Notwithstanding, a 
few positively selected Amino acid sites were detected in CRiSP3 with codeml model 8, FEL and REL.
Table 3.1.3 Maximum-likelihood parameter estimates for mammalian CRiSPs
FEL REL SLAC PAML
ω>1d ω<1e ω>1d ω<1e ω>1d ω<1e ω M8(ω) ω>1f
CRiSP1 0 32 0 All 0 10 0.50 0.55 N.S 5
CRiSP2 3 49 3 49 0 5 0.40 0.40 N.S -
CRiSP3 1 21 1 21 0 8 0.61 0.68 N.S 4
Legend
a: Fixed-effects likelihood
b: Random-effects likelihood
c: Single Likelihood Ancestor Counting
d: Number of positively selected sites at 0.05 significance
f: Number of positively selected sites under B.E.B approach with posterior probability greater than 
0.95
N.S: Not significant in comparison with the null model M7 (beta)
Selection analyses at the nucleotide level alone cannot distinguish events that may contribute 
to the diversification of the toxin molecules. The maximum likelihood method of evaluating positive 
selection may sometimes retrieve false positive results (Anisimova, Bielawski, Yang 2002; Ashkenazy 
et al. 2010). Hence, to provide additional support for the Amino acid sites detected to be under 
positive selection by PAML, we employed a complementary protein-level approach implemented 
in TreeSAAP (Woolley et al. 2003) (Table 4). TreeSAAP measures the selective influences on 31 
structural and biochemical amino acid properties during cladogenesis, and performs goodness-of-fit 
and categorical statistical tests based on ancestral sequence reconstruction. The number of radical 
changes in the Amino acid properties was used as a proxy for determining the strength of positive 
selection at a particular Amino acid position (more radical changes in Amino acid properties might 
indicate adaptive evolution). An empirical value of 6 Amino acid property changes was set as a 
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threshold. Thus, the residues that had lesser than 6 Amino acid property changes were categorized 
as type I sites while those that had more than 6 were categorized as type II sites. There were 41 sites 
detected by both PAML (Model 2 and Model 8, BEB analysis, PP ≥ 0.95) and TreeSAAP (p ≤ 0.001) 
as under positive selection in snake CRiSPs (Table 5). Ten of these sites were Type I (more than or equal 
to six radical changes in Amino acid properties).  However, in lizards, only 11 sites were detected by 
both PAML and TreeSAAP to be under positive selection and of these none were Type II. This further 
emphasizes that snake CRiSPs not only have more number of positively selected sites, but that they 
also experience greater selection pressures at these sites in comparison with their lizard homologs.
Table 3.1.4 Amino acid sites under positive selection
Position A. A M2a M8 Chemical Structural Total ASA
Snakes
30 Q 3.495±0.12 3.496±0.095 - αC  V0 2 92.9%
73 N 3.392±0.512 3.417±0.453 - αC 1 57.6%
75 N 3.31±0.664 - - αC 1 35.0%
76 L 3.396±0.444 3.421±0.444 - αC 1 7.0%
81 D 3.501±0.011 3.5±0.011 - αC 1 75.9%
82 Y 3.501±0.016 3.5±0.016 - αC  BI 2 78.9%
83 S 3.454±0.297 3.465±0.297 - αC BI 2 37.5%
87 E 3.499±0.053 3.499±0.053 - αC  2 57.7%
100 N 3.496±0.092 3.497±0.092 pK’ αC 2 82.6%
102 R 3.5±0.031 3.5±0.031 pK’ αC 2 28.2%
103 A 3.472±0.226 3.48± 0.226 pK’ αC 2 64.3%
106 E 3.492±0.121 3.494±0.121 pK’ αC 2 47.2%
110 L 3.501±0.005 3.5±0.005 pK’ αC Ra NS HP 5 32.9%
115 Y 3.497±0.081 3.497±0.081 pK’ αC Ra Pβ NS HP 6 47.1%
119 V 3.471±0.237 3.478±0.237 pK’ αC Ra Pβ NS HP 6 53.2%
145 I 3.501±0.011 3.5±0.011 pK’ αC Ra Pβ HP 5 0%
150 N 3.492±0.124 3.494±0.124 pK’ αC RaPβ HP 5 22.9%
156 E 3.501±0.005 3.5±0.005 pK’ αC Ra Pβ HP 5 63.9%
168 S 3.282±0.706 - pK’ αC RaPβ Hnc NS HP 7 21.7%
171 M 3.5±0.025 3.5±0.025 pK’ αC RF Ra Pβ Hnc NS HP 8 45.9%
172 R 3.501±0.004 3.5±0.004 - αC  BI RF Ra Pβ Hnc NS HP
8 87.0%
174 S 3.499±0.057 3.499±0.057 - αC  BI RF Ra Pβ Hnc NS HP
8 54.4%
186 G 3.386±0.475 3.409±0.475 - αC    BI PC RF Ra Pβ Hnc NS HP
9 41.7%
202 T 3.402±0.429 3.426±0.429 - αC  BI PC RF RaPβ NSαm HP
9 97.9%
203 L 3.501±0.004 3.5±0.004 - αC  BI PC RF RaPβ NS αm HP
9 65.1%
204 Y 3.499±0.058 3.499±0.058 - αC  BI PC RF Ra Pβ αm 7 33.6%
206 E 3.501±0.004 3.5±0.004 - αC  BI Ra Pβ αm 5 40.0%
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207 Y 3.45±0.308 3.462±0.308 - αC Pβ αm 3 35.3%
211 D 3.445±0.322 3.459± 0.322 - αC αm 2 88.7%
212 S 3.499±0.05 3.499±0.05 - αC αm 2 55.9%
214 V 3.356±0.535 3.383±0.535 - αC αm 2 47.6%
215 K 3.432±0.36 3.448±0.36 - αC αm 2 78.1%
217 S 3.501±0.005 3.5±0.005 - αC fαm 2 45.0%
218 S 3.5±0.035 3.5±0.035 - αC 1 60.0%
220 Q 3.46±0.278 3.469±0.278 - αC 1 95.6%
222 E 3.254±0.746 - - αC 1 90.8%
223 W 3.488±0.148 3.491±0.148 - αC 1 55.7%
224 I 3.481±0.19 3.486±0.19 - αC 1 4.1%
226 S 3.465±0.259 3.473±0.259 - αC 1 60.2%
231 S 3.394±0.445 3.42±0.445 - αC 1 19.9%
235 H 3.501±0.019 3.5±0.019 - αC 1 84.3%
Anguimorpha Lizards
18 H 3.634±0.736 2.016±1.129 - pHi  αC 2 -
65 T 3.678±0.661 3.086±0.581 - αC 1 59.1%
85 T 3.684±0.649 3.089±0.575 pK’ pHi   αC 3 86.3%
86 S 3.681±0.657 3.087±0.579 pK’ c   pHi   αC 3 86.1%
130 T 3.586±0.806 3.059±0.623 - pHi   αC 2 91.5%
149 T 3.600±0.790 3.060±0.623 - αC 1 0.0%
158 A - 3.000±0.703 - αC 1 80.3%
160 R 3.706±0.605 3.096±0.563 - αC 1 71.9%
176 E 3.671±0.676 3.084±0.585 - αC 1 100.0%
181 E - 3.015±0.680 - αC 1 33.3%
184 A 3.693±0.633 3.091±0.572 - αC 1 56.5%
187 E - 2.987±0.718 - pHi   αC 2 87.0%
207 H - 3.017±0.682 - pHi  αC 2 41.0%
210 Q 3.610±0.778 3.060±0.624 - pHi   αC 2 72.2%
Legend
Amino acid sites detected by PAML and TreeSAAP as under positive selection along with the ω 
estimation and Bayesian (BEB) analysis posterior probabilities for sites with P ≥ 95% under M2 and 
M8 models.
TreeSAAP: Radical changes in Amino acid properties (chemical, structural and other property 
changes) under category 6 and/or 7 and/or 8. Amino acid sites that belong to the Type II class 
(greater than 6 property changes) are represented in bold letters.
Amino acid property symbols used: Average number of surrounding residues (Ns), β-structure 
tendencies (Pβ), Bulkiness (Bl), Composition (c), Chromatographic index (RF), Coil tendencies 
(Pc), Equilibrium constant for ionization of COOH (pK’), Isoelectric point (pHi), Normalized 
consensus hydrophobicity (Hnc), Partial specific volume (V0), Polar requirement (Pr ), Power to be 
at C-terminus of the α-helix (αc), Power to be in the middle of an α-helix (αm), Solvent accessible 
reduction ratio (Ra), Surrounding hydrophobicity (Hp)
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Structural analyses
To investigate selection patterns and to assess their influence on the structure and function of 
these molecules, we mapped the sites under selection on the crystal structure of CRiSPs (Figure 2 and 
Figure 3). Previously-studied snake venom proteins like PLA2, three-finger toxins, etc. have evolved 
via mutations targeted around their functional domains while the structural residues are constrained 
and maintain a highly conserved scaffold (Mackessy 2002; Kini 2004; Fry et al. 2006; Yamazaki, 
Morita 2007; Doley et al. 2008; Fry et al. 2008). Similarly, both snake and lizard CRiSPs had a 
highly conserved structural scaffold while most mutations were located in the functional domains. 
They have 16 cysteines that form eight disulphide bridges and are universally conserved in all CRiSP 
proteins (Guo et al. 2005).  Interestingly, 10 of these cysteine residues are located in the c-terminus as 
part of the CRiSP domain. This Cysteine Rich Domain (CRD) has structurally flanking six cysteine 
repeats that exhibit a high degree of similarity with the K+ channel-blocking venom from anemones 
(Alessandri-Haber et al. 1999; Guo et al. 2005; Shikamoto et al. 2005; Lange et al. 2006; Suzuki 
et al. 2008). The CRD domain in one of the mammalian CRiSP has been shown to be associated 
with the ion channel regulatory activity (Gibbs et al. 2006). Hence, this region could mediate the 
interaction of CRiSPs with ion-gated channels in other toxicoferan-reptiles as well. In snake CRiSPs, 
44% (18) of the total Amino acids (41) under positive selection were located on the CRD domain. 
Remarkably, out of the 38 Amino acids defining the CRD, 18 were under positive selection. However, 
some findings suggest that CRD alone might not be enough to mediate such interactions and other 
domains, particularly PR-1 might also be essential (Suzuki et al. 2008). We found 22 positively-
selected amino acids within the PR-1 domain. Thus both CRD and PR-1 domains act as molecular 
hotspot for mutations which could facilitate the interaction of CRiSPs with various ion-gated 
channels. Variations in PR-1 domain could also be due to the bi-functionality of these proteins with 
the CRD mediating ion-channel interactions while PR-1 performs yet-to-be identified functions.
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Figure 3.1.2 Molecular Evolution of Caenophidian Cysteine-rich Secretory Proteins 
Legend: Three-dimensional model of snake CRiSPs depicting the locations of positively selected Amino 
acid sites detected by PAML (Model 2 and Model 8, PP ≥ 0.95) and TreeSAAP (p < 0.001). Type I (n ≤ 6 amino 
acid property changes) and type II Amino acid sites (n ≥ 6) are shown in dark and light colours, respectively.
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Figure 3.1.3 Molecular Evolution of Anguimorpha Lizard Cysteine-rich Secretory Proteins
Legend: Three-dimensional model of lizard CRiSPs depicting the locations of positively selected Amino 
acids detected by PAML (Model 2 and Model 8, PP ≥ 0.95) and TreeSAAP (p ≤ 0.001). Type I Amino acids 
(n ≤ 6 amino acid property changes) are shown. There were no type II residues (n ≥ 6) in the lizard CRiSPs.
Venom components like phospholipase A2 (PLA2: belongs to a family of diversely 
distributed protein phospholipases) in snakes are known to accumulate numerous mutations 
on the outer surface of the molecule (Kini, Chan 1999). Our analysis reveals that CRiSPs 
exhibit the same pattern (Figure 3). Of the 41 Amino acid sites identified to be under positive 
selection by both PAML and TreeSAAP, 31 (75.6%) were located on the outer surface of the 
snake CRiSP molecule with an Accessible Surface Area (ASA) ratio of at least 40%, while the 
remaining 10 are buried with an ASA of less than 20%. In the lizard CRiSPs, of the 14 Amino 
acids under selection, 11 (78.5%) were exposed while only 2 were buried. This is likely a general 
characteristic of venoms, where the molecular surface is diversified while the structurally important 
residues are constrained. This preserves the venom function (especially if it is an enzyme) while 
simultaneously diversifying the range of target cells and tissues. This enables predators to more 
readily adapt to the new ecological niches by being able to rapidly exploit new prey species.
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Figure 3.1.4 Surface accessibility of Cysteine-rich Secretory Proteins
Legend: A plot of Amino acid positions (x-axis) against accessible surface area (ASA) ratio (y-axis) 
indicating the positions of Amino acids (exposed or buried) in the crystal structure of toxicoferan-reptilian 
CRiSPs is presented. The snake CRiSP Amino acids are represented as small and large (positively selected) 
dots, while the lizard CRiSP Amino acids are represented as small and large (positively selected) squares. 
Amino acids with an ASA ratio of more than 50% are considered to be exposed to the surrounding 
solvent while those with a ratio lesser than 20% are considered to be buried. Three dimensional models 
of snake and lizard CRiSPs depicting the locations of positively selected sites are also presented.
Ancestral Sequence Analyses
We reconstructed the ancestral toxicoferan-reptilian CRiSPs to assess patterns and strength of 
selection pressures and to detect shifts in evolutionary pressures during the course of evolutionary 
time (Figure 4). We further mapped the sites under positive-selection on the crystal structure of 
CRiSPs to depict their locations and to determine the effect of selection on the structure and 
function of these proteins. Our analysis reveals that the ancestral cysteine-rich secretory proteins of 
both snakes and lizards were influenced less by positive selection than modern forms.  Many residues 
in the extant Viperidae CRiSPs appear to show less variation compared with the ancestral forms. 
Thus it is evident that these proteins undergo shifts in selection pressures across different time-scales.
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Figure 3.1.5 Amino acid variability in Ancestral and Extant toxicoferan CRiSPs
Legend: Three-dimensional models depicting the amino-acid variability in ancestral 
and extant toxicoferan reptilian CRISPs. Phylogenetic trees showing the nodes that 
were sampled for creating the three-dimensional models of ancestral toxicoferan 
CRISPs and for the calculation of selection pressures are shown on the right.
Functional Divergence
Greater magnitude of negative selection pressure at an Amino acid position can imply 
a functional importance of that Amino acid (Kimura 1983). Hence, the site-specific shifts in 
evolutionary rates of paralogous/orthologous proteins could imply functional divergence. The 
Gu99 likelihood ratio test was used to detect if proteins had functionally diverged in different 
lineages of toxicoferan reptilian and mammalian CRiSPs (Table 3). The theta-ML estimation 
indicates the level of functional divergence between proteins in different clusters of the tree. It also 
calculates the posterior probability to detect the Amino acids responsible for such a divergence. 
Significance of these comparisons is tested by a likelihood-ratio test between the alternate 
hypothesis that allows q to be more than zero with the null model that does not. The theta-ML 
estimate for the comparison between NFF advanced snakes and Elapidae (q=0.408), Viperidae 
and Elapidae (q=0.5048), Viperidae and Anguimorpha lizards (q=0.3336) and NFF advanced 
snakes and Viperidae (q=0.3112) were all significant. These estimations suggest that there could 
be drastic differences in the way the cysteine-rich secretory proteins function in these lineages.
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Table 3.1.5 Functional Divergence
Theta (q)a S.E (q)b LRTc Pd
Toxicofera
Lizards vs Elapidae 0.0010 ± 0.022361 0 N.S
Lizards vs NFF 0.1552 ± 0.081855 3.594956 N.S
Lizards vs Viperidae 0.3336 ± 0.130631 6.521658 p < 0.05
NFF vs Elapidae 0.4080 ± 0.097791 17.406791 p < 0.001
NFF vs Viperidae 0.3112 ± 0.103415 9.055442 p < 0.01
Elapidae vs Viperidae 0.5048 ± 0.14939 11.418214 p < 0.001
Mammals
CRiSP1 vs CRiSP2 0.5032 0.115574 18.956533 p < 0.001
CRiSP1 vs  CRiSP3 0.7000 0.137197 26.031785 p < 0.001
CRiSP2 vs  CRiSP3 0.8064 0.122422 43.389136 p < 0.001
Legend
a: Theta parameter or coefficient of functional divergence
b: Standard Error
c: Likelihood ratio test between the alternate model that allows q > 1 with the null model that does 
not
d: p-value; significant values are highlighted in bold letters
The comparative theta-ML estimates of CRiSP1 vs CRiSP2 (0.50), CRiSP1 vs CRiSP3 
(0.70) and CRiSP2 vs CRiSP3 (0.80) indicate shifts in function after the duplication event. 
CRiSP1 and CRiSP2 seem to be drastically different from CRiSP3 proteins. CRiSP1 and CRiSP 
2 (and CRiSP4 in mice) are mostly found in mammalian reproductive system while CRiSP3 has 
a wide distribution in the body and is hypothesized to play a role in innate immune response.
Evolutionary Fingerprint analyses
Evolutionary fingerprint analysis which fits the general discrete bivariate model of site to 
site variation in selection and detects the number of selective classes, the dN/dS rates for each 
class, was conducted for reptilian and mammalian CRiSPs. The intensities depicted in Figure 
5A and 5B correspond to the posterior density while the width of the circle corresponds 
to the accuracy of estimations (compact circles represent most accurate estimations).
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Figure 3.1.6A Evolutionary Fingerprint of Reptilian CRiSPs
Legend: Estimates of the distribution of synonymous (alpha) and non-synonymous (beta) substitution 
rates inferred for Reptilian CRiSPs. The ellipses reflect a Gaussian-approximated variance in each 
individual rate estimate, and colored pixels show the density of the posterior sample of the distribution 
for a given rate. The diagonal line represents the idealized neutral evolution regime (ω = 1), points above 
and below the line correspond to positive selection (ω>1) and negative selection (ω<1), respectively.
The plots reveal that the majority of Amino acids in snake CRiSPs have evolved under positive 
selection. In contrast, in lizards most were under negative or neutral selection and only a handful 
were influenced by positive selection (Figure 3.1.6A). The lineage-specific plots indicate that in 
NFF advanced snakes the majority of Amino acid sites were under positive selection while other 
sites are under negative selection. In Elapidae most sites were under either positive or neutral 
selection, while very few sites are evolving under negative selection. Although, many Amino acid 
sites in the Viperidae lineage seem to be under both positive and negative selection, the algorithm 
could not confidently classify them into these classes (Figure 5A). Almost all the sites were under 
negative selection in mammalian CRiSP1 and CRiSP2 proteins while very few sites in CRiSP3 were 
evolving under positive selection. A small proportion of sites in the CRiSP2 protein also seemed 
to be under the influence of positive selection, but the results were inconclusive (Figure 3.1.6B).
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Figure 3.1.6B Evolutionary Fingerprint of Mammalian CRiSPs
Legend: Estimates of the distribution of synonymous (alpha) and non-synonymous (beta) substitution 
rates inferred for Mammalian CRiSPs. The ellipses reflect a Gaussian-approximated variance in each 
individual rate estimate, and colored pixels show the density of the posterior sample of the distribution 
for a given rate. The diagonal line represents the idealized neutral evolution regime (ω = 1), points above 
and below the line correspond to positive selection (ω>1) and negative selection (ω<1), respectively.
3.1.5 Conclusions
Snake venoms appear to have evolved via a strategy of gene-recruitment (Fry, Wuster 
2004), where, an existing gene is channelised to neofunctionalisation by altered gene expression, 
followed by the accumulation of mutations, gene duplications and the preservation of 
functional constraints (Todd, Orengo, Thornton 1999; Miyata, Suga 2001). This often results 
in a multigene family where most proteins preserve their ancestral molecular scaffold while 
accumulating mutations on the outside of the molecule to amplify their biological targeting.
Reptilian CRiSPs became involved in the venom functional pathway through the modification 
of the ancestral salivary gland CRiSP (Fry 2005). The detailed evaluation of selection pressures at 
both nucleotide and amino acid level by the employment of the site, branch, branch-site and clade 
models demonstrate that these modifications were significantly influenced by positive selection in 
all the lineages of toxicoferan-reptiles, and in snakes more than in lizards, both in the number of 
residues under selection and the magnitude/strength of the selection (Table 1 and 1.2). If the principle 
function of reptilian CRiSPs is indeed subduing the prey by targeting various ion-channels, then an 
accelerated accumulation of mutations guided by positive selection would enable them to target new 
ion-channels and would be particularly useful for the reptiles venturing into new ecological niches. 
This should be distinguished from the arms race that exists between an adapting predator and prey.
Both snake and lizard CRiSPs possess a highly conserved structural scaffold while most of 
the mutations occur on the surface and in the functional regions. Although the main function 
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of CRiSPs is poorly understood, they possibly participate in the envenomation process by the 
blockage of various ion-channels such as cyclic nucleotide-gated (CNG) ion channels, Potassium 
and Calcium ion-channels and possible others yet to be discovered. The blockage of Ca2+ ion-
channel leads to inhibition of smooth muscle contraction and hypothermia which could cause 
dizziness in the prey and thus further subdues the prey. This would be particularly helpful for 
snakes that ingest their prey whole. The paralyses of prey is vital especially for the front-fanged 
snakes (Elapidae, Viperidae and Atractaspididae), as they could easily injure themselves or break 
fangs if the prey struggles while being swallowed. These snakes possess compressor muscles 
that squeeze the venom out of the venom gland, into the grooves of the front fangs. Vipers are 
equipped with retractable fangs that can stab and retract in less than a second. Thus, the front-
fanged snakes use a combination of venom-glands and front-fangs to deliver quick and deadly 
bites. They then wait for the victim to become completely paralysed or die of envenomation 
before swallowing them whole. In contrast, the NFF advanced snakes have primitive venom-
glands with no or only rudimentary compressor muscles. Hence, they have to chew on their soft 
skinned prey to deliver the deadly venom. Sustained compression during biting likely deforms and 
helps the release of venom from the gland in the absence of well-developed compressor muscles.
Accumulation of variations in CRiSP proteins likely facilitates the targeting of new ion-channels 
in the prey, which further subdue the prey. Many elapids, rely on other powerful neurotoxins to paralyse 
the prey, which might explain why selection pressures on elapid CRiSPs (ω=2.86) is not as high as 
in other lineages (Table 1). The NFF advanced snakes rely only on grip and constriction and hence 
CRiSPs in them, which exploit variations guided by positive selection (ω=4.10) may further assist 
these predators in subduing the prey. Most vipers possess a large proportion of haemotoxins as their 
principle venom component for the destruction of muscles, lymphatic systems, etc. But haemotoxins 
are generally considered to be less potent than neurotoxins as the latter can completely paralyse the 
prey in minutes while haemotoxins are relatively slow-acting. Perhaps this is why Viperidae CRiSPs 
(ω=4.19) exhibit a strong positive selection pressure in comparison to the Elapidae CRiSPs (Table 1).
Anguimorpha lizard CRiSPs are the least selected genes amongst the toxicoferan reptiles 
(ω =2.33), perhaps because these species depend mainly on speed and jaw strength to capture 
the prey, rather than prey paralyses. Moreover, it has been shown that CRiSPs form the major 
portion of the NFF advanced snake and Anguimorpha lizard venom (Fry et al. 2003b), further 
demonstrating the need for functional analyses of CRiSPs in reptiles, as they likely have multiple-
functions, similar to other snake venoms such as the three-finger toxins (Fry et al. 2003a).
The trends observed in our sequence analyses should also be studied in the future at 
population level to determine the importance of intraspecific and individual diversity. These 
predators do not rely on a single venom-type for killing and subduing their prey. Instead, a 
cocktail of different venom types is employed where one component may successfully bring 
down a specific type of prey while the same could be completely ineffective against the other. 
Moreover, the type of venom employed is not always consistent along lineages. Many vipers 
like the South American rattle snake (Crotalus durissus) employ neurotoxins (in contrast to the 
typical haemotoxins employed by most vipers) while some elapid venoms like that of a red-bellied 
black snake (Pseudechis porphyriacus) are chiefly composed of haemotoxins (rather than the usual 
elapid neurotoxins). Some NFF advanced snakes like the brown tree-snake (Boiga irregularis) 
employ neurotoxins while others like the Boomslang (Dispholidus typus), use deadly haemotoxins.
The presently known forms of mammalian CRiSPs resulted from mammalian lineage-specific 
duplication events. New copies of genes are relieved of any negative selection pressures after the 
duplication event and begin accumulating variations. In contrast, mammalian CRiSP duplicates 
remained under negative selection pressures (CRiSP1 = 0.55, CRiSP2 = 0.40 and CRiSP3 = 0.68) 
owing to the likely vital functional roles they play in the maintenance of homeostasis. None-the-less, 
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the branch-site model A, clade-model analyses, FEL and REL tests and the evolutionary fingerprint 
analyses detect a small number of sites under selection in CRiSP3 proteins (Table 3, Figure 5B and 
supplementary material). CRiSP3 is hypothesized to be associated with the innate immune response 
(Pfisterer et al. 1996; Haendler et al. 1997) and hence is likely to be benefited by such variation. 
Reptilian CRiSPs might derive their ability to interact with various ion-channels by the virtue of 
their cysteine-rich domain (CRD), where almost half the amount of mutations (~46%) of the whole 
protein occurs. As suggested previously (Suzuki et al. 2008), the pathogenesis-related group 1 (PR-
1) domain might supplement this ability. This domain accumulates the rest of the positively selected 
sites. However, the possibility of the multifunctionality of these proteins cannot be rejected, with 
CRD and the PR-1 domains performing different functions. Such directional mutagenesis of venom 
where molecular surface and functional regions act as hotspot for mutations should have diversified the 
ability of CRiSPs to target numerous cell and/or tissue types in the prey. The Amino acid diversification 
influenced by a strong positive selection on these proteins suggests that they are one of the most 
indispensable components of reptilian venom. In contrast, the significant negative selection pressures 
observed in mammalian CRiSPs highlights the important roles they play in mammalian systems.

3.2
Differential evolution and 
neofunctionalisation of snake 
venom metalloproteinase 
domains.
Peer-reviewed, scientific publications resulting from this chapter.
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4.1.1 Abstract
Snake venom metalloproteinases (SVMP) are composed of five domains: signal peptide, 
propeptide, metalloproteinase, disintegrin, and cysteine-rich. Secreted toxins are typically 
combinatorial variations of the latter three domains. The SVMP-encoding genes of Psammophis 
mossambicus venom are unique in containing only the signal and propeptide domains. We show 
that the Psammophis SVMP propeptide evolves rapidly and is subject to a high degree of positive 
selection. Unlike Psammophis, some species of Echis express both the typical multidomain and the 
unusual monodomain (propeptide only) SVMP, with the result that a lower level of variation is 
exerted upon the latter. We showed that most mutations in the multidomain Echis SVMP occurred 
in the protease domain responsible for proteolytic and haemorrhagic activities. The cysteine-rich 
and disintegrin-like domains, which are putatively responsible for making the P-III SVMPs more 
potent than the P-I and P-II forms, accumulate the remaining variation. Thus, the binding sites on 
the molecule’s surface are evolving rapidly whereas the core remains relatively conserved. Bioassays 
conducted on two posttranslationally cleaved novel proline-rich peptides from the P. mossambicus 
propeptide domain showed them to have been neofunctionalised for specific inhibition of mammalian 
a-7 neuronal nicotinic acetylcholine receptors. We show that the proline rich postsynaptic 
specific neurotoxic peptides from Azemiops feae are the result of convergent evolution within the 
precursor region of the C-type natriuretic peptide instead of the SVMP. The results of this study 
reinforce the value of studying obscure venoms for biodiscovery of novel investigational ligands.
4.1.2 Introduction
Snake venom metalloproteinases (SVMP) 1 evolved from ADAM (A disintegrin and 
metalloproteinase) proteins that were recruited into the venom of snakes near the base of the 
advanced snake (Caenophidia) radiation. They have been identified in the venoms of all lineages 
of advanced snakes (Fry et al. 2004; Fry et al. 2008; Peichoto et al. 2010; Weldon and Mackessy 
2012; Fry et al. 2012b). The ancestral SVMP (P-III) contains (in downstream order) five domains: 
signal propeptide metalloproteinase disintegrin cysteine-rich. Following the divergence of vipers 
from the remaining Caenophidia, extensive gene duplication, domain loss, and positive selection 
resulted in generation of the P-I and P-II classes of SVMP within the viperid lineage (Hite et al. 
1994; Casewell et al. 2011a; Casewell 2012). These two derived classes found in viper venoms 
lack either the cysteine-rich domain (P-II) or the cysteine-rich and disintegrin domains (P-I) (Fox 
and Serrano 2008; Casewell 2012). The signal peptide and the propeptide domain are typically 
cleaved off before expression although the latter has been detected in venoms on occasion (Fox 
and Serrano 2008). SVMP are often the dominant venom component in the venom of viperid 
snakes, but are typically much less significant in the venom of other snake families (Gutiérrez 
et al. 2008; Casewell et al. 2009; Wagstaff et al. 2009; Jiang et al. 2011; Petras et al. 2011; 
Ching et al. 2012). The majority of SVMP principally exhibit haemorrhagic activity, although 
other functions, such as the activation of prothrombin and Factor X, fibrin(ogen)olysis, apoptosis 
and the inhibition of platelet aggregation, have also been reported (Fox and Serrano 2005).
Although SVMP-induced haemorrhage is primarily dependent on the proteolytic activity 
of the metalloproteinase domain, the potency of this activity is increased by the presence of 
the additional domain structures that are absent from the P-I and P-II class (Fox and Serrano 
2005). Consequently, P-III SVMP typically exhibits the greatest haemorrhagic activities. SVMP 
represent a model system for investigating the evolutionary processes responsible for generating 
new protein functions. Extensive gene duplication and domain loss has resulted in the generation 
of a large multilocus gene family that encodes related proteins exhibiting divergent molecular 
structures (Casewell et al. 2011a). Additional diversity has arisen because of accelerated evolution 
within new SVMP classes following the loss of domains (Juárez et al. 2008; Casewell et al. 2011a). 
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Complicating matters is evidence that some SVMP genes are also capable of selectively expressing 
specific domains (Okuda et al. 2002; Fry et al. 2008; Casewell et al. 2011a); for example, some genes 
encode “short-coding disintegrins,” which consist solely of a signal peptide and a disintegrin domain 
(Okuda et al. 2002). There have also been two reports of P-III SVMP that encode only the propeptide 
domain of the SVMP gene. Truncated SVMPs that terminate at the end of the prodomain have been 
transcriptomically identified from the viper genus Echis (Casewell et al. 2009; Casewell et al. 2011a), 
although the proteins encoded by these genes have yet to be detected proteomically in venom. 
Notably, Echis venoms contain high levels of SVMP, with representatives of all three SVMP classes 
present. This prevalence of SVMP in the venom of these snakes is thought to be largely responsible 
for inducing the severe haemorrhaging observed in envenomated prey (Casewell et al. 2009; Wagstaff 
et al. 2009). SVMP found in the venom of the lamprophiid snake Psammophis mossambicus, on the 
other hand, consist entirely of selectively expressed propeptide domains, which have evolved via 
deletion of the metalloproteinase, disintegrin, and SVMP domains from the ancestral multidomain 
P-III SVMP gene (Fry et al. 2008). Despite this fascinating observation, the evolution and bioactivity 
of these atypical SVMP remain completely unexplored. Mass spectrometry of P. mossambicus 
venom revealed an abundance and diversity of peptides with molecular weights consistent to post-
translational proteolytically liberated peptides from the propetide precursor region (Fry et al. 2003c). 
Here we investigate the evolution of pro-domain SVMP genes in Psammophis and compare the 
rate of positive selection acting on these genes to propeptide and P-III SVMP genes isolated from 
Echis venom. We reveal that Psammophis SVMP have accumulated significantly higher numbers of 
positively selected sites in the propeptide domain than observed in Echis. We also demonstrate that 
positive selection pressures acting on the truncated structure of Psammophis SVMPs are directly 
responsible for driving protein neofunctionalisation in the form of novel neurotoxic activity. We 
used molecular phylogenetics to determine if monodomain propeptide expression in Echis shared an 
evolutionary history with Psammophis, and is thus ancestral to all advanced snakes, or if these were 
convergent derivations. In addition, it was recently shown that a unique type of proline-rich peptide 
isolated from the venom of the viperid snake Azemiops feae is neurotoxic like the P. mossambicus Pm1 
and Pm2 peptides. The A. feae peptide differs in activity by blocking the neuromuscular nicotinic 
acetylcholine receptor rather than the neuronal receptor targeted by the peptides in this study (Fry 
et al. 2003c). Before this study, the molecular evolutionary history of the A. feae peptide remained to 
be elucidated, as it was known only from the 21-residue posttranslationally processed form secreted 
in crude venom. Thus, we sequenced the full coding region for this neurotoxin from the mRNA 
of A. feae venom glands to determine whether the proline-rich neurotoxins from Psammophis 
and Azemiops shared a molecular evolutionary history or if they were convergently derived.
4.1.3 Methods
Sequence Retrieval and Alignment
Psammophis mossambicus monodomain, Echis spp. monodomain (E. coloratus and E. 
pyramidum leakeyi) and E. coloratus multidomain SVMP nucleotide sequences were recovered 
bioinformatically from the National Center for Biotechnology Information (NCBI: http://
www.ncbi.nlm.nih.gov/). The translated nucleotide sequences were aligned using PRANK 
(Löytynoja and Goldman 2005) and then adjusted manually to optimise the alignments. 
To avoid confusion, previously obtained sequences are given with their UniProt accession 
numbers while ones obtained in this study are given with their Genbank accession numbers.
Test for Recombination 
Recombination can mislead phylogenetic and evolutionary selection interpretations 
(Kosakovsky Pond et al. 2006). Hence, we evaluated the effect of recombination on Psammophis 
mossambicus and Echis spp. SVMPs by employing Single Breakpoint Recombination implemented 
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in the HyPhy package (Frost et al. 2005; Kosakovsky Pond et al. 2006; Delport et al. 2010). 
Potential breakpoints were detected using the small sample Akaike information Criterion 
(AIC) and the sequences were compartmentalised before conducting the selection analyses. 
Phylogenetic Reconstruction 
The best-fit model of nucleotide substitution for each dataset was determined using jModeltest 
(Posada 2008), according to AIC. Model-averaged parameter estimates of gamma shape parameter 
(a) and the proportion of invariant sites (pinvar) were used for phylogenetic reconstruction. 
Phylogenetic relationships were determined using Bayesian and maximum-likelihood approaches. 
MrBayes version 3.1 (Ronquist et al. 2012) was used for Bayesian inference. Tree searches were 
run using four Markov chains for 10 million generations, sampling every 100th tree. The log 
likelihood score of each saved tree was plotted against the number of generations to establish the 
point at which the log-likelihood scores of the analyses reached their asymptote. 25% of the total 
trees sampled were discarded as burn in. The posterior probabilities for clades were established by 
constructing a majority rule consensus tree for all trees generated after completion of the burn 
in. The analyses were repeated three times to ensure that the trees generated were not clustered 
around local optima. An optimal maximum likelihood phylogenetic tree was obtained using PhyML 
3.0 (Guindon et al. 2010) and node support was evaluated with 1,000 bootstrapping replicates.
Selection Analyses 
We employed sophisticated likelihood models of coding-sequence evolution (Goldman 
and Yang 1994; Yang 1998) as implemented in CODEML of the PAML (Yang 2007) package to 
estimate the selection pressures shaping the E. coloratus multidomain, Echis spp. and P. mossambicus 
monodomain SVMPs. We first employed the lineage-specific one-ratio model that assumes a single w 
for the entire phylogenetic tree. The one-ratio model is very conservative and can only detect positive 
selection if the w ratio averaged over all the sites along the lineage is significantly greater than one. 
The assumption of constant evolutionary selection pressure for the entire phylogenetic tree 
over millions of years is unrealistic. Thus, lineage-specific models like the one-ratio model fail to 
identify regions in proteins that might accumulate variation more often than others and hence 
they can underestimate the strength of selection. We therefore employed site-specific models 
that estimate positive selection statistically as a non-synonymous-to-synonymous nucleotide-
substitution rate ratio (w) significantly greater than 1. We compared likelihood values for three 
pairs of models with different assumed b distributions as no a priori expectation exists for the same: 
M0 (constant w rates across all sites) versus M3 (allows w to vary across sites within ‘n’ discrete 
categories, n ≥ 3); M1a (a model of neutral evolution) where all sites are assumed to be either 
under negative (w<1) or neutral selection (w=1) versus M2a (a model of positive selection), which 
in addition to the site classes mentioned for M1a assumes a third category of sites; sites with w>1 
(positive selection) and, finally, M7 (b) versus M8 (b and w); models that mirror the evolutionary 
constraints of M1 and M2 but assumes that w values are drawn from a b distribution (Nielsen 
and Yang 1998). Only if the alternative models (M3, M2a and M8: allows sites with w>1) show a 
better fit in Likelihood Ratio Test (LRT) relative to their null models (M0, M1a and M7: do not 
allow sites w>1), are their results considered significant. LRT is estimated as twice the difference 
in maximum likelihood values between nested models and compared with the c2 distribution with 
the appropriate degree of freedom - the difference in the number of parameters between the two 
models. The Bayes empirical Bayes (BEB) approach (Yang et al. 2005) was used to identify amino 
acids under positive selection by calculating the posterior probabilities that a particular amino acid 
belongs to a given selection class (neutral, conserved or highly variable). Sites with greater posterior 
probability (PP ≥ 95%) of belonging to the ‘w>1 class’ were inferred to be positively selected.
We employed Single Likelihood Ancestor Counting (SLAC), Fixed-Effects Likelihood 
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(FEL) and Random Effects Likelihood models (Kosakovsky Pond et al. 2005) implemented 
in HyPhy (Pond et al. 2005) to further provide significant support to the aforementioned 
analyses and to detect sites evolving under the influence of positive and negative selection. The 
more advanced Mixed Effects Model Evolution (MEME) (Murrell et al. 2012) was also used 
to detect episodic diversifying selection. MEME employs FEL along the sites and Random-
effects likelihood (REL) across the branches to detect episodic diversifying selection. For 
clear depiction of the proportion of sites under selection, an evolutionary fingerprint analysis 
was carried out using the ESD algorithm (Pond et al. 2010) implemented in Datamonkey. 
The direct comparison of omega values computed using the aforementioned methods can be 
misleading as different proportions of sites may be under selection. Hence, we partitioned the Echis 
coloratus SVMP domains and computed omega values simultaneously using Mgene and option 
G test (Yang 1996) from Codeml to assess the selection pressures on various SVMP domains.
Structural analyses 
In order to depict the differential selection pressures on various domains of E. coloratus 
SVMP, we constructed a homology model using the Phyre 2 webserver (Kelley and Sternberg 
2009) and mapped the sites under positive selection using Pymol (DeLano 2002). The crystal 
structure of 2E3X:A was selected as the best-fit template for the target sequence GU012165.1 
for homology modelling. The program GETAREA (Fraczkiewicz and Braun 1998) was used to 
calculate the Accessible Surface Area (ASA) (i.e., solvent exposure) of amino acid side chains. It 
uses the atom coordinates of the PDB file and indicates if a residue is buried or exposed to the 
surrounding medium by comparing the ratio between side-chain ASA and the “random coil” 
values per residue. An amino acid is considered to be buried if it has an ASA less than 20% and 
exposed if ASA ≥ 50%. The Consurf webserver was used for mapping the evolutionary selection 
pressures on the three-dimensional homology model of E. coloratus SVMPs (Ashkenazy et al. 2010).
cDNA library construction 
Venom glands of an Azemiops feae specimen from Hunan, China were dissected under 
surgical anaesthesia 3 days after stimulation by pilocarpine. Total RNA was extracted using the 
standard TRIzol Plus method (Invitrogen). Extracts were enriched for mRNA using an RNeasy 
mRNA mini kit (Qiagen). mRNA was reverse transcribed, fragmented and ligated to a unique 
10-base multiplex identifier (MID) tag prepared using standard protocols and applied to one 
PicoTitrePlate (PTP) for simultaneous amplification and sequencing on a Roche 454 GS FLX+ 
Titanium platform (Australian Genome Research Facility). Automated grouping and analysis 
of sample-specific MID reads informatically separated sequences from the other transcriptomes 
on the plates, which were then post-processed to remove low quality sequences before de novo 
assembly into contiguous sequences (contigs) using MIRA software. Assembled contigs were 
processed using CLC Main Work Bench (CLC-Bio) and the Blast2GO bioinformatic suite (Conesa 
et al. 2005; Conesa and Götz 2008; Gotz et al. 2008) to provide Gene Ontology, BLAST and 
domain/Interpro annotation. The above analyses assisted in rationalisation of the large numbers 
of assembled contigs into phylogenetic ‘groups’ for detailed phylogenetic analyses outlined below.
Peptide synthesis 
In order to explore potential neofunctionalisation derivations, we constructed two variations 
of proline rich peptides encoded by the propeptide domain. Protected Fmoc-amino acid derivatives 
were purchased from Novabiochem (address) or Auspep (Melbourne, Australia). The following 
side chain protected amino acids were used: Cys(Trt), His(Trt), Hyp(tBu), Tyr(tBu), Lys(Boc), 
Trp(Boc), Arg(Pbf ), Asn(Trt), Asp(OtBu), Glu(OtBu), Gln(Trt), Ser(tBu), Thr(tBu), Tyr(tBu). All 
other Fmoc amino acids were unprotected. Peptide-synthesis grade dimethylformamide (DMF), 
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dichloromethane (DCM), diisopropylethylamine (DIEA), and trifluoroacetic acid (TFA) were 
supplied by Auspep. 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate 
(HBTU), triisopropyl silane (TIPS), HPLC grade acetonitrile, aceticanhydride and methanol 
were supplied by Sigma Aldrich (address). The resin used was Fmoc-Arg(Pbf )-wang resin 
(0.33 mmol/g) from Peptide International. Ethane dithiol (EDT) was from Merck (address). 
P. mossambicus propeptide SVMPs Pm1 and Pm2 were synthesised on a Protein Technology 
(Symphony) automated peptide synthesizer using Fmoc-Arg(Pbf )-Wang resin (0.1 mmol). Assembly 
of the peptides was performed using HBTU/DIEA in-situ activation protocols (Schnolzer et al., 
2007) to couple the Fmoc-protected amino acid to the resin (5 equiv. excess, coupling time 20 
min). Fmoc deprotection was performed with 30% piperidine/DMF for 1 min followed by a 2 min 
repeat. Washes were performed 10 times after each coupling as well as after each deprotection step. 
After chain assembly and final Fmoc deprotection the peptide resins were washed with methanol 
and dichloromethane and dried in a stream of nitrogen. Cleavage of peptide from the resin was 
performed at room temperature (RT) in TFA:H2O:TIPS:EDT (87.5:5:5:2.5) for 3 h. Cold diethyl 
ether (30 mL) was then added to the filtered cleavage mixture and the peptide precipitated. The 
precipitate was collected by centrifugation and subsequently washed with further cold diethyl 
ether to remove scavengers. The final product was dissolved in 50% acetonitrile and lyophilized 
to yield a white solid product. The crude, reduced peptide was examined by reversed-phase HPLC 
for purity and the correct molecular weight confirmed by electrospray mass spectrometry (ESMS).
Analytical HPLC runs were performed using a Shimadzu HPLC system LC10A with a dual 
wavelength UV detector set at 214 nm and 254 nm. A reversed-phase C18 column (Zorbax 300-SB 
C-18; 4.6 x 50 mm) with a flow rate of 2 mL/min was used. Elution was performed using a 0–80% 
gradient of Buffer B (0.043% TFA in 90% acetonitrile) in Buffer A (0.05% TFA in water) over 20 
min. Crude peptides were purified by semi-preparative HPLC on a Shimadzu HPLC system LC8A 
with a reversed-phase C18 column (Vydac C-18, 25 cm x 10 mm) running at a flow rate of 5 mL/
min with a 1%/min gradient of 5–50% Buffer B. The purity of the final product was evaluated by 
analytical HPLC (Zorbax 300SB C18: 4.6 x 100 mm) with a flow rate of 1 mL/min and a 1.67 %/min 
gradient of Buffer B (5–45%). The final purity of all synthesized peptides was >95%. Electrospray 
mass spectra were collected inline during analytical HPLC runs on an Applied Biosystems API-150 
spectrometer operating in the positive ion mode with an OR of 20, Rng of 220 and Turbospray 
of 350 degrees. Masses between 300 and 2200 amu were detected (Step 0.2 amu, Dwell 0.3 ms). 
Bioactivity testing 
Pharmacological activity of the peptides was assessed using the FLIPRTETRA fluorescence 
plate reader (Molecular Devices, Sunnyvale, CA) as previously described (Dutertre and Lewis 
2010; Vetter and Lewis 2010; Vetter et al. 2012). SH-SY5Y human neuroblastoma cells (a 
kind gift from Victor Diaz, Max Planck Institute for Experimental Medicine, Goettingen, 
Germany) endogenously expressing human voltage-gated calcium channels (Cav), voltage-
gated sodium channels (Nav) and nicotinic acetylcholine receptors (nAChR) were maintained 
in RPMI medium (Invitrogen, Australia) supplemented with 15% foetal bovine serum and 
2 mM L-glutamine and passaged every 3–5 days using 0.25% trypsin/EDTA (Invitrogen).
SH-SY5Y cells were plated at a density of 50,000 cells/well 48 hours prior to fluorescence Ca2+ 
assays on black-walled clear bottom 384-well plates (Corning) and incubated for 30 min at 37°C with 
Calcium-4 NW dye (Molecular Devices) prepared in physiological salt solution (PSS; composition in 
mM: NaCl 140, glucose 11.5, KCl 5.9, MgCl2 1.4, NaH2PO4 1.2, NaHCO3 5, CaCl2 1.8, HEPES 
10). Fluorescence responses (excitation 470–495 nm; emission 515–575 nm) were assessed after 5 
min pre-treatment with peptides. To assess activity at L- and N-type Cav, fluorescence responses after 
addition of 90 mM KCl/5 mM CaCl2 were assessed in the absence or presence of nifedipine (10XM), 
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respectively. Activity at Nav was assessed after stimulation with the Nav agonist veratridine. a3b2/4-
containing nAChR were activated by addition of nicotine (30 mM), while activity at the human a7 
nAChR endogenously expressed in SH-SY5Y neuroblastoma cells was assessed in the presence of the 
a7-selective allosteric modulator PNU120596 (10 mM; Sapphire Bioscience, Waterloo, Australia) 
after stimulation with the a7 agonist choline (30 mM). Raw fluorescence readings were converted 
to response over baseline using the FLIPRTetra software SCREENWORKS 3.1.1.4 (Molecular 
Devices) and were expressed relative to the maximum increase in fluorescence of control responses. 
Male chicks (4–10 days) were killed by CO2 and exsanguination. Both chick biventer cervicis 
nerve muscle preparations were isolated and mounted on wire tissue holders under 1 g resting tension 
in 5 ml organ baths containing Krebs solution (NaCl, 118.4 mM; KCl, 4.7 mM; MgSO4, 1.2 mM 
KH2PO4, 1.2 mM; CaCl2, 2.5 mM; NaHCO3, 25 mM and glucose, 11.1 mM), maintained at 
34ºC and bubbled with 95% O2 /5% CO2. Indirect twitches were evoked by electrical stimulation 
of the motor nerve (supramaximal voltage, 0.2 ms, 0.1 Hz) using a Grass S88 stimulator (Grass 
Instruments, Quincy, MA). d-Tubocurarine (10 mM) was added, and subsequent abolition of 
twitches confirmed selective stimulation of the motor nerve, after which thorough washing with 
Krebs solution was applied to re-establish twitches. In the absence of electrical stimulation, contractile 
responses to acetylcholine (ACh; 1 mM for 30 s), carbachol (CCh; 20 mM for 60 s) and potassium 
(KCl; 40 mM for 30 s) were obtained prior to the addition of peptide and at the conclusion of the 
experiment. The preparation was equilibrated for 30 min before the addition of peptide. Peptides 
were left in contact with the preparation for a maximum of 3 h to test for slow-developing effects.
4.1.4 Results
Molecular Evolution:
Phylogenetic analyses showed that the prepro-only expression in Psammophis and 
Echis are convergent derivations (Fig. 3.2.1). Sequence alignment showed extreme variation 
in the Psammophis monodomain form whereas the Echis monodomain prepro form was 
almost identical to the prepro region expressed as part of the multidomain gene (Fig. 3.2.2).
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Figure 3.2.1
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Figure 3.2.2
Selection Analyses:
By using the one-ratio model, the simplest of the lineage-specific models that computes a 
single value for all branches in the phylogeny, the global was estimated to be 0.94, 0.39, and 0.39 
for the Psammophis monodomain, Echis monodomain, and Echis coloratus multidomain SVMP 
genes, respectively. Because this value is an average over all codons in each lineage, it suggests 
a rapid accumulation of mutations in the Psammophis SVMP propeptide domain. In contrast, 
the Echis propeptide domains seem to be under negative selection. The global w estimates for 
the Echis SVMP protease, disintegrin-like and cysteine-rich domains were 1.33, 0.92, and 0.97, 
respectively. This highlights the strong influence of positive selection on the protease domain 
that is responsible for haemorrhagic activity. The Bayes empirical Bayes approach implemented 
in site-model 8 estimated that about 8.5% of sites were under positive selection in the P. 
mossambicus monodomain propeptide region (1.23) whereas the Echis monodomain (0.52) and 
E. coloratus multidomain (0.46) SVMPs evolve under negative selection (Fig. 3.2.3; Table 3.2.1).
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Table 3.2.1
Figure 3.2.3
Omega estimates for the protease, disintegrin-like, and cysteine-rich domains of E. coloratus 
SVMP under this approach were 1.60 (32% of sites), 1.33 (25% of sites), and 1.39 (21% of 
sites), respectively, highlighting the strong influence of positive selection on the evolution of 
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these domains (Table 3.2.2 and Fig. 3.2.4). Direct comparison of w values computed using the 
aforementioned algorithms could potentially be misleading as these genes may have a different 
proportion of sites under selection. Hence, for a better comparison of selection pressures acting 
on different domains of the E. coloratus multidomain SVMP, we employed Mgene with option 
G analysis of Codeml. This test simultaneously estimated w of 0.38, 1.28, 0.91, and 1.04 for 
the propeptide, protease, disintegrin-like and cysteine-rich domains, respectively (Table 3.2.2). 
Moreover, the site-specific model 8 analyses using the Bayes empirical Bayes approach identified 28 
( 53% of positively selected sites), 9 (17%) and 15 ( 29%) amino acid sites under positive selection 
in the protease, disintegrin-like and cysteine-rich domains, respectively, confirming the greater 
influence of positive selection on the protease domain than any other domain (Table 3.2.2 and 
Fig. 3.2.4). In contrast to the Echis protease domain and the Psammophis monodomain propetide 
region, the E. coloratus multidomain and the Echis spp. monodomain SVMP propeptide regions 
have evolved under negative selection (0.38 and 0.52, respectively). We mapped positively selected 
sites onto the homology model of E. ocellatus multidomain SVMP to clearly depict their location 
in the toxin (Fig. 3.2.4). Our analyses show that almost 60% of these positively selected sites are 
confined to the molecular surface, whereas only 12% are buried in the conserved core of the toxin.
Table 3.2.2
 135
Chapter III
Figure 3.2.4
Bioactivity Testing:
Assessment of the pharmacological activity of two Psammophis mossambicus proline-rich SVMP 
propeptide only domain variants: Pm1 (VYNLHGSVPAPPWQPHARRPRPKNR encoded by uniprot 
A7X4A6) and Pm2 (VYNLHGSVPAPPWQPHARRPRPKYR encoded by uniprot A7X461) using 
high-throughput FLIPR assays revealed that these peptides did not exhibit any agonist-like activity at 
concentrations up to 1 mM, and were inactive at L-type and N-type Cav, Navand a3b2/4 nAChR (data 
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not shown). However, both peptides caused concentration-dependent inhibition of endogenously 
expressed human a7 nAChR, with IC50s of 11.99 mM and 11.83 mM (pIC50 4.921±0.058 and 
4.927±0.094), respectively (Fig. 3.2.5). Psammophis mossambicus SVMP propeptide only domain 
variants Pm1 and Pm2 had no significant inhibitory effect on twitch height in the chick biventer cervicis 
nerve-muscle preparation (n=4, data not shown) at concentrations up to 10XmM over a period of 3 h.
Figure 3.2.5
Convergent Derivation of Proline Rich 
Neurotoxic Peptides:
It was revealed that the A. feae proline-
rich peptides were not derivations of the 
SVMP propeptide region but rather the 
propeptide region of the c-type natriuretic 
peptide expressed in snake venoms. The A. 
feae peptide was encoded in tandem repeats, 
with some forms containing two repeats of 
the proline-rich neurotoxic domain whereas 
other transcripts contain three repeats 
(genbank accession numbers JX467171 
and JX467172). Intriguingly, sequence 
alignment reveals that this region is distinct 
from the domain that encodes the bradykinin 
potentiating peptides in the CNP precursor 
(Fig. 3.2.6). To avoid confusion, previously obtained sequences are given with their UniProt accession 
numbers whereas ones obtained in this study are given with their Genbank accession numbers.
Figure 3.2.6
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4.1.5 Discussion
Chelation of the Zn2  ion present in proteases inhibits the proteolytic effect of these enzymes. 
Although it is unclear which domain of multidomain SVMP is responsible for the haemorrhagic 
effect of this toxin, chelation of the Zn2  ion in the protease domain inhibits this activity. It is likely, 
therefore, that the protease domain of multidomain SVMP is responsible for the haemorrhaging 
often observed in envenomations by snakes with venoms rich in this toxin type (Bjarnason and Tu 
1978; Bjarnason and Fox 1994). Moreover, it is hypothesized that the presence of the cysteine-rich 
and disintegrin-like domains results in the increased potency of some forms of SVMP (P-III) in 
comparison with those that lack them (P-I and P-II). We show that more than half of the positively 
selected sites detected were confined to the protease domain whereas the remaining variations were 
shared between the cysteine-rich and disintegrin-like domains, suggesting that these domains play a 
prominent role in SVMP-induced inflammatory reactions. It has been shown in the past that venom 
components accumulate mutations in functional regions, on the molecular surface and in the tips 
of loops of the toxins while preserving the ancient scaffold that provides structural stability (Kini 
and Chan 1999; Sunagar et al. 2012). Most venom novelties are derived from mutations of the 
protein surface residues, which not only increase the number target sites in the prey for these toxins 
but could also aid in avoiding the host immune response. We have shown that snake venom 
metalloproteinases exhibit a similar phenomenon with 60% of all positively selected residues being 
confined to the molecular surface of the toxin whereas only 12% were buried (the remaining 29% 
could not be assigned into exposed or buried classes (Fig. 3.2.4). Moreover, 37 cysteine-residues 
remain unmodified, which is indicative of the importance of cysteine residues in stabilization of 
venom proteins (Fry 2005). P. mossambicus SVMP consist solely of the propeptide domains, with 
the additional domains typically found in SVMP having been lost from the ancestral scaffold. Our 
results demonstrate that the loss of these domains has exposed the propeptide domains to novel 
evolutionary selection pressures (Table 3.2.1; Fig. 3.2.3 and 3.2.4). Importantly, as a logical 
consequence of the partial loss of weaponry, an increased selection pressure is applied, driving a 
rapid rate of mutations. Driven by positive selection, this has resulted in neofunctionalisation of 
these venom components. We report here the genesis of a novel postsynaptic neurotoxic activity 
through inhibition of postsynaptic a7 nicotinicacetylcholinereceptorsbysomeof the Psammophis 
propeptide SVMP forms (uniprot accession numbers A7X4A6 and A7X461). Given the rapid rate 
of mutations and strong evolutionary selection pressures, the possibility of participation by the 
other Psammophis SVMP isoforms in envenoming through additional novel mechanisms cannot be 
ruled out. In contrast to Psammophis, E. coloratus expresses all the SVMP domains specialized for 
envenoming (protease, cysteine-rich, and disintegrin-like domains - i.e. P-III SVMP). Consequently, 
the propeptide region, which is posttranslationally excised from the final toxin, exhibits no evidence 
of adaptive evolution (0.46), suggesting that it lacks a significant role in envenoming (Table 3.2.1; 
Fig. 3.2.3 and 3.2.4). Some species of Echis not only selectively express the propeptide region of the 
SVMP but also have venom genes encoding highly lethal multidomain SVMP. Hence, they do not 
exhibit any variation in the propeptide-only toxins, which evolve under the influence of negative 
selection (0.52). It has previously been hypothesized that snake toxins often consist of the smallest 
functional domain of a large multidomain protein, which acts as a provision for innovations 
(Junqueira-de-Azevedo et al. 2006). In contrast to this, we show that domains that contribute 
toward envenoming are still capable of accumulating rapid mutations under the influence of positive 
selection. Evaluation of selection pressures on different domains of Echis SVMP revealed that most 
of the mutations were directed toward the protease domain (54%; 1.28), highlighting the importance 
of variation in this region believed to be responsible for inducing haemorrhage (Table 3.2.2 and Fig. 
3.2.4). We speculate that such mutations may be important for sub-functionalisation or increasing 
the potency of these proteins, or perhaps act as a weapon in the co-evolutionary arms race against 
prey resistance (Heatwole and Powell 1998; Biardi and Coss 2011). A major proportion of the 
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remaining variations in Echis SVMP were detected in the cysteine-rich and disintegrin-like domains 
(29%, 1.04 and 17%, 0.91, respectively). The fact that 60% of all positively selected sites (and 
associated variations) occur on the molecular surface whereas only 12% correspond to buried 
residues highlights the importance of changes in the surface chemistry (Fig. 3.2.4). Accumulation 
of surface mutations may facilitate interaction with novel targets and may also aid in avoidance of 
the host’s immune response. The complete conservation of the 37 ancestral cysteine residues 
highlights the prominent role that disulfide bridges play in stabilizing and structurally scaffolding 
venom peptides and proteins. Evidence provided by various analyses [Site-specific model 2a, model 
3, model 8, Single Likelihood Ancestor Counting, Fixed-Effects Likelihood, Random-effects 
likelihood, MEME (Table 3.2.2); Evolutionary fingerprint analyses (Appendix 3.2.1) and Mgene 
with option G test (Table 3.2.2) highlight the strong influence of positive Darwinian selection in 
shaping the various domains of E. coloratus multidomain SVMP responsible for toxicity (protease, 
disintegrin-like and cysteine-rich). The propeptide domain, which is not known to play a significant 
role in envenoming, was subject to negative selection. This region is excised from the final protein 
as part of the post-translational modification and never forms part of the lethal multidomain SVMP 
toxin. In contrast, P. mossambicus selectively expresses the propeptide region because of the deletion 
of ancestral domains. Hence, this domain experiences significant selection pressure and evolves 
under the influence of positive selection (Fig. 3.2.3). We show that positive selection has influenced 
the Psammophis monodomain SVMP propeptide domain more than its E. coloratus multidomain 
SVMP counterpart. A few species of Echis that express similar propeptide-only domains also express 
the regular multidomain SVMPs. Hence, they do not require the same level of variation as the 
Psammophis protein. Evidently, these Echis monodomain propetide-only SVMP seem to be subject 
to the same regime of negative selection as the propeptide domain expressed as part of the 
multidomain gene. Thus, the molecular evolution patterns and expression levels are consistent with 
a significant role being played by the propeptide-only toxins in the venom of P. mossambicus (extreme 
diversification and high expression) but not in Echis sp. (little diversification and low expression). 
This work reveals that the neglected proline-rich peptides are a source of novel ligands that, because 
of their uniqueness and small size, may prove to be of significant value in drug design and 
development. Functional testing of P. mossambicus SVMP propeptide only domain variants Pm1 
and Pm2 yielded responses on neuronal nAChRs, specifically on the human a7 neuronal receptor 
(Fig. 3.2.5). a7 neuronal receptors, which are nAChRs comprised solely of a7 subunits, have been 
documented as being convergently targeted by toxins such as a-conotoxin PnIA (A10L D14K), 
which expresses a high affinity for the a7 neuronal receptor (Celie et al. 2005). Eleven subunits of 
mammalian neuronal nAChRs have been classified to date; eight a subunits (Hite et al. 1994; Fox 
and Serrano 2008; Fry et al. 2008; Gutiérrez et al. 2008; Peichoto et al. 2010; Casewell et al. 2011a; 
Weldon and Mackessy 2012; Fry et al. 2012b) and three b subunits (Fry et al. 2008; Peichoto et al. 
2010; Weldon and Mackessy 2012) with an additional a subunit; a8 present in the chick optic 
nerve (Gotti et al. 1997). Similarities in receptors are apparent between species as it had been 
documented that neuronal nAChR subunits in the chicken, in particular 2, 3, and 4 subunits, 
exhibit similarity of 85% in conserved domains when compared with that of a human or mouse 
(Nef et al. 1988). Despite the various similarities between chick and mammalian neuronal and 
potentially neuromuscular, nAChR subtypes and their respective encoded genes, there are large 
disparities in the pharmacology of the expressed receptors between the two species (McGehee and 
Role 1995), which may account for species-specific toxins. One such example is denmotoxin, an 
avian-specific post-synaptic neurotoxin isolated from Boiga dendrophila, which expresses potent 
activity at neuromuscular nAChRs in the chick but an effect of lower magnitude in the mouse 
(Pawlak et al. 2006). Dissimilar to neuronal nAChRs, neuromuscular nAChRs consist of five 
subunits comprising of and in addition to subunits with a stoichiometry of (Fry et al. 2004) in 
which the subunit replaces the subunit in developed forms of the receptor (Boyd 1997). 
Neuromuscular nAChRs have been documented as being targeted by a-neurotoxins, also referred to 
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as curare-mimetic or post-synaptic neurotoxins (Kuruppu et al. 2008), an example of which includes 
acantoxin IVa isolated from Acanthophis sp. seram (Wickramaratna et al. 2004). An absence of any 
activity of Pm1 and Pm2 at the muscle end plate nAChR in the chick biventer cervicis and activity 
on human a7 neuronal receptors confirms that both variants affect neuronal opposed to 
neuromuscular nicotinic acetyl-choline receptors. The two peptides tested in this study are good 
examples that, because of the extreme selection pressure they are subjected to, venom components 
often have exquisitely subtle sources of functional variation. Despite varying by only a single amino 
acid (Y for N at the second to last position) there was a slight but significant difference in potency 
between the two forms of Psammophis propeptide, with Y-containing Pm2 the more potent of the 
two. The peptides from Psammophis and Azemiops are a remarkable example of convergent evolution 
using two different gene types as the starting material (SVMP and CNP respectively). In both cases, 
there was the de novo evolution of proline-rich peptides in the propeptide domain of a precursor. 
Addtionally, there was a degree of functional convergence as both target the nicotinic acetylcholine 
receptor, although each targets a different subtype (neuronal and neuromuscular respectively). Both 
the variation between the two Psammophis peptides and the convergence of the Psammophis and 
Azemiops peptides reinforce the wealth of novel peptides to be found in understudied snake venoms.

3.3
Three-fingered RAVERs:
Rapid accumulation of 
variations in exposed residues 
of snake venom 
toxins
Peer-reviewed, scientific publications resulting from this chapter.
 143
Chapter III
3.3.1 Abstract
Three-finger toxins (3FTx) represent one of the most abundantly secreted and potently 
toxic components of the elapid and colubrid snake venom arsenal. Despite their structural 
similarity, they perform a diversity of biological functions. Although they are theorized to 
undergo adaptive-evolution, the underlying diversification mechanisms remain elusive. Here, we 
report the molecular evolution of different 3FTx functional forms and show that positively-
selected point-mutations have driven the rapid evolution and diversification of 3FTx. These 
diversification events not only correlate with the evolution of the advanced venom-systems 
(VDS) in Caenophidia, but in particular the explosive diversification subsequent to the evolution 
of a high pressure, hollow-fanged VDS in Elapidae, highlighting the significant role of these 
toxins in the evolution of advanced snakes. We show that Type I, II and III a-neurotoxins 
have evolved extremely rapidly under the guidance of positive-selection. We also show that 
novel Oxyuranus/Pseudonaja Type II forms, lacking the Type II characteristic loop-2 stabilising 
derived cysteine doublet, are not plesiotypic in relation to other Type II as previously thought, 
but have originated within rapidly evolving Type II a-neurotoxins, on at least two separate 
occasions. Not all 3FTxs have evolved rapidly: k-neurotoxins, which form non-covalently-
associated hetero-dimers, have experienced a relatively weaker influence of diversifying-selection; 
while cytotoxic 3FTx, with their functional sites dispersed over 40% of the molecular surface, 
have been extremely constrained by negative-selection. We theorize Rapid Accumulation of 
Variations in Exposed Residues (RAVER) to illustrate the significance of point-mutations, 
guided by focal mutagenesis and positive-selection in the evolution and diversification of 3FTxs.
3.3.2 Introduction
Venoms are key evolutionary innovations of Kingdom Animalia and are complex concoctions 
of biologically active proteins (from polypeptide globular enzymes to small peptides), salts, and 
organic molecules such as polyamines, amino acids and neurotransmitters (Fry et al. 2009a). Venom 
components originate via toxin recruitment events during which ordinary protein-encoding genes, 
typically those involved in key regulatory processes (such as homeostasis or neurotransmission) 
are duplicated, and the new copies are selectively expressed in the venom gland (Olivera 2002; Fry 
et al. 2003a; Inceoglu et al. 2003; Fry 2005; Escoubas et al. 2006; Fry et al. 2009; Fry et al. 2012). 
These novel paralogues can further duplicate and give rise to multigene families, following the 
“birth-and-death” mode of evolution, where the rapid evolution of these families results in extensive 
neofunctionalisation of some copies, while the other non-functional forms are lost through 
degradation or get transformed into pseudogenes (Nei et al. 1997). Research has shown that despite 
the extraordinary diversity of animal toxins, most belong to a limited number of enzymatic (e.g. 
phospholipases, serine proteases, metalloproteinases) and non-enzymatic (e.g. three-finger toxins, 
natriuretic peptides, Kunitz peptides, lectins) protein superfamilies which have been convergently 
recruited in various organisms to perform similar functions (Fry 2005; Fry et al. 2009a).
Three-finger toxins (3FTx) are one of the most abundantly secreted non-enzymatic 
components of elapid and colubrid snake venom. They are characterized by a broad diversity 
of functional forms (Table 3.3.1). In the past, 3FTx were considered to be exclusive to 
elapid snake venoms (Fry et al. 2003a). The discovery of a-colubritoxin, however, revealed 
this potent toxin type to be widespread in ‘non-front-fanged’ (NFF) canophidian snake 
lineages (Fry et al. 2003b). Subsequent studies revealed the broad taxonomic distribution 
of this toxin type (Fry et al. 2003c; Lumsden et al. 2004a; Lumsden et al. 2004b; Pawlak et 
al. 2006; Doley et al. 2008; Fry et al. 2008; Pawlak et al. 2009), which appears to have been 
recruited into the snake venom arsenal near the base of the snake tree (Fry et al. 2013b).
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Table 3.3.1
Functional Class Mode of Action
Basal-type a-neurotoxins
Antagonists of a1 nicotinic acetylcholine receptors, with a 100-
fold greater potency to avians/reptiles than mammals. Produces 
flaccid paralysis. (Pawlak, et al. 2009)
Type I a-neurotoxins Antagonists of a1  nicotinic acetylcholine receptors. Produces flaccid paralysis. (Barber, et al. 2013)
Type II a-neurotoxins Antagonists of a1and a7 nicotinic acetylcholine receptors. Produces flaccid paralysis.  (Barber, et al. 2013) 
Type III a-neurotoxins Antagonists of a1 nicotinic acetylcholine receptors. Produces flaccid paralysis. (Gong, et al. 1999)
k-neurotoxins Antagonistes of a3b2 neuronal nicotinic acetylcholine receptor subtype. Produces flaccid paralysis. (Chiappinelli, et al. 1996)
Adrenergic/Muscarinic 
neurotoxins
Antagonists of a wide variety of adrenergic and muscarinic 
subtypes with extreme specificity for receptor subtypes.  (Carsi and 
Potter 2000; Fruchart-Gaillard, et al. 2008; Jianmongkol, et al. 
1999; Jolkkonen, et al. 1994; Jolkkonen, et al. 1995; Karlsson, et 
al. 1994; Koivula, et al. 2010; Kornisiuk, et al. 1995; Krajewski, et 
al. 2001; Kukhtina, et al. 2000; Quinton, et al. 2010; Rouget, et 
al. 2010; Toomela, et al. 1994)
Type B Muscarinic toxins Antagonists of M2 muscarinic acetylcholine receptors (Carsi, et al. 1999)
ASIC channel blockers
Acts as a reversible gating modifier toxin by antagonistically 
binding to closed/inactivated ASIC1a-ASIC2a (ACCN2-ACCN1) 
channels in central neurons and ASIC1b-containing channels in 
nociceptors.  (Diochot, et al. 2012)
Calcium channel blockers Antagonists of L-type calcium channels, thus inhibiting the transmission of the action potential (de Weille, et al. 1991)
Acetylcholinesterase 
inhibitors
Inhibit acetylcholinesterase through competitive binding 
(Karlsson, et al. 1984)
Platelet inhibitors
Competitively bind to platelet GPIIb/IIIa receptor utilizing 
the RGD functional motif, thus blocking platelet aggregation.
(McDowell, et al. 1992)
Cytotoxins
Cell-damaging activity mediated by hydrophobis-patch on 
molecular surface that interacts non-specifically with hydrophobic 
aspects of the cell phospholipid bilayer. (Konshina, et al. 2012)
Synergistic Alone are non-toxic but form complexes with a-neurotoxins to dramatically enhance neurotoxicity (Joubert and Viljoen 1979)
3FTx are characterized by the presence of three a-loops that extend from the toxin’s small, 
hydrophobic core, which gives them the three-finger like appearance and hence their name. 
The plesiotypic 3FTx form, such as that found in NFF advanced snakes, has ten cysteines in a 
distinctive pattern, reflective of their molecular origin from the recruitment of a LYNX/SLUR 
nicotinic receptor binding neuromodulation peptide [(Fry et al. 2003a; Fry et al. 2003b; Fry 
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2005; Fry et al. 2008) Fig. 3.3.1]. All described 3FTx types from henophidian, NFF and viperid 
snakes contain these ten cysteines and all those with determined bioactivities are a-neurotoxic, 
with a potency much greater against birds and/or reptiles than mammals (Fry et al. 2003b; 
Lumsden et al. 2004b; Pawlak et al. 2006; (Pahari et al. 2007; Fry et al. 2008; Pawlak et 
al. 2009; Fry et al 2013). This taxon specificity in action led to the plesiotypic a-neurotoxins 
being mistakenly referred to as ‘weak neurotoxins’ [c.f. (Utkin et al. 2001)]. Similarly, this 
taxon-specific toxicity led to misinterpretation of prey-handling behaviour in an experiment 
investigating the role of venom in the feeding ecology of NFF snakes (Rochelle and Kardong 1993).
Figure 3.3.1
Legend: Bayesian molecular phylogeny of representative three-finger toxins. Uniprot 
(http://www.uniprot.org/) accession numbers are given for each. Cysteine frame-work 
variation is displayed, with ancestral cysteines in black and newly evolved cysteines in red.
Subsequent to the elapid snakes evolving a high pressure, syringe-like delivery system 
including venom gland compressor musculature and hollow front fangs, derived forms of 3FTx 
emerged, characterised by a loss of plesiotypic cysteines 2 and 3 (Fig. 3.3.1), a change resulting 
in a dramatic potentiation of the a-neurotoxicity through the uncoupling of loop-1, with these 
derived forms much more potent upon mammalian receptors than the more constrained plesiotypic 
forms (Fry et al. 2003b). This increased toxicity enhanced the role of these proteins in prey 
capture and resulted in a high level expression of a-neurotoxins (a-ntx), lacking the second and 
third plesiotypic cysteines [Type I (aka: short-chain) and Type II (aka: long-chain) a-ntx] in the 
venom glands of these snakes. The increased level of expression was accompanied by punctuated 
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molecular evolution, resulting in a myriad of structural and functional derivations (Fry et al. 2003a). 
Structurally novel forms included a-ntxs with newly evolved cysteines that stabilised the second 
loop (Type II a-ntx). Venoms of snakes from the Oxyuranus and Pseudonaja clade are unusual in 
containing significant amounts of 3FTx that display all the features of Type II a-ntx but lack the 
derived cysteine pair characteristic of this type (St Pierre et al. 2007b). These toxins have been 
presumed to represent the plesiotypic state of this 3FTx clade. Another derived 3FTx structural 
variation is represented by the k-neurotoxins (aka: k-bungarotoxins), which form non-covalently-
associated heterodimers. A number of novel functions also emerged [(Fry et al. 2003a) Table 3.3.1; 
Fig. 3.3.1], such as k-ntx specifically targeting the neuronal nicotinic receptors. The most extreme 
neofunctionalisation is represented by the cytotoxins, which have deviated from the highly-focused 
ion-channel targeting of the a-ntx (Bhaskaran et al. 1994). Instead, they exhibit a number of 
novel biological activities, including lysis of various types of cells (erythrocytes, epithelial cells, 
etc.), enzyme inhibition [protein kinase C: (Harvey et al. 1982); Na+/K+ ATPase: (Bougis et al. 
1989)], depolarisation and contraction of muscle cells, prevention of platelet aggregation, etc. All 
structurally and functionally derived 3FTxs lack plesiotypic cysteines 2 and 3 (Fig. 3.3.1), and 
are expressed in the venoms of elapid snakes in much higher levels than the plesiotypic a-ntxs.
Although it has been hypothesized and demonstrated through obsolete selection assessments 
that snake venom three-finger toxins have evolved under the influence of positive Darwinian 
selection (Gong et al. 2000; Fry et al. 2003a; Jiang et al. 2011), the precise underlying mechanisms 
of evolution, driving the diversification of functional forms remains unclear. The molecular 
evolution of several 3FTx toxin types, such as k-ntx, plesiotypic 3FTxs from Henophidia, NFF 
and elapid snakes, Type III a-neurotoxins from Australian elapids, etc., remain unstudied to 
date. Molecular mechanisms underlying the evolution of the 3FTx gene in Viperidae snakes, 
which have independently evolved a sophisticated high-pressure, hollow-fanged venom delivery 
system from those of Elapidae, also remain elusive. Moreover, interpretations regarding the 
evolution of certain 3FTx types, such as cytotoxins (Jiang et al. 2011), have been questionable. 
As the general organization of the 3FTx gene is highly conserved and ordered, Doley et al. (2008) 
postulated a phenomenon of Accelerated Segment Switch in Exons to alter Targeting (ASSET), as the 
mechanism driving the molecular evolution of 3FTx. This theory suggests that during the evolution 
of the 3FTx gene, segments in exonic regions have been exchanged with distinctly different ones 
and the resultant ‘switching’ of segments has generated the observed sequence variations and the 
functional diversity of 3FTx. The authors further speculated that point mutations alone could not 
account for the diversity of 3FTx functional forms and that they could only be helpful in fine tuning 
receptor binding capabilities, which originally arise through ASSET (Doley et al. 2008; Doley et 
al. 2009). However, this study attempted to classify regions in 3FTx based on simplistic ‘degree of 
identity’ comparisons. Crucially, such analysis does not take into account the fact that proteins adopt 
regionally differential rates of evolution. It has been previously demonstrated in other toxin types that 
structurally important residues are constrained by negative selection, while regions responsible for 
biological function and/or those forming the molecular surface, accumulate variations under an arms 
race scenario (Sunagar et al. 2012; Brust et al. 2013). This not only facilitates functional diversification, 
but also increases the number of active residues on the surface of venom components that can non-
specifically interact with novel receptors in prey and induce a plethora of pharmacological effects.
In order to provide further insights into the evolution and diversification of this toxin 
superfamily, we reconstructed the complex molecular evolutionary history of 3FTxs. In particular, 
this study examined: the relative rate of evolution of the plesiotypic a-ntx (i) before and after 
the evolution of the advanced venom-delivery apparatus in Caenophidia (advanced snakes); (ii) 
before and after the invention of the sophisticated, high pressure and hollow-fanged venom-
delivery system in Elapidae and Viperidae; (iii) the relative rate of 3FTx evolution subsequent 
to the loss of two plesiotypic cysteines and resultant potentiation of a-neurotoxicity; (iv) the 
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relative rate of evolution subsequent to the derivation of non-covalently-associated dimeric 
forms; and (v) the relative rate of evolution subsequent to the derivation of cytotoxins.
3.3.3 Methods
Specimens
Azemiops feae specimen was from Hunan, China.
Azemiops feae library construction 
Total RNA was extracted from the dissected venom gland using the standard TRIzol Plus 
method (Invitrogen). Extracts were enriched for mRNA using standard RNeasy mRNA mini 
kit (Qiagen) protocol. mRNA was reverse transcribed, fragmented and ligated to a unique 10-
base multiplex identifier (MID) tag prepared using standard protocols and applied to one 
PicoTitrePlate (PTP) for simultaneous amplification and sequencing on a Roche 454 GS FLX+ 
Titanium platform (Australian Genome Research Facility). Automated grouping and analysis of 
sample-specific MID reads informatically separated sequences from the other transcriptomes on the 
plates, which were then post-processed to remove low quality sequences before de novo assembly 
into contiguous sequences (contigs) using v 3.4.0.1 of the MIRA software program. Assembled 
contigs were processed using CLC Main Work Bench (CLC-Bio) and Blast2GO bioinformatic 
suite (Gotz et al. 2008) to provide Gene Ontology, BLAST and domain/Interpro annotation.
Sequence retrieval and alignment
To assess the molecular evolutionary history of various three-finger toxins, we retrieved nucleotide 
sequences from National Center for Biotechnology Information (NCBI: http://www.ncbi.nlm.nih.
gov/). The new toxin sequence recovered from Azemiops feae in this study was identified by comparison of 
the translated DNA sequence with those of previously characterised toxins using a BLAST search (Altschul 
et al. 1997) implemented in the UniProtKB protein database. Translated nucleotide sequences were 
aligned using MUSCLE 3.8 (Edgar 2004) and the alignments were manually inspected to rectify errors.
Phylogenetics 
Phylogenetic analyses were performed to allow the reconstruction of the molecular evolutionary 
history of various types of three-finger toxins. Since many three-finger toxin forms are only known 
from their amino acid sequences, amino acid datasets were used for the Bayesian inference. Trees 
were generated using both Bayesian and maximum-likelihood inferences. MrBayes 3.2.1 (Ronquist 
et al. 2012) was employed for the Bayesian inference, using lset rates=invgamma with prset 
aamodelpr=mixed command, which enables the program to optimise between nine different amino 
acid substitution matrices implemented in MrBayes. WAG (Whelan and Goldman 2001)  was 
chosen as the best substitution matrix by the program. The analysis was performed by running a 
minimum of 1X107 generations in four chains, and saving every 100th tree. The log-likelihood score 
of each saved tree was plotted against the number of generations to establish the point at which the 
log likelihood scores reached their asymptote, and the posterior probabilities for clades established 
by constructing a majority-rule consensus tree for all trees generated after completion of the burn-in 
phase. Maximum-likelihood method implemented in PhyML (Guindon et al. 2010) was also employed 
on the nucleotide datasets and node support was evaluated with 1,000 bootstrapping replicates.
Test for Recombination 
To overcome the effects of recombination on the phylogenetic and evolutionary 
interpretations (Posada and Crandall 2002), we employed Single Breakpoint algorithms 
implemented in the HyPhy package and assessed recombination on all the toxin forms 
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examined in this study (Kosakovsky Pond et al. 2006; Delport et al. 2010). When 
potential breakpoints were detected using the small sample Akaike information Criterion 
(AICc), the sequences were compartmentalized before conducting selection analyses.
Selection Analyses 
We evaluated the influence of natural selection on various types of three-finger toxins using 
maximum-likelihood models (Goldman and Yang 1994; Yang 1998) implemented in Codeml of the 
PAML (Yang 2007). We utilized the three-ratio model as well as the optimised branch-site test (Yang 
and Nielsen 2002; Zhang et al. 2005) to detect evolutionary selection pressures acting upon various 
toxin lineages. The three-ratio model evaluates selection across the lineages alone, while the branch-
site model allows w to vary across the sites of the protein and along the branches in the tree. The latter 
is known for its reasonable power and accuracy to detect short bursts of episodic adaptations (Zhang 
et al. 2005). However, both the three-ratio and branch-site models require the foreground (lineages 
under positive selection) and background lineages (lineages lacking positive selection) to be defined a 
priori. Such predefined biological hypotheses are often unavailable and it becomes difficult to define 
the foreground lineages. Therefore, we treated each 3FTx type being compared as a foreground 
branch alternatively and tested multiple hypotheses. A likelihood-ratio test was then conducted by 
comparing the model that allows w to be greater than 1 in the foreground branch, with a null model 
that does not (w constrained 1). It has been suggested that while implementing multiple hypotheses 
using branch and branch-site models, it is necessary to control the family-wise error rate (FWER 
or Type I error) (Zhang et al. 2005). We used Bonferroni correction to account for such errors. It 
uses a/n as the significance level to test each hypothesis, where ‘a’ is the significance level and ‘n’ is 
the number of independent true null hypotheses. We further utilized branch-site Random Effects 
Likelihood (REL) (Kosakovsky Pond et al. 2011) to identify lineages evolving under the influence 
of episodic diversifying selection pressures. Unlike the aforementioned lineage-specific models, 
branch-site REL does not require a priori identification of foreground and background branches.
Since lineage-specific models assess the effects of selection only along the branches, they 
often fail to identify regions in proteins that might be affected by episodic selection pressures 
and ultimately underestimate the strength of selection. Hence, we employed site-specific models 
that estimate positive selection statistically as a non-synonymous-to-synonymous nucleotide-
substitution rate ratio (w) significantly greater than 1. We compared likelihood values for three 
pairs of models with different assumed w distributions as no a priori expectation exists for the same: 
M0 (constant w rates across all sites) versus M3 (allows w to vary across sites within ‘n’ discrete 
categories, n ≥ 3); M1a (a model of neutral evolution) where all sites are assumed to be either 
under negative (w <1) or neutral selection (w=1) versus M2a (a model of positive selection) which 
in addition to the site classes mentioned for M1a, assumes a third category of sites; sites with w>1 
(positive selection) and M7 (b) versus M8 (b and w), and models that mirror the evolutionary 
constraints of M1 and M2 but assume that w values are drawn from a beta distribution (Nielsen 
and Yang 1998). Only if the alternative models (M3, M2a and M8: allow sites with w>1) show a 
better fit in Likelihood Ratio Test (LRT) relative to their null models (M0, M1a and M7: do not 
allow sites w>1), are their results considered significant. LRT is estimated as twice the difference 
in maximum likelihood values between nested models and compared with the c2 distribution with 
the appropriate degree of freedom—the difference in the number of parameters between the two 
models. The Bayes empirical Bayes (BEB) approach (Yang et al. 2005) was used to identify amino 
acids under positive selection by calculating the posterior probabilities that a particular amino acid 
belongs to a given selection class (neutral, conserved or highly variable). Sites with greater posterior 
probability (PP ≥ 95%) of belonging to the ‘w>1 class’ were inferred to be positively selected.
FUBAR (Murrell et al. 2013) implemented in HyPhy (Pond et al. 2005) was employed to 
provide additional support to the aforementioned analyses and to detect sites evolving under the 
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influence of pervasive diversifying and purifying selection pressures. Mixed Effects Model Evolution 
(MEME) (Murrell et al. 2012) was also employed to efficiently detect episodically diversifying 
sites. Further support for the results of the nucleotide-level selection analyses was obtained 
using a complementary protein-level approach implemented in TreeSAAP (Woolley et al. 2003).
Direct comparison of w values computed from different datasets can be misleading, as they can 
have different proportion of sites under selection. Hence, we assessed the selection pressures shaping 
different 3FTx clades by employing clade model analyses implemented in Codeml and simultaneously 
estimated w values (Bielawski and Yang 2004). The significance of the analysis was tested by 
comparing the likelihood of this model with that of model M1a. To clearly depict the proportion of 
sites under different regimes of selection, an evolutionary fingerprint analysis was carried out using 
the evolutionary selection distance (ESD) algorithm implemented in datamonkey (Pond et al. 2010).
Structural analyses 
To depict the natural selection pressures influencing the evolution of various three-finger 
toxins, we mapped the sites under positive selection on the homology models created using Phyre 2 
webserver (Kelley and Sternberg 2009). Pymol 1.3 (DeLano 2002) was used to visualize and generate 
the images of homology models. Consurf webserver (Armon et al. 2001) was used for mapping 
the evolutionary selection pressures on the three-dimensional homology models. GETAREA 
(Fraczkiewicz and Braun 1998) was used to calculate the Accessible Surface Area (ASA) or the solvent 
exposure of amino-acid side chains. It uses the atom co-ordinates of the PDB file and indicates if 
a residue is buried or exposed to the surrounding medium by comparing the ratio between side 
chain Accessible Surface Area (ASA) and the “random coil” values per residue. An amino-acid is 
considered to be buried if it has an ASA less than 20% and exposed if ASA is more than or equal 
to 50%. When ASA ratio lies between 40%-50%, it is highly likely that the residues have their side 
chains exposed to the surrounding medium (Fraczkiewicz and Braun 1998; Osorio et al. 2007).
3.3.4 Results
Bayesian and maximum-likelihood molecular phylogenetic analyses retrieved phylogenetic 
trees with similar topologies (Fig. 3.3.1). The overall topology of these phylogenetic trees was largely 
in concordance with the previously published 3FTx phylogeny (Fry et al. 2003a; Fry et al. 2008). 
A particularly notable finding was that the novel Type II w-ntx sequences from Oxyuranus and 
Pseudonaja which lack the Type II a-ntx characteristic cysteine doublet (-2C) between plesiotypic 
cysteines 5 and 6 were not plesiotypic to the other Type II, nor were they monophyletic, but 
rather were interspersed with the regular Type II forms (+2C) (Fig. 3.3.2). This suggests that they 
have been independently derived from the rapidly evolving Type II a-ntxs, and that the derived 
cysteine doublet characteristic of Type II a-ntx was secondarily lost on at least two occasions. Our 
analysis of the venom gland transcriptome of the unique viperid snake Azemiops feae recovered 
a 3FTx transcript that formed a clade with representative sequences from the pit-viper Sistrurus 
catenatus (Fig. 3.3.1). This is the first non-Sistrurus 3FTx to be recovered from a viper. Based 
on an unresolved neighbour joining tree based upon a questionable alignment, Viperidae 3FTx 
were previously reported as polyphyletic, with some sequences nested within the Elapidae 3FTx 
clade, and others in the ‘non-front-fanged’ advanced snake 3FTx clade (Pahari et al. 2007). 
However, both Bayesian and maximum-likelihood phylogenetic analyses in this study place all 
Viperidae sequences as a monophyletic clade outside the Elapidae 3FTx clade with strong node 
support (Fig. 3.3.1). This is consistent with the viperid snakes having diverged from the remaining 
advanced snakes nearly 54 million years ago (Vidal et al. 2009). Viperidae 3FTx homologues 
retrieved to date indicate that derived structural and functional forms, such as Type I, II and III 
a-ntxs, k-ntxs and cytotoxins were derived in elapid advanced snakes after this split (Fig. 3.3.1).
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Figure 3.3.2
Legend: Bayesian molecular phylogeny and structural and functional evolution of +2C/-2C Type II 
(long-chain) a-neurotoxins. Pseudonaja/Oxyuranus -2C and +2C sequences are coloured purple and 
green, respectively. Sequences presented (uniprot): 1) R4FIT5 Pseudonaja modesta, 2) R4FIU6 Pseudonaja 
modesta, 3) A8HDK6 Pseudonaja textilis, 4) R4FK68 Pseudonaja modesta, 5) A8HDK8 Oxyuranus 
microlepidotus, 6) A7X4Q3 Oxyuranus microlepidotus, 7) A8HDK7 Oxyuranus microlepidotus, 8) 
A7X4R0 Oxyuranus microlepidotus, 9) A8HDK9 Oxyuranus scutellatus, 10) Q9W7J5 Pseudonaja textilis, 
11) R4FIT0 Pseudonaja modesta, 12) R4G7K3 Pseudonaja modesta, 13) R4G321 Pseudonaja modesta, 
14) R4G2J4 Pseudonaja modesta, 15) R4G319 Pseudonaja modesta and 16) R4FK75 Pseudonaja modesta.
The one-ratio model (ORM), the simplest of the lineage-specific models, computed a wide 
range of w (dN/dS) values for various types of 3FTx. This highly conservative model can only detect 
positive selection when the w ratio, averaged over all sites along the lineages in a phylogenetic tree, is 
significantly greater than one. Despite this, the w value for most three-finger toxins was significantly 
greater than 1, indicating the strong influence of positive selection in shaping the evolution of 3FTx: 
plesiotypic a-ntx from Viperidae, NFF and Elapidae: 1.79, 1.29 and 1.30, respectively; Type I, Type 
II and Type III a-ntx: 1.92, 2.01 and 2.59, respectively; and k-ntx: 1.64. Oxyuranus/Pseudonaja Type 
II a-ntx with (+2C) and without the cys doublet (-2C) were significantly different, with w values 
of 0.97 and 2.69, respectively. In contrast to all other 3FTx types, ORM estimated an w  value of 
0.32 for cytotoxins, indicating an unprecedented lack of variation in this unique three-finger toxin.
The segregation of sero-mucous mixed maxillary glands into discrete protein and mucus glands 
at the base of the advanced snake tree and the subsequent evolution of a high pressure, hollow-fanged 
venom delivery apparatus independently in Elapidae and Viperidae were major evolutionary advances 
in snake feeding ecology (Fry et al. 2008; Fry et al. 2012a). In order to assess the effect of these 
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derivations on the evolution of 3FTx, we employed the three-ratio model (3RM) and the branch-
site test A (BST) on the plesiotypic a-ntx from the advanced snakes (NFF, Viperidae and Elapidae). 
While, 3RM - which assesses selection pressures only across lineages - estimated w of 1.13, 1.37 and 
2.21 for the plesiotypic a-ntx from NFF, Elapidae and Viperidae, respectively; BST - which assess 
selection pressures across the sites and along the lineages in a tree - estimated w of 2.16 (22% sites), 
4.09 (23% sites) and 6.54 (31% sites), respectively (Table 3.3.2). NFF and Elapidae comparisons were 
insignificant (p>0.05) for 3RM, while all other comparisons were significant (significant at 0.001 
after Bonferroni corrections). 3RM and BST indicated a greater influence of positive selection on the 
plesiotypic a-ntxs in elapid and viperid snakes, which have independently evolved very sophisticated 
high pressure and hollow fanged venom delivery system in comparison with the NFF advanced snakes.
We also employed these tests to assess selection pressures along the lineages of the three types of 
Elapidae specific derived a-ntxs that lack plesiotypic cysteines 2 and 3: Type I, II and III a-ntxs (Table 
3.3.3). The three-ratio model (3RM) estimated w of 1.89, 1.94 and 2.39 for Type I, Type II and Type 
III a-ntxs, respectively. BST estimated w of 4.39 (10% sites), 4.09 (18% sites) and 4.77 (24% sites), 
respectively for the three types. All these comparisons were significant at 0.001 after Bonferroni correction.
Since the aforementioned lineage-specific models often fail to detect episodic diversifying 
selection that only affects certain sites in proteins, we also employed site-specific models. Similar 
to ORM, model 8 estimated w that ranged widely (Table 3.3.4; Fig. 3.3.3 and Fig. 3.3.4). The 
computed w and the number of positively selected sites detected by model 8 suggest that most 
three-finger toxins have evolved under the strong influence of positive selection; Viperidae: 
3.28 [30 positively selected (PS) sites; 55% of sites)]; plesiotypic a-ntx from NFF: 1.63 (37 PS; 
47% of sites); plesiotypic a-ntx from elapid snakes: 1.75 (28 PS; 41% of sites); Type I a-ntx: 
1.72 (19 PS; 30.0% of sites); Type II a-ntx: 1.45 (21 PS; 26% of sites); Oxyuranus/Pseudonaja 
Type II a-ntx with cys doublet (+2C): 3.67 (18 PS; 33% of sites); Oxyuranus/Pseudonaja Type 
II a-ntx without cys doublet (-2C): 3.41 (20 PS; 58% of sites); Type III a-ntx 2.61 (30 PS; 
42% of sites); k-bungarotoxins: 2.11 (5 PS; 9.3% of sites) (Table 3.3.4; Fig. 3.3.3 and 3.3.4). 
FUBAR and MEME identified several episodically diversifying sites in various forms of 3FTxs, 
highlighting the rapid evolution of these toxins (Table 3.3.4). In contrast, M8 estimated w of 
0.53 (2 PS and 3% of sites) for cytotoxic 3FTx, suggesting that they have evolved under a regime 
of strong negative-selection. As compared to the a-ntxs, k-bungarotoxins have experienced a 
weaker influence of positive diversifying selection, as reflected by the very few number of positively 
selected sites detected in this lineage by various analyses (5 PS and 9% of sites; Table 3.3.4).
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Figure 3.3.3
Legend: Molecular evolution of plesiotypic 3FTxs. Three dimensional homology models 
of various three-finger toxins, depicting the locations of positively selected sites are 
presented. Site-model 8 computed omega and the total number of positively selected sites 
detected by its Bayes Empirical Bayes (BEB) approach (PP ≥ 0.95) are also indicated.
Since lineages may have different proportion of sites under the influence of selection, the 
direct comparison of w values computed by the aforementioned analyses could be misleading. 
Hence, we employed the clade model c approach to simultaneously compute w values for different 
3FTx clades. Clade-model analyses computed w of 2.20, 4.48 and 6.23 for the plesiotypic a-ntxs 
from NFF, Elapidae and the viperid snakes, respectively (Table 3.3.2). This highlights a greater 
influence of positive selection on 3FTx from Elapidae and Viperidae snake lineages (significant 
at 0.001 in comparison with site model M1a, Bonferroni correction), relative to NFF and 
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Henophidia 3FTxs. Within elapid snake specific 3FTx lineages, clade analyses estimated w of 
3.36, 4.14 and 3.26 for Type I, Type II and Type III a-ntxs, respectively, indicating a greater 
influence of positive Darwinian selection on Type II a-ntx compared to the rest (Table 3.3.3).
Table 3.3.2 Lineage-specific analyses of plesiotypic three-finger toxins
Model wa Likelihood (i) Prop. of sites with w>1b Significance REL
Plesiotypic a-neurotoxins from Henophidia
Four-ratio Model 0.43 -6575.915465 - *P << 0.01
0.80Branch-site 
Model A 2.90 -6357.464344 6.0% P > 0.05
NS
Clade Model C 1.25 -6239.894424 51.4% *P << 0.001 (8PS and 4NS)
Plesiotypic a-neurotoxins from ‘non-front-fanged’ advanced snakes
Four-ratio Model 1.20 -6585.217134 - P > 0.05NS
1.80Branch-site 
Model A 3.0 -6336.988922 9.3% *P << 0.001
Clade Model C 2.65 -6239.894424 51.4% *P << 0.001 (7PS and 13NS)
Plesiotypic a-neurotoxins from Elapidae
Four-ratio Model 1.40 -6585.331436 - P < 0.05
2.79Branch-site 
Model A 4.36 -6330.311921 21.3% *P << 0.001
Clade Model C 5.09 -6239.894424 51.4% *P << 0.001 (23PS and 6NS)
Viperidae 3FTx
Four-ratio Model 1.99 -6583.291211 - *P < 0.01
Branch-site 
Model A 3.21 -6351.460779 24.1% *P < 0.01 4.46
Clade Model C 4.21 -6239.894424 47.8% *P << 0.001 (3PS and 8NS)
Legend:
a: mean dN/dS (weighted average)
b: Proportion of sites with ω>1
c: Number of sites with ω>1 under the Bayes empirical Bayes approach with a posterior probability 
(PP) of more than or equal to 0.99 and 0.95
d: Significance of the model in comparison with the null model
REL: Omega and the number of positively (PS) and negatively (NS) evolving sites by Random effects 
likelihood model (HyPhy)
*: Significant after Bonferroni correction
NS: Not significant
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Table 3.3.3 Lineage-specific analyses of a-neurotoxins
Model wa Likelihood (i) Prop. of sites with w>1b Significance REL
a-neurotoxins
Type I
Three-ratio Model 1.75 -11133.720063 - *P << 0.001
1.78Branch-site 
Model A 3.80 -10735.132802 19.7% *P << 0.001
Clade Model C 1.97 -8637.762930 41.5% *P << 0.001 (29
PS and 
4NS)
Type II
Three-ratio Model 2.06 -11134.518859 - *P << 0.001
3.02Branch-site 
Model A 4.05 -10655.352624 28.3% *P << 0.001
Clade Model C 3.30 -8637.762930 41.5% *P << 0.001 (26
PS and 
25NS)
Type III
Three-ratio Model 2.38 -11133.629588 - *P << 0.001 dN>>dS
(dS nearly 
0)#
Branch-site 
Model A 5.06 -10662.800906 29.5% *P << 0.001
Clade Model C 5.71 -8637.762930 41.5% *P << 0.001 (16
PS and 
26NS)
Oxyuranus / Pseudonaja Type II a-neurotoxins
With cysteine doublet
Two-ratio Model 0.82 -1487.238564 - P > 0.05NS dN>>dS
(dS nearly 
0)#
Branch-site 
Model A 4.96 -1463.715403 3.8% P > 0.05
NS
Clade Model C 1.38 -1442.241862 39.6% *P << 0.001 (12
PS and 
1NS)
Without cysteine doublet
Two-ratio Model 1.50 -1488.937026 - P > 0.05NS dN>>dS
(dS nearly 
0)#
Branch-site 
Model A 8.97 -1456.799730 6.4% *P << 0.001
Clade Model C 5.44 -1442.241862 39.6% *P << 0.001 (19
PS and 
1NS)
Legend:
a: mean dN/dS (weighted average)
b: Proportion of sites with ω>1
c: Number of sites with ω>1 under the Bayes empirical Bayes approach with a posterior probability 
(PP) of more than or equal to 0.99 and 0.95
d: Significance of the model in comparison with the null model
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REL: Omega and the number of positively (PS) and negatively (NS) evolving sites by Random effects 
likelihood model (HyPhy)
*: Significant after Bonferroni correction
NS: Not significant
#: Since dS is close to zero, the computed omega (dN/dS) is extremely larger than 1. Hence, it is not 
shown here.
To provide further support to the positively detected sites by the nucleotide-level selection 
analyses, we employed a complementary protein-level approach implemented in TreeSAAP. With this 
combined approach we were able to identify 18/19 positively selected (PS) sites in Type I, all 21 PS 
sites in Type II, 13/30 PS sites in Type III a-ntxs; 21/30 sites in Viperidae 3FTx; 11/37 PS sites in NFF 
and 2/2 PS sites in cytotoxic 3FTx. However, this approach failed to identify positively selected sites 
in k-bungarotoxins and Elapidae plesiotypic 3FTx lineages and +2C and -2C type II a-ntx lineages, 
suggesting that mutations in these toxin types may not be as radical as the ones in the aforementioned types.
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Figure 3.3.4
Legend: Molecular evolution of derived 3FTx. Three dimensional homology models 
of various three-finger toxins, depicting the locations of positively selected sites are 
presented. Site-model 8 computed omega and the total number of positively selected 
sites detected its Bayes Empirical Bayes (BEB) approach (PP ≥ 0.95) are also indicated.
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Evolutionary fingerprint analyses clearly depict several residues in most 3FTxs as evolving 
under the influence of positive selection, while conversely the majority of sites in cytotoxic 
3FTx remained constrained under negative selection (Appendix 3.3.1). Branch-site REL (BSR) 
identified a number of branches in the phylogenetic trees of various 3FTx types as episodically 
diversifying: plesiotypic a-ntx from NFF, Elapidae and viperid snakes: 9, 8 and 6 branches, 
respectively; Type I, Type II and Type III a-ntx 9, 24 and 13 branches, respectively; +2C and 
-2C Oxyuranus/Pseudonaja Type II a-ntx: 7 and 2 branches, respectively. This test detected two 
and three branches, respectively in k-ntxs and cytotoxins, indicating that even these toxin types 
have experienced the influence of episodic bursts of selection, probably during their early stages 
of evolution. Computation of surface accessible area ratio indicated that a majority of positively 
selected sites in 3FTx were exposed (completely or partially) to the surrounding medium [a-ntx: 
Type I 79% (11% buried), Type II 70% (15% buried) and Type III 74% (11% buried); plesiotypic: 
NFF: 69% (8% buried), Viperidae: 83% (11% buried) and Elapidae: 85% (11% buried); and all 
positively selected sites were found to be exposed in k-ntxs and cytotoxins] (Fig. 3.3.5). Note that 
the difference between the percentage of exposed and buried residues represents the percentage 
of those residues that couldn’t be assigned into buried/exposed classes. Mapping of positively 
selected sites onto the alignment of various 3FTx genes revealed that nearly all the hypermutable 
sites are located outside the structurally and functionally important regions, suggesting that 
3FTx genes have adopted a very sophisticated focal mutagenesis (Fig. 3.3.2 and 3.3.6-3.3.8).
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Figure 3.3.5
Legend: Surface accessibility of three-finger toxins. A plot of amino acid positions (x-axis) against accessible 
surface area (ASA) ratio (y-axis) indicating the locations of amino acids (exposed or buried) in the crystal 
structure of various three-finger toxins is presented. Positively selected residues are presented as large dots, 
while the remaining sites are presented as small dots in the plot. Residues with an ASA ratio greater than 
50% are considered to be exposed (ASA of 40%-50% are likely to have exposed side chains), while those 
with a ratio lesser than 20% are considered to be buried to the surrounding medium. Three dimensional 
structures of various 3FTx types, depicting the locations of positively selected (PS) sites along with 
model 8 omega values and the number of exposed and buried positively selected sites are also presented.
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Figure 3.3.6
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Legend: Structural and functional evolution of plesiotypic 3FTxs. Sequence alignment and 
homology models depicting structurally and functionally important residues and hypermutable 
sites of various three-finger toxins are shown. Extremely well conserved residues implicated in 
structural/functional roles, and hypermutable sites are shaded. Sequences presented (uniprot): A. 
1) M9T1L2 Aspidites melanocephalus, 2) M9T271 Aspidites melanocephalus, 3) M9SZR1 
Cylindrophis ruffus and 4) M9SZV9 Cylindrophis ruffus; B. 1) A5X2W8 Sistrurus catenatus 
edwardsii, 2) B4Y146 Sistrurus catenatus edwardsii, 3) A5X2W7 Sistrurus catenatus edwardsii, 
4) B4Y143 Sistrurus catenatus edwardsii, 5) B4Y144 Sistrurus catenatus edwardsii and 6) M9T2J4 
KC862258 Azemiops feae; C. 1) Q06ZW0 Boiga dendrophila, 2) A0S864 Boiga irregularis, 3) 
A0S865 Boiga irregularis, 4) A7X3V0 Telescopus dhara and 5) A7X3S0 Trimorphodon biscutatus; D. 1) 
Q6IZ95 Bungarus candidus, 2) Q9PW19 Bungarus multicinctus, 3) Q9YGH9 Bungarus multicinctus, 
4) Q8AY51 Bungarus candidus, 5) Q2VBN2 Ophiophagus hannah and 6) Q9YGI2 Naja atra.
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Figure 3.3.7
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Legend: Structural and functional evolution of derived a-neurotoxins and k-neurotoxins. 
Sequence alignment and homology models depicting structurally and functionally important 
residues and hypermutable sites of various three-finger toxins are shown. Extremely well conserved 
residues implicated in structural/functional roles, and hypermutable sites are shaded. Sites that are 
shown to be structurally/functionally important but exhibit less than 70% identity are indicated 
by arrow heads in the alignment. Sequences presented (uniprot): A. 1) B5G6F6 Oxyuranus 
microlepidotus, 2) H8PG58 Suta nigriceps, 3) P60770 Naja atra, 4) P10455 Laticauda colubrina, 
5) B2BRS2 Austrelaps labialis and 6) F8J2H2 Drysdalia coronoides; B. 1) F8J2E0 Drysdalia 
coronoides, 2) Q8UW29 Hydrophis hardwickii, 3) P01384 Notechis scutatus, 4) P82662 Ophiophagus 
hannah, 5) R4G2L3  Suta fasciata and 6) R4G2E5 Brachyurophis roperi; C. 1) R4G2S0 Cacophis 
squamulosus, 2) R4G7H6 Furina ornata, 3) R4G332 Pseudonaja modesta, 4) Q9W7K2 Pseudonaja 
textilis, 5) R4G7F3 Brachyurophis roperi and 6) R4G7M0 Vermicella annulata; D. 1) Q8AY56 
Bungarus candidus, 2) Q8AY55 Bungarus candidus, 3) P15817 Bungarus multicinctus, 4) P01398 
Bungarus multicinctus, 5) O12962 Bungarus multicinctus and 6) Q9W729 Bungarus multicinctus.
Figure 3.3.8
Legend: Structural and functional evolution of cytotoxins. Sequence alignment and homology models 
depicting A. the locations of putative functional residues and B. hydrophobic regions of cytotoxins are 
presented. Extremely well conserved residues implicated in structural/functional roles, and hypermutable 
sites are shaded. Sequences presented (uniprot): 1) P60301 Naja atra, 2) P60303 Naja kaouthia, 3) Q9DGH9 
Naja kaouthia, 4) P60301 Naja sputatrix, 5) Q02454 Naja sputatrix and 6) O93471 Naja sputatrix.
3.3.5 Discussion
Evolution of an advanced venom delivery apparatus and subsequent evolution of a high 
pressure, hollow-fanged venom delivery system has facilitated rapid evolution of three-finger toxins.
The early evolution of a venom system has been shown to have played a significant role in 
the diversification of toxicoferan reptiles (Fry et al 2006; Fry et al 2008; Fry et al 2009; Fry et al 
2010; Fry et al 2012; Fry et al 2013). While the elapid and viperid snakes possess sophisticated 
venom delivery apparatus that facilitates the easier injection of venom into the prey, the most 
basally-divergent Henophidia are not dependent on envenoming, and instead use a derived strategy 
(constriction) for predation. Various selection analyses employed in this study indicated that these 
contrasting prey-capture strategies and the evolution of the advanced venom-delivery apparatus in 
Caenophidia have significantly influenced the evolution of the plesiotypic a-ntxs (Fig. 3.3.3 and 
Fig. 3.3.6; Tables 3.3.2 and 3.3.4). Not surprisingly, plesiotypic a-ntxs in NFF [a=1.63 and 37 
Positively Selected (PS) sites], Viperidae [a=3.28 and 30 PS] and Elapidae (a=1.75 and 28 PS) 
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accumulated tremendous variations, while their henophidian homologues (a=0.77 and 0 PS) lacked 
variation completely (Tables 3.3.2 and 3.3.4; Fig. 3.3.3 and Fig. 3.3.6). This is consistent with 
3FTx variation being unwarranted in powerfully constricting snakes, which are not known to use 
venom for capturing prey (Fry et al. 2013b). Interestingly, Aspidites (Henophidia: Pythonidae) and 
Cylindrophis (Henophidia: Cylindrophiidae) are separated by ~92 million year evolution, almost 
as long as their common ancestor has been separated from the advanced snakes [approximate date 
of divergence 103 mya: (Vidal et al. 2009)]. Extreme conservation of 3FTx in the overwhelmingly 
mucus producing maxillary and mandibular glands of these basally-divergent snakes (Fry et al. 
2013b), despite their 90+ million years of independent evolution is enigmatic. However, due to 
the paucity of 3FTx sequences (primarily a result of their extremely low levels of venom gland 
specific transcription), the precise role of these proteins in the venom glands of Henophidia 
and the reason for the lack of variation in their coding sequences remain to be understood.
The significant amount of variation observed in the plesiotypic a-ntxs from the venoms of 
NFF is consistent high expression levels in the Colubridae (Fry et al. 2003c; Fry et al. 2008). 
3FTx from several NFF snakes have been demonstrated to be potently toxic, and in some cases 
exhibit prey-specific toxicity (Prado-Franceschi et al. 1996; Fry et al. 2003b; Pawlak et al. 2006; 
Pawlak et al. 2009). However, various selection analyses presented in this study indicate a greater 
accumulation of variations in the plesiotypic a-ntxs from Viperidae and Elapidae, relative to the 
NFF snake a-ntx homologues: Tables 3.3.2 and 3.3.4; Fig. 3.3.3 and 3.3.6). The sophisticated 
venom delivery apparatus of Elapidae facilitates efficient injection of the toxin cocktail into prey 
animals. Thus, the derivation of the high pressure, hollow-fanged venom delivery apparatus 
appears to have had a considerable influence on the rapid diversification of Elapidae and Viperidae 
3FTxs in comparison with NFF snakes. The polyphyletic NFF snakes have been demonstrated to 
employ a characteristically different venom arsenal from that of the Elapidae snakes. The venom 
in most elapid snakes is rich in three-finger toxins, while only the venoms of gracile snakes in 
the family Colubridae have been shown to contain large amounts of this toxin type (Fry et al. 
2003b; Fry et al. 2003c; Fry et al. 2008). Hence, the differences in overall venom composition 
could have also influenced the differential rate of 3FTx evolution in these lineages. It has already 
been demonstrated that some venom components that are secreted in large amounts by NFF 
snakes experience a greater influence of positive selection relative to those of their elapid snake 
counterparts (Sunagar et al. 2012). Since most viperid snakes are known to employ a haemorrhagic, 
haemolytic toxin cocktail, the neurotoxic 3FTx may only play an ancillary role in envenoming 
by these snakes. Evidently, viper venoms are dominated by hydrolytic enzymes (e.g. snake venom 
metalloproteinases, serine proteases, esterases, etc.), while 3FTx expression appears to occur 
only in insignificant amounts. Hence, the presence of considerable coding sequence variation in 
Viperidae 3FTx gene is enigmatic. Further sequencing and functional assessment of 3FTx from 
this lineage is warranted to precisely understand the participation of these proteins in envenoming.
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Table 3.3.4 Dynamic molecular evolution of three-finger toxins (3FTx)
SLACa FELb RELc FUBARd MEMEe PAMLf
M8 M2a Clade Model C
Henophidia
3FTx
w>1g 0 0 8 0
0 0
w<1h 0 4 4 0 0 1.25
w= 0.48 - 0.80 - 0.78 0.78
NFF-snake 
plesiotypic
a-ntx
w>1g 1 9 7 16 29 26
w<1h 6 6 13 8 13 (20+9) (19+7) 2.65
w= 1.23 - 1.80 - 1.49 1.53
Elapid
plesiotypic
a-ntx
w>1g 0 2 23 13 28 24
w<1h 1 3 6 3 6 (22+6) (15+9) 5.09
w= 1.30 - 2.79 - 1.75 1.79
Viperidae
3FTx
w>1g 0 0 3 7 30 24
w<1h 0 3 8 1 3 (18+12) (13+11) 4.21
w= 1.62 - 4.46 - 3.28 3.28
Cytotoxins
w>1g 0 1 5 2 1
0
w<1h 1 4 40 3 5 (0+1) -
w= 0.39 - 0.51 - 0.51 0.53
Kappa
ntx
w>1g 0 2 4 6 5 5
w<1h 0 2 0 0 3 (3+2) (3+2) -
w= 1.52 - 1.82 - 2.11 2.11
Type I
a-ntx
w>1g 1 6 29 15 16 13
w<1h 2 2 4 1 12 (13+3) (10+3) 1.97
w= 1.44 - 1.78 - 1.57 1.51
Type II
a-ntx
w>1g 8 13 26 21 27 25
w<1h 7 8 25 7 26 (25+2) (23+2) 3.30
w= 1.76 - 3.02 - 1.80 1.85
Type III
a-ntx
w>1g 13 14 13 29 29 29
w<1h 3 4 29 3 19 (27+2) (26+3) 5.71
w= 2.31 - 1.77 - 2.62 2.70
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SLACa FELb RELc FUBARd MEMEe PAMLf
Oxyuranus / Pseudonaja Type II a-neurotoxin
With
Cys 
Doublet
w>1g 0 0 12 1 15 12
w<1h 1 3 1 1 3 (3+12) (1+11) 1.38
w= 1.40 - dN>>dS - 1.83 1.83
Without 
Cys 
Doublet
w>1g 0 0 19 4 13 9
w<1h 0 2 1 1 3 (6+7) (5+4) 5.44
w= 1.75 - dN>>dS - 2.93 2.92
Legend
a: Single Likelihood Ancestor Counting 
b: Fixed-effects likelihood 
c:  Random-effects likelihood
d: Fast Unbiased Approximate Bayesian
e: Sites detected as experiencing episodic diversifying selection (0.05 significance) by the Mixed  
Effects Model Evolution (MEME)
f: Positively selected sites detected using the Bayes Empirical Bayes approach implemented in M8 
and M2a. Sites detected at 0.99 and 0.95 significance are indicated in the parenthesis
w: mean dN/dS
g: Number of positively selected sites at 0.05 significance (for SLAC, FEL) or 50 Bayes factor (for 
REL) / number of sites under pervasive diversifying selection at the posterior probability ≥0.9 
(FUBAR)
h: Number of negatively selected sites at 0.05 significance (for SLAC, FEL) or 50 Bayes factor 
(for REL) / number of sites under pervasive purifying selection at the posterior probability ≥0.9 
(FUBAR)dN>>dS: Since dS is close to zero, the computed omega (dN/dS) is extremely larger than 
1. Hence, it is not shown.
NFF: Non-front-fanged advanced snakes
ntx: Neurotoxin
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The deletion of plesiotypic cysteine resides (2 and 3) triggered an explosive diversification
Comparative assessments revealed that though all three forms of derived a-ntxs that lack the 
2nd and 3rd plesiotypic cysteines have evolved particularly rapidly, Type II forms have experienced a 
greater influence of positive selection than Type I or Type III a-ntxs (Tables 3.3.3 and 3.3.4; Fig. 3.3.4 
and 3.3.7). Unlike Type I a-ntx that can only antagonize the muscle nicotinic acetylcholine receptors 
(a1-nAChR) (the plesiotypic functional activity), Type II a-ntxs can strongly bind to neuronal a7-
nACh receptors as well. This expanded target potential makes them extremely useful for prey paralysis 
and probably explains the greater influence of positive selection on this type of 3FTx. Type III a-ntx 
has been demonstrated to exhibit the activities similar to that of Type I a-ntxs, but at a lower potency, 
in experiments conducted on mice (Gong et al. 1999). Prey specific toxicity has been demonstrated 
in a variety of a-ntxs (Prado-Franceschi et al. 1996; Pawlak et al. 2006; Pawlak et al. 2009). Hence, 
Type III a-ntx in the venoms of Australian elapids could be less potent against mammals, but 
extremely potent against the other types of organisms they feed on, such the lizards which the species 
of small Australian elapid snakes that are rich in Type III specialise upon (Shine 1980a; Shine 1980b; 
Shine 1981; Shine 1988; Shine 1989). The preponderance of Type III a-ntxs have been recovered 
from the venom gland transcriptomes of small Australian elapid snakes that feed exclusively on 
reptiles. The possibility that this toxin type may exhibit taxon-specific toxicity should be investigated 
further, as it may account for the tremendous influence of positive selection on this toxin type.
The dramatic rate of evolution of Type II a-neurotoxins may have resulted in the loss of 
characteristic cysteine doublets on multiple occasions in Oxyuranus/Pseudonaja
Oxyuranus and Pseudonaja, two closely related genera of Australian elapid snakes with 
unusually potent venom, are known to express the regular Type II a-ntx (+2C) and an additional 
type that lacks the two derived cysteine residues involved in stabilizing loop 2 (-2C). It was 
previously suggested that the absence of the cysteine pair (-2C) was a plesiotypic character and 
that the Type II a-ntx form with the cysteine pairs (+2C) represented the more derived form (St 
Pierre et al. 2007a). However, our molecular phylogenetic analyses revealed that the -2C forms 
are in fact derived in nature and originate from within the larger Type II a-ntx clade (Fig. 3.3.1 
and 3.3.2). Type II a-ntxs have experienced a strong influence of positive selection pressure 
and some of these in Oxyuranus and Pseudonaja species have accumulated mutations even in 
structurally important regions that are typically constrained by negative-selection. As a result, 
on multiple occasions they have lost the two derived cysteine residues that are characteristic 
of Type II a-ntxs (Tables 3.3.3 and 3.3.4; Fig. 3.3.2 and 3.3.4). Taxon-specific variations in 
potency of the +2C versus -2C have not been investigated but such studies will be illuminating.
Not all three-finger toxin clades evolve via positive Darwinian selection.
Evidence provided by various analyses [Codeml site, branch, branch-site and clade-specific 
models: M8, M2a, M3, M0, three-ratio model, branch-site test A, clade model c; HyPhy: 
MEME, FUBAR, Branch-site REL; TreeSAAP: protein-level selection analyses and evolutionary 
fingerprint analyses (Tables 3.3.2-3.3.4; Fig. 3.3.1-3.3.7; Appendix 3.2.1), clearly demonstrates 
the substantial influence of positive diversifying selection on the evolution of various three-finger 
toxin types. Conspicuously, while most 3FTx lineages evolved rapidly, cytotoxins (w=0.53; 2 PS-
sites) remain constrained by negative-selection (Table 3.3.4; Fig. 3.3.4 and 3.3.8). The precise 
molecular mechanism by which cytotoxic 3FTx exert their cell-damaging effects remains unclear, 
but it has been proposed that a highly conserved hydrophobic patch on the cyotoxin’s molecular 
surface interacts with hydrophobic regions of the cell’s phospholipid bilayer (Condrea 1976; 
Dufton and Hider 1988). Hydrophobic residues that facilitate such non-specific interactions are 
spread over the three loops of the cytotoxins (Fig. 3.3.8: B) and cover nearly 40% of the molecular 
surface (Bilwes, et al. 1994). Additionally, cytotoxins are known to exhibit a diversity of biological 
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functions and the residues implicated in these activities are distributed all along length of the toxin 
sequence (Fig. 3.3.8). In contrast to a-ntx, which bind to specific receptor sites, cytotoxins bind 
in a much more non-specific manner and thus may escape the classic predator-prey chemical arms 
race that influences the diversification of other toxin types. Thus, a lack of variation within the 
cytotoxins is reflective of negative selection pressure on these functionally/structurally important 
residues and against a loss of activity or potency. In contrast, a-neurotoxins and an array of ion-
channels they target, exert reciprocal selection pressure upon each other which results in the 
diversification of the 3FTx gene, in a classic ‘Red Queen’ co-evolutionary arms race scenario.
Conversely, k-ntxs (w=2.11; 5 PS-sites) have accumulated fewer variations than the a-ntxs 
(Table 3.3.4; Fig. 3.3.4 and 3.3.7: Panel D), despite also targeting a narrowly defined ion-channel 
type (Grant and Chiappinelli 1985). The lack of variations in the k-ntxs could be attributed to 
their unique ability amongst 3FTx to form non-covalent dimers (Grant and Chiappinelli 1985). 
Thus, most residues in these toxins evolve under the influence of negative selection to prevent the 
accumulation of mutations capable of affecting the three-dimensional structure of the toxin, and 
thus the ability to non-covalently form dimers. It is noteworthy that k-ntxs are characterized by 
two stabilising cysteines in loop 2, which maintain a more rigid three dimensional structure and 
are homologous to the same derived disulphide-bond in loop II of the Type II a-ntxs. Besides 
the van der Waal’s bond between Phe47 and Leu55 (Fig. 3.3.7: Panel D), as many as six main 
chain and three side chain hydrogen bonds are known to stabilize this toxin. The necessity to form 
these bonds exerts a strong structural constraint against the accumulation of variation in k-ntxs. 
Thus variation in k-ntx is largely limited to five positively selected sites, most of which are found 
in loop II. Loop III and the region between C9-C10, along with the functionally/structurally 
important residues evolve under the constraints of negative selection (Fig. 3.3.7: Panel D).
a-ntxs and k-ntxs have been theorized to originate from a common ancestral 3FTx subtype gene 
(Chang et al. 2002; Fry et al. 2003a). They are characterized by the highly conserved signal peptide 
and 3’ non-coding regions (Danse and Garnier 1990; Chang et al. 1997; Chang et al. 1999; Chang et 
al. 2002). Moreover, comparison of the structural motifs in type II a-ntxs and the k-ntxs, particularly 
the residues around the shared cysteines (n=10), indicates how closely related the two genes are (Fig. 
3.3.7: Panels B and D). Hence, it is very likely that they have originated from a common ancestral 
3FTx subtype gene and the differential rate of evolution has resulted in the observed functional and 
structural differences between the two homologues. In contrast to a-ntxs, k-bungarotoxin sequences 
are very well conserved, as a result of the aforementioned structural constraints (Fig. 3.3.7: Panel D).
The role of Rapid Accumulation of Variations in Exposed Residues (RAVER) and the focal 
mutagenesis in the evolution of snake venom three-finger toxins
Considering the highly conserved organization of the exonic regions of 3FTx, Doley et al. 
(2008) developed a hypothesis of ‘Accelerated Segment Switch in Exons to alter Targeting’ (ASSET), 
to explain the molecular mechanism of 3FTx evolution. They have postulated that during the evolution 
of the 3FTx gene, segments in exonic regions have been exchanged with distinctly different ones and 
the resultant ‘switching’ of segments has generated the coding sequence variation and the diversity 
of 3FTx. The molecular mechanism of segment ‘switching’ was attributed to genetic recombination, 
splicing variation, and independent recruitment events. We argue that these suggested mechanisms 
are unlikely to have played a major role in the evolution of three-finger toxins. Recombination 
cannot account for the tremendous variations observed in extremely short segments of 3FTx; all 
the observed hypermutations were concentrated in 1-6 adjacent amino acid sites (Fig. 3.3.6-3.3.8). 
Furthermore, recombination would not discriminate between functionally/structurally important 
and unimportant residues. All 3FTx have highly conserved residues (including the 8-10 cysteines), 
involved in maintaining functional and/or structural stability, and none of the hyper-mutable sites 
coincide with these (Fig. 3.3.6-3.3.8). In contrast, evidence supporting the hypothesis that all 3FTx 
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genes originated from the same ancestral gene is strong [Fig. 3.3.1; (Fry et al. 2003a)]. Hence, 
the suggestion of multiple independent recruitment of 3FTx as means to explain the observed 
variations is implausible. Though alternate splicing or the errors associated with this process can 
introduce variation in toxin length, like recombination, they cannot account for the considerable 
variations observed in very short segments of 3FTx. In addition, insertions and/or deletions in 
shared molecular scaffolds are more plausible explanations for the variations in sequence length.
The role of point mutations in shaping the diversity of 3FTx gene was underrated by 
the aforementioned authors (Doley et al. 2009). They speculated that point mutations alone 
could not account for the diversity of 3FTx functional forms and could have only been helpful 
in fine-tuning receptor binding capabilities, which arise through ASSET (Doley et al. 2008; 
Doley et al. 2009). A prominent role for point mutations in the evolution of 3FTx gene was 
discounted based on the following reasoning: i) point mutations would require numerous 
generations to account for the observed variations, ii) all intermediates would have to be 
selected for via positive selection and iii) point mutations would have to occur independently 
in unrelated lineages to produce the same structurally/functionally important conserved motif. 
We argue that these reasons for rejection are not valid. Predatory venom-encoding genes have 
been demonstrated to evolve under the significant influence of positive Darwinian selection, coupled 
with focal mutagenesis (Fry et al. 2003a Sunagar et al. 2012; Brust et al. 2013). They are involved 
in a co-evolutionary arms race, where evolving venom resistance in prey and the evolution of novel 
venom components exert reciprocal selective pressures on one another. The recruitment of the 3FTx 
gene to reptilian venom systems was previously thought to have occurred within the caenophidian 
snakes between the divergence of the pareatid snakes approximately 65 million years ago (MYA) and 
that of the viperid snakes approximately 54 MYA (Vidal et al. 2009). We have recently recovered 
3FTx transcripts from the venom glands of henophidian snakes, demonstrating that this recruitment 
event in fact occurred within the ancient Afrophidian snake clade circa 104 MYA (Fry et al. 2013b). 
3FTx genes explosively diversified subsequent to the evolution of the advanced venom delivery 
apparatus in Elapidae, 40 Mya (Tables 3.3.2-3.3.4; Fig. 3.3.3-3.3.8). Therefore, an appropriately large 
number of generations have passed for point mutations, under the guidance of positive Darwinian 
selection to shape the diversity of 3FTxs and account for the tremendous variations observed.
The aforementioned study (Doley et al. 2008) also failed to take into account the essence of 
focal mutagenesis, in which point mutations in certain regions of the toxins, such as the molecular 
surface, may confer adaptive significance. In order to conserve catalytic functions, most mutations 
in proteins can be found concentrated in structurally and/or functionally unimportant regions. 
Mutations do occur randomly and accumulate even within important regions of proteins. However, 
if such mutations do not confer any adaptive significance (or if they disrupt the normal functioning), 
then they are likely filtered out of the population by natural selection. Synthesis and secretion of 
venom-components is energetically extremely expensive. Hence, positive selection will favour the 
rapid accumulation of mutations in structurally/functionally unimportant regions, especially on the 
molecular surface of the toxin, as it confers adaptive significance. Evidently, venom components 
have been demonstrated to evolve via mutation of surface chemistry, which may increase the number 
of active residues on the molecular surface that can non-specifically interact with the cells of prey 
animals and cause a myriad of pharmacological effects (Kini and Chan 1999; Sunagar et al. 2012; 
Brust et al. 2013). In certain organisms like vampire bats, focal-mutagenesis in venom-components 
can be advantageous as it is likely to delay/prevent the development of immunological resistance in 
the prey by introducing extremely variable protein surface chemistry in the vampire bat population 
(Low et al. 2013). Mapping of mutations onto three-dimensional homology models and computation 
of accessible surface area ratios for various three-finger toxins, suggested that a greater proportion of 
mutations have accumulated on the molecular surface and in the loops of these toxins (Fig. 3.3.2-3.3.8). 
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Hence, we propose ‘Rapid Accumulation of Variations in Exposed residues’ (RAVER) to explain 
the molecular evolution of the 3FTx gene. We hypothesize that when venom proteins are involved in 
a co-evolutionary arms race, focal mutagenesis helps to preserve structural and functional residues, 
allowing the repeated mutations to accumulate on the molecular surface of the toxin, generating active 
residues or pharmacological sites. Rare mutations in structural and functional residues of rapidly 
evolving types may generate novel molecular scaffolds that get selected only if they considerably 
improve the potency of the toxin in comparison with the plesiotypic form. The frequency at which 
such ‘rare’ mutations are accumulated within a functional type, likely depends on the strength of 
positive Darwinian selection. Indeed, rapid accumulation of point mutations under the influence of 
positive selection in Type II a-ntx gene has led to the origination of -2C Type II a-ntxs, on multiple 
occasions, in Oxyuranus and Pseudonaja, two closely related genera of Australian elapid snakes with 
unusually potent venom (Fig. 3.3.2). Focal mutagenesis can further aid in accumulation of mutations in 
structurally/functionally unimportant regions that may act as raw materials for the derivation of novel 
functional forms. We hypothesize that most predatory venom-components evolve through RAVER.
Structure-function relationship in three-finger toxins
Mapping positively selected sites onto alignments of various three-finger toxins revealed that 
a large number of residues implicated in structural/functional roles were extremely well conserved 
(80% ≥ identity; Fig. 3.3.7 and 3.3.8). However, very few functionally/structurally important 
residues (A28, F29, R36 and F65) in Type II a-ntxs have been poorly conserved. This is not-
surprising given the rapid evolution of Type II a-ntxs, which has even resulted in the replacement 
of two cysteine residues that are usually invariants, and lead to the formation of new toxin type (-2C 
Type II a-ntxs) in Oxyurnus and Pseudonaja species. It has been demonstrated in erabutoxin (a Type 
I a-ntx; uniprot: P60775) that mutations at position 29 have a drastic effect on the binding affinity 
of this toxin to the Torpedo nAChR (Pillet et al. 1993). Evaluation of mutations at the homologous 
site in a-cobratoxin (a Type II a-ntx; uniprot: P01391) were shown to have varied effects on binding 
affinities (Antil et al. 1999). Although most sequences had a conserved phenylalanine residue at this 
position (F29; 49%), a number of others (33%) had tryptophan and histidine residues. It has been 
demonstrated that these substitutions (F29W and F29H) do not affect the binding affinity of Type II 
a-ntxs in anyway (Antil et al. 1999). Two other sequences (1%) had a leucine (F29L) residue in this 
position, which has been shown to substantially reduce the binding affinity of this toxin (Antil et al. 
1999). However, lysine residues in loop II (K23) and loop III (K49) have been shown to mediate the 
binding of Type II a-ntxs to a1-nAChRs and both these residues remain extremely well conserved 
in these toxins (Fig. 3.3.7: Panel B). Thus, a1-nAChR targeting capability of Type II a-ntxs remains 
intact, despite the mutation at the 29th position. Similarly, it has been demonstrated that A28R 
mutation does not affect the function of Type II a-ntxs (Antil-Delbeke et al. 2000) and evidently, 
a large number of sequences (77%) at this site either had alanine or arginine residues. Mutations at 
R36 and F65 have shown to only slightly affect the binding capabilities of Type II a-ntxs at both 
neuronal and muscle nAChRs. It should be noted that a-ntxs possess several extremely well conserved 
residues that mediate the specific binding of these toxins to either muscular or neuronal receptors 
(Fig. 3.3.7). Thus, despite the mutations at R36 and F65, these toxins can still bind to muscular 
and neuronal receptors. These examples clearly depict how Type II a-ntxs cope with rapid mutation 
rate. R33 in Type II a-ntx has been shown to be the most important site for toxicity, as it caused the 
greatest effect on the function of Type II a-ntxs in mutational studies. We noted that this site was 
extremely well conserved (86% identity). Mutational studies have also shown that T47 and D53, 
despite being very closely located to K49 on loop III, are unlikely to play any significant functional 
role (Antil et al. 1999). Interestingly, our selection analyses have detected these sites as hypermutable, 
among 21 other hypermutable sites in Type II a-ntxs (Fig. 3.3.7: Panel B). Rare mutations at 
functional sites, such as I26R in erabutoxin (P60775), have been demonstrated to increase the 
binding affinities of a-ntxs to their receptors (Trémeau et al. 1995). Hence, rapidly evolving a-ntxs 
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could derive extremely useful functional variations by conserving all but few functional residues.
Most hypervariable regions (73%) in Type III a-ntxs were concentrated in loop I and 
loop II (Fig. 3.3.7), regions that harbour residues implicated in binding of Type I a-ntx to a1-
nAChR. However, unlike Type I a-ntxs, Type III seem to have very well conserved region between 
plesiotypic cysteines 9 and 10 (Fry et al 2003a), which form the 4th disulphide bond in both 
these toxins. The corresponding region in Type II a-ntxs is also very well conserved, and shares 
with Type III a-ntx three highly conserved amino acids: S54, T55 and D56 (Fig. 3.3.7). It is 
very likely that this region, being the only well conserved region in Type III a-ntxs, plays an 
important structural or functional role. The invariant Asp 56 in this region seems particularly 
important for the activity of this toxin clade. Such a pattern of accumulation of hypermutations 
can also be explained by prey-specific and intraspecific conservation of residues in Type III a-ntxs. 
k-bungarotoxins and cytotoxins were unique among all 3FTx lineages examined in this 
study, in having extremely conserved amino acid sequences (Fig. 3.3.7 and 3.3.8). 52% (33 
residues) and 65% (53 residues) of sites in k-bungarotoxins and cytotoxins, respectively, were 
invariant. Although, toxins from these two clades accumulated a few positively selected sites (5 
and 2, respectively), they did not overlap with residues implicated in structural/functional stability. 
Mapping of hypermutable sites onto the alignments of the plesiotypic 3FTxs reveals the 
absence of conservation of most residues implicated in receptor binding of Type I and Type II 
elapid a-neurotoxins, which may be reflective of differences in taxon specificity. However, 
the residues implicated for activity in Type I and II may be specific to the assay utilised, with 
plesiotypic 3FTx shown to be dramatically more potent against aves than mammals but the 
specific receptors mediating the activity have not been elucidated. The residues of Type I or Type 
II binding may also be artefacts from testing in assays such as fish (Torpedo species), which may 
not be reflective of residues actually important in binding to the receptors of natural prey items. 
The impact of independently invented venom-delivery system (VDS) and its subsequent 
evolution in Caenophidia (advanced snakes), on the evolution of 3FTxs is intriguing. While all 
advanced snakes inherited 3FTxs, only Elapidae seem to have extensively exploited their usage for prey-
envenoming. As ‘non-front-fanged’ advanced snakes lack specialised VDS for efficiently delivering 
venom into prey animals, they use venom as part of a combined arsenal that includes variable use of 
constriction and bite pressure. Viperidae, arguably with the most efficient venom-delivery apparatus 
(hinged and grooved fangs), resorted to haemolytic and necrotic venom arsenal for prey-capture. The 
earliest elapid lineages, with fixed grooved-front-fangs, probably chiefly employed 3FTxs for prey-
subjugation. Hence, three-finger toxins in these snakes underwent rapid and explosive radiation under 
the significant influence of positive-Darwinian selection, resulting in the formation of a diversity of 
three-finger toxins (a-neurotoxins, k-neurotoxins, cytotoxins, non-conventional toxins, Muscarinic 
toxins, Fasciculins, b-cardiotoxins, Mambins or Dendroaspins, anticoagulant 3FTxs, Hennalgesin, 
Calciseptines, FS2s, etc.), which appear to be exclusively elapid lineage-specific. The plesiotypic 3FTxs, 
which are expressed in relatively lower amounts in Elapidae, Viperidae and a majority of ‘non-front-
fanged’ advanced snakes, could still play an ancillary envenoming function by mutating their molecular 
surface chemistry through RAVER and non-specifically inducing a plethora of pharmacological 
reactions in prey animals. Further sequencing and biochemical activity testing of plesiotypic 3FTx 
gene will unravel their molecular evolutionary history and the underlying mechanisms of action.
3.3.6 Conclusions
In this study, we show that point mutations, coupled with focal mutagenesis and positive 
selection, have played a primary role in the evolution and diversification of snake venom three-
finger toxins. We reject ASSET as a viable theory for explaining the molecular evolution of three-
finger toxins. Instead, we propose ‘Rapid Accumulation of Variations in Exposed residues’ (RAVE) 
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to explain the dynamic evolution of 3FTx. We elucidate an exquisite molecular mechanism in 
which the molecular surface and the regions not implicated in structural/functional stability, rapidly 
and periodically diversify, while the core structural/functional residues remain largely constrained 
by negative selection. However, even these highly conserved residues accumulate point mutations 
on occasion, especially in toxins with multiple targets such as Type II a-ntxs. Rare mutations in 
these highly conserved residues can generate unique toxin forms with novel folds, which might 
be more potent than the plesiotypic form. We show for the first time that not all 3FTx forms 
are influenced by positive selection. We highlight the differential rate of evolution of various 
3FTx types and show that unique forms like the k-ntxs have experienced weaker influence of 
positive selection than the a-ntx, while cytotoxins have been constrained by negative selection.
These results underscore the dynamic nature of venom evolution, where a myriad of forces, 
such as morphological refinement of the venom delivery system, shifts in feeding ecology, co-
evolutionary chemical arms races driving toxin neofunctionalisation via changes in targeting, 
evolution of toxin complexes with multiple subunits, etc. all influence the molecular evolutionary 
history of toxins, which in turn has a profound impact upon the biodiversity present in venoms 
of different snakes. This generates a molecular complexity that is both a blessing and a curse. 
On one hand, this complexity complicates snakebite treatment because of highly variable 
clinical sequelae and relative cross-reactivity of available antivenoms. On the other hand, it 
provides a rich pool of novel investigational ligands with tremendous potential for biodiscovery. 
It should be emphasized that this study only focused upon structural/functional 3FTx 
variants for which there were sufficient nucleotides to analyse. As shown in Figure 3.3.1 and 
Table 3.3.1, there are numerous functional variants that were not studied due to insufficient 
nucleotide sequences available (with some being known entirely only from the peptide sequence). 
In addition, as is clearly evident in Figure 3.3.1 and has been covered in-depth by us previously 
(Fry et al. 2003a), there is a tremendous diversity of 3FTxs for which no functional activity has 
been determined. Thus, 3FTx represent a tremendous resource not only for investigating the 
fundamentals of molecular evolution but also as a vast pool of novel peptides for biodiscovery. It 
is hoped that this study will stimulate further work on this very interesting class of snake toxin.
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4.1.1 Abstract
While vampire bat oral secretions have been the subject of intense research, efforts have 
concentrated only on two components: DSPA (Desmodus salivary plasminogen activator) and 
Draculin. The molecular evolutionary history of DSPA has been elucidated, while conversely 
draculin has long been known from only a very small fragment and thus even the basic protein class 
was not even established. Despite vampire bat venom having a multitude of effects unaccounted 
by the documented bioactivities of DSPA and draculin, efforts have not been made to establish 
what other bioactive proteins are secreted by their submaxillary gland. In addition, it has remained 
unclear whether the anatomically distinct anterior and posterior lobes of the submaxillary gland are 
evolving on separate gene expression trajectories or if they remain under the shared genetic control. 
Using a combined proteomic and transcriptomic approaches, we show that identical proteins are 
simultaneously expressed in both lobes. In addition to recovering the known structural classes 
of DSPA, we recovered a novel DSPA isoform as well as obtained a very large sequence stretch 
of draculin and thus established that it is a mutated version of the lactotransferrin scaffold. This 
study reveals a much more complex secretion profile than previously recognised. In addition to 
obtaining novel versions of scaffolds convergently recruited into other venoms (allergen-like, CRiSP, 
kallikrein, Kunitz, lysozyme), we also documented novel expression of small peptides related to 
calcitonin, PACAP, and statherin. Other over-expressed protein types included BPI-fold, lacritin, 
and secretoglobin. Further, we investigate the molecular evolution of various vampire bat venom-
components and highlight the dominant role of positive selection in the evolution of these proteins. 
Conspicuously many of the proteins identified in the proteome were found to be homologous 
to proteins with known activities affecting vasodilation and platelet aggregation. We show that 
vampire bat venom proteins possibly evade host immune response by the mutation of the surface 
chemistry through focal mutagenesis under the guidance of positive Darwinian selection. These 
results not only contribute to the body of knowledge regarding haematophagous venoms but 
also provide a rich resource for novel lead compounds for use in drug design and development.
4.1.2 Introduction
Venom is defined as a secretion produced in a specialised gland in an animal, which is 
delivered to a target animal by inflicting a wound (regardless of size). Venom must also contain 
molecules (toxins) that disrupt normal physiological and/or biochemical processes so as to 
facilitate feeding or defence by the producing animal (Fry et al. 2009a). This definition includes 
secretions produced by blood feeding (haematophagous) specialists such as fleas, ticks, leeches 
or vampire bats that disrupt the haemostatic defences of prey/host organisms. These secretions 
which facilitate haematophagy or blood feeding are considered a particular subtype of venom.
With the level of infamy that extends far beyond the boundaries of science, blood-sucking 
vampire bats (Chiroptera, Desmodotinae) have been the subject of folk tales, superstitions and 
stories associated with the legendary Count Dracula for centuries (Tuttle 1988; Villa, C. B., and 
Canela 1988). All the three species of vampire bats are confined to Central and South America 
and typically live in the caves, tree hollows, and abandoned mines (Ray, C. E., Linares, O. J., and 
Morgan 1988). The relatively rare hairy-legged vampire bat (Diphylla ecaudata) feeds exclusively on 
avian hosts, while the white-winged vampire bat (Diaemus youngi) thrives on both the mammalian 
and avian blood, but most likely favouring the latter (Koopman 1988; Tuttle 1988). In contrast, the 
common vampire bat, Desmodus rotundus feeds overwhelmingly on mammals and has established 
itself in large colonies over an increasingly extensive distribution (Bhatnagar 1988; Greenhall 
1988; Tuttle 1988). The expanding population of these bats is attributed to the increasing human 
population and the associated large number of domesticated animals and livestock, which provide a 
constant, high-density food supply (Greenhall 1988; Ray, C. E., Linares, O. J., and Morgan 1988). 
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All three species of vampire bats are highly specialised for a haematophagous lifestyle, 
especially D. rotundus (Ray, C. E., Linares, O. J., and Morgan 1988). Modifications of the teeth 
and limbs of vampire bats facilitate this lifestyle (Bhatnagar 1988)). Reinforcement of limb 
strength permits D. rotundus and the other vampire bat species to approach their prey from the 
ground via quadrupedal walking and jumping (Altenbach 1988; Greenhall 1988; Koopman 
1988). D. rotundus is the most specialised of all vampire bats, and possesses specialised sensory 
capabilities for the detection of prey (Schmidt 1988). Close-range thermal and mechanical 
sensitivity is utilised for locating capillaries during feeding, while long-range vision, olfaction, 
acute hearing and echolocation are utilised for the discovery of potential prey (Schmidt 1988). 
They also have razor-like upper and lower incisors (Hawkey 1967; Greenhall 1988; Koopman 
1988) that inflict a crater-shaped wound unique to D. rotundus. While feeding, their tongue 
darts in and out of the wound, releasing venom from the dorsal side of the tongue while drawing 
in blood via two straw-like ducts located on the ventral side of the tongue (Greenhall 1988). 
In order to facilitate blood-feeding, D. rotundus must be capable of interfering with their prey’s 
natural haemostatic response to injury during feeding and digesting (Hawkey 1988; Basanova et al. 
2002). A typical haemostatic response produces a fibrin clot within minutes of the infliction of a wound, 
preventing further blood loss. The response commences with the constriction of blood vessels, restricting 
blood flow to the wound, and is followed by the adhesion of activated platelets to the site of injury and 
the conversion of fibrinogen to insoluble fibrin, forming a blood clot (Hawkey 1988). In contrast to 
this normal response to injury, bleeding from a wound induced by vampire bats may be prolonged 
from minutes to hours, ensuring a constant flow of blood for the bat to feed upon (Hawkey 1988).
The gland predominantly associated with haematophagy in D. rotundus is the principle 
submaxillary gland, which consists of two separate anterior and posterior lobes (Disanto 1960). This 
gland is responsible for the secretion of venom with strong anticoagulant and proteolytic activities 
(Disanto 1960). The venom delays the onset of blood clotting by interfering with fibrin formation 
or acting upon fibrin as it is converted from fibrinogen. In addition it has a strong proteolytic 
action that breaks up any blood clots that may be formed. This is proteolytic action is accomplished 
through the activation of the host’s fibrinolytic system which converts plasminogen to plasmin, 
solubilising and removing fibrin clots to prevent excessive fibrin build up at the site of the wound. 
The venom of the vampire bat has been documented to disrupt the coagulation cascade via 
four distinct mechanisms: (i) inhibition of factor IXa, (ii) inhibition of factor Xa, (iii) activation of 
plasminogen and (iv) inhibition of platelets (Fry et al. 2009a). A venom component that has been 
researched considerably is draculin, an anticoagulant factor. It is an 88.5 kDa glycoprotein that 
inhibits activated factors IX (IXa) and X (Xa) of the coagulation mechanism (Apitz-Castro et al. 1995; 
Fernandez et al. 1999; Basanova et al. 2002). The irreversibly bonded complex of Xa-Draculin forms 
immediately upon contact, inhibiting factors IXa and Xa (Fernandez et al. 1999). The inhibition of IXa 
and Xa prevents the conversion of prothrombin to thrombin, which in turn prevents the conversion 
of fibrinogen to insoluble fibrin. Furthermore, the characteristic of non-competitive inhibition 
prevents the cleavage of draculin from Xa after binding, thus maintaining the toxin’s anticoagulant 
activity during feeding and digestion (Fernandez et al. 1998). Interestingly, a study conducted 
recently described the capacity of D. rotundus prey to develop immunity to draculin if they were 
targeted and fed upon over prolonged periods (Delpietro and Russo 2009). This kind of predator-
prey arms race scenario is similar to that observed between other venomous animals and their prey. 
The plasminogen activators or Desmokinase (Hawkey 1988), better known as DSPA 
(Desmodus rotundus salivary plasminogen activator), are the most intensively researched vampire 
bat venom components and the only ones to have been characterized from all three species of 
vampire bats (Hawkey 1988; Tellgren-Roth et al. 2009). The non-venom form of plasminogen 
activator consists of five domains: fibronectin type-I; EGF-like; kringle 1 (K1); kringle 2 (K2); 
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and serine protease. Plasminogen activators act upon fibrin clots, dissolving them and allowing a 
continuous flow of blood for feeding (Hawkey 1988). The ancestral vampire bat form, present in 
the avian feeding D. ecaudata, retains all these domains (Tellgren-Roth et al. 2009). In contrast, 
the plasminogen activators isolated from the venom systems of the mammalian feeders all lack 
one or more domains. The generalist feeder D. youngi lacks the K2 domain as do all the isoforms 
found in the mammalian specialist D. rotundus. However, all four D. rotundus forms (DSPAa1, 
DSPAa2, DSPAb and DSPAg (Kratzschmar et al. 1991) also lack the plasmin¬sensitive activation 
site. In addition, DSPAb and DSPAg lack the fibronectin type-I domain. DSPAg is the most 
derived form of this toxin in that it also lacks the EGF-like domain. Reflective of these domain 
variations, the two largest DSPA isoforms are DSPAa1 and a2, which share a 96% nucleotide 
sequence similarity (2165 out of 2245). The second largest DSPA is DSPAb, which is composed of 
a 2107 nucleotide sequence (138 nucleotide deletions) and the smallest, DSPAg, is composed of a 
1996 nucleotide sequence (249 nucleotide deletions) (Kratzschmar et al. 1991; Gulba et al. 1995). 
The DSPAs, especially DSPAa1, are remarkably similar to the human tissue-type plasminogen 
activator (tPA), and have been extensively investigated for use as a thrombolytic drug for strokes 
(Gulba et al. 1995). Zonneveld et al. (van Zonneveld et al. 1986) established the importance of the 
finger (F) and kringle 2 (K2) domains for the binding of plasminogen activators to fibrin, both of 
which are present in tPA (Kratzschmar et al. 1991). In spite of the K2 domain being absent in all 
four DSPA isoforms, they exhibit a kringle domain (K) that structurally resembles the kringle 1 (K1) 
domain in tPA , and functionally resembles tPA K2 domain (Gardell et al. 1989). The removal of the 
K2 domain not only facilitates increased specificity towards fibrin, it also decreases the plasminogen 
activator’s susceptibility towards plasminogen activator inhibitor 1 (PAI-1), which is present in 
mammalian but absent in avian fibrin clots (Dellas and Loskutoff 2005). Despite having equivalent 
glycosylation sites as the endogenous form t-PA (tissue plasminogen activator), the vampire bat 
forms are differentially glycosylated, having more highly bioprocessed N-glycans than the high 
mannose counterpart in t-PA (Gohlke et al. 1996; Gohlke et al. 1997; Ligabue-Braun et al. 2012). 
This difference results in the vampire bat forms being cleared at a four-fold lower rate than t-PA, 
resulting in a prolonged activity time. Another structural difference is that the lack of the plasmin-
activation site also enables the D. rotundus forms, uniquely, to be potently active as single chains, 
rather than the t-PA which is fully active only as a two-chain form (Tellgren-Roth et al. 2009).
Despite the extensive research focused on the plasminogen activating activity of draculin and 
DSPA, investigation of other effects of the D. rotundus venom on the prey’s hemostatic response 
has been limited. Hawkey (Hawkey 1988) reported the presence of a vasodilator that triggered 
leakage of skin capillaries into surrounding tissues in guinea pigs, as well as the presence of platelet 
aggregation inhibitors that prevented the adhesion of platelets to foreign substances. As this 
manuscript was being prepared, a transcriptome study that overlapped with ours was published 
(Francischetti et al. 2013). However, this study did not investigate the molecular evolution of the 
encoded venom proteins. Additionally, the different types of dominant transcripts between the 
studies are reflective of both variations in sequencing method and perhaps also regional/individual 
variations of study animals. For example, in this study we obtained draculin/lactotransferrin 
from the anterior and posterior lobes of the principal submaxillary gland while the other study 
recovered this protein type only from the accessory gland. Other types, such as calcitonin, were 
recovered from both glands through transcriptomics and proteomics in this study, but not 
discovered in the other study. In addition this study employed isoelectrically focused 2D gel 
analysis followed by LC-MS/MS guided mass spectrometry sequencing of in-gel digested spots as 
well as LC-MS/MS of trypsin digested crude secretions. Thus, the present study provides a much 
more in-depth investigation of the molecular evolution of secreted proteins, rather than providing 
a comprehensive catalog which includes intracellular proteins as (Francischetti et al. 2013).
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4.1.3 Methods
Specimens
Two adult male D. rotundus specimens were collected from Cuernavaca, Mexico 
by my collaborator Dr. Bryan Fry and his colleague Alejandro C. Alagon using mist nets.
Transcriptome library construction  
At collaborator’s institute anterior or posterior lobes of the principal submaxillary gland 
were dissected out and pooled and immediately frozen in liquid nitrogen for future use. Total 
RNA extracted using the standard TRIzol Plus method (In¬vitrogen). Extracts were enriched for 
mRNA using standard RNeasy mRNA mini kit (Qiagen) protocol. mRNA was reverse transcribed, 
fragmented and ligated to a unique 10-base multiplex identifier (MID) tag prepared using standard 
protocols and applied to one PicoTitrePlate (PTP) for simultaneous amplification and sequencing 
on a Roche 454 GS FLX+ Titanium platform (Australian Genome Research Facil-ity). Automated 
grouping and analysis of sample-specific MID reads informatically separated sequences from the 
other transcriptomes on the plates, which were then post-processed to remove low quality sequences 
before de novo assembly into con¬tiguous sequences (contigs) using v 3.4.0.1 of the MIRA software 
program. Assem-bled contigs were processed using CLC Main Work Bench (CLC-Bio) and Blast2GO 
bioinformatic suite (Gotz et al. 2008; Gotz et al. 2011) to provide Gene Ontology, BLAST and 
domain/Interpro annotation. The above analyses assisted in the rationalisation of the large numbers 
of assembled contigs into phylogenetic ‘groups’ for detailed phylogenetic analyses out¬lined below 
that focused upon types detected in the proteome, rather than providing a comprehensive catalog 
that included the various ordinary intracellular proteins [for such details, please see the parallel 
study (Francischetti et al. 2013)]. Public access of the data can be found at the National Center 
for Biotechnology Information (NCBI) under bioproject PRJNA174817. Raw sequence reads can 
be downloaded from the short read archives (SRA) of the NCBI under number SRA061642. This 
Transcriptome Shotgun Assembly project has been deposited at DDBJ/EMBL/GenBank,under the 
accession GAEE00000000. The version described in this paper, is the first version, GAEE01000000.
Proteomics 
Specimens were anaesthetized using zoletil (3 mg/kg) and then injected 
subcutaneously with pilocarpine (20 mg/kg) to stimulate salivation. Polyethylene 
equipment was used to collect and process samples in all cases. Samples were subsequently 
filtered using 20 Å syringe filters to remove large mucoidal strands and then lyophilised. 
For two-dimensional electrophoresis, venom samples (~2 mg) were directly solubilised in 
300 ml of rehydration buffer (8M urea, 100mM DTT, 4% CHAPS, 110mM DTT, and 0.5% 
ampholytes (Biolytes pH 3–10) and 0.01% bromophenol blue. Sample was mixed and centrifuged 
(5 min, 4₀C, 14 000rpm) to pellet any insoluble material and the supernatant was loaded onto 
IEF strips (Bio-Rad ReadyStrip, non-linear pH 3–10, 17 cm IPG) for 24 hrs passive rehydration. 
Proteins were focused in a PROTEAN i12 IEF CELL (Bio-Rad Lab, USA). The IEF running 
conditions were as follows: 100V for 1hr, 500V for 1hr 1000V for 1 hr and 8000V for 98400 V/
hr. After running IEF, IPG strips were equilibrated for 10 min in an equilibration buffer (50 mM 
Tris-HCl, pH 8.8, 6 M urea, 2% SDS, 30% glycerol, 2% DTT) followed by a second incubation 
for 20 min in an equilibration buffer that had DTT replaced with 2.5% iodoacetamide. IPG strips 
were briefly rinsed in SDS-PAGE running buffer and embedded on top of the 12% polyacrylamide 
gels (Protean-II Plus, 18 × 20 cm, Bio-Rad Lab, USA) and covered with 0.5% agarose. Second 
dimension gels were performed at 4₀C for 10mA/per gel for 20 minutes followed by 30mA/per gel 
for 4 hrs or until the bromophenol dye front was reached to 1cm from the base of the gel. Finally 
gels were briefly wash in Milli Q water and stain in 0.2% colloidal coomassie brilliant blue G250 
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(34% methanol, 3% phosphoric acid, 170g/L ammonium sulfate, 1g/L Coomassie blue G250) 
overnight and destained in 1% acetic acid/H2O. Visible spots were subsequently picked from gels 
and digested overnight (at 37₀C) using sequencing grade trypsin (Sigma, USA). Briefly, gel spots 
were washed with ultrapure water, destained (40mM NH4CO3/50% Acetonitrile (ACN)) and 
dehydrated (100% ACN). Gel spots were rehydrated in 10mL of 20µg/ml proteomics grade trypsin 
(Sigma-Aldrich) and incubated at 37°C overnight. Digests were eluted by washing the gel spots for 
20 minutes with each of the following solutions: 20mL 1% formic acid (FA), followed by 20mL of 5% 
ACN/0.5% FA. The cleaved peptides were eluted and thereafter subjected to LC-MS/MS analysis.
For shotgun sequencing, reduction and alkylation was performed by redissolving 3 
µg of sample in 50 µl of 100 mM ammonium carbonate. 50 µl of 2% iodoethanol/0.5% 
triethylphosphine in acetonitrile was then added to the re-dissolved samples. The reduced 
and alkylated sample was re-suspended in 20 µl of 40 mM ammonium bicarbonate, before 
being incubated overnight (at 37₀C) with 750 ng proteomics grade trypsin. Digestion was 
stopped by addition of 1µl of concentrated formic acid. 0.75 µg was processed by LC-MS/MS. 
LC-MS/MS was done using a Agilent Zorbax stable bond C18 column (2.1 mm ´  100 mm, 1.8 
mm particle size, 300 Å pore size) at a flow of 400 µl/min and a gradient of 1–40% solvent B (90% 
acetonitrile, 0.1% formic acid) in 0.1% formic acid over 15 min or 4 min for shotgun and 2D-gel 
spots, respectively, on a Shimadzu Nexera UHPLC coupled with an AB SCIEX 5600 Triple TOF 
mass spectrometer. MS2 spectra were acquired at a rate of 20 scans/sec, with a cycle time of 2.3 sec, 
and optimised for high resolution. Precursor ions were selected between 80-1800 m/z, charge state of 
2-5, and of an intensity of at least 120 counts per second, with a precursor selection window of 1.5 Da, 
and excluding isotopes within 2 Da for MS2. MS2 spectra were searched against known translated 
cDNA libraries or UniProt databanks with Proteinpilot v4.0 (ABSciex) using a thorough identification 
search, specifying alkylation method (iodoacetamide or iodoethanol), tryptic digestion, and allowing 
for biological and chemical modifications and amino acid substitions. This was done to maximize the 
identification of protein sequences from the transcriptome despite the inherent variability of toxins, 
and potential isoform mismatch with the transcriptomic data. Spectra were inspected manually 
to eliminate false positives, and the results further analysed using CLC Main Workbench v6.6.
Phylogenetics 
Phylogenetic analyses were performed to allow reconstruction of the molecular evolutionary 
history of each toxin type for which transcripts were bioinformatically recovered. Toxin sequences 
were identified by comparison of the translated DNA sequences with previously characterised 
toxins using a BLAST search (Altschul et al. 1997) of the UniProtKB protein database. Molecular 
phylogenetic analyses of toxin transcripts were conducted using the translated amino acid 
sequences. Comparative sequences from physiological gene homologs identified from non-venom 
gland transcriptomes were included in each dataset as outgroup sequences. To minimize confusion, 
all sequences obtained in this study are referred to by their Genbank accession numbers (http://
www.ncbi.nlm.nih.gov/sites/entrez?db=Nucleotide) and sequences from previous studies are 
referred to by their UniProtKB accession numbers (http://www.expasy.org/cgi-bin/sprot-search-
ful). Resultant sequence sets were aligned using CLC Mainbench. When presented as sequence 
alignments, the leader sequence is shown in lowercase and cysteines are highlighted in black. > and 
< indicate incomplete N/5’ or C/3’ ends, respectively. Datasets were analysed using the Bayesian 
inference implemented in MrBayes, version 3.0b4 (Ronquist et al. 2012), using lset rates=gamma 
with prset aamodelpr=mixed command to optimise between the nine amino acid substitution 
matrices implemented in MrBayes. The analysis was performed by running a minimum of 1X107 
generations in four chains, and saving every 100th tree. The log-likelihood score of each saved tree 
was plotted against the number of generations to establish the point at which the log likelihood 
scores reached their asymptote, and the posterior probabilities for clades established by constructing 
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a majority-rule consensus tree for all trees generated after completion of the burn-in phase.
Test for Recombination 
To overcome the effects of recombination on phylogenetic and evolutionary interpretations 
(Posada and Crandall 2002), we employed Single Breakpoint algorithms implemented in the HyPhy 
package and assessed recombination on all the toxin forms examined in this study (Kosakovsky 
Pond et al. 2006; Delport et al. 2010). When potential breakpoints were detected (depicted 
in Appendices 4.1 and 4. 2) using the small sample Akaike information Criterion (AICc), the 
sequences were compartmentalized before conducting the selection analyses (Appendix 4.1 and 4.2).
Selection Analyses 
We evaluated selection pressures on D. rotundus venom components using maximum-likelihood 
models (Goldman and Yang 1994; Yang 1998) implemented in CODEML of the PAML (Yang 
2007). We first employed the one-ratio model that assumes a single w for the entire phylogenetic 
tree. This model tends to be very conservative and can only detect positive selection if the w ratio 
averaged over all the sites along the lineage is significantly greater than one. Because such lineage-
specific models assume a single w for the entire tree, they often fail to identify regions in proteins 
that might be affected by episodic selection pressures and ultimately, underestimate the strength of 
selection. Hence, we employed site-specific models which estimate positive selection statistically as a 
non-synonymous-to-synonymous nucleotide-substitution rate ratio (w) significantly greater than 1. 
We compared likelihood values for three pairs of models with different assumed w distributions as no 
a priori expectation exists for the same: M0 (constant w rates across all sites) versus M3 (allows the w 
to vary across sites within ‘n’ discrete categories, n≥3); M1a (a model of neutral evolution) where all 
sites are assumed to be either under negative (w<1) or neutral selection (w=1) versus M2a (a model of 
positive selection) which in addition to the site classes mentioned for M1a, assumes a third category 
of sites; sites with w>1 (positive selection) and M7 (b) versus M8 (b and w), and models that mirror 
the evolutionary constraints of M1 and M2 but assume that w values are drawn from a b distribution 
(Nielsen and Yang 1998). Only if the alternative models (M3, M2a and M8: allow sites with w>1) 
show a better fit in Likelihood Ratio Test (LRT) relative to their null models (M0, M1a and M7: do 
not allow sites w>1), are their results considered significant. LRT is estimated as twice the difference 
in maximum likelihood values between nested models and compared with the c2 distribution with 
the appropriate degree of freedom - the difference in the number of parameters between the two 
models. The Bayes empirical Bayes (BEB) approach (Yang et al. 2005) was used to identify amino 
acids under positive selection by calculating the posterior probabilities that a particular amino acid 
belongs to a given selection class (neutral, conserved or highly variable). Sites with greater posterior 
probability (PP ≥ 95%) of belonging to the ‘w>1 class’ were inferred to be positively selected.
Fast, Unconstrained Bayesian AppRoximation (FUBAR) implemented in HyPhy (Murrell et al. 
2013) was employed to provide additional support to codeml analyses and to detect sites evolving under 
the influence of pervasive diversifying and purifying selection pressures. Mixed Effects Model Evolution 
(MEME) (Murrell et al. 2012) was also used to detect episodic diversifying selection. Further support 
for the results of the selection analyses was obtained using a complementary amino acid-level approach 
implemented in TreeSAAP (Woolley et al. 2003). We assessed selection pressures shaping multi-
domain proteins by employing the option G test (with Mgene=4) (Yang 1996). We further employed 
branch-site REL (Kosakovsky Pond et al. 2011) to identify lineages undergoing episodic adaptations.
Structural analyses
In order to depict the selection pressures influencing the evolution of D. rotundus venom 
components, we mapped the sites under positive selection on the homology models created using 
Phyre 2 webserver (Kelley and Sternberg 2009). Pymol 1.3 (DeLano 2002) was used to visualize 
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and generate the images of homology models. Consurf webserver (Armon et al. 2001) was used 
for mapping the evolutionary selection pressures on the three-dimensional homology models. 
GETAREA (Fraczkiewicz and Braun 1998) was used to calculate the Accessible Surface Area (ASA) 
or the solvent exposure of amino acid side chains. It uses the atom co-ordinates of the PDB file and 
indicates if a residue is buried or exposed to the surrounding medium by comparing the ratio between 
side-chain Accessible Surface Area (ASA) and the “random coil” values per residue. An amino acid 
is considered to be buried if it has an ASA less than 20% and exposed if ASA is more than or equal 
to 50%. An ASA ratio between 40%-50% indicates partially exposure of amino acid side chains.
4.1.4 Results
Proteomics and Transcriptomics 
Through our combined proteomic and transcriptomic approaches, with the proteomics 
results guiding the selection of transcripts to focus on for molecular evolutionary investigations, we 
discovered a rich suite of secreted proteins in D. rotundus venom glands (Fig. 4.1, Tables 4.1-4.3).
Figure 4.1 Two-dimensional gel-electrophoresis of vampire bat venom
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Table 4.1 Summary of Desmodus rotundus shotgun mass spectrometry sequencing
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The same peptide/protein types sequenced in the transcriptomes were also detected 
in the proteome, demonstrating concordance between transcription and translation. DSPA 
isoforms were difficult to detect in the 2D gel due to the high levels of glycosylation interfering 
with efficient colloidal staining but DSPA a1, a2, b and g isoforms were readily detected 
in the shotgun sequencing, reflective of it’s significant level of secretion. We also recovered 
a partial sequence (with over-lapping fragments from both lobes) that was unique in being 
sequentially and phylogenetically intermediate between the a2 and b forms of DSPA (Fig. 4.2). 
Figure 4.2
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The partial sequence did not contain the region where a2 and b differ in domain 
loss, so relative affinity could not be fully ascertained. Until recently (Francischetti et al. 
2013), draculin had long only been known from a small 16 amino acid fragment and it 
was thus unknown which protein family the toxin belonged to. In this study, we recovered 
a 1164 base-pair partial sequence (incomplete on the 3’ end) that revealed Draculin to 
be a member of the lactotransferrin family secreted in the submaxillary glands (Fig. 4.3). 
Figure 4.3
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Table 4.2 Summary of Desmodus rotundus 2D gel spots and shotgun mass spectrometry
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Table 4.3 Activities of Desmodus rotundus venom homologues
We also recovered and identified protein types previously unknown from vampire bat 
venom, or sequenced in the concurrent parallel study (Francischetti et al. 2013), with related non-
venomous isoforms having characterised activities including anticoagulation (Kunitz peptides), 
immunomodulation (BPI fold-containing family A, secretoglobin), secretion promotion (lacritin), 
peripheral vasodilation (CRiSP) and vasodilation (calcitonin, kallikrein and PACAP). We further 
identified a highly modified version of the salivary androgen-binding protein/allergen-protein family 
that included the major cat allergen fel-d4 and the major horse allergen Equ-c1, and also an extremely 
derived form of the statherin peptide type (Table 4.1). Transcriptome analysis revealed Kunitz and 
PACAP to be multi-domain precursors. Kunitz peptides were derived from an ancestral tri-product 
encoding precursor, with the plesiotypic form expressed in the submaxillary gland being bi-domain 
(Fig. 4.4). Additional derived forms include loss of the first or second domains of the bi-domain form. 
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Figure 4.4
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The PACAP peptides were also encoded by a bi-domain precursor, that includes not only the 
vasodialatory PACAP peptide, but also the PACAP-related peptide, the activity of which remains 
undiscovered (Fig. 4.5: A). Both domains preserved the high alpha-helical content of the ancestral 
non-venom peptides (Fig. 4.5: B). The newly derived vampire bat form had two distinct isoform 
types that formed a discrete clade within the ancestral peptide family (Fig. 4.5: C). In addition, 
our proteomics studies revealed that a third peptide is posttranslationally cleaved from within this 
precursor (Fig. 4.5: A). This peptide is located upstream from the other two peptides and starts 
at the point where the signal peptide is cleaved off, and is characterised by being proline rich.
Figure 4.5
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The allergen-related lipocalin proteins (which we termed Desmallipins as an acronym for 
‘Desmodus allergen-related lipocalins’) contained an N-terminal region cysteine not present in 
the ancestral form from the bat Myotis lucifugus (Fig. 4.6). Some of the submaxillary gland forms 
had an additional newly-evolved cysteine located between the first and second ancestral cysteines. 
Figure 4.6
Molecular evolution of venoM  
While the calcitonin peptides were highly conserved relative to the ancestral peptides 
(Fig. 4.7), the statherin-peptide type (stathlipin) which differed considerably from the 
ancestral form in the number and pattern of C-terminal region prolines (Fig. 4.8).
Figure 4.7
Figure 4.8
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Molecular evolution
The global omega values computed using the one-ratio model (ORM) for different D. rotundus 
venom components ranged from indicating positive selection (Desmallipins: w=1.03; Plasminogen 
Activator: w=1.04) to near-neutral evolution (PACAP: w=0.86) and negative selection (Kunitz domain 
I: w=0.29; Kunitz domain II: w=0.39). Since ORM averages dN/dS over the entire length of the coding 
sequence, it often fails to detect episodic diversifying selection that is confined to small regions of protein. 
Hence, we employed the site-specific models (Table 4.4; Fig. 4.9; 4.10). Site-model 8 highlighted the 
dominant role of positive selection on the evolution of D. rotundus venom components: Desmallipins 
w=1.28; Kunitz domain I w=1.39; Kunitz domain II w=1.28; PACAP w=1.24 and plasminogen 
activator w=1.23. The BEB approach implemented in site-model 8 detected large proportions of 
sites in aforementioned toxins as evolving under the influence of positive selection: Desmallipins 
[22% and 18 positively selected sites (PS)]; Kunitz domain I (28% and 4 PS); Kunitz domain II 
(35% and 5 PS); PACAP (20% and 7 PS) and plasminogen activator (36% and 23 PS) (Table 4.4). 
Figure 4.9
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Table 4.4 Molecular evolution of Desmodus rotundus venom-encoding genes
FUBARa PAML MEME Sitesb
M8 M2a
w>1c 14
w>1e
18 13
Desmalippin w<1d 6 (12+6) (6+7) 9
w = - w = 1.28 1.27
w>1g 9
w>1e
16 17
Kunitz Protease w<1h 34 (6+10) (6+11) 7
w = - w = 1.45 1.67
Kunitz Protease
Domain I
w>1g 0
w>1e
4
0 1
w<1h 8 (2+2)
w = - w = 1.39 0.55NS
Kunitz Protease
Domain II
w>1g 3
w>1e
5 1
w<1h 15 (1+4) (0+1) 1
w = - w = 1.28 1.21
w>1g 4
w>1e
7 2
PACAP w<1h 4 (1+6) (1+4) 3
w = - w = 1.24 1.24
Plasminogen
Activator
w>1g 16
w>1e
23 17
w<1h 3 (6+17) (2+15) 1
w = - w = 1.23 1.27
Calcitonin Not enough sequences for analyses (n=3). All three sequences were extremely conserved.
PACAP: Pituitary Adenylate Cyclase-Activating Polypeptide; Desmalippin: Desmodus allergen-like 
lipocalins
Legend:
a: Fast Unbiased Approximate Bayesian
b: Sites detected as experiencing episodic 
diversifying selection (0.05 significance) by the 
Mixed  Effects Model Evolution (MEME)
c: Number of sites detected by FUBAR as under 
pervasive diversifying selection at the posterior 
probability ≥0.9
d: Number of sites detected by FUBAR as under 
pervasive purifying selection at the posterior 
probability ≥0.9 
e: Number of positively selected sites detected 
using the Bayes Empirical Bayes approach 
implemented in M8 and M2a. Sites detected at 
0.99 and 0.95 significance are indicated in the 
parenthesis.
w: mean dN/dS
NS: Not significant
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We further employed option G test to compare the evolutionary regimes adopted by different 
PACAP and plasminogen activator domains. This test computed differential evolutionary rates for 
various PACAP domains. The propeptide domain was extremely conserved and evolved under the 
regime of negative selection (w=0.43). Extremely low amount of non-synonymous to synonymous 
mutations detected in this region suggests that it is likely involved in efficient excision and liberation of 
PACAP domains (Fig. 4.10). This test further revealed that both PACAP-related (w=1.75) and PACAP 
(w=1.59) domains evolve rapidly under the influence of positive selection (Fig. 4.10). Option G test 
also highlights the differential evolution of D. rotundus plasminogen activator domains (Fibronectin 
type-I: w=0.86; EGF-like: w=0.90 and Kringle domain: w=1.08 and peptidase-S1 w=0.91) (Fig. 4.10).
Figure 4.10
Not all non-synonymous mutations are capable of influencing a change in the structure 
and/or function of the protein. This is especially true when the mutant amino acid has the 
identical or similar biochemical properties as its ancestral amino acid. Such mutations are more 
likely to have no effect on the fitness of the organism. In order to decide which mutations could 
have a greater impact on the structure and/or function of the protein, we assessed the selective 
influence on 31 structural and biochemical amino acid properties using TreeSAAP. TreeSAAP 
measures the selective influences during cladogenesis, and performs goodness-of-fit and categorical 
statistical tests based on ancestral sequence reconstruction. This combined approach revealed that 
Desmallipins, Kunitz (domain I and II) and plasminogen activator genes accumulated radical 
mutations which introduced amino acids with quite divergent biochemical and/or structural 
properties. On the contrary, none of the positively selected sites detected by PAML in PACAP 
were identified as positively selected by the protein-level analyses. Hence, we theorize that the 
rapid radical changes accumulating in Desmallipins (83% positively selected sites), Kunitz (89% 
positively selected sites) and plasminogen activators (48% positively selected sites) are more 
likely to have a greater impact on the fitness of these vampire bats than the hypermutable sites 
of PACAP proteins. Evolutionary fingerprint of vampire bat toxins revealed a large proportion of 
sites as evolving under the significant influence of positive selection (Appendix 4.3). Branch-site 
REL test identified several branches in all the vampire bat toxin lineages examined in this study as 
episodically diversifying: Desmallipins (7), PACAP (4), Kunitz (9) and plasminogen activator (2).
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Thus, evidence provided by various selection analyses [site-specific model 2a, 3, 
8; FUBAR, MEME; protein-level analyses: (Table 4.4; Fig. 4.9; 4.10), Evolutionary 
fingerprint analyses, Branch-site REL and option G test] suggested a strong influence 
of positive selection on D. rotundus venom components examined in this study.
4.1.5 Discussion
It was previously unclear whether the principal gland anterior and posterior lobes were 
evolving on different evolutionary trajectories, or if they remained under shared genetic control. 
Recovery of identical transcripts from the cDNA libraries in this study provides evidence that 
they remain a single expression system. Multiple transcripts of the majority of each protein type 
were recovered from the cDNA libraries, a pattern consistent with accelerated diversification in 
toxin multigene families as observed in other venoms (Duda et al. 1999; Fry et al. 2003b; Fry 
2005). The differential domain loss in the Kunitz peptide followed a pattern of selection pressure 
for the expression of particularly useful domains, such as seen in reptile venoms [(Fry et al. 2004; 
Fry et al. 2010a) and Fig. 4.10]. Numerous transcripts were recovered with significant variations 
including changes in key functional residues and changes in the number of cysteine residues, 
modifications typically associated with neofunctionalisation (evolution of novel bioactivities).
Cysteine number variation was particularly evident in the Desmallipins, which are extremely 
intriguing as they represent a convergent modification of the fel-d4/equ-c1 type allergen scaffold, 
derived forms of which have been documented as the primary protein toxin in the venom of 
Nycticebus sp. (slow lorises) (Hagey et al. 2006).  The ancestral proteins formed cysteine-linked 
homodimers, thus any modification of cysteine-pattern may greatly affect the structure of the 
monomer and thus its ability to form dimers. In the plesiotypic form of D. rotundus Desmallipins, 
there is an even number of cysteines, and thus these isoforms may not form dimers at all, but rather 
monomers with a unique structural fold. In the further derived forms, there is another new cysteine, 
which may promote dimerisation but with a unique three-dimensional structure of each subunit. 
Our identification of draculin as a lactotransferrin with a neofunctionalised activity is further proof 
of the principle that vampire bats are modifying ancestral molecular scaffolds for new targeting. 
Another form of neofunctionalisation seen in other venoms is guided not through 
variations in cysteine pattern, but rather changes in relative proline-bracketing of linear 
peptides, such as seen in the helokinestatin peptides (Fry et al. 2010a; Fry et al. 2010b). Such 
de novo creation of a new posttranslationally liberated proline-rich domain was seen in the third 
PACAP-precursor peptide discovered in this study. While the sthalipin peptides evolved from 
the proline-rich statherin peptides, significant changes in the number and pattern was evident. 
Nucleotide and complementary amino acid-level selection analyses provide the first evidence 
that D. rotundus venom components evolve under the regime of positive selection, accumulating 
rapid mutations. However, not all mutations seem to have a significant impact on the structure 
and function of these toxins; only the mutations in Kunitz (domain I and II), Desmallpins 
and plasminogen activators were identified by protein-level selection assessments as capable of 
introducing radical changes. Hence, we theorize that mutations in these toxins are not only capable 
of affecting the structure and function of the toxin, but may also influence the fitness of vampire bats.
All the positively selected sites in D. rotundus Kunitz (domain I and domain II) and 43% of 
positively selected sites in plasminogen activator (22% buried; rest couldn’t be conclusively assigned 
to exposed/buried class) were found on the molecular surface of the toxin. A strong evolutionary 
constraint on the non-secreted PACAP propeptide, reflective of its role in efficient liberation of toxin 
domains, and on the active sites of plasminogen activator gene was observed (Fig. 4.10). We theorize 
that focal mutagenesis, in which a large proportion of mutations are confined to the molecular 
surface and structurally and/or functionally unimportant regions, not only aids in conservation 
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of structural and functional integrity of these toxins, but may also prevent the mounting of 
immunological resistance against these secretions in prey animals. Evidently, prey animals of D. 
rotundus have been shown to develop immunity to venom components like draculin if targeted 
and fed upon over prolonged periods (Delpietro and Russo 2009). Hence, we hypothesize that 
frequent mutation of toxin molecular surface chemistry in vampire bat population prevents the rapid 
development of immunological resistance in prey-animals. Focal or site-directed mutagenesis has 
been demonstrated in a wide array of venom proteins, as a means of preserving residues responsible 
for structural and/or functional stability, while generating rapid variation of the molecular surface 
of venom (Kini and Chan 1999; Sunagar et al. 2012; Brust et al. 2013; Ruder et al. 2013). 
Thus, toxins in a diversity of venomous lineages have likely, convergently adopted site-directed 
mutagenesis or focal mutagenesis as a strategy to evade immune responses of their prey animals.
4.1.6 Conclusions
The recovery of novel protein scaffolds from the glands studied here reveals how little is known 
about the protein composition of vampire bat venoms. This is further reinforced by the number 
and diversity of novel scaffolds recovered, despite the relatively limited sampling employed. More 
extensive sampling will no doubt recover entirely new toxin classes. Follow-up investigations should 
focus on the structure-function relationships of the novel components. These results highlight the 
relatively untapped potential of such complex mixtures as sources of novel investigation ligands 
or lead compounds for use in drug design and development. It is hoped that these results will 
stimulate further investigation of the hitherto neglected venom systems of all species of vampire bat.

Chapter V
Molecular evolution of 
vertebrate neurotrophins:
Co-option of the highly 
conserved nerve growth factor 
gene into the advanced snake 
venom arsenal
Peer-reviewed, scientific publications resulting from this chapter.
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5.1 Abstract
Neurotrophins are a diverse class of structurally related proteins, essential for neuronal 
development, survival, plasticity and regeneration. They are characterized by major family 
members, such as the nerve growth factors (NGF), brain-derived neurotrophic factors (BDNF) and 
neurotrophin-3 (NT-3), which have been demonstrated here to lack coding sequence variations 
and follow the regime of negative selection, highlighting their extremely important conserved role 
in vertebrate homeostasis. However, in stark contrast, venom NGF secreted as part of the chemical 
arsenal of the venomous advanced snake family Elapidae (and to a lesser extent Viperidae) have 
characteristics consistent with the typical accelerated molecular evolution of venom components. 
This includes a rapid rate of diversification under the significant influence of positive-selection, 
with the majority of positively-selected sites found in the secreted b-polypeptide chain (74%) 
and on the molecular surface of the protein (92%), while the core structural and functional 
residues remain highly constrained. Such focal mutagenesis generates active residues on the toxin 
molecular surface, which are capable of interacting with novel biological targets in prey to induce 
a myriad of pharmacological effects. We propose that caenophidian NGFs could participate in 
prey-envenoming by causing a massive release of chemical mediators from mast cells to mount 
inflammatory reactions and increase vascular permeability, thereby aiding the spread of other toxins 
and/or by acting as proapoptotic factors. Despite their presence in reptilian venom having been 
known for over 60 years, this is the first evidence that venom-secreted NGF follows the molecular 
evolutionary pattern of other venom components, and thus likely participates in prey-envenomation.
5.2 Introduction
Venom, a complex biochemical cocktail of biologically active components, such as proteins, 
peptides, amino acids, neurotransmitters and polyamines, has underpinned the diversification and 
evolutionary success of several animal lineages (Fry et al. 2009). This key evolutionary innovation is 
employed by a plethora of animals for predation,  competitor deterrence  and defence (Heatwole and 
Powell 1998; Bush et al. 2002; Massey et al. 2012; Casewell et al. 2013).  The scientific consensus 
is that venom components originate via toxin recruitment events, as part of which physiological 
protein-encoding genes are duplicated and the new copies are selectively expressed in the venom 
gland (Olivera 2002; Fry et al. 2003b; Fry 2005; Escoubas 2006; Weinberger et al. 2010; Casewell et 
al. 2011a; Chang and Duda 2012; Kozminsky-Atias and Zilberberg 2012; Zhu et al. 2012; Casewell 
et al. 2013; Fry et al. 2013). Over the years, our understanding of the origin and diversification 
of snake venoms has greatly increased, largely due to advances in transcriptomics and proteomics 
(Fry et al. 2002; Fry et al. 2003c; Calvete et al. 2007; Casewell et al. 2009; Gutiérrez et al. 2009; 
Boldrini-França et al. 2010). However, the precise role of certain proteins, which are secreted as 
part of the biochemical venom arsenal, still remains to be elucidated. Nerve growth factor (NGF), 
a key member of the neurotrophin family, is one such class of protein whose presence in snake 
venoms has been intriguing. Since its discovery in the late 1950s , NGF has been reported from 
the venoms of various caenophidian (advanced) snakes, including members of the front-fanged 
elapid and viperid families as well as from venomous lizards (Hogue-Angeletti et al. 1976; Siigur 
et al. 1985; Oda et al. 1989; Fry et al. 2006; Fry et al. 2008; Fry et al. 2010; Koludarov et al. 
2012), but its function and relative importance in snake venoms remains unknown (Fry 2005).
Neurotrophins represent a family of structurally related proteins, crucial for neuronal 
development, survival, death, regeneration and plasticity. According to the classical neurotrophic 
hypothesis, neurotrophins are produced in limiting amounts and the survival of the innervating 
neurons is dependent on winning the competition for sufficient quantities of these factors (Hamburger 
and Levi-Montalcini 1949; Jaaro et al. 2001). Neurotrophins contain gene family members such 
as nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-
3) and neurotrophin-4/5 (NT-4/5) (Korsching 1993; Lindsay et al. 1994; Lewin and Barde 1996; 
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Huang and Reichardt 2001), all of which function by interacting with the p75 neurotrophin 
receptor (NTR) in their proneurotrophin forms and various structurally related tropomyosin-
related kinase or Tyrosine kinase receptors (Trk) in their active cleaved form (Meakin and Shooter 
1992; Barbacid 1994). While NGF specifically activates TrkA (Kaplan et al. 1991), BDNF and 
NT-4/5 interact with TrkB (Klein et al. 1991; Barbacid 1994). NT-3 primarily interacts with TrkC 
and is unique in also being capable of weakly binding to both TrkA and TrkB (Barbacid 1994).
 Neurotrophins have been extensively studied not only because they are perceived as 
one of the primary factors responsible for the complexity of vertebrate nervous systems, but 
also because of their involvement in cognition and memory. Knockout of the genes encoding 
NGF, BDNF and NT-3 genes is fatal in mice, highlighting the importance of these proteins for 
survival and normal neuronal development. Not surprisingly, abnormalities associated with the 
production of neurotrophins have been linked with neuropathies and neurodegenerative disorders.
 In order to investigate the role of NGF in the venom of Toxicofera reptiles (Fry et al. 2006), 
we have investigated the molecular evolution of these proteins in reptilian (turtles; squamates: 
Laterata, Scinciformata, Gekkota; Toxicofera lizards: Anguimorpha and Iguania; Henophidia snakes; 
advanced snakes: Elapidae, Viperidae and ‘non-front-fanged’ advanced snakes) and mammalian 
lineages, by employing sophisticated protein and codon-level selection assessments. We further 
compare the molecular evolution of NGF with the other major members of the neurotrophin family, 
namely BDNF and NT-3, in a wide array of reptilian and mammalian lineages. Molecular evolution 
analyses conducted on a dataset of 1183 nucleotide sequences revealed that these genes have remained 
largely unchanged since their origin over 300 million years (the split between mammals and reptiles: 
www.timetree.org) due to the extremely important functions they play in vertebrate homeostasis.
5.3 Methods
Phylogenetic Analyses
Phylogenetic analyses were performed to allow the reconstruction of the molecular evolutionary 
history of vertebrate NGF, BDNF and NT-3 genes. Nucleotide sequences were downloaded from 
the National Center for Biotechnology Information database (NCBI: http://www.ncbi.nlm.nih.
gov/) and a dataset of 1183 sequences (NGF: 308; BDNF: 434; NT-3: 441) was compiled. Resultant 
sequence sets were aligned using MUSCLE (Edgar 2004). The phylogenetic relationships were 
determined using Bayesian and maximum-likelihood approaches. MrBayes version 3.2 (Ronquist 
et al. 2012) was used for Bayesian inference. Tree searches were run using four Markov chains 
for a minimum of 10 million generations, sampling every 100th tree. The log likelihood score 
of each saved tree was plotted against the number of generations to establish the point at which 
the log-likelihood scores of the analyses reached their asymptote. 25% of the total trees sampled 
were conservatively discarded as burnin. The posterior probabilities for clades were established by 
constructing a majority rule consensus tree for all trees generated after the completion of the burnin. 
The analyses were repeated three times to make sure that the trees generated were not clustered 
around local optima. An optimal maximum likelihood phylogenetic tree was obtained using PhyML 
3.0 (Guindon et al. 2010) and node support was evaluated with 1,000 bootstrapping replicates.
Test for Recombination
To overcome the effects of recombination on the phylogenetic and evolutionary 
interpretations (Posada and Crandall 2002), we employed Single Breakpoint algorithm 
implemented in the HyPhy package and assessed recombination on all the toxin forms 
examined in this study (Kosakovsky Pond et al. 2006; Delport et al. 2010). When 
potential breakpoints were detected using the small sample Akaike information Criterion 
(AICc), the sequences were compartmentalized before conducting selection analyses. 
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Selection Analyses
We evaluated the influence of natural selection on various members of vertebrate neurotrophins 
using maximum-likelihood models (Goldman and Yang 1994; Yang 1998) implemented in 
CODEML of the PAML (Yang 2007). In order to detect evolutionary selection pressures acting 
upon individual lineages, we employed the two-ratio model as well as the optimised branch-site 
test (Yang and Nielsen 2002; Zhang et al. 2005). The two-ratio model evaluates selection across 
the lineages alone, while the branch-site model allows w to vary across the sites of the protein and 
along the branches in the tree. The latter is known for its reasonable power and accuracy to detect 
short bursts of episodic adaptations (Zhang et al. 2005). However, both the two-ratio and branch-
site models require the foreground (lineages under positive selection) and background lineages 
(lineages lacking positive selection) to be defined a priori. Such predefined biological hypotheses are 
often unavailable and it becomes difficult to define the foreground lineages. Therefore, we treated 
each clade being compared as foreground branches alternatively and tested multiple hypotheses. 
A likelihood-ratio test was then conducted by comparing the model that allows w to be greater 
than 1 in the foreground branch, with a null model that does not (w constrained 1). It has been 
suggested that while implementing multiple hypotheses using branch and branch-site models, it 
is necessary to control the family-wise error rate (FWER or Type I error) (Zhang et al. 2005). 
We used Bonferroni correction to account for such errors. It uses a/n as the significance level to 
test each hypothesis; where ‘a’ is the significance level and ‘n’ is the number of independent true 
null hypotheses. We further utilized branch-site REL implemented in HyPhy to identify lineages 
affected by positive selection pressures. Unlike the aforementioned lineage-specific models, branch-
site REL does not require the identification of foreground and background branches a priori.
Because lineage-specific models either assume a single w for the entire tree or assess the effects of 
selection only along the branches, they often fail to identify regions in proteins that might be affected 
by episodic selection pressures and ultimately underestimate the strength of selection. Hence, we 
employed site-specific models which estimate positive selection statistically as a non-synonymous-
to-synonymous nucleotide-substitution rate ratio (w) significantly greater than 1. We compared 
likelihood values for three pairs of models with different assumed b distributions as no a priori 
expectation exists for the same: M0 (constant w rates across all sites) versus M3 (allows the w to vary 
across sites within ‘n’ discrete categories, n ≥ 3); M1a (a model of neutral evolution) where all sites 
are assumed to be either under negative (w < 1) or neutral selection (w = 1) versus M2a (a model of 
positive selection) which in addition to the site classes mentioned for M1a, assumes a third category 
of sites; sites with w >1 (positive selection) and M7 (b) versus M8 (b and w), and models that mirror 
the evolutionary constraints of M1 and M2 but assume that w values are drawn from a b distribution 
(Nielsen and Yang 1998). Only if the alternative models (M3, M2a and M8: allow sites with w >1) 
show a better fit in Likelihood Ratio Test (LRT) relative to their null models (M0, M1a and M7: do 
not allow sites w >1), are their results considered significant. LRT is estimated as twice the difference 
in maximum likelihood values between nested models and compared with the c2 distribution with 
the appropriate degree of freedom (i.e., the difference in the number of parameters between the two 
models). The Bayes empirical Bayes (BEB) approach (Zhang et al. 2005) was used to identify amino 
acids under positive selection by calculating the posterior probabilities that a particular amino acid 
belongs to a given selection class (neutral, conserved or highly variable). Sites with greater posterior 
probability (PP ≥ 95%) of belonging to the ‘w > 1 class’ were inferred to be positively selected.
SLAC, FEL, REL and FUBAR  (Kosakovsky Pond et al. 2005; Murrell et al. 2013) 
implemented in HyPhy (Pond et al. 2005) were employed to provide additional support to 
the aforementioned analyses and to detect sites evolving under the influence of positive and 
negative selection. MEME (Murrell et al. 2012) was also used to detect episodic diversifying 
selection. Further support for the results of the nucleotide-level selection analyses was obtained 
using a complementary protein-level approach implemented in TreeSAAP (Woolley et al. 2003).
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Direct comparison of w values computed from different datasets can be misleading, as they 
can have different proportion of sites under selection. Hence, we assessed the selection pressures 
shaping the evolution of NGF along various toxicoferan reptilian lineages by employing clade 
model analyses implemented in codeml and simultaneously estimated w values (Bielawski and Yang 
2004). The significance of the analysis was tested by comparing the likelihood of this model with 
that of model M1a. To clearly depict the proportion of sites under different regimes of selection, 
an evolutionary fingerprint analysis was carried out using the evolutionary selection distance (ESD) 
algorithm implemented in datamonkey (Pond and Frost 2005; Delport et al. 2010; Pond et al. 
2010). Evolutionary fingerprint analysis fits a versatile general discrete bivariate model of site-to-site 
variation in selection pressures and comprises a description of the number of selective classes, the dN/
dS (w) ratio for each class and the assignment of sites to classes (Delport et al. 2010; Pond et al. 2010).
Structural Analyses 
To depict the natural selection pressures influencing the evolution of various neurotrophins, we 
mapped the sites under positive selection on the homology models created using Phyre 2 webserver 
(Kelley and Sternberg 2009). Pymol 1.3 (DeLano 2002) was used to visualize and generate the images of 
homology models. The consurf webserver (Armon et al. 2001) was used for mapping the evolutionary 
selection pressures on the three-dimensional homology models. GETAREA (Fraczkiewicz and Braun 
1998) was used to calculate the ASA ratio or the solvent exposure of amino-acid side chains. It uses the 
atom co-ordinates of the PDB file and indicates if a residue is buried or exposed to the surrounding 
medium by comparing the ratio between side-chain ASA and the “random coil” values per residue. 
An amino-acid is considered to be buried if ASA is less than 20% and exposed if ASA is ≥ 50%.
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5.4 Results
Bayesian and maximum-likelihood analyses of NGF, BDNF and NT-3 genes 
retrieved trees with the same topology (Fig. 5.1-5.3; Appendices 5.1-5.4), which were in 
concordance with the earlier reported phylogenies of neurotrophins (Hallbook et al. 1998).
Figure 5.1
Legend: Bayesian molecular phylogeny of nerve growth factors (NGF). Branches with the 
Bayesian posterior probability (B.P.P) of less than 0.85 are highlighted in grey (remaining in 
colours). Site model 8 (M8) computed omega values for respective lineages are presented. The 
number of positively selected sites (PP ≥ 0.95) detected by M8’s Bayes-Empirical Bayes (BEB) 
approach in Elapidae lineage is also indicated. Elapid sequences representing putative duplicate 
genes are indicated with red labels [NFF: “non-front-fanged” advanced snakes; Sci: Scinciformata].
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Figure 5.2
Legend: Bayesian molecular phylogeny of  brain-derived neurotrophic factors (BDNF). Branches 
with the Bayesian posterior probability (B.P.P) of less than 0.85 are highlighted in grey (remaining 
in colours). Site model 8 (M8) computed omega values for respective lineages are presented.
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Figure 5.3
Legend: Bayesian molecular phylogeny of neurotrophin-3 (NT-3). Branches with the 
Bayesian posterior probability (B.P.P) of less than 0.85 are highlighted in grey (remaining 
in colours). Site model 8 (M8) computed omega values for respective lineages are presented.
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One ratio model (ORM), the simplest of the lineage-specific models, computed w of less 
than 0.50, therefore indicating an influence of negative selection on NGF, BDNF and NT-3 
genes in all of the mammalian and reptilian lineages examined. This highly conservative model 
can only detect positive selection when the w ratio averaged over all the sites along the lineages 
in a phylogenetic tree is significantly greater than one. Nevertheless, the computed w of 0.86 
for the Elapidae NGF highlights a relatively greater accumulation of variation in this lineage.
To detect episodic diversifying selection that only affects certain sites in the protein, we employed 
site-specific models (Tables 5.1-5.3). Like ORM, site model 8 (M8) also indicated a strong influence 
of negative selection on various reptilian and mammalian NGF, BDNF and NT-3 genes (Tables 5.1-
5.3). However, Elapidae NGF was found to be rapidly evolving (w = 0.95). The Bayes Empirical 
Bayes (BEB) approach in M8 identified as many as 19 positively-selected sites (13% of the total sites 
with w of 4.09) in Elapidae NGF, indicating the strong influence of positive selection on this lineage 
(Table 5.1). Although, M8 failed to detect variation in the Viperidae (w = 0.77) and ‘non-front-
fanged’ advanced snake (w = 0.58) NGF lineages, as many as 9% (w = 2.40) and 8% (w = 2.50) of 
the total codon sites were detected as rapidly diversifying in the respective lineages. Single Likelihood 
Ancestral Counting (SLAC), Fixed Effects Likelihood (FEL), Random Effects Likelihood (REL), 
Mixed Effects Model of Evolution (MEME), Fast, Unconstrained Bayesian AppRoximation (FUBAR) 
and integrative approach, conclusively supported these findings and highlighted the complete lack 
of variations in NGF, BDNF and NT-3 genes in various reptilian and mammalian lineages examined 
(Tables 5.1-5.3). However, elapid venom NGF was found to be rapidly evolving under the influence 
of positive selection (integrative analyses: 34 positively selected sites). Viperidae NGF was also 
found to accumulate relatively greater variations (integrative analyses: 8 positively selected sites) 
in comparison to the non-venomous reptilian and mammalian NGF lineages. Analysis of NGF 
from the venom-glands of ‘non-front-fanged’ advanced snakes and venomous lizards (Anguimorpha 
and Iguania) was hampered by the scarcity of sequences. Despite this, the integrative approach 
was able to identify five positively selected sites in the ‘non-front-fanged’ advanced snake lineages.
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Table 5.1 Molecular evolution of Nerve Growth Factor (NGF)
SLACa FELb RELc FUBARd MEMEe PAMLf
M8 M2a Clade Model C
Advanced Snakes
w>1g 2 13 28 22 19 15
Elapidae w<1h 12 20 11 18 21 (14+5) (13+2) 2.38
w= 0.90 - 1.93 - 0.95 0.94
Viperidae
w>1g 0 0 2 0
0 0
w<1h 3 13 0 7 6 1.03
w= 0.65 - 0.88 - 0.77 0.77
‘Non-front-
fanged’ 
advanced
snakes
w>1g 0 1 3 2
0 0
w<1h 1 2 0 3 2 0.57
w= 0.59 - 0.67 - 0.58 0.58
Other Snakes
Henophidia
w>1g 0 0 0 0
0 0
w<1h 3 12 1 13 1 0.0001
w= 0.30 - 0.43 - 0.30 0.30
Toxicofera Lizards
w>1g 0 0 0 0
0 0
Iguania w<1h 35 55 73 83 4 0.20
w= 0.26 - 0.76 - 0.25 0.29
w>1g 0 0 0 0
0 0
Anguimorpha w<1h 4 13 0 15 1 0.20
w= 0.33 - 0.48 - 0.33 0.36
Other Lizards
w>1g 0 0 3 1
0 0
Gekkota w<1h 1 15 0 16 2 -
w= 0.24 - 0.34 - 0.25 0.25
w>1g 0 0 0 0
0 0
Scinciformata w<1h 8 18 All 18 1 -
w= 0.22 - 0.26 - 0.22 0.25
w>1g 0 0 0 0
0 0
Laterata w<1h 5 12 0 14 0 -
w= 0.26 - 0.36 - 0.26 0.27
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SLACa FELb RELc FUBARd MEMEe PAMLf
w>1e 0 0 0 1
0 0
Turtles w<1f 9 13 0 14 0 -
w= 0.33 - 0.38 - 0.32 0.34
w>1e 0 1 0 0
0 0
Mammals w<1f 24 54 All 86 3 -
w= 0.21 - 0.22 - 0.17 0.11
Legend:
a: Single Likelihood Ancestor Counting 
b: Fixed-effects likelihood 
c: Random-effects likelihood
d: Fast, Unconstrained Bayesian AppRoximation
e: Sites detected as experiencing episodic diversifying selection (0.05 significance) by the Mixed  
Effects Model Evolution (MEME)
f: Positively-selected sites detected using the Bayes Empirical Bayes approach implemented in M8 
and M2a. Sites detected at 0.99 and 0.95 significance are indicated in the parenthesis
w: mean dN/dS
g: Number of positively selected sites at 0.05 significance (for SLAC, FEL) or 50 Bayes factor (for 
REL) / number of sites under pervasive diversifying selection at the posterior probability ≥0.9 
(FUBAR)
h: Number of negatively selected sites at 0.05 significance (for SLAC, FEL) or 50 Bayes factor 
(for REL) / number of sites under pervasive purifying selection at the posterior probability ≥0.9 
(FUBAR)
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Table 5.2 Molecular evolution of Brain-derived Neurotrophic Factors (BDNF)
SLACa FELb RELc FUBARd MEMEe PAMLf
M8 M2a
Advanced Snakes
w>1g 0 0 0 0
0 0
Elapidae w<1h 1 3 0 3 0
w= 0.09 - 0.25 - 0.09 0.09
Viperidae
w>1e 0 0 0 0
0 0
w<1f 1 3 13 4 0
w= 0.10 - - - 0.11 0.11
‘Non-front-
fanged’ 
advanced
snakes
w>1e 0 0 0 0
0 0
w<1f 5 19 14 22 0
w= 0.08 - 0.35 - 0.06 0.06
Other Snakes
Typhlopoidea
w>1e 0 0 0 0
0 0
w<1f 27 47 0 93 0
w= 0.07 - 0.11 - 0.07 0.07
Boidae
(Henophidia)
w>1e 0 0  1 1
0 0
w<1f 3 10 3 10 0
w= 0.0 - 0.28 - 0.09 0.09
Pythonidae
(Henophidia)
w>1e 0 0 0 1
0 0
w<1f 0 2 11 7 0
w= 0.21 - 0.23 - 0.15 0.15
Toxicofera Lizards
Iguania
w>1e 0 0 0 0
0 0
w<1f 24 56 111 99 1
w= 0.05 - - - 0.05 0.05
Anguimorpha
w>1e 0 0 2 0
0 0
w<1f 9 22 9 23 0
w= 0.08 - 0.15 - 0.06 0.06
w>1e 0 0 0 0
0 0
Crocodiles w<1f 0 8 20 1 0
w= 0.09 - - - 0.12 0.12
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SLACa FELb RELc FUBARd MEMEe PAMLf
w>1e 0 0 4 0
0 0
Turtles w<1f 6 18 2 18 1
w= 0.10 - 0.14 - 0.05 0.06
w>1e 0 0 2 0
0 0
Mammals w<1f 48 72 51 113 2
w= 0.05 - - 0.05 0.06
Legend:
a: Single Likelihood Ancestor Counting 
b: Fixed-effects likelihood 
c: Random-effects likelihood
d: Fast, Unconstrained Bayesian AppRoximation
e: Sites detected as experiencing episodic diversifying selection (0.05 significance) by the Mixed  
Effects Model Evolution (MEME)
f: Positively-selected sites detected using the Bayes Empirical Bayes approach implemented in M8 
and M2a. Sites detected at 0.99 and 0.95 significance are indicated in the parenthesis
w: mean dN/dS
g: Number of positively selected sites at 0.05 significance (for SLAC, FEL) or 50 Bayes factor (for 
REL) / number of sites under pervasive diversifying selection at the posterior probability ≥0.9 
(FUBAR)
h: Number of negatively selected sites at 0.05 significance (for SLAC, FEL) or 50 Bayes factor 
(for REL) / number of sites under pervasive purifying selection at the posterior probability ≥0.9 
(FUBAR)
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Table 5.3 Molecular evolution of of Neurotrophin 3 (NT-3)
SLACa FELb RELc FUBARd MEMEe PAMLf
M8 M2a
Advanced Snakes
w>1g 0 0 0 0
0 0
Elapidae w<1h 1 4 0 4 0
w= 0.19 - 0.21 - 0.18 0.19
Viperidae
w>1e 0 0 0 0
0 0
w<1f 0 5 0 3 0
w= 0.30 - 0.49 - 0.28 0.30
‘Non-front-
fanged’ 
advanced
snakes
w>1e 0 2 5 1
0 0
w<1f 43 61 79 82 2
w= 0.22 - 0.35 - 0.20 0.27
Other Snakes
Typhlopoidea
w>1e 1 2 8 2
0 0
w<1f 48 69 49 106 2
w= 0.24 - 0.49 - 0.23 0.26
Boidae
(Henophidia)
w>1e 0 0 0 1
0 0
w<1f 7 23 10 26 2
w= 0.24 - 0.51 - 0.24 0.28
Other Lizards
w>1e 0 0 0 0
0 0
Scinciformata w<1f 7 27 75 30 0
w= 0.13 - - - 0.12 0.13
Toxicofera Lizards
Iguania
w>1e 0 2 4 3
0 0
w<1f 27 41 23 58 3
w= 0.25 - 0.43 - 0.23 0.26
Anguimorpha
w>1e 0 0 0 0
0 0
w<1f 7 20 All 23 1
w= 0.24 - 0.32 - 0.21 0.24
w>1e 0 0 0 0
0 0
Crocodiles w<1f 0 1 all 1 0
w= 0.08 - 0.08 - 0.07 0.07
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SLACa FELb RELc FUBARd MEMEe PAMLf
w>1e 0 0 0 0
0 0
Turtles w<1f 3 4 all 5 0
w= 0.19 - 0.21 - 0.17 0.17
w>1e 0 0 1 0
0 0
Mammals w<1f 77 124 134 167 1
w= 0.06 - - 0.05 0.07
Legend:
a: Single Likelihood Ancestor Counting 
b: Fixed-effects likelihood 
c: Random-effects likelihood
d: Fast, Unconstrained Bayesian AppRoximation
e: Sites detected as experiencing episodic diversifying selection (0.05 significance) by the Mixed  
Effects Model Evolution (MEME)
f: Positively-selected sites detected using the Bayes Empirical Bayes approach implemented in M8 
and M2a. Sites detected at 0.99 and 0.95 significance are indicated in the parenthesis
w: mean dN/dS
g: Number of positively selected sites at 0.05 significance (for SLAC, FEL) or 50 Bayes factor (for 
REL) / number of sites under pervasive diversifying selection at the posterior probability ≥0.9 
(FUBAR)
h: Number of negatively selected sites at 0.05 significance (for SLAC, FEL) or 50 Bayes factor 
(for REL) / number of sites under pervasive purifying selection at the posterior probability ≥0.9 
(FUBAR)
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We further evaluated selection pressures along the elapid and viperid NGF lineages using 
two-ratio model (which assesses selection pressures only across lineages) and the branch-site test A 
(which assesses selection pressures across the sites and along the lineages). The two-ratio model failed 
(p>0.05) to detect positive selection in elapid (w = 0.85) and viperid NGF (w = 0.82). However, 
branch-site test A indicated a strong influence of positive selection on elapid NGF [w = 3.90; 4.5% 
positively selected (PS) sites; significant at 0.001 after Bonferroni correction] and to a lesser extent on 
Viperidae NGF (w = 2.01 and 8.1% of PS-sites; significant at 0.001 after Bonferroni correction). We 
further employed the clade model c approach to simultaneously compute and compare the w values of 
various Toxicofera NGF lineages (Table 5.1). Clade model analyses indicated the influence of positive 
selection in shaping the evolution of Elapidae NGF (w = 2.38, while the remaining lineages were 
found to be constrained by negative selection (but again with the caveat that fewer ‘non-front-fanged’ 
advanced snake and Toxicofera lizard venom-gland specific NGF sequences were available; Table 5.1). 
To derive further support for the sites detected as positively selected by the nucleotide 
analyses of elapid NGF, we employed a complementary amino acid-level approach implemented 
in TreeSAAP (Table 5.4). Since a mutated amino acid can share similar/identical biochemical 
and structural properties with the ancestral amino acid being replaced, not all non-synonymous 
mutations may affect the structure and function of a protein. Hence, the evaluation of the influence 
of selection on the biochemical and structural properties of proteins provides further insights 
about the strength of a mutation in affecting the fitness of an organism. With this combined 
approach, we were able to identify 13 positively selected sites (68% of positively selected sites) 
in elapid NGF (Table 5.4). Mapping of these mutations onto the three-dimensional structure 
of NGF revealed that a majority of detected hypermutable sites (74%) were concentrated in 
the secreted region (b-polypeptide chain) of Elapidae NGF (Appendix Fig. 5.5). Mutation 
mapping also revealed that a greater proportion of amino acid residues (92%; remaining 
sites couldn’t be assigned to exposed/buried class) were exposed to the surrounding medium, 
indicating that these Elapid venom proteins evolve through focal mutagenesis (Table 5.4).
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Table 5.4 Nucleotide and complementary protein-level selection assessment of Elapidae Nerve 
Growth Factors (NGF)
Site CodeML TreeSAAP ASA
Codon AA M2aa M8b Propertyc Magnituded
57 R
4.241±0.515 3.894±0.510
- - -
(0.994) (0.998)*
72 A
4.260±0.453 3.899±0.493
- - -
(0.999)** (1.0)**
116 T
4.227±0.553 3.892±0.513
RA ,am 6, 7 -(0.990)* (0.997)**
123 A
4.243±0.509 3.895±0.506
RA ,am 6, 7 -(0.994) ( 0.998)*
125 R
4.132±0.769 3.857±0.601
- - -
(0.961)* (0.986)*
127 N
4.262±0.448 3.900±0.492
RA,am 6, 7 -(1.0)** (1.0)**
133 Q
4.262±0.446 3.900±0.491
RA,am 6, 7 -(1.0)** (1.0)**
144 D
4.258±0.459 3.899±0.495
RA,am 6, 7
69.5
(0.999)** (1.0)** Exposed
150 T
4.252±0.481 3.897±0.500
am 6
77.5
(0.997)** (0.999)** Exposed
155 R
4.146±0.740 3.867±0.576
am 6
87.0
(0.965)* (0.990)* Exposed
158 V
4.247±0.498 3.896±0.504
- -
76.9
(0.995)** (0.999)** Exposed
163 E
4.257±0.464 3.898±0.496
am 6
65.9
(0.998)* (0.999)** Exposed
167 L
4.024±0.940 3.824±0.670
am 6
65.0
(0.929) (0.976)* Exposed
170 E
4.260±0.453 3.900±0.493
- -
73.0
(0.999)** (1.0)** Exposed
182 R
3.951±1.036 3.789±0.736
- -
57.3
(0.907) (0.965)* Exposed
207 Q
4.255±0.471 3.898±0.499
RA 6
32.2
(0.998)** 0.999** NA
211 R
4.260±0.455 3.899±0.493
RA 6
53.1
(0.999)* (1.0)** Exposed
219 Q
4.262±0.446 3.900±0.491
RA 6
73.8
(1.0)** (1.0)** Exposed
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Site CodeML TreeSAAP ASA
240 D
4.004±0.970 3.804±0.712
RA 6
66.9
(0.923) (0.969)* Exposed
Legend:
a, b: Bayes Empirical Bayes (BEB) posterior probability and post-mean omega (indicated in 
brackets) for the sites detected as positively selected by the site models M2a and M8, respectively. 
Significant values are highlighted in bold.
c: amino acid property experiencing positive diversifying selection
d: magnitude of selection on the amino acid property
ASA: Accessible surface area.
Note: Codon sites with significant support from both nucleotide and protein-level selection analyses 
are highlighted in bold.
Evolutionary fingerprint analyses, which is based on the probability distribution of site-to-site 
synonymous (a or dS) and nonsynonymous (b or dN) substitution rates in an alignment, identified 
a significantly large proportion of sites in elapid NGF as evolving under the influence of positive 
selection, while the remaining reptilian and mammalian NGF, BDNF and NT-3 lineages were depicted 
as constrained by extreme negative selection pressures. It is noteworthy that a small fraction of sites in 
all snake lineages (Caenophidia and Henophidia) seem to have accumulated a greater proportion of 
non-synonymous to synonymous mutations, although these observations lacked significant statistical 
support (indicated by the density and compactness of the circles). Branch-site REL identified four, 
three and two branches (p<0.05), respectively in elapid, viperid and ‘non-front-fanged’ advanced 
snake NGFs as evolving under the influence of episodic diversifying selection. This highlights the 
episodic nature of natural selection on the evolution of advanced snake venom-specific nerve growth 
factors. This test failed to identify positive diversifying selection in other non-venomous reptilian or 
mammalian NGF and any BDNF and NT-3 gene lineages, including those of the advanced snakes.
5.5 Discussion
Distinct rates and trajectories of neurotrophin evolution
Evidence provided by various analyses (codeml site, branch, branch-site, and clade-specific 
models: M8, M2a, M3, M0, two-ratio model, branch-site test A, clade model c; HyPhy: SLAC, FEL, 
REL, MEME, FUBAR, integrative analyses, branch-site REL; TreeSAAP: protein-level selection 
assessment and the evolutionary fingerprint analysis) not only revealed the strong influence of positive 
diversifying selection on Elapidae venom NGF (and to a lesser extent on the venom NGF of other 
advanced snake lineages, particularly the Viperidae NGF), but also highlighted the role of purifying 
selection pressures in shaping the molecular evolution of various non-venomous reptilian and 
mammalian NGF lineages (Tables 5.1-5.3; Fig. 5.1-5.5). The accumulation of variation in advanced 
snake NGFs, in a fashion similar to other venom proteins (Fry et al. 2003b; Fry 2005; Casewell et al. 
2013) is suggestive of a role in envenomation and prey-capture. As envenomation is their primary 
method of prey subjugation, elapid and viperid snakes rely on the swift and potent action of venom 
for foraging. Hence, most elapid and viperid venom components experience extreme selection 
pressures, likely as a result of a co-evolutionary arms race with their prey (Fry et al. 2003b; Casewell 
et al. 2013). Although NGF constitutes a very small proportion (1X5 mg/g of venom) of the total 
venom in most snakes (Siigur et al. 1985; Siigur et al. 1987; Koyama et al. 1992; Sanz et al. 2006), 
the venom of snakes of the genus Oxyuranus (Taipans) has been shown to contain larger quantities 
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of NGF (Morrison et al. 1982; Morrison et al. 1984; Earl et al. 2006). NGF seems to make up nearly 
0.5% (w/w) of the total venom injected by these snakes (Morrison et al. 1982; Morrison et al. 1984; 
Earl et al. 2006). Thus, NGF could be secreted in elevated amounts by several species of caenophidian 
snakes, which could be enough to cause toxicity in the prey. ‘Non-front-fanged’ advanced snakes 
have been shown to possess several rapidly evolving venom components that participate in prey 
envenoming (Fry et al. 2003a; Ching et al. 2006; Ching et al. 2012; Fry et al. 2012a; Sunagar et al. 
2012; Fry et al. 2012b). Selection analyses in the present study identify several residues and branches 
in both the ‘non-front-fanged’ and viperid advanced snake NGF lineages as evolving under positive 
Darwinian selection (Table 5.1: integrative approach). However, due to the scarcity of NGF sequences 
from both these lineages, the extent to which NGF participates in their envenoming remains elusive.
The aforementioned analyses also demonstrated the influence of negative selection on the 
evolution of all reptilian and mammalian BDNF and NT-3 gene lineages examined in this study. The 
lack of variation in these genes despite their origin over 300 million years ago is probably due to their 
significance in neuronal development, maintenance and survival. NGF, BDNF and NT-3 deficiencies 
have been correlated with severe peripheral neuropathy and death of the organism (Snider 1994). 
Figure 5.4
Legend: Molecular evolution of nerve growth factors. Three-dimensional homology 
models of nerve growth factors (NGF), depicting the locations of positively selected 
sites (in red). The omega values (Model 8) for the respective taxa along with the number 
of positively selected sites (PP ≥ 0.95, Bayes-Empirical Bayes approach) are indicated.
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Figure 5.5
Legend: Molecular evolution of brain-derived neurotrophic factors. Three-dimensional 
homology models of brain-derived neurotrophic factors (BDNF), depicting the 
molecular evolution of these non-venomous homologues. The omega values (Model 
8) for the respective taxa (PP ≥ 0.95, Bayes-Empirical Bayes approach) are indicated.
Focal mutagenesis of venom nerve growth factors
The synthesis and secretion of venom proteins is an energetically expensive process (Nisani 
et al. 2007; Nisani et al. 2012; Morgenstern and King 2013). Hence, mutations that disrupt the 
structure/function of proteins are filtered out of the population by negative selection pressures, 
favouring the conservation of catalytic and structurally important core residues. As a result, most 
mutations in proteins can be found concentrated in structurally and/or functionally unimportant 
regions. Moreover, the accumulation of point mutations under the influence of positive Darwinian 
selection in certain regions of the toxin, such as the molecular surface (a phenomenon we refer 
to as focal mutagenesis), may confer adaptive significance. We and others have postulated that 
predatory venom components undergo focal mutagenesis that results in the generation of 
a diversity of novel amino acids (and their side-chains) on the molecular surface, which could 
non-specifically interact with prey cells and cause a myriad of pharmacological effects (Kini 
and Chan 1999; Kini 2003; Kini 2005; Casewell et al. 2011a; Sunagar et al. 2012; Brust et al. 
2013; Ruder et al. 2013). Mapping of hypermutable sites onto the three-dimensional homology 
model of elapid NGFs and the calculation of accessible surface area (ASA) ratio for each residue 
indicated that 92% of the positively selected residues  in these proteins are located on the molecular 
surface (Table 5.4; remaining sites couldn’t be conclusively assigned to exposed/buried class). 
Moreover, a large proportion of these positively selected sites (74%) were found concentrated in 
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the b-chain of Elapidae NGF, which is the only secreted region of the mature toxin and hence the 
only region that is likely to experience an arms race (Appendix 5.5). Thus, it is highly likely that 
elapid NGFs follow the regime of focal mutagenesis and favour the accumulation of hypermutable 
sites in specific regions of the secreted toxin that are able to influence the fitness of the animal.
Putative role of nerve growth factors in venom
Nerve growth factors are known to inhibit venom metalloproteinase-dependent proteolysis 
(Wijeyewickrema et al. 2010). Hence, the presence of large amounts of NGF, relative to 
metalloproteinases in viper venom (Cohen 1959; Wijeyewickrema et al. 2007) has been viewed as 
an indication of their role in prevention of venom autolysis (Wijeyewickrema et al. 2010). However, 
additional plausible mechanisms of action exist for both the direct and indirect participation of 
rapidly evolving caenophidian NGF in prey envenoming, potentially resulting in an increase in the 
potency of the toxicoferan venom arsenal. The injection of large amounts of NGF into the lymphatic 
system of prey would result in NGF overdose, triggering a variety of reactions. Nerve growth factors 
are also known to cause apoptosis of cells lacking the expression of TrkA receptors (Frade et al. 1996; 
Frade and Barde 1998; Frade and Barde 1999) and thus the caenophidian venom NGFs could act 
as cytotoxic proapoptotic factors, after being introduced into tissues where they are not typically 
found. Venom components like hyaluronidase have been shown to degrade hyaluronic acid in the 
extra-cellular matrix and function as spreading factors, facilitating the easier diffusion of other 
venom components (Girish et al. 2002). NGF, which is known to trigger the release of granules 
containing histamines, serotonins and other chemical mediators from mastocytes (Lindholm et al. 
1987; Woolf 1996), could perform a similar ancillary venom function by facilitating the efficient 
absorption of other venom components. The degranulation of mast cells that are located primarily 
in perivascular spaces, often close to neurons and blood vessels, has been correlated with increased 
vascular permeability and even neurogenic inflammations (Theoharides 1990). While controlled 
degranulation aids in orchestrating and mounting acute inflammatory reactions, massive releases 
can be associated with anaphylaxis, bronchoconstriction (suffocation) and vasodilation (Payne and 
Kam 2004). Over the years, both glycosylated and non-glycosylated forms of NGFs have been 
reported from snake venoms (Pearce et al. 1972; Pearce and Thompson 1986; Katzir et al. 2003; 
Earl et al. 2006). Glycosylation has been proposed to prolong the circulation time of serum proteins 
by increasing their stability (Marshall 1972). Interestingly, Asn 23, which has been postulated as 
a putative glycosylation site in mature venom NGF (Kornfeld and Kornfeld 1985; Gavel and von 
Heijne 1990), is highly conserved in the entire squamate lineage (except in a few elapid snakes: 
genus Naja, Notechis scutatus, Pseudechis australis, Pseudechis porphyriacus, etc.), while being 
completely absent from mammalian and turtle NGFs (Appendix 5.5). These observations are not 
surprising since mammalian NGFs are not known to undergo glycosylation. Snake venom NGFs 
could undergo posttranslational glycosylation in order to circulate longer in the bloodstream of 
the prey and spread further throughout the prey animal’s system. Rapidly evolving caenophidian 
NGFs with a diversity of amino acids on their molecular surface could not only induce a plethora 
of pharmacological effects by non-specifically interacting with novel receptors of the prey, but 
could further aid in evading the prey immune response. Thus, caenophidian NGFs could directly 
and/or indirectly participate in prey-envenoming through a number of plausible mechanisms.
Putative duplication of nerve growth factors in Elapidae
Genes encoding venom proteins are known to evolve via the birth-and-death model of evolution 
where new genes are created by repeated duplication events, and are subsequently either maintained 
in the genome, deleted or become non-functional pseudogenes (Fry et al. 2003b; Fry 2005). The 
molecular phylogeny of NGFs clearly indicates the presence of two independent NGF genes in Naja 
sputatrix, with very strong support for the node separating them (915 bootstrap and 1.0 Bayesian 
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posterior probability: Fig. 5.1). The phylogenetic placement of these two gene homologues suggests 
that the gene duplication event responsible for their origin occurred in an early elapid ancestor 
(Fig. 5.1) – we might therefore expect to find additional copies of NGF in other elapid snakes in 
the future. Although one might initially assume that the original copy of NGF would continue the 
ancestral role in homeostasis, thereby releasing the novel duplicate gene to evolve a function specific 
to venom, in N. sputatrix both NGF genes were found to be expressed in the venom gland (Koh et 
al. 2004). However, considering how important NGF and other neurotrophins appear to be for the 
survival of an organism (Snider 1994), it is highly unlikely that both gene copies would be exclusively 
associated with a role in prey envenoming. We therefore propose that co-expression of an NGF gene 
occurs in different tissue types, similar to that recently proposed for other toxin families (Casewell et 
al. 2012). Specifically, we postulate that despite the elevated mutation rate in the Elapidae NGF, the 
ancestral copy of the gene has retained its biochemical functions by undergoing focal mutagenesis 
and continues to ensure homeostasis. A greater accumulation of mutations on the molecular surface 
and the loops of the protein ensures the preservation of structurally and functionally important core 
residues. Clearly, a large number of residues across the entire vertebrate NGF lineage appear to be 
highly conserved (Appendix 5.5). Moreover, it has been demonstrated on numerous occasions that 
snake venom NGFs exhibit biological activities similar to their mammalian counterparts (Katzir et 
al. 2003; Earl et al. 2006). This would seemingly free the duplicate elapid NGF gene to participate 
exclusively in prey envenoming. In contrast to the Elapidae NGF, only one copy was found in the 
venom glands of the Anguimorpha lizard Abronia graminea, which was identical to the one recovered 
from genomic sequencing for use in taxonomy studies (Koludarov et al. 2012). Moreover, despite 
extensive BLAST searches using sequence templates from a wide array of mammalian and reptilian 
NGFs against the genomes of Anolis carolinensis (Iguania) and Python molurus (Henophidia), 
we were only able to retrieve a single copy of the NGF gene. Hence, we further speculate that the 
ancestral NGF gene is co-expressed in physiological tissues and the venom-gland, while the new gene 
duplicates are more likely to be tissue-specifically expressed in the venom gland alone. Experimental 
investigation in the future regarding the copy number of NGF should reveal if the NGF duplication 
occurred in an early elapid ancestral lineage or at the base of the Toxicofera phylogenetic tree.
Note on the usage of NGF in the phylogenetic reconstructions of Toxicofera reptiles
NGF is a commonly used gene in reptilian phylogenetic studies (Wiens et al. 
2008; Wiens et al. 2010; Townsend et al. 2011; Wiens et al. 2012). However, the 
detection of gene duplication events and the accelerated evolution of the advanced snake 
NGFs indicate that these genes should not be employed in phylogenetic inferences of 
Toxicofera reptiles, as these factors can undermine such analyses (Casewell et al. 2011b).
5.6 Conclusions
In this study, we show that BDNF and NT-3, two major members of the neurotrophin family, 
lack variations completely and evolve under the regime of negative selection, indicating their extreme 
importance in the maintenance of homeostasis. In complete contrast, this study points for the first time 
towards venom-specific NGF evolving in a manner typical of toxic proteins and consequently suggests 
a hitherto unappreciated role in envenomation. We highlight an exquisite mechanism of venom 
evolution where focal mutagenesis has facilitated the transformation of a key regulatory protein into a 
toxin, without hampering its participation in homeostasis. Structure-function studies of mutant NGF 
may reveal a suite of novel activities, some of which may be of use in drug design and development.
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6.1.1 Abstract
Scorpions, which are believed to have originated nearly 430 million years ago in the 
Silurian period, represent one of the most ancient and enigmatic lineages of venomous animals 
on our planet.  In contrast to some snake venoms, which are rich in enzymatic toxins, scorpion 
venom arsenals are enriched with peptide toxins that predominantly fold into one of the four 
major structural scaffolds: i) cysteine-stabilised a/b (CSa/b motif ); ii) cysteine-stabilised a/a 
(CSa/a motif ); iii) inhibitor cysteine knot (ICK) motif and iv) the disulphide-directed b-hairpin 
(DDH) motif.  Large periods of evolutionary time has resulted in significant divergence of toxin 
sequences in scorpions. Consequently, the nature and strength of selection pressures that have 
shaped their molecular evolution of scorpion venom peptides have remained enigmatic to date. 
In this study, we not only reconstruct the complex phylogenetic histories of various scorpion 
toxins, but have also unravelled the significant influence of episodic positive Darwinian selection 
on the evolution of various scorpion toxins, using state-of-art selection assessment methodologies. 
We postulate novel evolutionary links between various linear scorpion toxin scaffolds.
6.1.2 Introduction
The scientific consensus is that venom-encoding genes undergo dynamic molecular 
evolution, predominantly as a result of variations in prey preference and/or predatory strategy 
employed (Daltry et al. 1996; Kordis and Gubensek 2000; Fry et al. 2003; Fry et al. 2008; 
Barlow et al. 2009; Duda and Lee 2009; Puillandre et al. 2010; Weinberger et al. 2010; 
Casewell et al. 2011; Sunagar et al. 2012; Brust et al. 2013; Low et al. 2013). The underlying 
molecular diversity of venom however, could be obscured by the episodic nature of selection 
on genes that encode them and the extreme sequence divergence that occurs over long periods 
of evolutionary time. This is particularly true for venom-encoding genes in some of the oldest 
venomous lineages, such as cnidarians, centipedes, scorpions, spiders, coleoids, etc. In addition, 
full recognition of the natural biocomplexity is hampered by the limited taxon selection in 
biodiscovery oriented research, with easy to obtain or medically important species typically being 
the subject to a disproportionate level of research relative to the true taxonomical diversity present.
Scorpions are an ancient and species rich venomous lineage. Buthidae are not only the largest 
family among scorpion lineages, but is also the one that includes all the medically significant 
species. As apparent from the extreme potency of their venom and the relatively smaller pincers in 
comparison to a rather large stinger, which is particularly pronounced in the fat-tailed scorpions 
genera (Androctonus and Parabuthus), members of this family heavily rely on the venom arsenal 
for predation. This is in contrast with the non-buthid families that use a combined arsenal of 
strong pincers and envenoming for prey-subjugation, with the pincers as the primary weapon.
Over the course of 400+ million years of evolutionary time (Dunlop and Selden 2009), 
scorpions have evolved venoms that exert toxic activities on a wide range of biological targets. The 
toxin diversity has been potentiated by the slow migration rates and divergent population structures 
combined with their long geological history (Zeh 1990; Gantenbein and Largiadèr 2003; Bryson 
et al. 2013; Yamashita and Rhoads 2013). In contrast to some snake venoms which are rich in 
enzymatic toxins, scorpion venoms are dominated by peptide toxins (Table 6.1.1). Among the 
several toxin types present in scorpion venoms [see (Rodríguez de la Vega et al. 2013) for a review], the 
CSa/b scaffold (cysteine-stabilised a/b) are particularly complex. Scorpion CSa/b toxins include 
sodium channel (NaV) modulators [NaScTx or NaV-CSa/b or sodium ion-channel scorpion toxins: 
subtypes a-toxins (site-3 binding) and b-toxins (site-4 binding)], atypical NaV-CSa/b (birtoxin 
and similar toxins including the so-called ‘lipolytic toxins’), potassium ion-channel (KV) targeting 
toxins (KTx) (short and long subtypes) and the chloride toxin family (Possani et al. 2001; Catterall 
et al. 2007; Rodríguez De La Vega et al. 2010; Klint et al. 2012; Quintero-Hernández et al. 2013).
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Despite this recognised complexity, the relative phylogenetic relationships remain enigmatic 
and thus the molecular evolutionary history remains unclear. Similarly, while scorpions have 
globally been the subject of intensive research, the species in Australia have been largely neglected 
by toxicological research. Only one scorpion species (Urodacus yaschenkoi) from Australia has had 
its venom transcriptome sequenced to date (Luna-Ramírez et al. 2013). Only studies have examined 
isolated peptides: two very similar DDH peptides from two very closely related scorpion species 
[Liocheles australasiae and L. waigiensis; (Matsushita et al. 2007; Smith et al. 2011; Smith et al. 2013)]; 
and a third examining a peptide related to the SVC arthropod peptides (Miyashita et al. 2007). Such a 
scarcity of knowledge from an entire continent’s worth of scorpions has hampered our understanding 
of scorpion venom peptide molecular evolution. Thus, in this study we selected representatives of the 
taxonomical diversity of buthid and non-buthid species of Australian scorpions in order to examine 
the molecular complexity through transcriptome sequencing. These new sequences allowed us to 
robustly reconstruct the complex molecular evolutionary histories of scorpion peptide toxin types.
Table 6.1.1
toxin typE GEnEralisEd bioaCtivity KEy rEfErEnCEs
Bradykinin Potentiating 
Peptide (BPP) family
Potent cytotoxins leading to cell 
haemolysis and death. Documented 
antimicrobial activity is a side effect due 
to generalised cell-killing. C-terminal 
coil region contributes additional 
activity of bradykinin potentiation.
(Miyashita et al. 2010; 
Ruiming et al. 2010; Zeng et 
al. 2012)
NDBP 5 linear peptide 
family
Potent cytotoxins leading to cell 
haemolysis and death. Documented 
antimicrobial activity is a side effect due 
to generalised cell-killing.
(Yan et al. 2011; Almaaytah 
et al. 2012; Cao et al. 2012; 
Ramírez-Carreto et al. 2012)
Short cationic 
Antimicrobial Peptide 
(AMP) family
Potent cytotoxins leading to cell 
haemolysis and death. Documented 
antimicrobial activity is a side effect due 
to generalised cell-killing.
(Zeng et al. 2004; Dai et 
al. 2008; Fan et al. 2011; 
Almaaytah et al. 2012)
Anionic uncharacterised
(Zeng et al. 2004; Diego-
García et al. 2005; Luo et 
al. 2005; D’Suze et al. 2009; 
Ruiming et al. 2010; Diego-
García et al. 2012)
CSa/b
Alpha Prevent inactivation by binding to sodium channel receptor site 3
(Céard et al. 2001; del Río-
Portilla et al. 2004; Rodríguez 
De La Vega and Possani 2005; 
Zeng et al. 2006; Diego-
García et al. 2007; Diego-
García et al. 2008; Pedraza 
Escalona and Possani 2013; 
Rodríguez de la Vega et al. 
2013)
Beta Promote activation by binding to sodium channel receptor site 4
Lipolytic Lipolysis
Chlorotoxin Chloride channel
Short-chain Potassium channel
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toxin typE GEnEralisEd bioaCtivity KEy rEfErEnCEs
Long-chain Potassium channel and antimicrobial
Scorpine Potassium channel and antimicrobial
Glycine uncharacterised (Ruiming et al. 2010)
ICK/DDH
sv-svC Functionally uncharacterised
(Miyashita et al. 2007; Silva et 
al. 2009; Ruiming et al. 2010; 
Zeng et al. 2013)
ICK
Strong agonist of ryanodine receptors 
(calcium release channels). Induces 
voltage- and concentration-dependent 
subconductance states in both skeletal 
(RYR1 and RYR3) and cardiac (RYR2) 
ryanodine receptors by binding 
to a single, cytosolically accessible 
site different from the ryanodine 
binding site. Enhances calcium 
release. A derivative (GU187948) 
inhibits Shaker K+ channels
(Valdivia et al. 1992; Zamudio 
et al. 1997; Tripathy et al. 
1998; Fajloun et al. 2000; 
Mosbah et al. 2000; Nabhani 
et al. 2002; Zhu et al. 2003; Lee 
et al. 2004; Zeng et al. 2006; 
Zhijian et al. 2006; Capes et 
al. 2008; Schwartz et al. 2009; 
Chen et al. 2010; Ruiming 
et al. 2010; Gao et al. 2013)
DDH
Types such as P60252 from 
Opistophthalmus carinatus, P59868 
from Pandinus imperator and B8QG00 
from Hadrurus gertschipotently and 
reversibly modify channel gating 
behavior of the type 1 ryanodine 
receptor (RYR1) by inducing prominent 
subconductance behavior. Binds a 
different site as ryanodine. Others with 
different cysteine frameworkds such 
as P0DJ08 Liocheles waigiensis are 
insect-selective toxins. Provokes a dose-
dependent contractile paralysis in crickets 
and blowfly larvae, followed by death.
(Lazarovici et al. 1982; 
Matsushita et al. 2007; 
Silva et al. 2009; Horita 
et al. 2011; Smith et al. 
2011; Smith et al. 2013)
6.1.3 Methods
Specimens Examined Captured in
bothriuridaE
Cercophonius squama Wauchope NSW
buthidaE
Australobuthus xerlomnion Lake Gardner, South Australia
Isometroides vescus Port Pirie South Australia
Lychas buchari Port Pirie South Australia
urodaCidaE
Urodacus manicatus Traralgon, Victoria
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Sequence Retrieval and Alignment
Amino acid sequences were aligned in CLC Main Work Bench (CLC-Bio) using default parameters 
and were then edited manually to align any misaligned region (Chairman and Kusk 2011). Amino acid 
alignments generated this way were used for guiding the nucleotide alignments, which were trimmed 
before conducting selection analyses to remove regions with gaps in more than 50% of sequences.
Transcriptome library construction 
In order to minimise individual or time-course variation, 4-6 days post-milking, six telsons for 
each species were dissected out (two per day) and pooled and immediately frozen in liquid nitrogen 
for future use. Total RNA extracted using the standard TRIzol Plus method (Invitrogen). Extracts 
were enriched for mRNA using standard RNeasy mRNA mini kit (Qiagen) protocol. mRNA 
was reverse transcribed, fragmented and ligated to a unique 10-base multiplex identifier (MID) 
tag prepared using standard protocols and applied to one PicoTitrePlate (PTP) for simultaneous 
amplification and sequencing on a Roche 454 GS FLX+ Titanium platform (Australian Genome 
Research Facility). Automated grouping and analysis of sample-specific MID reads informatically 
separated sequences from the other transcriptomes on the plates, which were then post-processed 
to remove low quality sequences before de novo assembly into contiguous sequences (contigs) using 
v 3.4.0.1 of the MIRA software program. Assembly details (number of sequences, total number 
of bases, average sequence length and number of contigs and assembled bases (average per contig) 
were: Australobuthus xerlomnion 53510, 20833026, 389, 3531, 1962322 (556); Cercophonius 
squama 59174, 21515356, 363, 2733, 1531957 (561); Isomteroides vescus IvGS, 65490, 22911959, 
349, 2856, 1572328 (551); Lychas buchari 75950, 27265869, 358, 5534, 3402763 (615); and 
Urodacus manicatus UmGS 76540, 26715502, 349, 6884, 4043703 (587). Public access of the data 
can be found at the National Center for Biotechnology Information (NCBI) under bioprojects: 
Australobuthus xerlomnion PRJNA201348; Cercophonius squama PRJNA201349; Isometroides vescus 
PRJNA201350; Lychas buchari PRJNA201351; Urodacus manicatus PRJNA201352. Sequenced 
analysed in this study have the accession numbers of: Australobuthus xerlomnion GALG01000001-
GALG01000002; Cercophonius squama GALH01000001-GALH01000013; Isometroides vescus 
GALK01000001-GALK01000018; Lychas buchari GALL01000001-GALL01000032; Urodacus 
manicatus GALI01000001- GALI01000019. Assembled contigs were processed using CLC 
Main Work Bench (CLC-Bio) and Blast2GO bioinformatic suite (Gotz et al. 2008; Gotz et al. 
2011) to provide Gene Ontology, BLAST and domain/Interpro annotation. The above analyses 
assisted in the rationalisation of the large numbers of assembled contigs into phylogenetic ‘groups’ 
for detailed phylogenetic analyses out¬lined below that focused upon the peptide toxin types.
Phylogenetic analyses
The molecular evolutionary histories of various scorpion toxins were reconstructed 
using phylogenetic analyses. Trees were generated using the Bayesian inference implemented 
in Mr. Bayes 3.2.1 (Ronquist et al. 2012), which is well known for its ability to deal with 
divergent datasets. The command block lset rates=invgamma with prset aamodelpr=mixed was 
used, which enables the program to optimise between nine different amino acid substitution 
matrices implemented in MrBayes. The analysis was performed by running a minimum of 
1x107 generations in four chains, and saving every 100th tree. The log-likelihood score of each 
saved tree was plotted against the number of generations to establish the point at which the log 
likelihood scores reached their asymptote, and the posterior probabilities for clades established 
by constructing a majority-rule consensus tree for all trees generated after completion of the 
burn-in phase. An optimal maximum likelihood phylogenetic tree was obtained using PhyML 
3.0 (Guindon et al. 2010) and node support was evaluated with 1,000 bootstrapping replicates.
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Test for Recombination
To overcome the effects of recombination on the molecular evolution interpretations we 
employed Single Breakpoint algorithm implemented in the HyPhy package and assessed the 
effect of recombination on all the toxin types examined in this study (Kosakovsky Pond et al. 
2006). When potential breakpoints were detected using the small sample Akaike information 
Criterion (AICc), the sequences were compartmentalized before conducting selection analyses.
Selection analyses
The influence of natural selection on various scorpion toxin types was evaluated using the 
maximum-likelihood models (Goldman and Yang 1994; Yang 1998) implemented in CODEML of 
the PAML (Yang 2007). We employed site-specific models that estimate positive selection statistically 
as a non-synonymous-to-synonymous nucleotide-substitution rate ratio (ω) significantly greater than 
1. We compared likelihood values for three pairs of models with different assumed ω distributions as 
no a priori expectation exists for the same: M0 (constant ω rates across all sites) versus M3 (allows the 
ω to vary across sites within ‘n’ discrete categories, n≥3); M1a (a model of neutral evolution) where all 
sites are assumed to be either under negative (ω <1) or neutral selection (ω = 1) versus M2a (a model 
of positive selection) which in addition to the site classes mentioned for M1a, assumes a third category 
of sites; sites with ω >1 (positive selection) and M7 (b) versus M8 (b and ω), and models that mirror 
the evolutionary constraints of M1 and M2 but assume that ω values are drawn from a b distribution 
(Nielsen and Yang 1998). Only if the alternative models (M3, M2a and M8: allow sites with ω >1) 
show a better fit in Likelihood Ratio Test (LRT) relative to their null models (M0, M1a and M7: do 
not allow sites ω >1), are their results considered significant. LRT is estimated as twice the difference 
in maximum likelihood values between nested models and compared with the c2 distribution with 
the appropriate degree of freedom - the difference in the number of parameters between the two 
models. The Bayes empirical Bayes (BEB) approach (Yang et al. 2005) was used to identify codon 
sites under positive selection by calculating the posterior probabilities that a particular amino acid 
belongs to a given selection class (neutral, conserved or highly variable). Sites with greater posterior 
probability (PP ≥ 95%) of belonging to the ‘ω > 1 class’ were inferred to be positively selected.
Fast, Unconstrained Bayesian AppRoximation (FUBAR) approach implemented in 
HyPhy (Pond et al. 2005; Murrell et al. 2013) was employed to provide additional support to 
the aforementioned analyses and to detect sites evolving under the influence of pervasive 
diversifying and purifying selection. Mixed Effects Model Evolution (MEME) (Murrell et al. 
2012) was also used to detect episodic diversifying selection. We utilised the branch-site REL 
test (Kosakovsky Pond et al. 2011) to detect lineages in scorpion toxin phylogenies that evolve 
under the influence of episodic adaptation. To derive further support for the sites detected as 
positively selected by the nucleotide-level selection analyses, we employed a complementary 
protein-level approach implemented in TreeSAAP (Woolley et al. 2003). To clearly depict the 
proportion of sites under different regimes of selection, an evolutionary fingerprint analysis 
was carried out using the ESD algorithm implemented in datamonkey (Pond et al. 2010).
Structural analyses
To depict the natural selection pressures influencing the evolution of various three-finger toxins, 
we mapped the sites under positive selection on the homology models created using Phyre 2 webserver 
(Kelley and Sternberg 2009). Pymol 1.3 (DeLano 2002) was used to visualize and generate the images 
of homology models. Consurf webserver (Armon et al. 2001) was used for mapping the evolutionary 
selection pressures on the three-dimensional homology models. GETAREA (Fraczkiewicz and Braun 
1998) was used to calculate the Accessible Surface Area (ASA) or the solvent exposure of amino-acid 
side chains. It uses the atom co-ordinates of the PDB file and indicates if a residue is buried or exposed 
to the surrounding medium by comparing the ratio between side chain Accessible Surface Area (ASA) 
and the “random coil” values per residue. An amino-acid is considered to be buried if it has an ASA 
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less than 20% and exposed if ASA is more than or equal to 50%. When ASA ratio lies between 40%-
50%, it is highly likely that the residues have their side chains exposed to the surrounding medium.
6.1.4 Results and Discussion
Transcriptomics of scorpion venom-glands highlights the true diversity of scorpion venom-
arsenal
Assembly details [number of sequences, total number of bases, average sequence length and 
number of contigs and assembled bases (average per contig)] are as follows: Australobuthus xerlomnion 
53510, 20833026, 389, 3531, 1962322 (556); Cercophonius squama 59174, 21515356, 363, 2733, 
1531957 (561); Isomteroides vescus IvGS, 65490, 22911959, 349, 2856, 1572328 (551); Lychas buchari 
75950, 27265869, 358, 5534, 3402763 (615); and Urodacus manicatus UmGS 76540, 26715502, 
349, 6884, 4043703 (587). BLAST searches revealed the transcriptomes to contain a myriad of 
peptides and proteins. Public access of the data can be found at the National Center for Biotechnology 
Information (NCBI) under bioprojects: Australobuthus xerlomnion PRJNA201348; Cercophonius 
squama PRJNA201349; Isometroides vescus PRJNA201350; Lychas buchari PRJNA201351; 
Urodacus manicatus PRJNA201352. Sequenced analysed in this study have the accession 
numbers of: Australobuthus xerlomnion GALG01000001-GALG01000002; Cercophonius squama 
GALH01000001-GALH01000013; Isometroides vescus GALK01000001-GALK01000018; Lychas 
buchari GALL01000001-GALL01000032; Urodacus manicatus GALI01000001-GALI01000019.
For the purpose of this study we focused upon the wide diversity of peptide toxin types (Table 
6.1.1). We obtained novel sequences from three families of linear toxin peptides (cytotoxic, anionic 
and glycine-rich): i) the first cytotoxin peptide sequences from members of the Bothriuridae family 
(3 from Cercophonius squama) and the Urodacidae family (5 from Urodacus manicatus); ii) the first 
anionic peptide sequences from a member of the Urodacidae family (1 from Urodacus. manicatus), as 
well as additional isoforms from Bothriuridae (1 from Cercophonius squama) and Buthidae (3 from 
Isometroides vescus and two from Lychas buchari) which like other members of this peptide type, had 
extremely negative charges (pI 2); and iii) the first glycine-rich peptide sequence from a member of 
the Urodacidae family (1 Urodacus manicatus), which also represents the first sequences from a non-
buthid scorpions, as well as additional Buthidae isoforms (4 from Lychas buchari). In addition, we were 
able to retrieve the first DDH sequences from a member of the Urodacidae family (3 from Urodacus 
manicatus), and the first SV-SVC sequences from members of the Bothriuridae family (2 from 
Cercophonius  squama) in addition to additional Buthidae SV-SVC isoforms (3 from Lychas buchari). 
We also recovered an extensive array of CSa/b isoforms: 1 from Australobuthus xerlomnion; 6 from 
Cercophonius squama; 8 from Isometroides vescus; 16 from Lychas buchari; and 4 from Urodacus manicatus.
Implications for the origin and evolution of scorpion toxin scaffolds 
Sequence alignments and Bayesian phylogenetic analyses were employed to 
reconstruct the complex molecular evolutionary histories of the different scorpion peptide 
toxins, which revealed several fascinating results regarding their origin and diversification.
Apotypic (derived) NaV-CSa/b scaffolds
Consistent with the scorpion organismal evolutionary history, phylogenetic analyses in this 
study revealed that some non-buthid three-disulphide bond NaV-CSa/b sequences were plesiotypic 
relative to buthid NaV-CSa/b (Figure 6.1.1). However, reflective of the early derivation of NaV-
CSa/b within scorpion venom prior to the splitting off of the Buthidae family, the 3 disulphide 
bond containing NaV-CSa/b were not reciprocally monophyletic between non-buthid and buthid 
species. As scorpion CSa/b peptides evolved from a six cysteine defensin peptide (Froy and Gurevitz 
2003; Rodríguez De La Vega and Possani 2005), this is consistent with our phylogenetic results 
that the 3 disulphide bond NaV-CSa/b are plesiotypic to the 4 disulphide bond containing a- 
and b-NaV-CSa/b toxins. Since the three disulphide bonded plesiotypic-NaV-CSa/b and the four 
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disulphide bonded apotypic b-NaV-CSa/b toxins share the site-4 activity, this indicates that this is 
the plesiotypic functional activity of the NaV-CSa/b, with our phylogenetic results thus consistent 
with previously proposed functional evolution theories in this regard (Rodríguez De La Vega 
and Possani 2005; Bosmans and Tytgat 2007). Thus the site-3 activity of the the a-NaV-CSa/b 
(which are stabilised by four disulphide bonds like the b-NaV-CSa/b) is functionally apotypic. 
Figure 6.1.1
Legend: Bayesian phylogenetic reconstruction of the NaV-CS a/b clade. 
Outgroups were the KV-CSa/b Q0GY40 Hadrurus gertschi and Q95NK7 
Mesobuthus martensi. *Chaerilus tricostatus contig sequence is from He et al. 2013.
Within the apotypic lipolytic group, the novel non-buthid sequences of this type rendered 
the buthid sequences non-monophyletic, thus indicating that this apotyposis within the NaV-
CSa/b is early evolving prior to the splitting off of buthid scorpions. The lipolytic have a newly 
evolved 7th cysteine (located in the C-terminal region), thus giving an odd-number of cysteines 
and consequently promoting dimerization. The non-buthid sequences within the lipolytic clade 
Anuroctonus phaiodactyl (Q5MJP3, Q5MJP4 and Q5MJP5) have a newly evolved 8th cysteine 
located in the C-terminal region and thus have an even number of cysteines (Figure 6.1.1). In 
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the related non-buthid sequence form Urodacus manicatus (CSa/b-Uro-1), which shares this 
new cysteine with A. phaiodactyl sequences, an additional cysteine has been evolved, while 
a plesiotypic cysteine has been deleted. Thus the odd number of cysteines in this toxin type 
could consequently promote unique dimerization combinations. In contrast, the common 
ancestor of the a-NaV-CSa/b and b-NaV-CSa/b forms evolved two new cysteines with one in 
the C-terminal region and one located in the N-terminal region (Figure 6.1.1). Despite having 
evolved a novel cysteine residue in the C-terminal region, the lipolytic NaV-CSa/b and the a- 
and b-NaV-CSa/b clades lack sequence similarity and form reciprocally non-monophyletic clades, 
suggesting that the two toxin types have independently evolved the additional cysteine residue. 
SV-SVCs: the plesiotypic ICK-DDH scaffold
Although there have been suggestions in the past that the three-disulphide bond ICK fold 
has originated from the simpler, two-disulphide bond DDH scaffolds (Wang et al. 2000; Smith 
et al. 2011), phylogenetic investigations to unravel the precise evolutionary origin of ICK and 
DDH scaffolds remain unattempted to date. Our Bayesian molecular phylogenetic reconstructions 
of these toxin types were particularly intriguing. We not only documented additional forms 
sequenced from our libraries of both the DDH type and the ICK type, but we also investigated 
the link between SV-SVC peptides (scorpion venom single von Willebrand factor C-domain 
peptides) and the DDH and ICK peptides. The results of our phylogenetic reconstructions and 
sequence alignments clearly highlight the evolutionary origin of DDH and ICK sequences from 
the SV-SVC peptides (Figures 6.1.2-6.1.4). The SV-SVC as the plesiotypic state for this entire 
clade is supported by this cysteine framework being widely distributed within arthropods (Zeng 
et al. 2013), in comparison to the conspicuous absence of likely ancestral non-toxin arthropod 
forms of the ICK or DDH motifs. Hence, we rooted our tree using related arthropod non-
toxin sequences that have been shown to be homologues of the SV-SVC (Zeng et al. 2013). It is 
noteworthy that SV-SVC have been retrieved from both buthid and non-buthid scorpion lineages, 
which is consistent with our single early evolution hypothesis. Similarly the SV-SVC apotypic 
forms (ICK and DDH) have been retrieved from both buthid and non-buthid venoms, indicative 
of their apotyposis occurring before the buthid split at the base of the scorpion evolution tree.
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Figure 6.1.2
Legend: Bayesian phylogenetic reconstruction of the SV-SVC, ICK and DDH clade. 
Outgroups were the non-toxin SVC peptides B4M772 Drosophila virilis and B4NQ53 
Drosophila willistoni. *SmpIT2 Scorpio maurus palmatus is from Lazarovici et al. 1982.
While the DDH peptides have been proposed to be the plesiotypic state, with the ICK as a 
apotypic state (Smith et al. 2011), our results instead indicate that the DDH are actually a highly 
apotypic condition, phylogenetically nested within the ICK peptides, with the SV-SVC being the 
plesiotypic state and, as would be expected, are non-monophyletic relative to the DDH/ICK (Figure 
6.1.2). The differences in cysteine pattern can be interpreted as a step-wise loss due to domain-
deletions (Figures 6.1.3 and 6.1.4), which is consistent with the mapping of the known activities. 
While the SV-SVC are functionally uncharacterised, despite accounting for the majority of the 
venom in some species (Miyashita et al. 2007), the ICK and DDH both target and activate the 
ryanodine receptor intracellular calcium release channel. In tests on mammalian receptors with 
the DDH more potent in action than the ICK peptides (Smith et al. 2013). While the effects 
upon insect receptors remains unknown, the higher degree of potency of the DDH peptides on 
mammalian receptors in comparison to the ICK peptides (Smith et al. 2013) is in agreement 
with our proposed evolutionary model, as selection pressure is likely to produce a more refined 
and potent form of a framework with a useful activity. The relative conservation of toxin binding 
and activity between insect and mammalian ryanodine receptors in has not been elucidated and 
Molecular evolution of venoM  
thus the potency patterns may shift in testing of insects (the prey item and thus the evolutionarily 
selected target). However, the functional pattern is consistent with molecular evolution patterns 
seen in other venoms such as exendin peptides in Heloderma venoms, where selection pressure 
has resulted in more potent cardiotoxic forms with apotypic sequence motifs (Fry et al. 2010) and 
also in the elapid snake venom 3FTx (three finger toxin) where selection pressure has resulted in 
more potent alpha-neurotoxic forms which lack two of the plesiotypic cysteines (Fry et al. 2003).
Figure 6.1.3
Legend: SV-SVC, ICK and DDH sequence alignment: 1. D2CFI7 Mesobuthus martensii; 2. C5J895 
Opisthacanthus cayaporum; 3. K7WMX6 Heterometrus spinifer; 4. GALH01000011 Cercophonius 
squama; 5. L0GCJ1 Urodacus yaschenkoi; 6. E4VP44 Mesobuthus eupeus; 7. GALL01000029 Lychas 
buchari; 8. P60253 Opistophthalmus carinatus; 9. Q8I6X9 Mesobuthus martensii; 10. B8XH22 
Buthus occitanus israelii; 11. F1CIZ6 Buthotus judaicus; 12. GALI01000016 Urodacus manicatus; 
13. C5J894 Opisthacanthus cayaporum; 14. GALI01000015 Urodacus manicatus; 15. P0DJ08 
Liocheles waigiensis. Signal peptide is shown in lowercase, propeptide in underlined lowercase.
In addition to our suggestion that the DDH are ICK derivatives and the ICK are in turn 
derivatives of the SV-SVCs, we propose another alternative view of another aspect of their complex 
molecular evolutionary history. DDH and ICK differ by the number of cysteines, and thus 
disulphide bonds, with DDH having four cysteines and two disulphide bonds and ICK having 
six cysteines and three disulphide bonds. Of the shared cysteines, it has been previously proposed 
that they differ by the relative presence of the first and fourth of the ICK cysteines (Horita et 
al. 2011; Smith et al. 2011; Smith et al. 2013). However, we propose an alternate scenario that 
the DDH and ICK differ by the relative presence of the third and sixth ICK cysteine (scenario 
2 in Figure 6.1.4). This scenario is more consistent in regards to the relative presence of charged 
resides. It should be noted, that it does not affect the relative structure of DDH toxins, but 
merely proposes an alternate evolutionary history of the cysteines shared between the DDH 
and ICK in regards to which ICK cysteines were deleted in the derivation to the DDH form.
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Figure 6.1.4
Legend: The two alternate scenarios of the cysteine relationships between DDH and ICK 
peptides. Sequences presented: 1. B8QG00 Hadrurus gertschi; 2. P59868 Pandinus imperator; 
3. B8XH22 Buthus occitanus israel; 4. P0DJL0 Isometrus maculatus; 5. P0C5F2 Liocheles 
australasiae; 6. F8W670 Liocheles australasiae; 7. GALI01000016 Urodacus manicatus; 8. C5J894 
Opisthacanthus cayaporum; 9. GALI01000015 Urodacus manicatus; 10. P0DJ08 Liocheles waigiensis; 
11. SmpIT2 Scorpio maurus palmatus (Lazarovici et al. 1982) and 12. GALI01000017 Urodacus 
manicatus. ICK connectivity schematic image adopted from (Smith et al. 2011). Scenario 
1 is that proposed previously (Horita et al. 2011; Smith et al. 2011; Smith et al. 2013) while 
scenario 2 is the alternative proposed in this study to better reflect charge molecule distribution.
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Putative common origin of cytotoxic peptides 
Our analyses suggested that the cytotoxic peptides [classified by the uniprot database 
into bradykinin potentiating peptides (BPP), linear non-disulphide bridged peptide 
(NDBP; referred to as linear henceforth) and short cationic antimicrobial peptide (AMP)] 
could have originated via a single early recruitment event. Despite the variations in 
sequences between the three clades (Figure 6.1.5), in all variants the posttranslationally 
liberated antimicrobial peptides formed well-developed alpha-helices (Figure 6.1.6).
Figure 6.1.5
Legend: Sequence alignment of cytotoxic linear peptides: 1. GALK01000016 Isometroides 
vescus; 2. GALK01000016 Isometroides vescus; 3. GALL01000023 Lychas buchari; 4. D9U2B7 
Lychas mucronatus; 5. Q9Y0X4 Mesobuthus martensii; 6. C9X4J0 Tityus discrepans; 7. P0CF38 
Isometrus maculatus; 8. P83312 Parabuthus schlechteri; 9. Q9GQW4 Mesobuthus martensii; 10. 
B8XH50 Buthus occitanus israelii; 11. I0DEB4 Vaejovis mexicanus smithii; 12. GALH01000010 
Cercophonius squama; 13. P0C8W1 Hadrurus gertschi; 14. C5J886 Opisthacanthus cayaporum; 
15. P0DJ03 Heterometrus petersii; 16. L0GCV8 Urodacus yaschenkoi; 17. P0DJO3 Scorpiops 
tibetanus; 18. GALH01000009 Cercophonius squama; 19. GALI01000003 Urodacus manicatus; 20. 
GALI01000004 Urodacus manicatus; 21. GALI01000007 Urodacus manicatus; 22. GALI01000005 
Urodacus manicatus; 23. GALH01000008 Cercophonius squama; 24. linear GALI01000006 
Urodacus manicatus; 25. L0GCI6 Urodacus yaschenkoi; 26. H2CYR5 Pandinus cavimanus; 27. 
G8YYA6 Androctonus amoreuxi; 28. B9UIY3 Lychas mucronatus; 29. GALL01000021 Lychas 
buchari; 30. GALK01000015 Isometroides vescus; 31. Q5G8B3 Tityus costatus; 32. E4VP60 
Mesobuthus eupeus; 33. Q5G8B5 Tityus costatus; 34. D9U2B8 Lychas mucronatus; 35. C7B247 
Isometrus maculatus; 36. G1FE62 Chaerilus tricostatus; 37. GALL01000022 Lychas buchari. 
Signal peptide and C-terminal cleaved propeptides are shown in lowercase. BPP domain 
shown in black and the cytotoxic posttranslationally processed peptide is highlighted in gray.
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Figure 6.1.6
Legend: Mid-point rooted bayesian phylogenetic reconstruction of the cytotoxic linear 
peptides. *Chaerilus tricostatus and C. tryznai contig sequences are from He et al. 2013.
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In addition to the conserved alpha-helix secondary structure (Miyashita et al. 2010; Cao et al. 
2012; Zeng et al. 2012), the cytolytic domain is characterised by extremely high pI values, with all 
forms having PI a value that exceeds 8.5. PI value of this domain the BPP clade approached 10.5. 
As these toxins have been shown to be lethal and synergistically enhance the excitatory effects of 
CSa/b ion-channel-specific neurotoxins by interaction with the neuronal membranes (Verdonck 
et al. 2000; Moerman et al. 2002; Willems et al. 2002; Moerman et al. 2003; Willems et al. 2004; 
Miyashita et al. 2010; Zeng et al. 2012), we consider any antimicrobial activity attributed to them 
in laboratory investigations (but without supporting natural history data) to be an incidental 
activity as a consequence of the powerful cytotoxicity, rather than an evolutionarily selected activity. 
This is in contrast to the alpha-helical frog antimicrobial peptides which play a protective role 
on the moist skin of frog, which is constantly targeted by microbial infections (Roelants et al. 
2013). The scorpion cytolytic peptides probably aid in external digestion through cytotoxicity. The 
cytolytic domain in BPP-type is followed by a highly variable in C-terminal region random-coil 
domain, which is probably responsible for the additional activity of bradykinin potentiation. We 
propose the name CYLIP (cytotoxic linear peptide) to refer to the collective group of these peptides.
Unravelling the dynamic molecular evolution of scorpion toxins
Site-specific models, implemented in codeml of PAML package (Yang 2007), failed to detect 
the influence of positive selection on the evolution of most scorpion toxin types (Tables 6.1.2 
and 6.1.3; Figure 6.1.7). Only the plesiotypic NaV-CSa/b toxins were found to be positively 
selected, having an overall omega of more than 1 (ω=1.63; 6 positively selected sites; Table 6.1.2). 
Although widely used for selection assessment, most computational analyses are known to be 
influenced by sequence divergence in datasets (Yang and Nielsen 1998; Anisimova et al. 2002; 
Reboiro-Jato et al. 2012) and often fail to detect episodic adaptations (Murrell et al. 2012). Not-
surprisingly, site-specific assessments were only able to detect a handful of positively selected sites 
in very few CSa/b toxins: 6 in the plesiotypic-NaV-CSa/b; 2 in the lipolytic-NaV-CSa/b; 5 in 
the a-NaV-CSa/b; 4 in the b-NaV-CSa/b; and 2 in the ClV-CSa/b) (Table 6.1.2; Figure 6.1.7).
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Figure 6.1.7
Legend: Molecular evolution of scorpion toxins. Three dimensional homology models of 
various scorpion CSa/b and non-CSa/b toxins, depicting the locations of positively selected 
sites are presented. Site-model 8 computed omega and the total number of positively selected 
sites detected by its Bayes Empirical Bayes (BEB) approach (PP ≥ 0.95) are indicated, along 
with the number of episodically diversifying sites detected by MEME (at 0.05 significance).
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Table 6.1.2 Molecular evolution of scorpion CSa/b toxins
FUBARa MEMEb BSRc PAMLd
M8 M2a
Plesiotypic
NaV-CSa/b
ω>1e : 2
ω<1f : 11
5
(6.3%)
6 5
4 (3+3) (3+2)
1.63 1.76
Lipolytic
NaV-CSa/b
ω>1e : 0
ω<1f : 20
2
(2.0%)
2 5
1 (2+0) (2+3)
0.76 1.28
a-NaV-CSa/b
ω>1e : 5
ω<1f : 33
 19
(22.0%)
5 5
14 (0+5) (1+4)
0.54 0.80
b-NaV-CSa/b
ω>1e : 0
ω<1f : 37
18
(22.2%)
4 8
16 (2+2) (6+2)
0.53 1.03
Long-KV-CSa/b
ω>1e : 0
ω<1f : 51
8
(8.4%)
1 1
1 (0+1) (1+0)
0.30 0.97
Short-KV-CSa/b
ω>1e : 1
ω<1f : 26
3
(5.0%)
0
1
1 (1+1)
0.40 0.95
ClV-CSa/b
ω>1e : 0
ω<1f : 10
5
(8.3%)
2
0
2 (0+2)
0.60 0.62
NaV: Sodium ion-channel   KV: Potassium ion-channel   ClV: Chloride ion-channel
Legend
a: Fast Unconstrained Bayesian AppRoximation
b: Sites detected as experiencing episodic 
diversifying selection (0.05 significance; 
percentage indicated in paranthesis) by the 
Mixed  Effects Model Evolution (MEME).
c: Number of branches detected by the branch-
site REL (Random effects likelihood) test as 
episodically diversifying
d: Positively selected sites detected by the Bayes 
Empirical Bayes approach implemented in 
M8 and M2a. Sites detected at 0.99 and 0.95 
significance are indicated in the parenthesis
e: number of sites under pervasive diversifying 
selection at the posterior probability ≥0.9 
(FUBAR)
f: Number of sites under pervasive purifying 
selection at the posterior probability ≥0.9 
(FUBAR)
ω: mean dN/dS
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In contrast, no positively selected sites were detected in any of the non-CSa/b toxins. Moreover, 
the computed ω values for the non-CSa/b toxins were extremely low and ranged from 0.14-0.34 
(Table 6.1.3), indicating the significant role of negative selection in the evolution of non-CSa/b toxins.
Table 6.1.3 Molecular evolution of scorpion non-CSab toxins
FUBARa MEMEb BSRc PAMLd
M8 M2a
ω>1e : 2
ω<1f : 32
3
(2.6%)
0 0
SV-SVC 0
0.34 0.68
ICK
ω>1e : 0
ω<1f : 12
0
(0%)
0 0
0
0.34 0.49
DDH
ω>1e : 0
ω<1f : 6
1
(1.3%)
0 0
0
0.32 0.32
AMP
CYLIP
ω>1e : 1
ω<1f : 34
2
(2.7%)
1
0
0 (0+1)
0.33 0.34
Linear
CYLIP
ω>1e : 0
ω<1f : 45
3
(4.4%)
0 0
0
0.27 0.42
Bradykinin
CYLIP
ω>1e : 0
ω<1f : 36
2
(2.4%)
0 0
0
0.20 0.22
Anionic
ω>1e : 0
ω<1f : 33
0
(0%)
0 0
0
0.22 0.27
Glycine-rich
ω>1e : 0
ω<1f : 22
1
(0.9%)
0 0
1
0.14 0.35
SV-SVC: Scorpion venom-single von Willebrand factor C-domain   ICK: Inhibitor cysteine knot
DDH: Disulfide-directed b-hairpin   AMP: Antimicrobial peptide
CYLIP: Cyclic linear peptide
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Legend
a: Fast Unconstrained Bayesian AppRoximation
b: Sites detected as experiencing episodic 
diversifying selection (0.05 significance; 
percentage indicated in paranthesis) by the 
Mixed  Effects Model Evolution (MEME).
c: Number of branches detected by the branch-
site REL (Random effects likelihood) test as 
episodically diversifying
d: Positively selected sites detected by the Bayes 
Empirical Bayes approach implemented in 
M8 and M2a. Sites detected at 0.99 and 0.95 
significance are indicated in the parenthesis
e: number of sites under pervasive diversifying 
selection at the posterior probability ≥0.9 
(FUBAR)
f: Number of sites under pervasive purifying 
selection at the posterior probability ≥0.9 
(FUBAR)
ω: mean dN/dS
We further employed Fast, Unconstrained Bayesian AppRoximation [FUBAR (Murrell et al. 
2013)], which supersedes methods such as Single Likelihood Ancestor Counting (SLAC), Fixed 
Effects Likelihood (FEL) and Random Effects Likelihood (REL) (Kosakovsky Pond et al. 2005), and 
detects sites evolving under the influence of pervasive diversifying and purifying selection pressures. 
FUBAR detected very few sites in both CSa/b and non-CSa/b scorpion toxin types (Tables 6.1.2 and 
6.1.3). Subsequently, additional support for the sites detected as positively selected by the nucleotide-
specific analyses and the radicalness of non-synonymous replacements at these hypermutable sites 
was assessed by utilising an amino acid-level selection assessment method implemented in TreeSAAP 
(Woolley et al. 2003), which measures selective inﬂuences on 31 structural and biochemical amino 
acid properties. Using this complementary nucleotide and amino acid-level approach, we were able 
to identify several sites in most CSa/b toxins as accumulating radical amino acid replacements 
(Table 6.1.4), which can alter the fitness of the organism by influencing toxin structure and function.
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Table 6.1.4 Nucleotide and complementary amino acid-level selection assessment of CSa/b 
toxins
Site CodeML TreeSAAP ASA
Codon AA M2aa M8b Propertyc Magnituded
Plesiotypic NaV-CSa/b
33 D
5.858±1.374 4.775±1.168
Pb, aC 7, 8 -(0.997)** (0.998)**
42 N
5.752±1.531 4.726±1.233
V0 6 -
(0.975)* (0.986)*
47 K
5.827±1.427 4.761±1.189
V0 6 -
(0.990)** (0.995)**
51 D
5.703±1.587 4.707±1.253
V0 6 -
(0.966)* (0.982)*
65 Y
5.870±1.356 4.78±1.162
Pb, V
0, aC, ESM 7, 6, 6, 6 -(0.999)** (0.999)**
75 D
5.580±1.740 4.643±1.331
Pb 7 -(0.941) (0.966)*
Lipolytic NaV-CSa/b
61 H
4.678±0.900 3.042±0.857
- - -
(1.000)** (0.997)**
81 S
4.672±0.914 3.026±0.867
aC 6 -(0.998)** (0.991)**
a NaV-CSa/b
29 E
2.427±0.324 1.471±0.136
pHi, El , Mv, aC, ESM 8, 8, 7, 7, 6
74.0
(0.952)* (0.950)* Exposed
40 E
2.463±0.233 1.473±0.133
pHi, El, Mv, aC , ESM 8, 8, 7, 7, 6
63.2
(0.976)* (0.955)* Exposed
59 G
 2.464±0.232 1.478±0.121
Mv, ESM 7, 6
100.0
(0.977)* (0.962)* Exposed
61 K
2.491±0.122 1.492±0.083
El , Mv, ESM 8, 7, 6
74.4
(0.994)** (0.985)* Exposed
85 R
2.439±0.297 1.472±0.135
Mv 7, 6 -
(0.960)* (0.952)*
b NaV-CSa/b
27 S
2.500±0.001 1.498±0.035
Pa, K
0, pK! 6, 6, 8
100.0
(1.0)** (0.996)** Exposed
39 E
2.500±0.005 1.487±0.084
Pa, K
0 6, 8
76.9
(1.0)** (0.978)* Exposed
43 K
2.500±0.001 1.497±0.043
Pa, K
0 6, 8
71.8
(1.0)** (0.994)** Exposed
72 L
2.500±0.003 1.493±0.062
K0, pK!, F 8, 8, 8
83.1
(1.0)** (0.988)* Exposed
ClV-CSa/b
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Site CodeML TreeSAAP ASA
27 P
1.833±0.844 1.521±0.223
aC , Ra 6, 7
36.0
(0.814) (0.984)* NA
53 Y
1.792±0.963 1.508±0.244
Ra 7
100.0
(0.737) (0.966)* Exposed
Amino-acid property symbols used: a-helical tendencies (Pa), b-structure tenden-
cies (Pb), Compressibility (K
0), Equalibrium constant (ionization of COOH) (pK1), Isoelec-
tric point (pHi), Long-range n.b. energy (El), Mean R.M.S fluctuation displacement (F), Mo-
lecular volume (Mv), Partial specific volume (V0), Power to be at the C-terminus of a-helix 
(aC), Short and medium-range n.b. energy (Esm) and Solvent accessible reduction ratio (Ra).
Legend:
a: M2a Bayes Empirical Bayes (BEB) posterior 
probability (* ≥ 0.95; ** ≥ 0.99) and post-mean 
omega indicated in brackets
b: M8 Bayes Empirical Bayes (BEB) posterior 
probability (* ≥ 0.95; ** ≥ 0.99) and post-mean 
omega indicated in brackets
c: amino acid property under selection
d: magnitude of selection on the amino acid 
property
ASA: Accessible surface area (50% ≥ Side chains 
completely exposed; 20% ≤ Side chains buried)
Part. exposed: Partially exposed side-chains 
(ASA: 40%-50%)
Sites detected as positively selected by both 
nucleotide and amino acid-level analyses are 
indicated in bold.
Evolutionary fingerprint analyses highlighted a small proportion of sites in plesiotypic-NaV-
CSa/b, a-NaV-CSa/b and ClV-CSa/b as evolving under the influence of positive selection, while a 
major proportion of sites in all other CSa/b and non-CS-a/b toxin types were depicted as evolving 
under the strong influence of negative selection (Appendices 6.1.1 and 6.1.2). We also employed 
the Branch-site REL test (Kosakovsky Pond et al. 2011) to identify lineages that have experienced 
episodic bursts of adaptive selection. This test detected several branches in CSa/b scorpion toxin 
lineages as evolving under the influence of episodic diversifying selection pressures (plesiotypic-NaV-
CSa/b: 4; lipolytic-NaV-CSa/b: 1; a-NaV-CSa/b: 14; b-NaV-CSa/b: 16; long-KV-CSa/b: 1; short-
KV-CSa/b: 1; and ClV-CSa/b: 2; Table 6.1.2). In contrast, this test failed to identify episodically 
diversifying branches in all but glycine-rich (n=1) non-CSa/b scorpion toxin lineages (Table 6.1.3), 
further highlighting that these toxins evolve under the strong influence of negative selection.
It should be noted that site-specific assessments assume that the strength of selection remains 
constant across all lineages over time, which is not always biologically justified, and fail to identify 
rapidly evolving sites when a large number of sites follow the regime of negative selection (Murrell 
et al. 2012). In contrast, genes could experience episodic bursts of adaptive selection pressures 
(Murrell et al. 2012). Scorpions are well known for their low dispersal rate and have evolved over 400 
million years (Dunlop and Selden 2009). Combined with rapid time to sexual maturity, the toxin-
encoding genes responsible for scorpion venom arsenal have greatly diversified over long periods of 
evolutionary time. Therefore to address these shortcomings, we employed the Mixed Effects Model 
Evolution (MEME), which is known to reliably and accurately capture the molecular footprints of 
both episodic and pervasive diversifying selection (Murrell et al. 2012). MEME identified a large 
number of episodically diversifying sites in most scorpion CSa/b toxins: 5 (6.3% sites) in plesiotypic-
NaV-CSa/b; 2 (2% sites) in lipolytic-NaV-CSa/b; 19 (22% sites) in a-NaV-CSa/b; 18 (22.2% sites) 
in b-NaV-CSa/b; 8 (8.4% sites) in long-KV-CSa/b; 3 (5.0% sites) in short-KV-CSa/b; and 5 (8.3% 
sites) in ClV-CSa/b (Table 6.1.2; Figure 6.1.7), and thus indicated that episodic adaptive selection 
pressures sculpt CSa/b toxin scaffolds in scorpions. In contrast, this test failed to detect any episodically 
diversifying sites in ICK and Anionic toxin types and detected very few episodically diversifying sites 
in non-CSa/b toxins: 3 (2.6% sites) in SV-SVC; 1 (1.3% sites) in DDH; 2 (2.7% sites) in ‘AMP’ type 
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CYLIP; 3 (4.4% sites) in ‘Linear’ type CYLIP; 2 (2.4% sites) in ‘BPP’ type CYLIP; and 1 (0.9% sites) 
in Glycine-rich peptides (Table 6.1.3; Figure 6.1.7). Thus, both site-specific assessments and MEME 
suggested that non-CSa/b toxins have evolved under the extreme influence of negative selection.
Thus, although the widely used conventional site-specific methods for identifying the nature of 
selection, failed to detect the influence of positive Darwinian selection on the evolution of scorpion 
venom, state-of-art molecular evolutionary assessments (MEME and BSR test) that are designed 
to overcome the shortcomings of site-specific methods detected numerous positively selected sites 
in CSa/btoxins (particularly: a-, b-, plesiotypic NaV-, long-KV- and ClV-CSa/b) as evolving under 
episodic bursts of selection and highlighted the dynamic molecular evolution of scorpion venom. 
It is noteworthy that not all CSa/b toxins appear to have undergone rapid evolution. Selection 
analyses (Table 6.1.2) in this study detected very few episodically diversifying sites in the lipolytic 
(2% sites) and short-KV-CSa/b toxins (5% sites), which could be a result of non-specific action 
of these toxins or the fact that they target non-plastic molecular targets in the prey. Similarly, 
these highly sensitive methods failed to detect the influence of positive selection on the evolution 
of linear non-CSa/b toxins (0-4% of sites; Table 6.1.3), which are secreted in large quantities 
by the non-buthid scorpion lineages. Thus, genes encoding non-CSa/b toxins appeared to have 
followed the regime of negative selection. Unlike their homologues in spiders and cone snails, 
scorpion ICKs are known to target a limited number of ion-channels (Ca2+ and K+). Since scorpions 
have recruited a diversity of scaffolds to target K+ ion-channels, it has been theorized that scorpion 
ICK peptides targeting K+ ion-channels could exhibit weak potency (Gao et al. 2013). Therefore, 
ICKs are considered to play only an ancillary role in scorpion envenoming. Surprisingly, selection 
assessments conducted in this study revealed that ICK toxins have evolved under extreme constraints 
of negative selection. The lack of variation in their coding sequences, despite the fact that they have 
evolved over many millions of years, suggests that they probably play an important role in scorpion 
venom arsenal. The lack of variation in their coding sequences probably suggests that they attack 
extremely well conserved molecular targets, and as a result, are not involved in an evolutionary arms 
race. The fact that scorpions have recruited several toxin scaffolds to target KV ion-channels could 
have also lead to a decreased selection pressure for accumulating variations in KV targeting toxins.
Focal mutagenesis shapes the molecular evolution of scorpion CSa/b toxin families 
The state-of-art molecular selection assessments presented in this study clearly highlight the 
significant role of point-mutations, which episodically accumulate under the influence of positive 
Darwinian selection, in sculpting the diversity of CSa/b scorpion toxins. We have previously 
postulated that focal-mutagenesis favour the accumulation of point mutations in certain regions of 
predatory toxins, such as the molecular surface, loops, etc. (Sunagar et al. 2012; Brust et al. 2013; Low 
et al. 2013; Ruder et al. 2013). As a result of this intriguing evolutionary phenomenon, a diversity of 
residues are generated on the molecular surface of the toxin, which can interact with novel cell receptors 
when injected into prey animals. Despite favouring accumulation of variations, focal-mutagenesis 
ensures conservation of structurally and functionally important core residues in enzymatic toxins. 
Synthesis and secretion of venom-components is energetically expensive and hence focal-mutagenesis 
ensures the accumulation of essential variation in venom, while alleviating the risk of secreting 
faulty enzymes. In certain organisms like vampire bats, focal-mutagenesis in venom-components 
can be advantageous as it is likely to delay/prevent the development of immunological resistance in 
the prey by introducing extremely variable toxin surface chemistry in the vampire bat population 
(Low et al. 2013). Evidently, it has been demonstrated that prolonged targeting and feeding of prey-
animals by vampire bats leads to the development of immunological resistance in the prey against 
venom-components like draculin (Delpietro and Russo 2009). We and others have previously noted 
in a diversity of venomous animal lineages - such as, snakes, lizards, coleoids (cuttlefish, octopus and 
squid), vampire bats, etc., that predatory venom-components evolve through focal-mutagenesis (Kini 
and Chan 1999; Sunagar et al. 2012; Brust et al. 2013; Low et al. 2013; Ruder et al. 2013). Mapping 
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of mutations on the three-dimensional structures and computation of accessible surface area for 
scorpion CSa/b toxins revealed that a large proportion of hypermutable sites have accumulated on 
the molecular surfaces: four/five sites in a-NaV-CSa/b; all four sites in b-NaV-CSa/b; and one/two 
sites in ClV-CSa/b; one site each in a-NaV-CSa/b and ClV-CSa/b couldn’t be assigned to exposed/
buried class (Table 6.1.4; Figure 6.1.8). Moreover, amino acid-level selection assessments indicated 
that these non-synonymous replacements introduced radicle changes in the amino acid properties 
on the molecular surface of toxins (Table 6.1.4). Such toxins with extremely variable surface 
chemistry can interact with novel molecular targets of the prey animals. We theorize that this is one 
of the means through which predatory animal toxins neofunctionalize. Clearly, non-synonymous 
replacements that introduce a similar (neutral mutation) or the same amino acid (silent mutation) 
as the ancestral amino acid are least likely to affect the biological fitness of the organism. Therefore, 
such mutations are considered insignificant from an evolutionary perspective. This clearly highlights 
the role of focal-mutagenesis in the evolution of predatory peptide toxins in scorpion lineages.
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Figure 6.1.8
Legend: Surface accessibility of hypermutable sites. A plot of amino acid positions (x-axis) against 
accessible surface area (ASA) ratio (y-axis) indicating the locations of amino acids (exposed or buried) 
in the crystal structure of various scorpion toxins is presented. Positively selected residues are presented 
as large dots, while the remaining sites are presented as small dots in the plot. Residues with an ASA 
ratio greater than 50% are considered to be exposed, while those with an ASA ratio less than 20% are 
considered to be buried to the surrounding medium (ASA of 21%-39%: cannot be assigned to buried/
exposed class; ASA of 40%-50% are likely to have exposed side chains). Three dimensional homology 
models of various scorpion toxin types, depicting the locations of positively selected (PS) sites along with 
model 8 omega values and the number of exposed and buried positively selected sites are also presented.
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6.1.5 Conclusions
We not only unravel the evolutionary origin of major scorpion toxin scaffolds (CSa/b, ICK, 
DDH, linear peptides) for the first time, but we have also highlighted the putative common origin 
of different cytotoxic peptides (AMP, linear and BPP). For the first time, we have discovered the 
plesiotypic form (SV-SVCs) of ICK and DDH toxins. In addition to being a fascinating system 
for molecular evolutionary studies, this documentation of much greater range of complexity than 
previously recognised underscores the tremendous opportunity for biodiscovery within scorpion 
venoms. A large number of toxin clades contain abundant sequences that are either under-investigated 
or remain entirely neglected by toxinological research. For instance, despite being the major venom-
components in some species, peptide types like SV-SVCs remain functionally uncharacterised. 
Similarly, other peptide toxin types, such as anionic and glycine-rich toxins are yet to be functionally 
characterised. Even in the intensely investigated NaV-CSa/b clade, our results clearly demonstrate 
a rich biodiversity far beyond the traditional site-3 and site-4 toxins. In contrast to the molecular 
evolutionary patterns of CSa/btoxins (which are cysteine rich), the linear non-CSa/b peptides were 
shown to be extremely negatively-selected. We hope that our work not only stimulates research interest 
into the complex molecular evolutionary history of scorpion venom peptides from a theoretical 
perspective, but also stimulates investigation into the structure-function relationships and functional 
characterisations of novel peptide clades and their potential utilisation in drug design and development.


6.2
A proteomics and 
transcriptomics investigation 
of the Barychelidae spider
(Trittame loki) 
venom
Peer-reviewed, scientific publications resulting from this chapter.
 257
Chapter VI
6.2.1 Abstract
Although known for their potent venom and ability to prey upon both invertebrate and 
vertebrate species, the Barychelidae spider family has been entirely neglected by toxinologists. In 
striking contrast, the sister family Theraphosidae (commonly known as tarantulas), which last 
shared a most recent common ancestor with Barychelidae over 200 million years ago, has received 
much attention, accounting for 25% of all the described spider toxins while representing only 2% 
of all spider species. In this study, we evaluated for the first time the venom arsenal of a barychelid 
spider, Trittame loki, using transcriptomic, proteomic, and bioinformatic methods. The venom was 
revealed to be dominated by extremely diverse Inhibitor Cysteine Knot (ICK)/knottin peptides, 
accounting for 42 of the 46 full-length toxin precursors recovered in the transcriptomic sequencing. 
In addition to documenting differential rates of evolution adopted by different ICK/knottin 
toxin lineages, we discovered homologues with completely novel cysteine skeletal architecture. 
Moreover, acetylcholinesterase and neprilysin were revealed for the first time as part of the spider 
venom arsenal and Cysteine-rich Secretory Proteins (CRiSP) were identified for the first time in 
mygalomorph spider venoms. These results not only highlight the extent of venom diversification in 
this neglected ancient spider lineage, but also reinstate that unique venomous lineages are rich pools 
of novel biomolecules which may have significant applied uses as therapeutics and/or insecticides.
6.2.2 Introduction
In contrast to “modern” spiders (infraorder Araneomorphae), spider families in the 
infraorder Mygalomorphae have many characteristics that are considered primitive including 
large paraxial fangs, and a complete reliance on book lungs for atmospheric gas exchange 
(King 2004; Bond et al. 2012). The family Barychelidae comprises 44 genera and 307 extant 
species (Platnick 2012) accounting for 11% of all mygalomorphs, making it one of the most 
taxonomically diverse mygalomorph spider families. However, in striking contrast with their 
over 200 million year old sister family Theraphosidae (commonly termed as ‘tarantulas’), 
which is probably the most thoroughly studied spider family with venom gland transcriptomes 
of several species already examined (Yuan et al. 2007; Diego-García et al. 2010; Tang et al. 
2010; Herzig and King 2013), barychelids have so far been entirely neglected by toxinological 
research. Over 200 peptide toxins have been described from theraphosid venoms (accounting 
for 25% of all described spider toxins while representing only 2% of all spider species) 
(Herzig et al. 2011), whereas not even a single barychelid venom has been examined to date. 
Spider venoms in general are complex mixtures of salts, low molecular mass compounds, 
acylpolyamines, peptide toxins, and enzymes (Kuhn-Nentwig 2011; King and Hardy 2013). 
Primitive spider venoms such as those of theraphosids are dominated by cystine-knotted 
peptide toxins (“knottins”) with molecular masses of 3–7 kDa that mainly act as modulators 
of ion channels to provide rapid incapacitation of prey (Klint et al. 2012; Herzig and King 
2013). Since they are closely related to theraphosids with a common ancestor dating back to 
the Triassic (Selden and Penney 2010), one might assume a similar overall composition for 
barychelid venoms. However, it remains to be examined whether barychelid venoms have 
evolved novel peptide-toxin scaffolds and/or novel venom components with new modes of action 
over the 200 million years of independent evolution since their divergence from theraphosids. 
Recently, spider peptide toxins have been suggested as leads for the development of novel 
therapeutics (Saez et al. 2010) and insecticides (Windley et al. 2012). Hence, the identification of 
novel structural scaffolds from barychelid venoms might add to the pool of already known spider 
toxin scaffolds, thereby increasing the chances of selecting useful lead candidates for insecticide and/
or drug development. In order to unravel some of these hidden treasures, we have studied the venom 
gland proteome of the Australian barychelid Trittame loki using a combination of transcriptomic, 
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peptidomic and bioinformatic methods. We present the first toxin sequences from barychelid venom, 
which includes novel cysteine scaffolds, thus providing new insights into the evolution of spider venoms.
6.2.3 Methods
Specimens
Trittame loki specimens were collected from Cairns, Queensland. 
Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) was used to examine the three dimensional shape and 
internal anatomy of the venom glands. Formalin-ethanol fixed heads were first submersed in 
Fomblin (Solvay Solexis) and placed under vacuum to prevent air artefacts. Imaging was performed 
on a 9.4 T vertical 89-mm-bore systems (Bruker BioSpin, Rheinstetten, Germany) with a Bruker 
Micro2.5 gradient system of 1 T/m and transmit/receive birdcage radiofrequency coil with diameter 
of 10–30 mm. Bruker ParaVision 4.0 software was used for image acquisition. Anatomical images 
were acquired using a 3D gradient echo sequence. The field-of-view and matrix were varied to 
fit the individual samples, resulting in voxel sizes between (40)3 mm3 and (70)3 mm3. Imaging 
parameters were: TE = 8 ms, TR = 40 ms, flip angle 200, 4–8 averages. Total scan time was 3–9 
h per sample, depending on size and resolution. Image segmentation of glands was performed 
manually in Amira 4.1 (Mercury Computer Systems Inc.) and 3D surface renderings generated.
cDNA library construction 
Paired venom glands were dissected out and pooled. Total RNA was extracted using the 
standard TRIzol Plus method (In¬vitrogen), and extracts were then enriched for mRNA using 
a RNeasy mRNA mini kit (Qiagen). mRNA was reverse transcribed, fragmented, and ligated to 
a unique 10-base multiplex identifier (MID) tag prepared using standard protocols and applied 
to one PicoTitrePlate (PTP) for simultaneous amplification and sequencing on a Roche 454 GS 
FLX+ Titanium platform (Australian Genome Research Facil-ity). Automated grouping and analysis 
of sample-specific MID reads informatically separated sequences from the other transcriptomes 
on the plates, which were then post-processed to remove low quality sequences before de novo 
assembly into con¬tiguous sequences (contigs) using v 3.4.0.1 of the MIRA software program. 
Assem-bled contigs were processed using CLC Main Work Bench (CLC-Bio) and the Blast2GO 
bioinformatic suite (Gotz, et al. 2011; Gotz, et al. 2008) to provide Gene Ontology, BLAST and 
domain/Interpro annotation. The above analyses assisted in rationalisation of the large numbers of 
assembled contigs into phylogenetic ‘groups’ for detailed phylogenetic analyses as out¬lined below.
Proteomics 
Specimens were anaesthetized using carbon dioxide gas. Polyethylene equipment was used to 
collect and process samples in all cases. Samples were subsequently filtered using 20 Å syringe filters 
to remove large mucoidal strands and then lyophilised. Reduction and alkylation was undertaken by 
redissolving 3 µg of sample in 50 µl of 100 mM ammonium carbonate. 50 µl of 2% iodoethanol/0.5% 
triethylphosphine in acetonitrile was then added to the re-dissolved sample. The reaction mixture was 
incubated for 2 h at 37˚C, before being dried by vacuum centrifugation and re-suspended in 20 µl 
of 2.5% acetonitrile (ACN), 1% formic acid. Additionally, 3 µg of reduced and alkylated sample was 
resuspended in 20 µl of 40 mM ammonium bicarbonate, before being incubated overnight with 750 
ng trypsin. Digestion was stopped by addition of 1 µl of concentrated formic acid. 5 µl (0.75 µg) of 
each sample was processed by LC/MS using a Vydac Everest C18 column (150 mm x 7.5 mm, 5 mm 
particle size, 300 Å pore size) at a flow of 500 ml/min and a gradient of 1–40% solvent B (90% ACN, 
0.1% formic acid) over 25 min coupled with an AB SCIEX 5600 Triple TOF mass spectrometer. MS2 
 259
Chapter VI
spectra were aquired at a rate of 20 scans/sec. MS2 spectra were searched against the translated cDNA 
library using Proteinpilot v4.0 (ABSciex) and further analysed using CLC Main Workbench v6.6.
Phylogenetics 
Toxin sequences were identified by comparison of the translated DNA sequences with those 
of previously characterised toxins using a BLAST search (Altschul et al. 1997) implemented in 
the UniProtKB protein database (http://www.uniprot.org/help/uniprotkb). Phylogenetic analyses 
were conducted not only using the translated amino acid sequences recovered in this study, but 
also those already published, and the molecular evolutionary history of the T. loki ICK peptides 
was reconstructed. All sequences obtained in this study are indicated by their Genbank accession 
numbers (http://www.ncbi.nlm.nih.gov/sites/entrez?db=Nucleotide) and sequences from previous 
studies are referred to by their UniProtKB accession numbers (http://www.expasy.org/cgi-bin/
sprot-search-ful). Resultant sequence sets were aligned using CLC Mainbench, using the default 
algorithm. Sequence alignments are depicted with their leader sequence shown in lowercase and 
cysteines highlighted in bold. Datasets were analysed using a Bayesian inference implemented in 
MrBayes version 3.2.1 (Ronquist et al. 2012) and the command block lset rates = gamma with 
prset aamodelpr = mixed, which enables the program to optimize between nine different amino acid 
substitution matrices, was employed. The analysis was performed by running a minimum of 1x107 
generations in four chains, and saving every 100th tree. The log-likelihood score of each saved tree 
was plotted against the number of generations to establish the point at which the log likelihood 
scores reached their asymptote, and the posterior probabilities for clades established by constructing 
a majority-rule consensus tree for all trees generated after completion of the burn-in phase.
Test for Recombination 
Since phylogenetic and evolutionary interpretations (Posada and Crandall 2002) 
are influenced by recombination, we employed Single Breakpoint algorithm implemented 
in the HyPhy package and assessed the role of recombination on ICK peptide-encoding 
genes examined in this study (Pond et al. 2005; Kosakovsky Pond et al. 2006). When 
potential breakpoints were detected using the small sample Akaike information Criterion 
(AICc), the sequences were compartmentalized before conducting selection analyses.
Selection Analyses 
We evaluated the influence of natural selection on the venom of the barychelid spider T. 
loki using maximum-likelihood models (Goldman and Yang 1994; Yang 1998) implemented in 
CODEML of the PAML package (Yang 2007). One-ratio model that assumes a single ω for the 
entire phylogenetic tree was employed. However, this model tends to be very conservative and 
can only detect positive selection when the ω ratio averaged over all the sites along the lineage is 
significantly greater than one. Since a lineage-specific model like the one-ratio model assumes a single 
ω for the entire tree, it often fails to identify regions in proteins that might be affected by episodic 
selection pressures and hence underestimates the strength of selection. We therefore employed site-
specific models that estimate positive selection statistically as a non-synonymous-to-synonymous 
nucleotide-substitution rate ratio (ω) significantly greater than 1. We compared likelihood values 
for three pairs of models with different assumed ω distributions as no a priori expectation exists for 
the same: M0 (constant ω rates across all sites) versus M3 (allows ω to vary across sites within ‘n’ 
discrete categories, n ≥ 3); M1a (a model of neutral evolution) where all sites are assumed to be either 
under negative (ω <1) or neutral selection (ω = 1) versus M2a (a model of positive selection) which 
in addition to the site classes mentioned for M1a, assumes a third category of sites; sites with ω >1 
(positive selection) and M7 (Beta) versus M8 (Beta and ω), and models that mirror the evolutionary 
constraints of M1 and M2 but assume that ω values are drawn from a beta distribution (Nielsen and 
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Yang 1998). Only if the alternative models (M3, M2a and M8: allow sites with ω >1) show a better 
fit in Likelihood Ratio Test (LRT) relative to their null models (M0, M1a and M7: do not allow 
sites with ω >1), are their results considered significant. LRT is estimated as twice the difference 
in maximum likelihood values between nested models and compared with the c2 distribution with 
the appropriate degree of freedom—the difference in the number of parameters between the two 
models. The Bayes empirical Bayes (BEB) approach (Yang et al. 2005) was used to identify amino 
acids under positive selection by calculating the posterior probabilities that a particular amino acid 
belongs to a given selection class (neutral, conserved or highly variable). Sites with greater posterior 
probability (PP ≥ 95%) of belonging to the ‘ω > 1 class’ were inferred to be positively selected.
Single Likelihood Ancestor Counting (SLAC), Fixed-Effects Likelihood (FEL), and 
Random Effects Likelihood (REL) models (Kosakovsky Pond et al. 2005) implemented in 
HyPhy (Pond et al. 2005) were employed to provide additional support to the aforementioned 
analyses and to detect sites evolving under the influence of positive and negative selection. 
Mixed Effects Model Evolution (MEME) (Murrell et al. 2012) was also used to detect episodic 
diversifying selection. A complementary protein-level approach implemented in TreeSAAP 
(Woolley et al. 2003)  was used to derive further support for the sites detected as positively 
selected by the nucleotide-level selection analyses. Proportion of sites under different regimes of 
selection was depicted using an evolutionary fingerprint analysis, which uses a ESD algorithm, 
implemented in datamonkey (Delport et al. 2010). We further employed branch-site REL 
to identify lineages undergoing episodic bursts of adaptation (Kosakovsky Pond et al. 2011).
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6.2.4 Results and Discussion
MRI revealed that T. loki retained the primitive characteristic of large fangs 
and venom glands contained entirely within the massive chelicerae (Figure 6.2.1). 
Figure 6.2.1 Magnetic resonance imaging of Trittame loki venom glands
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Transcriptomics recovered six toxin types: 42 diverse isoforms of the classic ICK/
knottin spider peptide toxin (Figure 6.2.2); variants of the previously characterised spider 
toxins CRiSP, kunitz and prokineticin/colipase, with CRiSP sequenced for the first time 
from any mygalomorph spider venom; and the enzymes acetylocholinesterase (Figure 
6.2.3) and neprilysin (Figure 6.2.4) were recovered for the first time from the spider venom 
arsenal.  Proteomics confirmed the translation of each transcript type into the secreted venom.
Figure 6.2.2
Legend: Phylogenetic reconstruction of Trittame loki and related ICK/
knottin peptide toxins, conserved ancestral cysteines are shown in black, newly 
evolved cysteines are in red. Sequences obtained in this study are in green.
 263
Chapter VI
Figure 6.2.3
Legend: Sequence alignment of the Trittame loki venom acetylcholinesterase 
and the non-venom homologue P56161 Anopheles stephensi.
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Figure 6.2.4
Legend: Sequence alignment of the Trittame loki venom nephrilysin and the 
snake venom convergent nephrilysin homologue T1E4Z0 Crotalus horridus.
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The most abundant transcript type was of the ICK/knottin neurotoxic peptide type which 
showed significant evidence of accelerated evolution and diversification, with this diversity 
accompanied by extensive variation in cysteine pattern including multiple independent de novo 
evolutions of novel cysteines (Figure 6.2.2). These peptides were phylogenetically diverse, with 
the Trittame loki ICK/knottin toxin clades forming 8 clades, with two of them being particularly 
large and diverse (Figure 6.2.2). The one-ratio model, the simplest of the lineage-specific models, 
estimated an ω of 1.36 and 0.46 for the major ICK/knottin toxin clades 1 and 2, respectively. This 
highly conservative model can only detect positive selection when the ω ratio, averaged over all 
sites along the lineages in a phylogenetic tree, is significantly greater than one. Hence, an ω of 1.36 
estimated for the major ICK/knottin toxin clade 1 clearly highlights the dominant role of positive 
selection in shaping their evolutionary history. Since lineage-specific models often fail to detect 
episodic diversifying selection that only affects certain sites in protein-encoding genes, we further 
employed site-specific models (Table 6.2.1). Model 8 estimated an ω of 1.81 and 0.67 for the major 
ICK/knottin toxin clades 1 and 2, respectively, highlighting the significant influence of positive 
selection on the evolution of the major ICK/knottin toxin clade 1 (Table 6.2.1). In contrast to the 
rapidly evolving clade 1, an ω of 0.67 estimated for the ICK/knottin toxin clade 2 indicated that 
this toxin clade has evolved under tremendous constraints of negative selection pressure and that 
a major part of its coding sequence remains extremely well conserved.  The Bayes Empirical Bayes 
(BEB) method identified as many as 17 (33% of sites) positively selected sites in the major ICK/
knottin toxin clade 1 and detected only 5 (11% of sites) positively selected sites in toxin clade 2 
(Table 6.2.1), further highlighting the differential influence of evolutionary selection pressures on 
these two toxin clades. Other methods of evaluating the nature of selection, such as FEL, REL, 
MEME, FUBAR and integrative approach, conclusively supported these findings and indicated that 
in contrast to the rapidly evolving clade 1, clade 2 remains extremely well conserved (Table 6.2.1).
Table 6.2.1. Molecular evolution of Trittame loki major ICK toxin clades
SLACa FELb RELc MEMEd FUBARe Integrativef BSRg PAMLh
SLAC + FEL + 
REL + MEME M8 M2a
ω>1i 0 2 22 13 22 17 12
Clade I ω<1j 0 4 0 2 sites 0 4 3 (9+8) (6+6)
ω= 1.41 - 1.62 - - 1.81 1.81
ω>1i 0 0 0 0 0 5 3
Clade II ω<1j 3 11 0 0 sites 14 15 4 (1+4) (1+2)
ω= 0.42 - 0.47 - - 0.67 0.67
Legend:
a: Single Likelihood Ancestor Counting.
b: Fixed-effects likelihood .
c:  Random-effects likelihood.
d: Sites detected as experiencing episodic diversifying selection (0.05 significance) by the Mixed 
Effects Model Evolution (MEME).
e: Fast Unconstrained Bayesian AppRoximation.
f: Sites detected in common by SLAC, FEL, REL, MEME and FUBAR (the integrative approach).
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g: Number of branches detected by the branch-site REL (Random effects likelihood) test as 
episodically diversifying.
h: Positively selected sites detected by the Bayes Empirical Bayes approach implemented in M8 and 
M2a. Sites detected at 0.99 and 0.95 significance are indicated in the parenthesis.
i: Number of positively selected sites at 0.05 significance (for SLAC, FEL) or 50 Bayes factor 
(for REL); or number of sites under pervasive diversifying selection at 0.9 posterior probability 
(FUBAR).
j: Number of negatively selected sites at 0.05 significance (for SLAC, FEL) or 50 Bayes factor (for 
REL); or number of sites under pervasive purifying selection at 0.9 posterior probability (FUBAR).
ω: mean dN/dS.
With a combined nucleotide and amino acid-level approach, we were able to identify 7 and 
5 positively selected sites in the major ICK/knottin toxin clade 1 and 2, respectively (Table 6.2.2). 
Interestingly, all five hypermutational sites identified in clade 2 were extremely varied in terms of 
biochemical and/or structural properties, relative to their ancestral residues. Radical mutations are 
more likely to influence the fitness of the organism, since they are capable of altering the structure 
and/or function of the protein, in contrast to neutral mutations that result in the introduction of 
residues with similar biochemical properties. Evolutionary fingerprint analyses clearly depicted several 
residues in the major ICK/knottin toxin clade 1 as evolving under the influence of positive selection, 
while a majority of sites in the toxin clade 2 were found to be evolving under the regime of negative-
selection (Appendix 6.2.1). The branch-site REL test detected 4 and 3 branches respectively in the 
two major ICK/knottin toxin clades as evolving under episodic burst of adaptation (Appendix 6.2.2).
Table 6.2.2. Nucleotide and amino acid-level selection assessment
Site CodeML TreeSAAP
Codon AA M2aa M8b Propertyc Magnituded
Clade I
22 N
4.173±0.768 3.926±0.637
- -
0.990* 0.996**
24 H
4.19±0.736 3.933±0.619
- -
0.995** 0.998**
26 A
4.104±0.879 3.898±0.692
- -
0.970* 0.988*
31 R
4.189±0.738 3.933±0.62
- -
0.995** 0.998**
52 G
4.178±0.759 3.929±0.628
- -
0.991** 0.997**
56 M
4.068±0.928 3.885±0.717
El 8
0.960* 0.984*
58 V
3.944±1.073 3.828±0.812
El 8
0.925 0.967*
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Site CodeML TreeSAAP
61 D
3.888±1.134 3.796±0.862
El 8
0.908 0.957*
65 Y
4.194±0.727 3.935±0.616
El 8
0.996** 0.999**
69 R
4.161±0.79 3.921±0.647
- -
0.986* 0.994**
74 S
4.144±0.82 3.913±0.664
- -
0.981* 0.992**
75 E
4.203±0.709 3.938±0.609
- -
0.999** 1.000**
77 S
3.820±1.186 3.771±0.892
- -
0.891 0.950*
78 K
4.116±0.862 3.904±0.681
- -
0.974* 0.989*
81 -
3.941±1.092 3.804±0.857
El 8
0.922 0.959*
83 F
4.191±0.733 3.933±0.619
El 8
0.995** 0.998**
87 R
3.926±1.095 3.817±0.83
El 8
0.919 0.963*
Clade II
76 N
4.919±1.842 4.280±1.366
Bl, h, an 6, 6, 6
0.927 0.986*
84 S
5.094±1.796 4.275±1.394
Bl, h, an, ESM 6, 6, 6, 6
0.952* 0.981*
87 S
4.743±2.013 4.193±1.455
Bl, h, ESM 6, 6, 6
0.880 0.962*
91 S
5.072±1.791 4.284±1.378
Bl, ESM 6, 6
0.950* 0.985*
112 I
5.296±1.580 4.339±1.323
h, ESM 8, 6
1.000** 1.000**
Legend:
a: M2a Bayes Empirical Bayes (BEB) posterior probability and post-mean omega indicated in 
brackets
b: M8 Bayes Empirical Bayes (BEB) posterior probability and post-mean omega indicated in 
brackets
c: amino-acid property under selection
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d: magnitude of selection on the amino-acid property
Thus, the evidence provided by various analyses, such as codeml site and lineage-specific 
models (M8, M2a, M3 and M0), various models of HyPhy (SLAC, FEL, REL, MEME and 
FUBAR), the amino acid-level approach implemented in TreeSAAP, the evolutionary fingerprint 
analyses and branch-site REL (Tables 6.2.1 and 6.2.2), clearly highlighted the differential rate 
of evolution adopted by the major ICK/knottin toxin clades and is indicative of extreme venom 
diversification in the barychelid spider T. loki. The major ICK/knottin toxin clade 1 in particular 
was found to experience a significant influence of positive selection, while most amino acids in 
clade 2 evolved under the regime of negative selection and thus remained well conserved. The 
conspicuous rapid accumulation of variations under the influence of positive Darwinian selection 
in the major ICK/knottin toxin clade 1 is strongly suggestive of its role in prey envenoming. We 
propose that these toxins are highly likely to play a central role in prey-envenoming and capture, 
and are likely to be involved in a coevolutionary predator-prey arms race with their molecular 
targets in prey animals. Not-surprisingly, we identified a large number of novel cysteine variants 
in this rapidly evolving ICK/knottin peptide toxin class (Figure 6.2.2). The identification of novel 
enzymes like acetylcholinesterase and neprilysin points to a more complex venom arsenal than 
previously known. While acetylcholinesterase  is known for reducing the amount of available 
neurotransmitter, neprilysin can cause tissue destruction. Therefore the former enzyme may 
participate in prey envenoming and capture, while the latter could facilitate prey digestion.
6.2.5 Conclusion
In conclusion, our multidisciplinary approach has revealed: (i) the differential rate of 
evolution adopted by T. loki toxins, where some clades are extremely well conserved under negative 
selection, while others rapidly accumulate variations under positive selection; (ii) the evolution 
of novel molecular scaffolds through the invention of new cysteine residues; (iii) the important 
role of positive selection in the evolution and diversification of ICK/knottin toxin clades; (iv) 
identification of novel enzymes (acetylcholinesterase and neprilysin) for the first time in the spider 
venom arsenal and (v) identification of CRiSP toxins for the first time in the mygalomorph spider 
venom. Venom components employed for predation often experience a greater influence from 
positive selection and accumulate variations that are necessary not only for acquiring different 
types of prey (Lynch 2007; Casewell et al. 2011; Sunagar et al. 2012), but also in escaping host 
immune response (Low et al. 2013). The likelihood of identifying novel venom components for 
drug design is theoretically higher in organisms with extremely variant and rapidly evolving venom 
arsenals. The results of this study reinstate the significance of studying even obscure spider lineages.
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7.1 Abstract
In this study, we report for the first time a detailed evaluation of the phylogenetic history and 
molecular evolution of the major coleoid toxins: CAP, carboxypeptidase, chitinase, metalloprotease 
GON-domain, hyaluronidase, pacifastin, PLA2, SEcephalotoxin, and serine proteases, with the 
carboxypeptidase and GON-domain documented for the first time in the coleoid venom arsenal. We 
show that although a majority of sites in these coleoid venom-encoding genes have evolved under the 
regime of negative-selection, a very small proportion of sites are influenced by the transient selection 
pressures. Moreover, nearly 70% of these episodically adapted sites are confined to the molecular 
surface, highlighting the importance of variation of the toxin surface chemistry. Coleoid venoms 
were revealed to be as complex as other venoms that have traditionally been the recipient of the 
bulk of research efforts. The presence of multiple peptide/protein types in coleoids similar to those 
present in other animal venoms identifies a convergent strategy, revealing new information as to 
what characteristics make a peptide/protein type amenable for recruitment into chemical arsenals. 
Coleoid venoms have significant potential not only for understanding fundamental aspects of 
venom evolution but also as an untapped source of novel toxins for use in drug design and discovery.
7.2 Introduction
Venoms are key evolutionary innovations under-pinning the explosive radiation of many 
clades. Research to-date has been heavily taxonomically biased, with cone snails, scorpions, snakes, 
and spiders receiving a disproportionate amount of attention. The cephalopods are a conspicuously 
neglected area of venom research. The group as a whole has been the subject of scant research and 
even so, strongly biased towards the octopuses, with little attention devoted to other coleoids such as 
cuttlefish and squid. This narrow taxonomical view complicates the further study of venom molecular 
evolution (Fry et al. 2003b). Recently, we have shown that octopus and cuttlefish share a common, 
venomous ancestor (Fry et al. 2009b), confirming that cephalopods add new protein scaffolds to their 
arsenals via the duplication of body regulatory proteins and subsequent selective overexpression in the 
venom gland (Fry 2005; Fry et al. 2009b), yet the number of species examined in detail remains low.
Toxicity of octopus saliva from the posterior pair of salivary glands to invertebrates was 
established as early as 1888 (Lo Bianco 1888). Ghiretti subsequently succeeded in isolating the 
crab toxic fraction from Sepia officinalis, Octopus vulgaris and Octopus macropus, which he 
termed cephalotoxin (GHIRETTI 1959; Ghiretti 2006). Ghiretti also notes that the initial hyper 
excitability observed in crabs is due to the amides present in coleoid venom, whilst the lethal phase 
was a result of cephalotoxin. (Cariello and Zanetti 1977) isolated five proteins toxic to crabs from 
Octopus vulgaris PSG homogenate. However due to impurities in their samples only two components 
were further described: a and b cephalotoxin. Both were found to consist of approximately 50% 
carbohydrate, indicating heavy glycosylation. Tachykinins such as Eledoisin (Anastasi and Erspamer 
1962), isolated from Eledone aldrovandi and Eledone moschata, OctTK 1 & 2 isolated from Octopus 
vulgaris (Kanda et al. 2003) and an OctTK 1 homologue from Octopus kaurna (Fry et al. 2009b) 
have been isolated from octopus. SE-cephalotoxin, was described by Udea et al (Ueda et al. 2008). 
(Fry et al. 2009b) described six novel putative toxins with no homology to any known peptide 
type, in addition to CriSP, and phospholipase A2, proteins from Hapalochlaena maculosa, Octopus 
kaurna and Sepia latimanus (Fry et al. 2009b). Enzymes also play key roles in coleoid toxicity 
in addition to the small organic molecules, peptides, and non-enzymatic proteins. Indeed, large 
amounts of S1 peptidase gene transcripts from both H. maculosa and O. kaurna have been recently 
identified (Fry et al. 2009b). Other studies also associate proteolytic activity with PSG extract 
of both Eledone cirrhosa (Grisley and Boyle 1987; Grisley 1993) and Octopus vulgaris (Morishita 
1974). Hyaluronidase and Chitinase have also been identified from octopus venom (Romanini 
1952; Grisley and Boyle 1990; Fry et al. 2009b). Further evidence of functional diversification is 
that enzymes from the venoms of octopus species living in Antarctica have sub-zero temperature 
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optimum efficiency, with decreased activity at higher temperatures (Undheim et al. 2010). 
Whilst some toxic secretions of coleoids have been previously investigated, literature to 
date shows high toxin diversity and offers little insight into the evolutionary aspects of coleoid 
toxicity. This leaves questions regarding the genetic origin and the strategies of venom recruitment 
of coleoid toxins entirely up to speculation. In this study we present for the first time a glimpse 
into the coleoid venom phylogenetic history and molecular evolution. We report a particularly 
detailed evaluation of the major coleoid toxins (PLA2, CAP, pacifastin and serine proteases) and 
highlight the prominent role of episodic diversifying selections in shaping some of these toxins.
7.3 Methods
Tissue Sampling and Taxon Selection
Posterior secretory glands were dissected from freshly euthanized specimens collected from 
tropical to polar waters, thus providing wide taxiconomical and ecological coverage: cuttlefish species 
included were Sepia latimanus (Osprey Reef, Coral Sea), Sepia pharaonis (Hong Kong); octopus 
species include Abdopus aculeatus (Lizard Island, Queensland Australia), Adelieledone polymorpha 
[East Antarctica coastal waters off of George V’s Land (1398E to 1458E)], Hapalochlaena maculosa 
(Mornington Peninsula, Victoria Australia), Octopus cyanea (Lizard Island, Queensland Australia), 
Octopus kaurna (Mornington Peninsula, Victoria Australia), Pareledone turqueti  [East Antarctica 
coastal waters off of George V’s Land (1398E to 1458E)]; squid species included Loliolus noctiluca 
(Moreton Bay, Queensland Australia) and Sepioteuthis australis (Moreton Bay, Queensland Australia).
cDNA Library Construction and Analysis 
Total RNA extracted using the standard TRIzol Plus method (Invitrogen). Extracts were 
enriched for mRNA using standard RNeasy mRNA mini kit (Qiagen) protocol. mRNA was 
reverse transcribed, fragmented and ligated to a unique 10¬base multiplex identifier (MID) tag 
prepared using standard protocols and applied to one PicoTitrePlate (PTP) for simultaneous 
amplification and sequencing on a Roche 454 GS FLX+ Titanium platform (Australian Genome 
Research Facility). 50,000 sequences for each sample were read. Automated grouping and analysis 
of sample-specific MID reads informatically separated sequences from the other transcriptomes 
on the plates, which were then post-processed to remove low quality sequences before de novo 
assembly into contiguous sequences (contigs) using v 3.4.0.1 of the MIRA software program. 
Assembled contigs were processed using CLC Main Work Bench (CLC-Bio) and Blast2GO 
bioinformatic suite (Conesa et al. 2005; Conesa and Götz 2008; Gotz et al. 2008) to provide 
Gene Ontology, BLAST and domain/Interpro annotation. The above analyses assisted in the 
rationalisation of the large numbers of assembled contigs into phylogenetic ‘groups’ for the detailed 
phylogenetic analyses outlined below. Sequences are available from Genbank with the Bioproject 
and Biosample retrieval numbers of: Abdopus aculeatus PRJNA188569 SAMN01911391, 
Adelieledone polymorpha PRJNA188570 SAMN01911392, Hapalochlaena maculosa PRJNA188571 
SAMN01911430, Loliolus noctiluca PRJNA188572 SAMN01911444, Octopus cyanea 
PRJNA188574    SAMN01911445, Octopus kaurna PRJNA188658 SAMN01911449, Pareledone 
turqueti PRJNA188575 SAMN01911446, Sepia latimanus PRJNA188659 SAMN01911447, Sepia 
pharaonis PRJNA188577 SAMN01911448, Sepioteuthis australis PRJNA188576 SAMN01911450.
Phylogenetics 
Phylogenetic analyses of the bioinformatically recovered transcripts were performed to allow 
reconstruction of the molecular evolutionary history of each toxin type. Toxin sequences were identified 
by comparison of the translated DNA sequences with previously characterised toxins using a BLAST 
search (Altschul et al. 1997) of the UniProtKB protein database. Molecular phylogenetic analyses of 
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toxin transcripts were conducted using the translated amino acid sequences. Comparative sequences 
from physiological gene homologs identified from non-venom tissues were included in each dataset 
as outgroup sequences. To minimize confusion, all sequences obtained in this study are referred by 
their Genbank accession numbers (http://www.ncbi.nlm.nih.gov/sites/entrez?db=Nucleotide) and 
sequences from previous studies are labeled with their UniProtKB accession numbers (http://www.
expasy.org/cgi-bin/sprot-search-ful). Resultant sequence sets were aligned using CLC Mainbench. 
When presented as sequence alignments, the leader sequence (as identified through use of SignalP) 
is shown in lowercase and cysteines are highlighted in black. > and < indicate incomplete N/5’ 
or C/3’ ends, respectively. Datasets were analysed using Bayesian inference implemented on 
MrBayes, version 3.0b4 (Ronquist and Huelsenbeck 2003). Two different run conditions were used 
in order to test for congruence: lset rates=invgamma with prset aamodelpr=fixed (WAG) and lset 
rates=gamma with prset aamodelpr=mixed. The analysis was performed by running a minimum 
of 1x107 generations in four chains, and saving every 100th tree. The log-likelihood score of each 
saved tree was plotted against the number of generations to establish the point at which the log 
likelihood scores reached their asymptote, and the posterior probabilities for clades established by 
constructing a majority-rule consensus tree for all trees generated after completion of the burn-in 
phase. Trees shown are invgamma with WAG, which are identical in topology to gamma with mixed.
Test for Recombination 
To overcome the effects of recombination on phylogenetic and evolutionary 
interpretations (Posada and Crandall 2002), we employed GARD and Single Breakpoint 
algorithms implemented in the HyPhy package and assessed recombination on all the toxin 
forms examined in this study (Delport et al. 2010; Kosakovsky Pond et al. 2006). When 
potential breakpoints were detected using the small sample Akaike information Criterion 
(AICc), the sequences were compartmentalized before conducting the selection analyses. 
Selection Analysis 
We evaluated selection pressures by using maximum-likelihood models (Goldman and Yang 
1994; Yang 1998) implemented in CODEML of the PAML (Yang 2007). We first employed the 
one-ratio model that assumes a single w for the entire phylogenetic tree. This model tends to be very 
conservative and can only detect positive selection if the w ratio averaged over all the sites along 
the lineage is significantly greater than one. Because such lineage-specific models assume a single w 
for the entire tree, they often fail to identify regions in proteins that might be affected by episodic 
selection pressures and ultimately, underestimate the strength of selection. Hence, we employed site-
specific models which estimate positive selection statistically as a non-synonymous-to-synonymous 
nucleotide-substitution rate ratio (w) significantly greater than 1. We compared likelihood values 
for three pairs of models with different assumed w distributions as no a priori expectation exists for 
the same: M0 (constant w rates across all sites) versus M3 (allows the w to vary across sites within 
‘n’ discrete categories, n≥3); M1a (a model of neutral evolution) where all sites are assumed to be 
either under negative (w<1) or neutral selection (w=1) versus M2a (a model of positive selection) 
which in addition to the site classes mentioned for M1a, assumes a third category of sites; sites with 
w>1 (positive selection) and M7 (b) versus M8 (b and w), and models that mirror the evolutionary 
constraints of M1 and M2 but assume that w values are drawn from a b distribution (Nielsen, 
and Yang 1998). Only if the alternative models (M3, M2a and M8: allow sites with w>1) show a 
better fit in Likelihood Ratio Test (LRT) relative to their null models (M0, M1a and M7: do not 
allow sites w>1), are their results considered significant. LRT is estimated as twice the difference in 
maximum likelihood values between nested models and compared with the c2 distribution with the 
appropriate degree of freedom - the difference in the number of parameters between the two models. 
The Bayes empirical Bayes (BEB) approach (Yang, Wong, Nielsen 2005) was used to identify amino 
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acids under positive selection by calculating the posterior probabilities that a particular amino acid 
belongs to a given selection class (neutral, conserved or highly variable). Sites with greater posterior 
probability (PP ≥ 95%) of belonging to the ‘w>1 class’ were inferred to be positively selected. 
Single Likelihood Ancestor Counting (SLAC), Fixed-Effects Likelihood (FEL) and Random 
Effects Likelihood models (Kosakovsky Pond et al. 2005) implemented in HyPhy (Kosakovsky Pond 
et al. 2005) were employed to provide additional support to the aforementioned analyses and to detect 
sites evolving under the influence of positive and negative selection. Mixed Effects Model Evolution 
(MEME) (Kosakovsky Pond et al. 2011) was also used to detect episodic diversifying selection. 
Since, the three domains of the coleoid pacifastin gene are expressed as multiple products, we also 
assessed the selection pressures influencing them simultaneously using Mgene (4) and option G test 
(Yang 1996) from Codeml. Further support for the results of the selection analyses was obtained 
using a complementary protein-level approach implemented in TreeSAAP (Woolley et al. 2003). 
Structural analyses 
In order to depict the selection pressures influencing the evolution of venom components, we 
mapped the sites under positive selection on the homology models created using Phyre 2 webserver 
(Kelley and Sternberg 2009). Pymol 1.3 (DeLano 2002) was used to visualize and generate the 
images of homology models. Consurf webserver (Armon et al. 2001) was used for mapping 
the evolutionary selection pressures on the three-dimensional homology models. GETAREA 
(Fraczkiewicz, and Braun 1998) was used to calculate the Accessible Surface Area (ASA) / solvent 
exposure of amino-acid side chains. It uses the atom co-ordinates of the PDB file and indicates if a 
residue is buried or exposed to the surrounding medium by comparing the ratio between side-chain 
Accessible Surface Area (ASA) and the “random coil” values per residue. An amino-acid is considered 
to be buried if it has an ASA less than 20% and exposed if the ASA is more than or equal to 50%.
7.4 Results
Analysis of coleoid posterior gland cDNA libraries, recovered sequences previously known 
from one or more coleoid lineages (Fry et al. 2009): CAP (CRiSP/Allergein/ PR-1 protein 
family) (previously sequenced only from cuttlefish and octopus), chitinase (previously sequenced 
only from octopus), hyaluronidase (known only from its activity in octopus venom but never 
sequenced), PLA2 (previously sequenced only from cuttlefish), SE-cephalotoxin (previously 
sequenced only cuttlefish) and serine protease (previously sequenced only from cuttlefish and 
octopus) (Table 7.1). The phylogenetic history of these toxin types was previously unclear due 
to limited taxonomical sampling that had been done in earlier studies. Serine protease was 
shown to be present in the common coleoid ancestor while PLA2 was recovered only from 
decapodiforme lineages (cuttlefish and squid). In contrast, chitinase and hyaluronidase transcripts 
were only identified in octopodiformes. For each protein type, our phylogenetic analyses 
resolved all coleoid venom gland sequences into a monophyletic group to the exclusion of non-
venom gland related sequences, thus demonstrating a shared history of the venom gland forms. 
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Table 7.1
Variable degree of sequence conservation was evident between the different protein 
types. CAP cysteines were highly conserved while the prolines and charged residues were 
more variable. However, octopus CAP had a basic pI (~8.44) while squid and cuttlefish 
were acidic to neutral/slightly-acidic pI (5.72-7.40) (calculated using the Expasy pI/MW 
online service). The globular enzymatic hyaluronidase showed the least variation of all 
the recovered sequences. Like other type III PLA2, the coleoid sequences have a lengthy 
propeptide region, followed by a 10 cysteine arrangement in the processed final form (Fig. 7.1). 
Figure 7.1
Legend: Sequence alignment of venom type III PLA2 precursors from the coleoids 1) Sepioteuthis 
australis PLA2-SepT-1, 2) Loliolus noctiluca PLA2-Lol-2, 3) Sepia pharaonis PLA2-Sepea-1, 4) 
Sepia latimanus (B6Z1Y5), 5) the scorpion Hadrurus gertschi (P0C8L9), 6) the bee Apis mellifera 
(P00630), and 7) the lizard Abronia graminea (RL8c9). Propeptide sequence is shown underlined. 
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The squid sequences, however, lacked the 9th ancestral cysteine, resulting in an odd number 
of cysteines, which may promote dimerization. The serine peptidase transcripts recovered were 
the most diverse and numerous of all toxin types recovered (Fig. 7.2). There is evidence for at 
least six gene duplication events prior to the divergence of octopus, cuttlefish and squid (Fig. 7.2). 
Cuttlefish and squid S1 proteases had basic pI values, including having the most basic sequences 
[Sepioteuthis australis c681 (9.39)]. In contrast, in octopoids, the values ranged widely from 
strongly acidic to basic. Such extreme variations occurred within even a single species and were 
phylogenetically interleaved, eg. Abdopus aculeatus c348 [8.07] and Abdopus aculeatus c257 [5.02] 
being phylogenetically sister sequences to each other. Although 10 cysteines were always conserved 
in the S1 proteases, there were considerable variation amongst both prolines and charged residues. 
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Figure 7.2
Legend: Phylogenetic reconstruction of coleoid serine proteases. Bracket values indicate calculate pI.
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Carboxypeptidease encoding transcripts were recovered included from all three coleoid lineages. 
The carboxypeptidase sequences feature a highly conserved enzymatic core region, with an increase 
in variability as either terminal is approached, including an uneven number of cysteines (Fig. 7.3). 
Figure 7.3
Legend: Sequence alignment of carboxypeptidase precursors from coleoid venom glands 1) Octopus 
cyanea Carb-Oct-1and 2) Sepioteuthis australis Carb-SepT-1 and related non-venom sequences from 3) 
Homo sapiens (Q8IVL8) and 4) Mus musculus (P15089). Propeptide sequence is shown underlined. 
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A number of recovered transcripts featured motifs characteristic of GON4 domains, alignments 
show a number of regions of high homology with major deletions in between, these deletions 
are highly variable in both length and location even within the same species (Fig. 7.4). However 
despite the domain deletions, all GON4 were basic, with pI values ranging from 8.28 to 9.18.
Figure 7.4
Legend: Sequence alignment of GON-domain sequences from coleoid venom glands 1) 
Sepioteuthis australis GON-SepT-1, 2) Sepioteuthis australis GON-SepT-2, 3) Loliolus noctiluca 
GON-Lol-1, 4) Sepia pharaonis GON-Sepea-1 and 5) Abdopus aculeatus GON-Abd-1. 
The greatest degree of variability was displayed by the multiple copies were recovered from 
all three coleoid lineages of a peptide type sequenced by us in an earlier publication which was 
phylogenetically unresolvable and simply referred to as ‘orphan 4’ (Fry et al. 2009b). We were able to 
identify them as highly modified versions of the pacifastin peptide family. The pacifastin peptides were 
revealed to be encoded by a tri-product precursor, with each peptide post¬translationally liberated 
from the others. The sequence previously obtained by us from H. maculosa (B6Z1Z0) was shown 
to contain only the first two domains while conversely the S. pharaonis sequence from this study 
was unique in having a fourth domain inserted between ancestral domains two and three (Fig. 7.5). 
Cysteines were highly conserved across the domains except domain 1 of O. cyanea c259, and domain 
2 of Abdopus aculeatus c6 and H. maculosa (B6Z1Z0). In contrast to the ancestral types, which are 
strongly basic in all domains (with the exception of the first domains of Q8MYK4, Q8MYK3 from 
Schistocerca gregaria), the coleoid sequences are shown to be highly variable in pI (isoelectric point) 
(Table 7.2). The acidic domain 1 forms are not monophyletic so this indicates convergent derivations. 
Domain 2 was also shown to be variable but to a lesser degree than Domain 1. Domain 3 however 
remains in the ancestral basic state. In addition, Sepia pharaonis c1101 had a fourth domain inserted 
after domains 2 and 3, which had a pI of 9.13 and a domain molecular weight of 4 kDa. The molecular 
weights of the coleoid forms (calculated between the first and last cysteines as the N- and C-terminal 
tails are variable in cleavage points) were consistently approximately 4 kDa for each domain. In 
contrast the ancestral forms (also calculated between first and last cysteines) were approximately 
3.1 kDa. The differences however may reflect a taxonomical trend, rather than a structural state 
impacting upon function. In contrast to the variability of the highly cysteine cross-linked scaffolds, 
the globular enzymes chitinase and hyaluronidase conversely showed extreme conservation. 
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Table 7.2 Molecular weights and isoelectric points of pacifastin peptides encoded by the 
multi-product precursors
 285
Chapter VII
Figure 7.5
Legend: Sequence alignment of pacifastin peptide precursors from coleoid venom glands 1) 
Hapalochlaena maculosa Paci-Hap-1, 2) Octopus kaurna Paci-Oct-1, 3) Loliolus noctiluca Paci-
Lol-1, 4) Sepia pharaonis Paci-Sepea-1, 5) Abdopus aculeatus Paci-Abd-1, 6) Hapalochlaena 
maculosa (B6Z1Z0), 7) Octopus cyanea Paci-Oct-2, 8) Abdopus aculeatus Paci-Abd-2, 9) 
Abdopus aculeatus Paci-Abd-3, 10) Octopus cyanea Paci-Oct-3, 11) Octopus cyanea Paci-
Oct-4, and 12) Sepioteuthis australis Paci-SepT-1. Pacifastin domains are shown in gray. 
In order to understand the molecular evolution of coleoid toxins, we first employed the 
conservative one-ratio model (ORM) which estimates a single omega value for the entire phylogenetic 
tree. It estimated an omega of 0.16, 0.15, 0.42 and 0.22 for the coleoid CAP, pacifastin, PLA2 and 
serine proteases, respectively, suggesting strong evolutionary conservation. ORM can only detect 
positive-selection if the average over all the sites along the lineage is significantly greater than one 
and hence fails to identify sites that are affected by episodic adaptations. We further employed the 
site-specific selection analyses. Site model 8 highlighted the strong influence of negative-selection on 
the coleoid toxins and computed omega values that ranged widely (Table 7.3):  0.22, 0.36, 0.52 and 
0.29 for the coleoid CAP, pacifastin, PLA2 and serine proteases, respectively. However, this model 
identified a single codon in the serine protease as evolving under the influence of positive-selection. 
Single Likelihood Ancestral Counting (SLAC), Fixed Effects Likelihood (FEL), Random Effects 
Likelihood (REL) and the evolutionary fingerprint analyses also supported the lack of variation in 
the coleoid toxins (Table 7.3; Appendix 7.1). The aforementioned models for identifying positive-
selection work best while detecting pervasive selection pressures. However, a large proportion of 
positively-selected sites are often subjected to transient or episodic adaptations. When the majority 
of lineages in a phylogenetic tree follow the regime of negative selection, they mask the signal of 
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positive-selection that might be only influencing a small number of lineages. Hence, these analyses 
may fail to identify positive-selection in such scenarios. To overcome this drawback, we employed 
the advanced Mixed Effects Model Evolution (MEME) (Kosakovsky Pond et al. 2011) which uses 
the Fixed-effects likelihood (FEL) along the sites and Random-effects likelihood (REL) across the 
branches to detect episodic diversifying selection and is capable of not only identifying the episodic 
adaptations but the pervasive selection pressures as well. MEME identified 26 and 3 sites in coleoid 
serine proteases and pacifastins, respectively which were influenced by the diversifying selection 
pressures, while identifying a single site in PLA2 and CAP (Table 7.3 and Fig. 7.6). Assessment of 
selection pressures by partitioning different pacifastin domains revealed that they have been extremely 
constrained by negative-selection (domain 1 w=0.15; domain 2 w=0.19 and domain 3 w=0.18).
Figure 7.6
Legend: This figure depicts the molecular evolution of different coleoid venom-
components. The homology models show the episodically adaptive sites in red (HyPhy, 
MEME approach). The total number of positively and negatively-selected sites detected by 
HyPhy integrative approach (SLAC and FEL: 0.05 significance; REL 50 Bayes factor) are 
also indicated. Due to the lack of sequence information (n=4), the molecular evolution of 
coleoid PLA gene couldn’t be mapped onto its homology model and hence it is shown in grey. 
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Table 7.3 Molecular evolution of coleoid venom-encoding genes
SLACa FELb RELc MEME Sitesd PAMLg
M8 M2a
w>1e 0 2 0
CAP w<1f 22 63 All 1 0 0
w = 0.34 - 0.34 0.22 0.37
Pacifastin
(All Domains)
w>1e 0 1 3
w<1f 19 34 22 3 0 0
w = 0.47 - 0.58 0.36 0.53
Pacifastin
Domain I w=0.15                       Domain II w=0.19                    Domain III w=0.18
w>1e 0 0 0
PLA2 w<1f 4 20 0 1 0 0
w = 0.56 - 0.74 0.52 0.60
w>1e 0 0 1 1
Serine Protease w<1f 119 139 120 26 (0+1) 0
w = 0.35 - 0.35 0.29 0.52
CAP: Cysteine-rich secretory proteins, Antigen 5, and Pathogenesis-related 1 proteins
PLA2: Phospholipase A2
Legend:
a: Single Likelihood Ancestor Counting 
b: Fixed-effects likelihood 
c:  Random-effects likelihood
d: Sites detected as experiencing episodic diversifying selection (0.05 significance) by the Mixed  Ef-
fects Model Evolution (MEME)
e: Number of positively selected sites at 0.05 significance (for SLAC, FEL) or 50 Bayes factor (for 
REL)
f: Number of negatively selected sites at 0.05 significance (for SLAC, FEL) or 50 Bayes factor (for 
REL)
g: Positively-selected sites detected using the Bayes Empirical Bayes approach implemented in M8 
and M2a. Sites detected at 0.99 and 0.95 significance are indicated in the parenthesis
w: mean dN/dS
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Mutation of the surface chemistry is one of the prominent characteristics of venom 
evolution. Estimation of the accessible surface area ratio or the surface accessibility of amino-
acid side chains revealed that 85% of the episodically adaptive sites in serine proteases were 
exposed, while only 15% were buried (excluding the 6 sites that could not be assigned to 
buried or exposed class), suggesting that most mutations are focussed on the molecular surface 
(Fig. 7.7). The mutation of the surface chemistry would not only increase the range of receptors 
these toxins can target but could also help in evading the host immune response. The remaining 
proportion of sites could not be significantly assigned to either buried or exposed class (Fig. 7.7).
Figure 7.7
Legend: In this figure, a plot of amino-acid positions (x-axis) against accessible surface area 
(ASA) ratio (y-axis) indicating the locations of amino-acids (exposed or buried) in the crystal 
structure of coleoid serine protease is presented. Amino-acids with an ASA ratio of more than 
or equal to 50% are considered to be exposed to the surrounding solvent while those with 
a ratio lesser than 20% are considered to be buried. Three-dimensional structure of coleoid 
serine protease is also presented and the episodically adaptive sites (HyPhy, MEME approach) 
with buried and exposed side chains are indicated by brown and blue labels, respectively. The 
sites which couldn’t be assigned to the aforementioned classes are indicated with white labels. 
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7.5 Discussion
The relative timing of recruitment of coleoid toxins has remained unclear due to the only 
limited sampling that has previously been undertaken combined with the lack of wide recognition 
that all coleoids share a single common venomous ancestor. Several of these toxins previously only 
known from one lineage, were shown to be in fact basal when more lineages were characterized. 
We anticipate that with further sampling efforts, several other toxin types will also show to have 
an earlier evolutionary origin than recognised based on current data. Our results also revealed that 
coleoid venoms are much more diverse than previously anticipated, rivalling in complexity with 
more intensively studied venoms such as those of snakes. It was also strongly suggested that at 
least some of these toxins are actively evolving under selection, with the cysteine-rich pacifastin 
and kallikrein types being particularly abundant and diverse. This is consistent with other venoms, 
where the components with the greatest cysteine content are the scaffolds most amenable to 
structural and functional mutations (Kordis and Gubensek 2000; Fry et al. 2003b; Weinberger 
et al. 2010; Casewell et al. 2011a; Chang and Duda 2012). In contrast, the globular enzymes 
such as carboxypeptidase and hyaluronidase showed extremely little variation, consistent with 
globular enzymes from other venoms (Fry 2005) that have a three dimensional structure driven 
by non-covalent interactions and a single amino acid change could decimate the correct folding.
Site-specific algorithms can only detect positive selection, when its influence at each site is 
constant throughout time. Thus they assume that the diversifying selection affects the majority 
of lineages in a phylogenetic tree. However, very rarely do we encounter scenarios where there is 
a constant influence of positive selection across all the lineages. Mixed-effects model of evolution 
(MEME), allows omega to vary not only from site to site but also from branch to branch at a 
site. Site-specific models suggested that most coleoid venom-components were extremely negatively 
selected, showing very little variation. However, MEME identified certain sites in most coleoid 
venom-components as under the influence of episodic diversifying selection (Table 7.3; Fig. 
7.6 and 7.7). To provide further support to these results, we assessed the selective influence on 
the 31 biochemical/structural amino-acid properties using TreeSAAP (Woolley et al. 2003). All 
the sites detected by MEME as episodically adaptive were also identified as positively-selected 
for one or more of the biochemical/ structural amino-acid properties, providing significant 
support to the nucleotide-level selection analyses.  Episodic nature of selection has ensured 
that the molecular scaffold of most coleoid toxins remains extremely conserved over time, 
while allowing subtle accumulation of advantageous changes in certain regions of the toxin.
Serine proteases are known for their diversified biological activities. They are involved in 
immune responses, cellular differentiation, digestion, complement activation, hemostasis, 
etc. The presence of serine proteases in the salivary secretions of coleoids might suggest 
for a digestive and/or prey envenoming role through proteolysis. Using the nucleotide and 
complementary protein-level selection analyses, we detected as many as 26 episodically adaptive 
sites in coleoid serine proteases that were accumulating rapid mutations (Table 7.3; Fig. 7.6; 
7.7). These variations could enable these aquatic predators to feed on a diverse variety of prey 
types. In snakes and bees, serine proteases are known to prevent blood coagulation in the bite-
victim, through fibrin(ogen)olysis, enabling the rapid spread of other venom-components 
through the blood stream. Serine proteases could thus perform a similar role in coleoids by 
preventing the coagulation of the blood and enhancing the effects of other venom-components. 
The recovery of novel protein scaffolds from the glands studied here reinforces how 
little is known about the protein composition of coleoid venoms. This is underscored by 
the number and diversity of novel scaffolds recovered despite the relatively limited sampling 
employed. More extensive sampling will no doubt recover novel isoforms of types identified to 
date as well as entirely new toxin classes. Of particular focus for follow-up research should be 
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the structure-function relationships, particularly for the small cysteine knotted peptides such 
as the pacifastins. It is hoped that these results will stimulate further investigation of these 
neglected glands and their secretory proteins in an increasingly diverse range of coleoid species.
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8.1 Main Findings
As part of my PhD, I studied the evolution of venom in a diversity of animal lineages: 
scorpions, spiders, centipedes, cone snails, coleoids (octopus, sepia and cuttlefish), mammals 
(vampire bats), snakes, lizards, etc. I not only reconstructed the molecular evolutionary histories 
of a plethora of venom-components [cysteine-rich secretory protein (CRiSP), three-finger 
toxin (3FTx), phospholipase A2, nerve growth factors (NGF), snake venom metalloproteinase, 
serine protease, Kunitz protease inhibitor, natriuretic peptide, helokinestatin, crotamine/b-
defensins, lectin, Kallikrein, pacifastin, L-amino acid oxidase, veficolin, epididymal secretory 
protein, cystatin, pituitary adenylate cyclase-activating polypeptide, desmallipins, plasminogen 
activator, hyaluronidase, etc.], but of their non-toxic homologues [CRiSP, NGF, brain-derived 
neurotrophic factor (BDNF), neurotrophin-3 (NT-3), scorpion venom single von Willebrand 
factor C-domain peptides (SV-SVCs), etc.] in non-venomous lineages (insects, mammals, turtles, 
crocodiles, birds, etc.), as well (Koludarov et al. 2012; Sunagar et al. 2012; Brust et al. 2013; 
Dutertre et al. 2013; Low et al. 2013; Ruder et al. 2013; Sunagar et al. 2013a; Sunagar et al. 
2013b; Fry et al. 2013c). These studies evaluated the molecular evolutionary histories of venom-
components using state-of-art methodologies, and enabled me to identify common evolutionary 
mechanisms permitting the adoption (and subsequent diversification) of the venom protein 
arsenal from non-toxic physiological proteins. I showed that most predatory venom-components 
from various animal lineages adopt RAVER (Rapid Accumulation of Variations in Exposed 
Residues; Sunagar et al. 2013a) and evolve under the significant influence of positive-Darwinian 
selection (Sunagar et al. 2012, 2013a, 2013b and 2013c; Koludarov et al. 2012; Brust et al. 2013; 
Dutertre et al. 2013; Low et al. 2013; Ruder et al. 2013; Terrat et al 2013; Fry et al. 2013c).
Selected highlights:
Three-finger toxins: My research on 3FTxs (Sunagar et al. 2013a), one of the most widely 
studied venom proteins, provided several intriguing insights into their evolutionary history. 
We evaluated the evolution of various 3FTxs (a-neurotoxins: Henophidia, Viperidae, 
Elapidae and ‘non-front-fanged’ advanced snakes (NFF), Type I, II and III, +2C and -2C 
Type II a-neurotoxins and cytotoxins] and correlated their molecular evolution with the 
development  and diversification of venom-delivery apparatus (VDS) in advanced and basal 
snake families. I also showed that cytotoxic 3FTxs, which were previously believed to diversify 
under positive selection (Jiang et al. 2011), evolve under the influence of negative selection 
due to their nonspecific mode of action, making them one of the rare examples of predatory 
proteins that evolve under heavy evolutionary constraints. k-neurotoxins were shown to 
have experienced the least influence of selection due to structural constraints (dimerisation).
CRiSP evolution of venom: I evaluated the molecular evolution of CRiSPs for the first time, in 
not only various advanced snake and Anguimorpha lizard (Toxicofera) families (Sunagar et al. 
2012), but also in many distantly related non-venomous (mammals and birds) (unpublished) and 
venomous (vampire bats) lineages (unpublished). We correlated the evolution of CRiSPs in various 
Toxicofera lineages with the invention and evolution of their VDS (Sunagar et al. 2012). On-
going investigations have highlighted an astonishing convergence in the evolution of CRiSPs of 
vampire bats and advanced snakes (unpublished). In contrast to venom CRiSPs, the non-venomous 
homologues that serve important functions in reproduction and immune system of mammals 
and birds were found to have experienced negative selection (Sunagar et al. 2012; unpublished).
Differential evolution of domains: The Group III snake venom metalloproteases (SVMP) are 
composed of signal peptide, propeptide, metalloprotease, disintegrin, and cysteine-rich domains. 
The ‘mature’ secreted toxins are typically combinatorial variations of the latter three domains. 
Molecular evolution of venoM  
The SVMP-encoding genes of Psammophis mossambicus venom are unique in containing only the 
signal and propeptide domains. We determined that the Psammophis SVMP propeptide evolves 
rapidly and is subject to a greater degree of positive selection. Unlike Psammophis, some species 
of Echis express both the typical multidomain and the unusual monodomain (propeptide only) 
SVMP, with the result that a lower level of variation is exerted upon the latter. We showed that 
most mutations in the multidomain Echis SVMP occurred in the protease domain responsible 
for proteolytic and haemorrhagic activities. The cysteine-rich and disintegrin-like domains, which 
are putatively responsible for making the P-III SVMPs more potent haemorrhagins than the P-I 
and P-II forms, accumulate the remaining variation. Thus, the binding sites on the molecule’s 
surface are evolving rapidly whereas the structure-defining core of the protein remains essentially 
unchanged – an evolutionary mechanism ensuring the structural integrity of proteins important 
for predation whilst enabling diversity of surface motifs to expand the range of vulnerable prey 
species. Bioassays conducted on two posttranslationally cleaved novel proline-rich peptides from 
the P. mossambicus propeptide domain showed them to have been neofunctionalised for specific 
inhibition of mammalian a7-neuronal nicotinic acetylcholine receptors. We demonstrated that the 
proline-rich postsynaptic specific neurotoxic peptides from Azemiops feae are the result of convergent 
evolution within the precursor region of the C-type natriuretic peptide instead of the SVMP.
Venom in basal Toxicofera: Assessing venom evolution in basal Toxicofera (Fry et al. 2013c), such 
as Boidae, Cylindrophiidae, Pythonidae and Iguania, Agamidae, Chameleonidae, Anguimorpha, 
etc., provided the first insight into the evolutionary history of the ancient toxicoferan reptile venom 
system. Several venom-components are still expressed in the venom-glands of these reptiles and 
some of them undergo episodic diversification, despite the apparent absence of these proteins 
playing a role in envenoming. Assessments of venom-secreting glands in neglected arboreal lizard 
lineages (Koludarov et al. 2012) revealed that even ‘clinically irrelevant’ species can be a rich source 
of novel venom-components, worthy of investigation for drug design and biomedical research.
Venom in mammals: My work on vampire bat secreted venom (Low et al. 2013) has revealed for the 
first time that several toxins expressed in their salivary glands evolve under the influence of positive-
Darwinian selection, in a manner similar to venom-components of other animal lineages. A majority 
of hypermutable sites detected in them were found on the molecular surface of toxin, indicating that 
these toxins evolve through RAVER (Sunagar et al. 2013a). We theorized that focal mutagenesis, in 
which a large proportion of mutations are confined to the molecular surface and structurally and/or 
functionally insignificant regions, not only aids in conservation of structural and functional integrity 
of these toxins, but may also prevent the mounting of immunological resistance against these secretions 
in prey animals. Evidently, prey animals of D. rotundus have been shown to develop immunity to 
venom-components like draculin if targeted and fed upon over prolonged periods (Delpietro and 
Russo 2009). Hence, we hypothesize that frequent mutation of toxin molecular surface chemistry in 
vampire bat population prevents the rapid development of immunological resistance in prey animals.
Evolution of vertebrate neurotrophins: By analysing over 1150 nucleotide sequences, I studied 
the evolution of neurotrophin genes, such as NGF, BDNF and NT3, in a diversity of vertebrate 
lineages (mammals, turtles, crocodiles, birds, basal snakes and lizards, Toxicofera) (Sunagar et 
al. 2013b). Despite the presence NGF in reptilian venom having been known for over 60 years, 
we provided the first evidence that venom NGF follows the molecular evolutionary pattern of 
venom, and highlight its putative role in envenomation. In contrast, NGF in mammals and basal 
reptilian lineages evolves under the influence of negative selection. BDNF and NT-3 remain 
extremely well conserved in all the lineages examined. My on-going research on 50 unpublished 
bird genomes has revealed extreme sequence conservation of neurotrophins in various bird families.
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Venom in invertebrates: As part of my PhD research, I have also examined the evolution of venom 
in several invertebrate animal lineages, many of which are reported for the first time (Ruder et al. 
2013; Undheim et al. 2013; Sunagar et al. 2013c). Evaluating the molecular evolution of toxins 
in various medically significant and insignificant scorpion lineages, unravelled the unique origin 
and diversification of the major toxin scaffolds (Sunagar et al. 2013c). For the first time, we show 
that ICK and DDH scorpion toxin scaffolds could have originated from SV-SVCs at the base of 
scorpion phylogenetic tree. We also propose novel evolutionary links between various lineage toxin 
peptides in scorpions. We have also shed light on the phylogenetic origin of CSa/b scaffolds. We 
show that toxins in Buthidae, which includes all the medically significant scorpion species, evolve 
under the significant influence of episodic diversifying selection, while toxins in non-buthid families 
are constrained by negative selection pressures. We theorize that this difference in selection has 
originated as a result of the contrasting prey-capturing strategies employed by the two lineages.
Venom in coleoids (octopus, cuttlefish and squid): I have also evaluated the phylogenetic histories 
and the molecular mechanisms shaping the evolution of major coleoid toxins: CAP, carboxypeptidase, 
chitinase, metalloprotease GON-domain, hyaluronidase, pacifastin, PLA2, SEcephalotoxin, and 
serine proteases. Our research documented carboxypeptidase and GON-domain for the first time 
in the coleoid venom arsenal. We show that although a majority of sites in coleoid venom-encoding 
genes have evolved under the regime of negative selection, a very small proportion of sites are 
influenced by the transient selection pressures. Moreover, these predatory toxins were found to 
evolve through RAVER. We highlight the biochemical complexity of coleoid venoms and show 
that they are as unique as other venoms that have traditionally been the recipient of the bulk of 
toxinological research efforts. The presence of multiple peptide/protein types in coleoids similar to 
those present in other animal venoms identifies a convergent strategy, revealing new information as 
to what characteristics make a peptide/protein type amenable for recruitment into chemical arsenals.
Intraspecific variation in venom: As part of my PhD research, I also investigated the intraspecific 
variation of venom in Crotalus oreganus helleri (the Southern Pacific rattlesnake; Sunagar et al. 
unpublished), one of the most medically significant snake species in all of North America. Due 
to  the  extreme  variation  of  venom in this species,  which  consequently  results  in  drastically 
variable  degrees  of neutralization by CroFab antivenom, the management and treatment of 
envenoming by C. o. helleri has been a clinician’s nightmare. This snake has also been the subject 
of sensational news stories (within the last few decades) regarding supposed rapid evolution of its 
venom. This research demonstrates for the first time that variable evolutionary selection pressures 
sculpt the intraspecific molecular diversity of venom components in C. o. helleri. We show that 
myotoxic b-defensin peptides are secreted in large amounts by all populations. However, the mature 
toxin-encoding nucleotide regions evolve under the constraints of negative selection, likely as a 
result of their nonspecific mode of action which doesn’t enforce them to follow the regime of the 
classic predator-prey chemical arms race. The haemorrhagic and tissue destroying snake  venom 
metalloproteinases (SVMP) were secreted  in  larger amounts  by  the  Catalina  Island  and  Phelan 
rattlesnake  populations,  moderate  amounts  in  the Loma Linda population and in only trace 
levels by the Idyllwild population. Only the Idyllwild population in the San  Jacinto  Mountains, 
contained  potent  presynaptic neurotoxic  phospholipase  A2  complex characteristic of Mohave 
Rattlesnake (Crotalus scutulatus) and Neotropical Rattlesnake (Crotalus durissus terrificus). The 
derived heterodimeric lectin toxins characteristic of viper venoms, which exhibit a diversity  of 
biological  activities, including anticoagulation, agonism/antagonism of platelet activation, or 
procoagulation, appear to have evolved under  extremely  variable  selection  pressures. While most 
lectin a- and b-chains evolved rapidly under the influence of positive Darwinian  selection, the 
b-chain  lectin  of  the Catalina Island population appears to have evolved  under  the  constraint 
of  negative  selection. Both  lectin  chains  were  conspicuously  absent  in  both  the proteomics 
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and  transcriptomics  of  the  Idyllwild  population. Thus,  we  not  only  highlight  the  tremendous 
biochemical diversity in C. o. helleri’s venom-arsenal, but we also show that they experience 
remarkably variable strengths of evolutionary selection pressures, within each toxin class among 
populations and among toxin classes within each population. The mapping of geographical venom 
variation not only provides additional information regarding venom evolution, but also has direct 
medical implications by allowing prediction of the clinical effects of rattlesnake bites from different 
regions. Such information, however, also points to these highly variable venoms as being a rich 
source of novel toxins which may ultimately prove to be useful in drug design and development.
Evolution of venom in neglected lineages of Toxicofera lizards: In the past, toxinological 
research on reptiles has focused principally on clinically important species. As a result, our 
understanding of the evolution of the venom system in most toxicoferan reptiles is limited. 
Here, for the first time, we described the structural and molecular evolutionary features of the 
mandibular toxin-secreting gland of Abronia graminea, a representative of one of the poorly known 
and entirely arboreal lineages of anguimorph lizards (Koludarov et al. 2012). We recovered a 
wide array of transcripts that were homologous to those encoded by the indisputably venomous 
helodermatid lizards. We showed that some of these toxin transcripts are evolving under active 
selection and show evidence of rapid diversification. Helokinestatin peptides in particular were 
revealed to have accumulated residues that have undergone episodic diversifying selections. 
Conversely, the natriuretic peptides have evolved under tremendous evolutionary constraints 
despite being encoded in tandem with helokinestatins by the same gene precursor. Of particular 
note is the sequencing for the first time of kunitz peptides from a lizard toxin-secreting gland. 
We showed that the plesiptypic toxicoferan kunitz toxins are dual domain encoding precursors. 
This research provides insight into the evolutionary history of the ancient toxicoferan reptile 
venom system. In addition, it shows that even “clinically irrelevant” species can be a rich source 
of novel venom components, worthy of investigation for drug design and biomedical research. 
Diversification of a single ancestral gene into a successful toxin superfamily in highly venomous 
Australian funnel-web spiders: Spiders have evolved pharmacologically complex venoms that serve 
to rapidly subdue prey. The major toxic factors in most spider venoms are small, disulfide-rich 
peptides. While there is abundant evidence that snake venoms evolved by recruitment of genes 
encoding normal body proteins followed by extensive gene duplication accompanied by explosive 
structural and functional diversification, the evolutionary trajectory of spider-venom peptides is less 
clear. I participated in the research that presented evidence of a spider-toxin superfamily encoding 
an exceptional degree of sequence and functional diversity that evolved by accelerated duplication 
and diversification of a single ancestral gene. Peptides within this superfamily are translated as 
prepropeptides that are posttranslationally processed to yield the mature toxin. The  N-terminal 
signal sequence and the protease recognition site at the junction between the propeptide and mature 
toxin are conserved, whereas the remainder of the propeptide and mature toxin sequences are highly 
variable. We showed that different pharmacological classes of toxins within this peptide superfamily 
evolved under different evolutionary selection pressures. The w-hexatoxins that target insect voltage-
gated calcium channels evolved under positive Darwinian selection in an episodic fashion, whereas 
the k-hexatoxins that target insect calcium-activated potassium channels appear to be under negative 
selection. A majority of the diversifying sites in the w-hexatoxins are concentrated on the molecular 
surface of the toxins, thereby facilitating the evolution of toxins with altered pharmacology. Overall, 
this study reinforces the hypothesis that spiders used a combinatorial peptide library strategy to 
evolve a complex cocktail of peptide toxins that target neuronal receptors in prey and predators.
Atractaspis aterrima toxins: The first insight into the molecular evolution of venom in side-
stabbers : Although snake venoms have been the subject of intense research, primarily because of 
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their tremendous potential as a bioresource for design and development of therapeutic compounds, 
some specific groups of snakes, such as the genus Atractaspis, have been completely neglected. 
To date only limited number of toxins, such as sarafotoxins have been well characterized from 
this lineage. In order to investigate the molecular diversity of venom from Atractaspis aterrima 
(the slender burrowing asp), we utilized a high-throughput transcriptomic approach completed 
with an original bioinformatics analysis pipeline (Terrat et al. 2013). Surprisingly, we found that 
Sarafotoxins do not constitute the major ingredient of the transcriptomic cocktail; rather a large 
number of previously well-characterized snake venom-components were identified. Notably, we 
recovered a large diversity of three-finger toxins (3FTxs), which were found to have evolved under the 
significant influence of positive selection. From the normalized and non-normalized transcriptome 
libraries, we were able to evaluate the relative abundance of the different toxin groups, uncover 
rare transcripts, and gain new insight into the transcriptomic machinery. In addition to previously 
characterized toxin families, we were able to detect numerous highly-transcribed compounds 
that possess all the key features of venom-components and may constitute new classes of toxins.
I was also part of the research that shows that cone snails employ distinct toxin cocktails for 
predation and defence (Dutertre et al. unpublished) and that their predatory toxins might have 
originated in the ancestral cone snails for a defensive purposes. We have also shown that novel synergistic 
mode of action by centipede toxins results in an increased interdependency, and consequently 
reduces the evolutionary selection pressure (Undheim et al. unpublished). Results of various studies 
conducted as part of my doctoral research are published in reputable peer-reviewed scientific journals.
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8.2 Conclusions
Animal venoms are complex amalgams of proteins, salts and organic molecules such as 
polyamines, amino acids, neurotransmitters, etc. Phylogenetically distinct animal lineages, such 
as cnidarians (anemones, jellyfish), insects, centipedes, spiders, scorpions, cephalopods (cuttlefish, 
octopus and squid), cone snails, ﬁsh, platypus, shrews, vampire bats and toxicoferan reptiles 
(Anguimorpha lizards and all snakes), have recruited venom for prey-paralysis. Physiological 
protein-encoding genes, particularly those involved in key regulatory processes, are recruited into the 
envenoming role through repeated rounds of duplications and often lead to the formation of toxin 
multigene families. Paralogous copies of the gene are relieved of prior negative selection constraints 
and hence freely accumulate non-synonymous mutations. Some of the genes may be selectively 
expressed in the venom gland, while others undergo deletion/pseudogenisation, as a result of rapid 
evolution and accumulation of mutations even in structurally/functionally important core residues. 
Newly created toxin multigene families often preserve the molecular scaffold (including the tertiary 
structure) of the ancestral protein, but the key functional residues outside the core scaffold are often 
modiﬁed and fine-tuned to acquire a myriad of newly derived activities (neofunctionalisation). 
Research has shown that despite the extraordinary diversity of animal toxins, most belong to a limited 
number of enzymatic (e.g. phospholipases, serine proteases, metalloproteinases) and non-enzymatic 
(e.g. three-finger toxins, natriuretic peptides, Kunitz peptides, lectins) protein superfamilies which 
have been convergently recruited in various organisms to perform similar functions (Fry 2005; 
Fry et al. 2009a). The convergent origin of toxins across the entire metazoan spectrum suggests 
that there are functional and/or structural constraints on the evolution of venom (Fry 2009a).
Research carried out as part of this fellowship lead to the unravelling of many other 
intriguing facets of molecular evolution of  animal venom, some of which have been 
outlined in the following section. The results of these studies highlighted the fascinating 
evolutionary convergence and showed that similar molecular mechanisms and evolutionary 
forces have shaped the evolution of venom-components in distinct animal lineages.
‘Most’ predatory venom-components rapidly evolve under the significant influence of positive 
Darwinian selection
Evaluation of selection pressures shaping the evolution of venom-encoding genes in 
various invertebrate and vertebrate animal lineages revealed that predatory toxin-encoding 
genes often evolve rapidly under the influence of positive Darwinian selection and accumulate 
a large amount of non-synonymous to synonymous mutations (Figure 8.1). My PhD research 
revealed that several venom components in animals follow this regime: 3FTx (various forms of 
a-neurotoxins and the k-neurotoxins), toxicoferan CRiSPs, toxicoferan NGFs, SVMPs, serine 
proteases, b-defensins, lectins, kallikreins, veficolins, desmallipins, PACAP, etc. Many of these 
components experience episodic bursts of selection pressures, indicating that the strength and 
nature of selection pressure is not constant over large periods of evolutionary time and thus 
highlights the dynamic nature of venom evolution. Variations in predatory toxins accumulate 
mainly as a result of a coevolutionary arms race between the venom-components of the secreting 
animal and their prey animals. Additionally, the variations in the secreting animal may help in 
avoiding detection by the immune system of the prey, while increasing its chances of binding to 
novel molecular receptors in the prey-animal at the same time. The molecular targets in the prey-
animals also vary exerting a reciprocal selection pressures upon the predatory toxins that target them.
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Figure 8.1 Molecular evolution of animal venom
Rapid Evolution of Variation in Exposed Residues of toxins: 
The synthesis and secretion of venom proteins is an energetically expensive process (Nisani 
et al. 2007; Nisani et al. 2012; Morgenstern and King 2013). Hence, mutations that disrupt the 
structure/function of proteins are filtered out of the population by negative selection pressures, 
favouring the conservation of catalytic and structurally important core residues. As a result, most 
mutations in proteins can be found concentrated in structurally and/or functionally unimportant 
regions. Moreover, the accumulation of point mutations under the influence of positive Darwinian 
selection in certain regions of the toxin, such as the molecular surface (a phenomenon we refer 
to as focal mutagenesis), may confer adaptive significance. We and others have postulated that 
predatory venom components undergo focal mutagenesis or RAVER (Rapid Accumulation 
of Variations in the Exposed Residues; Sunagar et al. 2013) under the significant influence of 
positive Darwinian selection that results in the generation of a diversity of novel amino acids on 
the molecular surface, which could nonspecifically interact with prey cells and cause a myriad 
of pharmacological effects (Kini and Chan 1999; Kini 2003; Kini 2005; Casewell et al. 2011a; 
Brust et al. 2013; Ruder et al. 2013; Sunagar et al. 2012, 2013a, 2013b and 2013c). Mapping of 
hypermutable sites onto the three-dimensional homology model and the calculation of accessible 
surface area (ASA) ratio of residues in venom-components studied during the course of my PhD 
for each revealed that most of the positively selected residues  in these proteins were located on 
the molecular surface.  Moreover, a large proportion of these positively selected sites were found 
concentrated in the secreted region of the mature toxin and hence the only region that is likely 
to experience an arms race. In certain organisms like vampire bats, focal mutagenesis in venom-
components can be advantageous as it is likely to delay/prevent the development of immunological 
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resistance in the prey by introducing extremely variable toxin surface chemistry in the vampire bat 
population (Low et al. 2013). Similarly, focal mutagenesis could be advantageous to venomous 
animals by potentially generating a plethora of active residues on the molecular surface that 
could nonspecifically interact with molecular receptors when injected into the predator/aggressor.
Not all toxins evolve rapidly 
As outlined in the sections above, most venom-components evolve under the significant influence 
of positive Darwinian selection. However, it is not necessary that every toxin encoding gene should evolve 
rapidly and follow the regime of positive selection. Only components that experience predator-prey 
coevolutionary arms race accumulate relatively greater proportion of non-synonymous to synonymous 
mutations. In contrast, venom-components that perform nonspecific toxic actions are not enforced 
to follow the regime of positive selection under predator-prey coevolutionary arms race scenario.
b-defensins are a diverse group of small cationic antimicrobial peptides and are integral 
components of the vertebrate innate immune system.  Despite a diversity of biological activities 
and variable coding sequences, the organization of genes encoding b-defensins is extremely well 
conserved. In our research that focussed on intrapopulation variation of venom in C. o. helleri, we 
detected relative large quantities of b-defensins in all the rattlesnake populations examined (Sunagar 
et al. unpublished). However,  these toxins seemed to have evolved under extreme influence of negative 
selection.    Mapping of mutations onto sequence alignments indicated that most hypermutable 
sites detected were concentrated in the non-secreted regions of the toxin that are likely not to 
contribute in the envenoming process. It was also evident that the entire stretch of nucleotides 
encoding the secreted region of b-defensins evolved under the extreme influence of negative 
selection, with 76% of residues being extremely well conserved (percent identity ≥ 90%; Figure 8.1).
Figure 8.2
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Legend: 
CI:1) Beta_def_CI1; 2) GAKQ01000001.1; 3) GAKQ01000002.1; 4) GAKQ01000003.1; 5) Beta_
def_CI5; 6) Beta_def_CI6
ID: 7) Beta_def_ID1; 8) GAKR01000001.1; 9) GAKR01000002.1; 10) Beta_def_ID4; 11) Beta_
def_ID5; 12) Beta_def_ID6; 13) Beta_def_ID7
LL: 14) GALC01000001.1; 15) Beta_def_LL2; 16) Beta_def_LL3; 17) Beta_def_LL4; 18) Beta_
def_LL5; 19) Beta_def_LL6; 20) Beta_def_LL7; 21)  Beta_def_LL8; 22)  Beta_def_LL9; 23)  Beta_
def_LL10; 24)  Beta_def_LL11; 25)  Beta_def_LL12
PH: 26) GAKS01000001.1; 27) GAKS01000002.1; 28) Beta_def_PH3; 29) Beta_def_PH5; 30) 
GAKS01000003.1; 31) Beta_def_PH7; 32) Beta_def_PH8; 33)  Beta_def_PH9; 34)  Beta_def_
PH10; 35)  Beta_def_PH11
The lack of variation in secreted regions of b-defensins is likely indicative of their nonspecific 
mode of action. These peptides are known to nonspecifically target and destabilises the negatively 
charged microbial membranes using their cationic amino acid residues, resulting in membrane 
permeabilisation. Not-surprisingly, 29% of residues in C. o. helleri b-defensins were cationic (K, R 
and H) and were extremely well conserved (percent identity ≥ 80%; Figure 8.2). Hence, it is expected 
that the evolutionary constraints favour the preservation of cationic residues required for toxicity. 
Figure 8.3
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Evaluation of molecular evolutionary forces that sculpt three-finger toxins highlighted 
the substantial influence of positive diversifying selection on the evolution of various three-
finger toxin types (Sunagar et al. 2013a). Conspicuously, while most 3FTx lineages evolved 
rapidly, cytotoxins (w=0.53 and 2 positively selected sites) were found to have been constrained 
by negative selection (Figure 3.3.8; Sunagar et al. 2013). The precise molecular mechanism by 
which cytotoxic 3FTx exert their cell-damaging effects remains unclear, but it has been proposed 
that a highly conserved hydrophobic patch on the cyotoxin’s molecular surface interacts with 
hydrophobic regions of the cell’s phospholipid bilayer (Condrea 1976; Dufton and Hider 1988). 
Hydrophobic residues that facilitate such nonspecific interactions are spread over the three loops 
of the cytotoxins (Figure 3.3.8: Panel B) and cover nearly 40% of the molecular surface (Bilwes, 
et al. 1994). Additionally, cytotoxins are known to exhibit a diversity of biological functions and 
the residues implicated in these activities are distributed all along length of the toxin sequence 
(Figure 3.3.8). In contrast to a-ntx, which bind to specific receptor sites, cytotoxins bind in a 
much more nonspecific manner and thus may evade the classic predator-prey chemical arms 
race that influences the diversification of other toxin types. Thus, a lack of variation within the 
cytotoxins is reflective of negative selection pressure on these functionally/structurally important 
residues and against a loss of activity or potency. In contrast, a-neurotoxins and an array of ion-
channels they target, likely exert reciprocal selection pressure upon each other which results in 
the diversification of the 3FTx gene, in a classic ‘Red Queen’ coevolutionary arms race scenario.
Conversely, k-ntxs (w=2.11; 5 positively selected sites) have accumulated fewer variations 
than the a-ntxs (Figures 3.3.4 and 3.3.7: Panel D; Sunagar et al. 2013a), despite also targeting a 
narrowly defined ion-channel type (Grant and Chiappinelli 1985). The lack of variations in the 
k-ntxs could be attributed to their unique ability amongst 3FTx to form non-covalent dimers 
(Grant and Chiappinelli 1985). Thus, most residues in these toxins evolve under the influence 
of negative selection to prevent the accumulation of mutations capable of affecting the three-
dimensional structure of the toxin, and thus the ability to non-covalently form dimers. It is 
noteworthy that k-ntxs are characterized by two stabilising cysteines in loop 2, which maintain a 
more rigid three dimensional structure and are homologous to the same derived disulphide-bond 
in loop II of the Type II a-ntxs. Besides the van der Waal’s bond between Phe47 and Leu55, as 
many as six main chain and three side chain hydrogen bonds are known to stabilize this toxin. 
The necessity to form these bonds exerts a strong structural constraint against the accumulation 
of variation in k-ntxs. Thus variation in k-ntx is largely limited to five positively selected sites, 
most of which are found in loop II. Loop III and the region between C9-C10, along with the 
functionally/structurally important residues evolve under the constraints of negative selection.
Venom varies geographically and intraspecifically
It is a well-established that most animal venom-components accumulate variations in their 
coding sequences. The scientific consensus regarding the primary function of snake venom is that 
it facilitates prey-immobilization. However, the extent to which the adaptive selection pressures 
drive the evolution of snake venom arsenal has been debated by some schools of thought, who 
mostly support an ‘overkill’ hypothesis of venom evolution, which postulates that, “due to the 
apparent high toxicity of many snake venoms and the large doses injected, variation in venom 
composition is unlikely to be subject to natural selection for lethality to prey, and that venom 
diversity largely results from neutral evolutionary processes” (Sasa 1999; Mebs 2001; Barlow et al. 
2009b). In contrast, several other authors have argued that snake venom composition is subject to 
strong natural selection, and venom diversity results from adaptation to speciﬁc diets (Daltry et 
al. 1996; Wüster et al. 1999; Kordis and Gubensek 2000). Resistance to venom in prey-animals 
has been found to have increased venom toxicity in certain species of snakes, likely as a result of 
reciprocal coevolutionary arm’s race with their prey. The synthesis and secretion of venom is an 
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expensive affair and thus represents a trade-off between the metabolic cost and foraging (McCue 
2006), and thus provides further support to the theory of ‘venom evolution via natural selection’. 
Without the forces of natural selection, mutations could destroy the molecular scaffolds required 
for the proper functioning of enzymes, consequently resulting in production of faulty enzymes. 
Shift in diet has been demonstrated to relieve pre-existing selection pressures and result in dramatic 
modification of the venom-glands and venom delivery system (Li et al. 2005b). Geographical 
variation in venom composition has been documented in several species of snakes (Daltry et al. 1996). 
In our work on Crotalus oreganus helleri, we not only show that different 
populations express distinct venom profiles (Figure 8.3), but we also show that 
venom-encoding genes, within and between populations examined, have experienced 
differential evolutionary selection pressures (Figure 8.4-8.6; Sunagar et al. unpublished).
Figure 8.4
Legend: LC-MS/MS annotated RP-HPLC chromatograms from the four different C. o. helleri 
populations examined.
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Differential rate of molecular evolution or expression occurred not only between toxin types within 
the venom of a particular population, but also for the same toxin type between populations (Figure 8.4-8.6). 
Figure 8.5 Molecular evolution of C. o. helleri b-defensins
Legend: Three-dimensional homology models (built using the PDB template 1Z99) of b-defensins 
with evolutionary conservation of amino acids mapped onto them, depicting the locations of 
positively selected sites (in red) detected by site-model 8 (PP ≥ 0.95, BEB) are presented. Schematic 
representation of the models, which not only depicts the locations of positively selected sites (red 
sticks) but also highlights disulphide bonds (orange sticks), a helices (purple) and b sheets (green), 
are also presented.
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Figure 8.6 Molecular evolution of C. o. helleri Kallikreins
Legend: Three-dimensional homology models (Loma Linda population modeled using the PDB 
template 1OP0; all others using 2AIQ) of kallikreins with evolutionary conservation of amino 
acids mapped onto them, depicting the locations of positively selected sites (in red) detected by 
site-model 8 (PP ≥ 0.95, BEB) are presented. Schematic representation of the models, which not 
only depicts the locations of positively selected sites (red sticks) but also highlights disulphide bonds 
(orange sticks), a helices (purple) and b sheets (green), are also presented.
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Figure 8.7 Molecular evolution of C. o. helleri a- and b-chain lectins 
Legend: Three-dimensional homology models (a-chain lectins: Catalina Island population and the 
‘combined set’ modeled using PDB template 1C3A; others using 1UMR; b-chain lectins: Loma 
Linda population modeled using the template 1V4L; all others using 1J34) of lectin a- and b- 
chains with evolutionary conservation of amino acids mapped onto them, depicting the locations of 
positively selected sites (in red) detected by site-model 8 (PP ≥ 0.95, BEB) are presented. Schematic 
representation of the models, which not only depicts the locations of positively selected sites (red 
sticks) but also highlights disulphide bonds (orange sticks), a helices (purple) and b sheets (green), 
are also presented.
These results demonstrate that the different populations of C. o. helleri follow distinct 
evolutionary trajectories, with the differential venom profiles likely driven by variation in predatory 
ecology. This is a reflection of the complex evolutionary history of this species, which lives from sea 
level to high mountain peaks. The mountains, along with some populations becoming isolated in 
high-elevation valleys, act to slow down gene flow. These results also indicate significant differences 
in potential human envenomation profiles, consistent with the complex clinical picture previously 
observed, with some populations being haemorrhagic while others are neurotoxic. The exquisite 
diversity of venom-components highlighted in this study and the variation in intensity and the 
nature of natural selection shaping the molecular toxin scaffolds may not only result in distinct 
envenoming profiles but may also induce variable responses to antivenom. Hence, understanding the 
true molecular diversity of venom and the evolutionary forces that shape them not only aids in the 
prediction of clinical effects but also reveals that these highly variable venoms are a rich source of novel 
toxins, some of which may have significant potential for use as lead compounds in drug design and 
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development. Thus, the results of our study not only contributed to the body of knowledge regarding 
venom evolution, but also has applied outcomes both from a clinical perspective and also drug design.
The influence of diet on venom variation
Despite the unparalleled diversity of venomous snakes in Australia, research has concentrated 
on a handful of medically-significant species, from which fewer toxins have been fully sequenced. 
I was part of the research that constructed venom gland transcriptomes of eleven species of small 
Australian elapid snakes, from eleven distinct genera, spanning a broad phylogenetic range. We 
recovered a huge diversity of three-finger toxin peptides, which allowed for a robust reconstruction 
of their dynamic molecular evolutionary history. We demonstrated that each species preferentially 
favours different types of a-neurotoxic 3FTx, probably as a result of differing feeding ecologies. The 
three forms of a-neurotoxin [Type I (aka: short-chain), II (aka: long-chain) or III] not only adopted 
differential rates of evolution (Figures 8.8-8.10), but have also conserved a diversity of residues, 
presumably to potentiate prey-specific toxicity (Figures 8.11-8.13). Despite these differences, the 
different a-neurotoxin types were shown to accumulate mutations in similar regions of the protein, 
largely in the loops and structurally/functionally unimportant regions, highlighting the significant 
role of focal mutagenesis. We theorize that this phenomenon affects not only toxin potency or 
specificity, but also generates necessary variation for preventing prey animals from acquiring venom-
resistance. This study also recovered the first full-length sequences for multimeric phospholipase A2 
(PLA2) ‘taipoxin/paradoxin’ subunits from non-Oxyuranus species, confirming the early recruitment 
of this extremely potent neurotoxin complex to the venom arsenal of Australian elapid snakes. 
We also recovered the first natriuretic peptides from an elapid that lack the derived C-terminal 
tail and resemble the plesiotypic form found in viper venoms. This provides supporting evidence 
for a single early recruitment of natriuretic peptides into snake venoms. Novel forms of kunitz 
and waprin peptides were recovered, including dual domain kunitz-kunitz precursors and the 
first kunitz-waprin hybrid precursors from elapid snakes. The novel sequences recovered in this 
study reveal that the huge diversity of unstudied venomous Australian snakes are of considerable 
interest not only for the investigation of venom and whole organism evolution but also represent an 
untapped bioresource in the search for novel compounds for use in drug design and development.
Molecular evolution of venoM  
Figure 8.8 Molecular evolution of Type I a-neurotoxins 
Legend:  Three-dimensional homology models of Type I a- neurotoxins from various species, depicting 
the locations of positively selected sites (Model 8, PP ≥ 0.95, Bayes-Empirical Bayes approach) is 
presented here. Species are: A) Brachyurophis roperi, B) Cacophis squamulosus, C) Drysdalia coronoides, 
D) Hemiaspis signata, E) Parasuta nigriceps and F) Vermicella annulata.
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Figure 8.9 Molecular evolution of Type II a-neurotoxins 
Legend:  Three-dimensional homology models of Type II a- neurotoxins from various species, depicting 
the locations of positively selected sites (Model 8, PP ≥ 0.95, Bayes-Empirical Bayes approach). Species 
are: A) Acanthophis wellsi, B) Brachyurophis roperi, C) Drysdalia coronoides, D) Echiopsis curta, E) Furina 
ornata, F) Hemiaspis signata, G) Parasuta nigriceps and H) Pseudonaja modesta.
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Figure 8.10 Molecular evolution of Type III a-neurotoxins 
Legend:  Three-dimensional homology models of Type III a- neurotoxins from various species, 
depicting the locations of positively selected sites (Model 8, PP ≥ 0.95, Bayes-Empirical Bayes 
approach). Species are: A) Furina ornata, B) Pseudonaja modesta and C) Vermicella annulata.
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Figure 8.11 Structural and functional evolution of Type I a-neurotoxins 
Legend:  Multiple sequence alignment of Type I a-ntxs depicting the locations of positively selected 
sites (Model 8, PP ≥ 0.95, Bayes-Empirical Bayes approach) in various species of Australian elapids 
is presented here. Homology model depicting the locations of positively selected sites from various 
species, indicated by different colour codes, is also presented. Representative sequences are from 
Brachyurophis roperi (1. GAHA01000012, 2. GAHA01000013, 3. GAHA01000016), Cacophis 
squamulosus (4. GAHB01000003, 5. GAHB01000008, 6. GAHB01000008), Drysdalia coronoides (7. 
FJ752483, 8. FJ752485, 9. FJ752487), Hemiaspis signata (10. GAHF01000010, 11. GAHF01000011, 
12. GAHF01000014), Parasuta nigriceps (13. FJ790454, 14. FJ790448, 15. FJ790450), Vermicella 
annulata (16. GAHJ01000013, 17. GAHJ01000014, 18. GAHJ01000015). Numerical IDs 
representing species lacking unique mutations are indicated by strikethrough.
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Figure 8.12 Structural and functional evolution of Type II a-neurotoxins 
Legend:  Multiple sequence alignment of Type II a-ntxs depicting the locations of positively selected 
sites (Model 8, PP ≥ 0.95, Bayes-Empirical Bayes approach) in various species of Australian elapids 
is presented here. Homology model depicting the locations of positively selected sites from various 
species, indicated by different colour codes, is also presented. Representative sequences are from 
Acanthophis wellsi (1. 3FTx-Aca-00018, 2. 3FTx-Aca-00053, 3. 3FTx-Aca-00055), Brachyurophis 
roperi (4. 3FTx-Bra-00008, 5. 3FTx-Bra-00003, 6. 3FTx-Bra-00006), Drysdalia coronoides (7. 
FJ481928, 8. FJ752461, 9. FJ752459), Echiopsis curta (10. 3FTx-Eci-00009, 11. 3FTx-Eci-00025, 12. 
3FTx-Eci-00037), Furina ornata (13. 3FTx-For-00010, 14. 3FTx-For-00024, 15. 3FTx-For-00033), 
Hemiaspis signata (16. 3FTx-Hem-00002, 17. 3FTx-Hem-00009, 18. 3FTx-Hem-00011), Parasuta 
nigriceps (19. 3FTx-Sut-00045, 20. 3FTx-Sut-00134, 21. FJ790457), Pseudonaja modesta (22. 3FTx-
Pse-00110, 23. 3FTx-Pse-00105, 24. 3FTx-Pse-00078, 25. 3FTx-Pse-00121, 26. 3FTx-Pse-00116, 
27. 3FTx-Pse-00038) and Vermicella annulata (28. 3FTx-Ver-00005, 29. 3FTx-Ver-00010, 30. 
3FTx-Ver-00007). Numerical IDs representing species lacking unique mutations are indicated by 
strikethrough.
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Figure 8.13 Structural and functional evolution of Type III a-neurotoxins 
Legend:  Multiple sequence alignment of Type III a-ntxs depicting the locations of positively 
selected sites (Model 8, PP ≥ 0.95, Bayes-Empirical Bayes approach) in various species of Australian 
elapids is presented here. Homology model depicting the locations of positively selected sites from 
various species, indicated by different colour codes, is also presented. Representative sequences 
are from Brachyurophis roperi (1. GAHA01000009, 2. GAHA01000010, 3. GAHA01000011), 
Cacophis squamulosus (4. GAHB01000009, 5. GAHB01000010, 6. GAHB01000011), Furina 
ornata (7. GAHE01000022, 8. GAHE01000023, 9. GAHE01000020, Pseudonaja modesta (10. 
GAHH01000009, 11. GAHH01000015, 12. GAHH01000022) and Vermicella annulata (13. 
GAHJ01000001, 14. GAHJ01000003, 15. GAHJ01000004). Numerical IDs representing species 
lacking unique mutations are indicated by strikethrough.
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The results of various studies conducted as part of my doctoral research highlight our 
limited understanding of the molecular evolution of animal venoms. They not only unravel 
several intriguing facets of the evolution of venom-encoding genes, but also highlight the 
hitherto untapped bioresource for drug design and development that the venoms of neglected 
animal lineages represent. Results of these studies, particularly the mutation mapping and 
the identification of hypermutable sites, have direct implications in designing antivenoms of 
greater efficacy that are required for treating thousands of envenomed patients around the 
globe. Collectively, these findings strongly support the notion that rapidly evolving venom 
in various animal lineages can have profound impact on therapeutics and drug design. 
Thus, as part of my doctoral research I have investigated the mechanisms that sculpt 
the molecular evolution of venom-components in a diversity of vertebrate and invertebrate, 
terrestrial and marine venomous animal lineages, which has particularly shed several intriguing 
insights into the evolution of predatory venoms. These investigations underscore the dynamic 
nature of venom evolution, where a myriad of forces, such as morphological refinement of the 
venom delivery system, shifts in feeding ecology, coevolutionary chemical arms races driving 
toxin neofunctionalisation via changes in targeting, evolution of toxin complexes with multiple 
subunits, etc. influence the molecular evolutionary history of animal toxins. In combination, these 
processes have defined the molecular evolutionary history of toxins and substantially expanded 
the molecular complexity/biodiversity of venomous animals - a molecular complexity that 
is both a curse and a blessing. A curse because this complexity manifests in numerous distinct 
pathological sequelae that significantly complicate clinical treatment of envenoming. The 
blessing is the extraordinary drug-discovery potential offered by the vast pool of venom ligands/
peptides that have been evolutionarily designed to interact, with numerous distinct specificities, 
to proteins/receptors/ion channels critical to human cardiovascular and neurological  systems.
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Chapter-wise arranged appendices are presented as follows...
Appendix 3.1.1 Sequence alignment of Caenophidian Cysteine-rich Secretory proteins
Legend: An alignment of advanced snake CRiSPs, with annotated domains, is depicted here. Cysteine 
residues, positively selected and glycosylation sites are marked in red, green and blue, respectively. 
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Appendix 3.1.2 Sequence alignment of Anguimorpha Cysteine-rich Secretory proteins
Legend: An alignment of Toxicofera lizard CRiSPs, with annotated domains, is depicted 
here. Cysteine residues and positively selected sites are marked in red and green, respectively. 
Appendix 3.2.1 Evolutionary fingerprint of SVMPs
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Appendix 3.3.1 Evolutionary fingerprint of three-finger toxins
Common Legend for 3.2.1 and 3.3.1: Estimates of the distribution of synonymous 
(a) and non-synonymous (b) substitution rates inferred for SVMPs and 3FTxs 
are shown as figures 3.2.1 and 3.3.1, respectively. The ellipses reflect a Gaussian-
approximated variance in each individual rate estimate, and coloured pixels show the 
density of the posterior sample of the distribution for a given rate. The diagonal line 
represents the idealized neutral evolution regime (w=1), points above and below the 
line correspond to positive selection (w>1) and negative selection (w<1), respectively. 
Site model 8 omega (w) along with the total number of positively selected sites 
detected by its Bayes Empirical Bayes (BEB) approach are also indicated below.
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Appendix 4.1 Sequence evolution of vampire bat plasminogen activator
Common Legend for 4.1 and 4.2: An alignment, with annotated domains, and the three-
dimensional homology model of vampire bat plasminogen activator is depicted as 4.1, while the 
alignments of  desmallipins, PACAP and Kunitz proteases are depicted in 4.2. Positively selected 
sites are indicated in red, while the active site is shown in pink. Residues important for structural 
stability are shown in orange, while the recombination breakpoint is indicated as dotted green line.
 353
Appendices
Appendix 4.2 Sequence evolution of vampire bat desmallipins, PACAP and Kunitz domains
Appendix 4.3 Evolutionary fingerprint of vampire bat venom
Legend: Estimates of the distribution of synonymous (a) and non-synonymous (b) 
substitution rates inferred for the scorpion CSa/b toxins are shown here. The ellipses reflect 
a Gaussian-approximated variance in each individual rate estimate, and coloured pixels 
show the density of the posterior sample of the distribution for a given rate. The diagonal 
line represents the idealized neutral evolution regime (w=1), points above and below the 
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line correspond to positive selection (w>1) and negative selection (w<1), respectively. 
Appendix 5.1 Maximum-likelihood phylogeny of vertebrate nerve growth factors
Legend: Branches with bootstrap support of less than 850 (out of 1000 bootstrap replicates) are 
highlighted in grey. [NFF: “non-front-fanged” advanced snakes; Atr: Atractaspidinae ; SCI: Scinciformata].
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Appendix 5.2 Maximum-likelihood phylogeny of vertebrate brain-derived neurotrophic 
factor
Legend: Branches with bootstrap support of less than 850 
(out of 1000 bootstrap replicates) are highlighted in grey. 
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Appendix 5.3 Maximum-likelihood phylogeny of vertebrate neurotrophin-3
Legend: Branches with bootstrap support of less than 850 (out of 1000 bootstrap replicates) are 
highlighted in grey. [ATR: Atractaspidinae; NFF: Non-front-fanged Advanced Snakes; SCI: Scinciformata]. 
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Appendix 5.4 Maximum-likelihood phylogeny of vertebrate neurotrophins
Legend: Branches with bootstrap support of less than 850 (out of 1000 bootstrap replicates) are 
highlighted in grey. [NFF: ‘non-front-fanged’ advanced snakes; Pyt: Pythonidae; Mam: Mammals].
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Appendix 5.5 Sequence alignment of vertebrate neurotrophins
Legend: An alignment of vertebrate nevrve growth factors, with annotated domains, is depicted here. 
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Appendix 6.1.1 Evolutionary fingerprint of Scorpion CSa/b toxins
Legend: Estimates of the distribution of synonymous (a) and non-synonymous (b) 
substitution rates inferred for the scorpion CSa/b toxins are shown here. The ellipses reflect 
a Gaussian-approximated variance in each individual rate estimate, and coloured pixels 
show the density of the posterior sample of the distribution for a given rate. The diagonal 
line represents the idealized neutral evolution regime (w=1), points above and below the 
line correspond to positive selection (w>1) and negative selection (w<1), respectively. 
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Appendix 6.1.2 Evolutionary fingerprint of Scorpion non-CSa/b toxins
Legend: Estimates of the distribution of synonymous (a) and non-synonymous (b) 
substitution rates inferred for the scorpion non-CSa/b toxins are shown here. The ellipses 
reflect a Gaussian-approximated variance in each individual rate estimate, and coloured 
pixels show the density of the posterior sample of the distribution for a given rate. 
The diagonal line represents the idealized neutral evolution regime (w=1), points above 
and below the line correspond to positive selection (w>1) and negative selection (w<1), 
respectively. Site model 8 omega (w) along with the total number of positively selected 
sites detected by its Bayes Empirical Bayes (BEB) approach are also indicated below.
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Appendix 6.2.1 Evolutionary fingerprint of funnel-web spider omega and kappa toxins
Legend: Estimates of the distribution of synonymous (a) and non-synonymous (b) 
substitution rates inferred for Trittame loki major ICK toxin clades are shown here. The 
ellipses reflect a Gaussian-approximated variance in each individual rate estimate, and 
coloured pixels show the density of the posterior sample of the distribution for a given rate. 
The diagonal line represents the idealized neutral evolution regime (w=1), points above 
and below the line correspond to positive selection (w>1) and negative selection (w<1), 
respectively. Site model 8 omega (w) along with the total number of positively selected 
sites detected by its Bayes Empirical Bayes (BEB) approach are also indicated below.
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Appendix 6.2.2 Branch-site REL of Trittame loki major ICK toxin clades
Legend: The hue of each colour indicates strength of selection, with primary red 
corresponding to w > 5, primary blue to w=0 and grey to w=1. The width of each 
colour component represents the proportion of sites in the corresponding class. 
Thicker branches have been classified as undergoing episodic diversifying selection 
(indicated by arrows) by the sequential likelihood ratio test at corrected p ≤ 0.05
 363
Appendices
Appendix 7.1 Evolutionary fingerprint of coleoid toxins
Legend: Estimates of the distribution of synonymous (a) and non-synonymous (b) 
substitution rates inferred for the coleoid toxins are shown here. The ellipses reflect 
a Gaussian-approximated variance in each individual rate estimate, and coloured 
pixels show the density of the posterior sample of the distribution for a given rate. 
The diagonal line represents the idealized neutral evolution regime (w=1), points above 
and below the line correspond to positive selection (w>1) and negative selection (w<1), 
respectively. Site model 8 omega (w) along with the total number of positively selected 
sites detected by its Bayes Empirical Bayes (BEB) approach are also indicated below.
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